MoneyControl-First-1-10-Pages-New.csv

time,Label,author,title,summary,description,article_text,url
"May 12, 2020 10:15 AM IST",-2,Rakesh Patil,Godrej Properties share price declines post Q4 nos; brokerages maintain buy,"Godrej Properties share price declined over 1 percent in the early trade on May 12 after the company announced its Q4 numbers on Monday.
However, revenue from operations increased 10.4 percent year-on-year to Rs 1,163.05 crore in Q4FY20.
Also Read - Godrej Properties Q4 profit plunges 35% to Rs 101 croreJefferies | Rating: Buy | Target: Raised to Rs 954 from Rs 945 per shareThe COVID has reduced visibility on sales outlook, while management is ready with a 15 msf launch pipeline.
The company is set for market share gains and maintain top pick status for the company.
Download a copyAt 09:20 hrs, Godrej Properties was quoting at Rs 613.30, down Rs 7.95, or 1.28 percent on the BSE.","Company's revenue from operations increased 10.4 percent year-on-year to Rs 1,163.05 crore in Q4FY20.","Godrej Properties share price declined over 1 percent in the early trade on May 12 after the company announced its Q4 numbers on Monday.

The company has reported a 35.5 percent year-on-year decline in consolidated profit at Rs 101.08 crore for the quarter ended March 2020 against profit of Rs 156.66 crore in the same quarter last year.

However, revenue from operations increased 10.4 percent year-on-year to Rs 1,163.05 crore in Q4FY20.

Also Read - Godrej Properties Q4 profit plunges 35% to Rs 101 crore

Jefferies | Rating: Buy | Target: Raised to Rs 954 from Rs 945 per share

The COVID has reduced visibility on sales outlook, while management is ready with a 15 msf launch pipeline.

The work has now commenced on half of the projects. It has a strong project pipeline, low gearing & strong execution track-record.

The company is set for market share gains and maintain top pick status for the company.

CLSA | Rating: Buy | Target: Rs 870 per share

The company's Q4 earnings was ahead of estimates led by revenue recognition from the trees project.

It aims to gain further market share with formidable new launches, while business development will gather pace, led by cash of Rs 2,500 crore.

The company also planning to raise debt up to Rs 1,000 crore.

CLSA likes the stock due to its ability to thrive during crisis & slowdown.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:20 hrs, Godrej Properties was quoting at Rs 613.30, down Rs 7.95, or 1.28 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/godrej-properties-share-price-declines-post-q4-nos-brokerages-maintain-buy-5253361.html
"May 12, 2020 02:30 PM IST",-2,Kshitij Anand,"'Not confident of rally, market has not fully factored in lockdown impact'","We reiterate our stand of not being optimistic on the market rally, but there will be stock-specific movement in the market, Sundar Sanmukhani, Head of Fundamental research desk, Choice Broking, said in an interview with Moneycontrol's Kshitij Anand.
We reiterate our stand of not being optimistic on the market rally, but here will be stock specific movement in the markets.
A) We don't think the market has fully factored in the lockdown impact on economic growth and that's why we are not optimistic on the market movement.
Q) Do you think lockdown could get extended beyond May 17?
A) Not confident about the specialty chemicals rally, but pharma rally seems to get extended in these uncertain times.",Any development of the medical solution to the Covid-19 will be taken positively by the investors. Markets are likely to be range-bound over the next few trading sessions.,"We reiterate our stand of not being optimistic on the market rally, but there will be stock-specific movement in the market, Sundar Sanmukhani, Head of Fundamental research desk, Choice Broking, said in an interview with Moneycontrol's Kshitij Anand.

Edited excerpt:

Q) It seems like the markets seem to have witnessed profit-taking at higher levels. What led to the sharp sell-off on D-Street and then some recovery towards the close of the week?

A) Till last Thursday, everything was okay, but certain domestic, as well as global developments, brought negativity in the equity markets.

Domestic factors like an extension of the lockdown and the government not coming up with stimulus package, brought nervousness in the market, while the ongoing quarterly results and the management commentary were not encouraging.

Apart from this, the US decision of imposing a new tariff on China in response to the COVID-19 pandemic has brought negativity across the global equity markets.

We reiterate our stand of not being optimistic on the market rally, but here will be stock specific movement in the markets.

Q) Any factors which investors should watch out for in the coming week?

A) There are no major events lined-up next week. But, on the domestic front, earning results will be tracked by the investors next week. On the global front, lockdown relaxation across major economies will be considered.

Any development of the medical solution to the Covid-19 will be taken positively by the investors. Markets are likely to be range-bound over the next few trading sessions.

Q) Another mega-deal in RIL's Jio platform. What are your views and estimates on the stock, and what should investor's do – buy, sell or hold?

A) Any news related to funding infusion in debt-laden RIL will be taken positively by the investors. Considering the quantum of funds to be raised in Q1 FY21 and the continued attractiveness of the strategic investors on its technology platforms, the outlook on RIL is positive.

The stock has ran-up already and is expected to be range-bound, till the right issue is executed. Investors are recommended to buy on every dip.

Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

Q) Small & Midcaps outperform in the week gone by. Looks like investors are slowly accumulating beaten down names?

A) The small & midcap have outperformed last week, considering the valuation gap between these and the large-cap stock, we are recommending investors to accumulate large-cap stocks.

If also there is a positive reversal, the rally will be narrow and these large caps will be in demand.

Q) Moody's says India's negative rating outlook reflects a rising risk of slower GDP growth. Do you think this is already factored in or will it weigh on markets and investor decision making?

A) We don't think the market has fully factored in the lockdown impact on economic growth and that's why we are not optimistic on the market movement. We are forecasting an economic contraction in FY21.

Q) Do you think lockdown could get extended beyond May 17? If yes, what is the kind of impact it could have on markets?

A) Analyzing the growth in the virus infections across major cities in India, we feel that there will be no pan-India lockdown after 17th May. But major impacted cities would remain in lockdown. This should be taken negatively by the market.

Q) Specialty Chemicals, Pharma best-placed sectors do ride out of COVID-19 storm. But, after a swift rally, are these still a good buy at current levels? What should investors do?

A) Not confident about the specialty chemicals rally, but pharma rally seems to get extended in these uncertain times. Thus investors are recommended to remain invested in the pharma stocks.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/not-confident-of-rally-market-has-not-fully-factored-in-lockdown-impact-5251791.html
"May 12, 2020 04:48 PM IST",1,Subhash Helgaokar,Accumulate ICICI Bank; target of Rs 385: Arihant Capital,"Arihant Capital 's research report on ICICI BankICICI Bank maintains a stable performance amid all the chaos of advance provisioning by major banks, well beyond RBI mandated 5% provisioning for Covid-19.
NII increased by 17.1% YoY/4.5% QoQ, PPOP increased by 18.6% YoY/down 2.1% QoQ and Net Income increased to Rs 1,221 Cr, up by 26.0% YoY / down 70.5% QoQ.
The decline in the bottomline could be attributed to the advance provisioning as per RBI guidelines for Covid-19 of Rs 2,725 Cr.
BV of INR 185 for standalone bank and use a SOTP approach to value its subsidiaries, arriving at a Target Price of INR 385 with an Accumulate rating.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Arihant Capital recommended accumulate rating on ICICI Bank with a target price of Rs 385 in its research report dated May 10, 2020.","Arihant Capital 's research report on ICICI Bank

ICICI Bank maintains a stable performance amid all the chaos of advance provisioning by major banks, well beyond RBI mandated 5% provisioning for Covid-19. NII increased by 17.1% YoY/4.5% QoQ, PPOP increased by 18.6% YoY/down 2.1% QoQ and Net Income increased to Rs 1,221 Cr, up by 26.0% YoY / down 70.5% QoQ. The decline in the bottomline could be attributed to the advance provisioning as per RBI guidelines for Covid-19 of Rs 2,725 Cr. Apart from the Corona crisis hit, the pre corona macroeconomic lull and slowing economy had an impact on the bank's growth as well, with advances growing by a mere 10.0% YoY while deposit mobilization remained strong for the 2nd largest lender, up by 18.1% YoY/7.6% QoQ, as term deposits grew sharply after crisis in several smaller Private banks triggering the flee of capital to larger banks.

Outlook

ICICI Bank is currently trading at a 2.1x P/Adj. BVFY20. We assign a P/adj. BV multiple of 1.5x on FY22E adj. BV of INR 185 for standalone bank and use a SOTP approach to value its subsidiaries, arriving at a Target Price of INR 385 with an Accumulate rating.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/accumulate-icici-bank-target-of-rs-385-arihant-capital-5255901.html
"May 12, 2020 05:16 PM IST",1,Sunil Matkar,Ind-Swift Labs locked in upper circuit on FDA all-clear for Punjab facility,"Ind-Swift Laboratories shares were locked in upper circuit on May 12 after the company received EIR from the US health regulator for its Punjab facility.
Ind-Swift Laboratories said it had received the Establishment Inspection Report (EIR) from the USFDA for the surveillance good manufacturing practise (GMP) inspection of its API manufacturing facility in Punjab's Dera Bassi.
The USFDA inspection was conducted from March 9 to 13.
The APIs manufactured at the Dera Bassi unit are supplied to more than 70 countries, the company said.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","The EIR has been issued without any Form 483 observations, said the company in its BSE filing.","Ind-Swift Laboratories shares were locked in upper circuit on May 12 after the company received EIR from the US health regulator for its Punjab facility.

The stock closed at Rs 21.65, up 4.84 percent on the BSE.

Ind-Swift Laboratories said it had received the Establishment Inspection Report (EIR) from the USFDA for the surveillance good manufacturing practise (GMP) inspection of its API manufacturing facility in Punjab's Dera Bassi.

The USFDA inspection was conducted from March 9 to 13. EIR has been issued without any Form 483 observations, the company told BSE.

The APIs manufactured at the Dera Bassi unit are supplied to more than 70 countries, the company said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Ind-Swift supplies 15 APIs to its customers based in the US.",https://www.moneycontrol.com/news/business/markets/ind-swift-labs-locked-in-upper-circuit-on-fda-all-clear-for-punjab-facility-5256471.html
"May 12, 2020 01:57 PM IST",-2,Kshitij Anand,India in a Bear Market! We continue to focus on LQV companies for investments: Unmesh Kulkarni,"A) We are currently in a ‘Bear Market', which started with the steep fall in March.
Some of the IT companies will benefit from changing business models and personal lifestyles (work from home) as well as the potential for increased outsourcing by global companies (from a cost reduction perspective).
From an investment strategy perspective, we continue to focus on LQV companies, i.e., companies that are ‘Leaders' (L) in their respective sectors, with good ‘Quality' of business + execution track record (Q) and are available at reasonable ‘Valuations' (V).
A) FIIs were big sellers in March, as risk appetite collapsed amidst the rout in global markets.
Global markets have taken all these developments positively and marched ahead with a “sense of hope”.","From an investment strategy perspective, we continue to focus on LQV companies, i.e., companies that are ‘Leaders' (L) with good ‘Quality' of business and are available at reasonable ‘Valuations' (V),","Industrial/Infrastructure spending can also see a pushback due to a decline in utilization levels and lower spending capacity/intent, in both the private and public sectors. And with the overall global slowdown, sectors such as commodities, shipping, and a certain type of exports are going to take some time to revive.

Financial services are likely to be affected this year with (a) overall demand coming down (b) risk of delinquencies going up among retail borrowers and (c) corporate stress going up, pulling down credit growth.

Demand for “services” of various types could also be affected as companies get into a cost-reduction mode. Trade, tourism/travel, and entertainment would be directly affected by spending cuts, social distancing, and curbs (forced or voluntary) on travel and cross-border movement of goods and people.

While there is some case for pent-up demand to show up just after lockdowns are lifted, the overall discretionary spend is likely to take a hit due to the potential loss of employment/income as well as overall prevailing uncertainty; this will keep demand for autos and some other high-ticket consumption items in check.

A) The COVID-19 pandemic and its economic impact are likely to put some medium-term brakes, both domestic and cross-border, on lifestyle and businesses, even after the lockdowns are lifted.

Consequently, the resultant effects may also include liquidity crunch, besides reduced domestic consumption. Prolonged social distancing could potentially disrupt capital formation, and ultimately labour participation and productivity.

The second-order impact would come from the countrywide lockdown and social distancing, driving factory closures/lower utilisations, reduced labour wage growth, travel bans, and decimated retail consumption. This will weigh on sectors such as retailers, aviation & airport operators, hospitality & tourism, and roads.

The impact on the economy is likely to unfold in stages. The first-order effect would come from the global slowdown and trade disruptions, with sectors such as textiles, automobile parts/components and commodities taking a direct hit in their revenue growth, as volumes and realizations will come under pressure.

The corporate earnings recovery story has been pushed back by a year, and we might see another level of reset in the Indian economy thanks to the COVID-19 related disruption.

Early results of Q4FY20 earnings season and management commentaries suggest more volatility and disruption in earnings ahead with several companies refraining from providing any sort of guidance till more clarity emerges.

In a way, demand has been destroyed as people will like to postpone certain discretionary spending because of a fall in income, loss of jobs, or even due to some sense of insecurity.

A) The COVID-19 episode and the lockdowns are likely to have a severe impact on the economy, for at least a couple of quarters, as it will take time for several parts of the economy to revive and return to pre-COVID levels in terms of demand and growth.

For markets to develop new optimism, we need the lockdowns to end, human and economic activity to resume and some longer-term support from the Government for the beleaguered part of the economy to accelerate the revival in demand and growth.

This is why the markets may lack direction over the next couple of quarters; in other words, we are currently in a sell-on-rise type of market.

We currently have a neutral view on the Indian equity markets. While we feel that the markets have bottomed out in the panic of March, we think that the markets need time to digest the actual impact of the COVID-19 in terms of the extent of the slowdown, any systemic stress, and the impact on earnings.

The hope that the Indian government would announce some major fiscal package(s) for the people as well as for businesses. And, as that has not exactly materialised, the rally seems to be fizzling out from early May.

While the March crash was because of fear of the unknown, the April rally was driven by hope. I hope that some antidote/vaccine would be announced somewhere in the world; hope that people would soon return to work.

A) We are currently in a ‘Bear Market', which started with the steep fall in March. With the onset of COVID-19 and the pursuant lockdowns, there is no doubt that the economy will take a sizeable hit and so will earnings across the board.

Q) The market seems to be taking one step forward and two steps back. What we saw in April was largely a bear market rally and at the beginning of May, we saw most of the gains evaporating. What are your views on markets in the near term?

From an investment strategy perspective, we continue to focus on LQV companies, i.e., companies that are ‘Leaders' (L) in their respective sectors, with good ‘Quality' of business + execution track record (Q) and are available at reasonable ‘Valuations' (V), Unmesh Kulkarni – Managing Director Senior Advisor, Julius Baer India, said in an interview with Moneycontrol's Kshitij Anand.

On the other hand, industries that are focused on essential consumption or which benefit from any changes in lifestyle post-COVID, are likely to be beneficiaries (to some extent). Demand for FMCG and staples will continue to hold up (though from the equity investment perspective their valuations are rich).

Pharmaceuticals and healthcare are likely to do well as (a) healthcare needs will stay high (incl. some preventive demand on account of COVID) (b) the US FDA seemingly becoming a bit relaxed in granting approvals to Indian pharma companies and (c) from equity market perspective, the sector had languished for about five years and had become relatively under-owned; hence, it is likely to be an out-performer in the near-to-medium term.

Some of the IT companies will benefit from changing business models and personal lifestyles (work from home) as well as the potential for increased outsourcing by global companies (from a cost reduction perspective). Here, opportunities could emerge in areas such as digital transformation and cloud migration as well as vendor consolidation, although on-site services will suffer due to restrictions on the movement of people.

The Telecom sector is already a clear beneficiary of the work-from-home environment, and the demand for internet services and entertainment is likely to continue post-COVID as people adjust to changes in lifestyle.

We believe that across industries, large corporates with strong balance sheets will likely withstand this onslaught, and will eventually gain market share at the cost of marginal players who could struggle for the next year.

From an investment strategy perspective, we continue to focus on LQV companies, i.e., companies that are ‘Leaders' (L) in their respective sectors, with good ‘Quality' of business + execution track record (Q) and are available at reasonable ‘Valuations' (V).

A) The current environment poses a challenge for growth; at the same time, there are concerns around liquidity and systemic stability, as there is a disruption in cashflows, supply-chain, and credit flows.

In such times, investors should ideally position their portfolios in favour of quality, safety, and liquidity.

With respect to the overall asset allocation, while it may be tempting to move away from equities in the current times of uncertainty, it would be in the best interest of investors to stay aligned with their strategic (long-term) asset allocation, as the longer-term potential of equities remains intact, and markets should gradually revert to their normal average by 2021.

Investors need to extend their time horizon, as equities may be range-bound (with a downward bias) over the next few months, while markets digest the data points emerging around growth and earnings.

Investors who are underweight equities in their portfolios could buy into market declines; on the other hand, investors should cut any overweight allocation to equities that they may have built over the last couple of years.

Within equities, a safer strategy would be large-cap companies and large cap-oriented equity funds, or at best multi-cap funds, as well as index funds.

Within fixed income, stay with short-to-medium term AAA debt fund strategies or AAA bonds; avoid both high yield and duration. High yield is likely to stay under pressure owing to the slowing economy, stress in balance sheets, and illiquidity in the secondary debt markets.

Duration strategies may be volatile as there is likely to be upward pressure on long-term yields owing to the large borrowing programme announced recently by the Government, and the expected jump in the fiscal deficit.

Q) How are FIIs positioned with respect to India? Do you foresee further selloff from the foreign investors?

A) FIIs were big sellers in March, as risk appetite collapsed amidst the rout in global markets. In April, with global markets as well as India staging a smart comeback, the FII selling abated to a large extend, although flows were still negative; the domestic flows primarily led the equity market rally.

Going forward, the road is expected to be bumpy. For foreign investors to turn optimistic on India, they will watch out for some long-term signals with respect to:(a) Covid-19 peaking out in India (we are still in the “up” trajectory),(b) lockdowns getting lifted and economic activity resuming (some part withdrawal of lockdown has just started, but we have still some time to go) and

(c) strong support from the Government and the RBI to revive growth and demand, as well as stabilize financial markets.

Given the extension of lockdowns and therefore the deeper impact on the economy and earnings, the FII activity is likely to be tepid for a few months, unless the Government steps in with some major package to revive demand and improve business sentiment.

Unless there is a global flow of liquidity towards equities as an asset class, including Emerging Market equities, in which case India could also benefit.

A) As of now, it looks like we created the bottom in the markets – both globally and in India – on 23rd March. This was the time when fear was at its peak, large-scale uncertainty was prevailing around the globe and Covid-19 was on the fast rise everywhere.

Since then, things have progressed on the Covid-19 front. Several countries in Europe have seen their Covid-19 cases flatten out, the US too looks heading in a similar direction and China already claims it has conquered the virus.

Lockdowns are expected to be lifted soon in several countries. There has been a massive support, both fiscal and monetary, by various global governments and central banks. And work is fast happening on the vaccine front, or at least with respect to some mitigants.

Global markets have taken all these developments positively and marched ahead with a “sense of hope”. The Nasdaq has already turned positive in 2020. As of 8th May, the S&P has recovered 31% from its bottom of 23rd March; India too is currently up 22% from its recent bottom.

We expect that markets will take a breather after the smart comeback, and may even witness a correction from current levels as the real impact on the economies and company earnings pans out in the coming weeks.

Globally, analysts now expect Q2 S&P 500 earnings to decline 37% against the same period last year, followed by a sequential rebound in Q3 and Q4 (the full year 2020, 18% decline).

However, for the next year, the consensus now expects a 28% earnings rebound, and S&P 500 profits to reach pre-crisis levels towards the end of Q2 2021. We expect that the S&P 500 will continue to gradually move up from current levels towards the year-end.

Given that governments and central bankers globally are all on the rescue job, it looks unlikely that markets will get into the same panic mode as we witnessed in March.

Back home, Indian markets will mostly follow the global sentiment, though we are likely to lag the global markets for some time owing to our lockdown being much more severe and therefore the economic and earnings recovery will take that much longer to bottom out.

A) The IMF expects the global economy to contract sharply by 3% in 2020, much worse than during the 2008-09 financial crisis, but expects it to rebound to 5.8% in CY21, helped by monetary and fiscal policy support. For India, the IMF has lowered the CY20 growth forecast to 1.9% from 5.8% estimated in Jan'20.

On average, every month of lockdown results in an output loss of ~8.5% of the annual total. If 75% of the economy is locked down for two months, the output loss will ~13%.

The severity of the economic impact from the lockdown necessitates a significant policy response from the RBI as well as the Government, to contain any near-term damages and provide the necessary impetus to revive growth and improve business sentiment.

Globally, most central banks and governments have already sprung into action and announced monetary and fiscal packages (totaling ~USD14tn) to deal with the aftermath of the Covid-19 crisis. In India, RBI has so far been on the forefront and has doled out a large rate cut (75 bps cut in repo) as well as several liquidity injection measures, to bring stability to the financial markets.

The government, on the other hand, released an Rs. 1.7 trillion packages for the poor, as its initial policy response. However, much more is desired to support the frail economy.

It is widely expected that the government will come up, after due analysis, with a comprehensive fiscal package for the larger part of the economy, including the industry and small-scale enterprises.

The practical challenge that the Government faces is that its revenues are under severe strain, so any financing of the fiscal package will have to be done out of market borrowings.

Recently, the Government announced a hike in its borrowing programme for FY21 to Rs. 12 trillion (earlier announced Rs. 7.8 trillion), which is a signal that a package is soon on its way.

While that would be good news for the country and temporarily for the equity markets, it will leave the bond markets greatly worried, as the fiscal deficit will likely jump from 3.5% of GDP to 5.5% (est.).

Here too, the RBI will have to play a crucial role in monetizing some of the borrowings so that the overall bond supply in the markets reduces.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/india-in-a-bear-market-we-continue-to-focus-on-lqv-companies-for-investments-unmesh-kulkarni-5251021.html
"May 12, 2020 04:31 PM IST",0,Sandip Das,Slideshow | Gainers & Losers: 10 stocks that moved the most on May 12,"Asian Paints | Share price was down almost 3 percent on growth worries.
Goldman Sachs also downgraded the stock to sell with a target at Rs 1,111 per share.
According to the firm, the stock is pricing in 23 percent average volume growth (3.3x of real GDP) in FY22-24E, leaving limited upside from current levels.
there are significant risks to sales growth as it expects consumers to down trade and extend the re-painting cycle given the macroeconomic slowdown.","Buying was witnessed in auto, IT, metal and FMCG sectors, while bank, energy, infra and pharma ended lower. BSE Smallcap and Midcap indices finished 0.5-0.7 percent lower.","Asian Paints | Share price was down almost 3 percent on growth worries. Goldman Sachs also downgraded the stock to sell with a target at Rs 1,111 per share. According to the firm, the stock is pricing in 23 percent average volume growth (3.3x of real GDP) in FY22-24E, leaving limited upside from current levels. there are significant risks to sales growth as it expects consumers to down trade and extend the re-painting cycle given the macroeconomic slowdown.",https://www.moneycontrol.com/news/business/stocks/slideshow-gainers-losers-10-stocks-that-moved-the-most-on-may-12-5255861.html
"May 12, 2020 04:50 PM IST",1,Subhash Helgaokar,Hold Shree Cement; target of Rs 16900: Prabhudas Lilladher,"Prabhudas Lilladher's research report on Shree CementSRCM reported Q4FY20 earnings in line with our estimates.
Company depicted strong maturity over last one year with tight discipline on volumes and prices in its Northern operations.
This is reflected in highest ever margins since FY09 and best ever absolute bottom line.
Company raised Rs24bn in Q3FY20 through QIP of equity to fund capacity expansion despite quality B/S and strong cash flow generation.
Overcapacity and weak demand would delay SRCM's capacity creation and hence, the RoE profile due to idle cash loaded in the B/S.","Prabhudas Lilladher recommended hold rating on Shree Cement with a target price of Rs 16900 in its research report dated May 11, 2020.","Prabhudas Lilladher's research report on Shree Cement

SRCM reported Q4FY20 earnings in line with our estimates. Company depicted strong maturity over last one year with tight discipline on volumes and prices in its Northern operations. This is reflected in highest ever margins since FY09 and best ever absolute bottom line. However, we see material downside risk to SRCM's margins due to competition from new capacities, weak demand outlook and increased likelihood of leakage on volumes coupled with widening gap between A and C category brands. Company raised Rs24bn in Q3FY20 through QIP of equity to fund capacity expansion despite quality B/S and strong cash flow generation. Overcapacity and weak demand would delay SRCM's capacity creation and hence, the RoE profile due to idle cash loaded in the B/S.

Outlook

Peaked out margins, slowing growth and stretched valuations (EV/EBITDA of 16.7x and P/E of 33x FY22E) leaves no scope for margin of safety. Hence, we maintain Hold with TP of Rs16,900 (earlier Rs16,680).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-shree-cement-target-of-rs-16900-prabhudas-lilladher-5255951.html
"May 12, 2020 04:52 PM IST",2,Subhash Helgaokar,Buy Persistent Systems; target of Rs 619: Cholamandalam securities,"Cholamandalam securities' research report on Persistent SystemsPSL's revenue of US$127mn in 4Q was up 7.4% YoY and down 1.8% QoQ in USD terms.
In INR terms, revenues grew by 11.4% YoY and 0.4% QoQ aided by favourable currency movement.
The linear revenue (services) grew by 4.2% QoQ while IP revenue declined QoQ by ~25%.
ISV Services (~41.7% of revenue) increased 5.0% QoQ and 8.7% YoY while IP revenue (~16.3% of total revenue) decreased 24.5% QoQ and 18.9% YoY in USD terms.
The share of accelerite business (~4.1% of revenue) grew 11.8% QoQ but decreased 29% YoY.","Cholamandalam securities is bullish on Persistent Systems has recommended buy rating on the stock with a target price of Rs 619 in its research report dated May 11, 2020.","Cholamandalam securities' research report on Persistent Systems

PSL's revenue of US$127mn in 4Q was up 7.4% YoY and down 1.8% QoQ in USD terms. In INR terms, revenues grew by 11.4% YoY and 0.4% QoQ aided by favourable currency movement. The linear revenue (services) grew by 4.2% QoQ while IP revenue declined QoQ by ~25%. The Alliance business (~22.2% of revenues) decreased by 18.4% QoQ and 3.8% YoY. ISV Services (~41.7% of revenue) increased 5.0% QoQ and 8.7% YoY while IP revenue (~16.3% of total revenue) decreased 24.5% QoQ and 18.9% YoY in USD terms. The share of accelerite business (~4.1% of revenue) grew 11.8% QoQ but decreased 29% YoY.

Outlook

We expect the demand environment to revive in H2'FY21 as the pandemic situation eases. At the CMP, the stock is trading at 12.4x/10.2x FY21E/22E. We arrive at a price target of INR 619 based on P/E of 12.0x FY22EPS and arrive at a BUY rating on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-persistent-systems-target-of-rs-619-cholamandalam-securities-5255971.html
"May 12, 2020 02:20 PM IST",2,Nishant Kumar,"Fertiliser sales up 47% in April, demand to remain healthy; 5 stocks to buy","Fertiliser sales were up 47 percent in April, brokerage firm Prabhudas Lilladher has said in a report.
""Total industry volume up 47 percent to 3.7 million tonne, driven by preponement of purchase, healthy underlying demand and low base.
Urea/NPK/DAP sales are at 2 million tonne/5.9 million tonne/7 million tonne, up 27 percent/102 percent/95 percent, respectively.
Experts highlight that the fertiliser players may not see a similar magnitude of sales in Rabi season due to stretched working capital.
Brokerage firm Edelweiss Securities has buy recommendations on Dhanuka Agritech and Coromandel International among the agro-chem players.",The fertiliser sector is likely to see positive growth due to healthy underlying demand as India's agricultural sector is seen as less effected by the coronavirus outbreak.,"The coronavirus outbreak has pushed most sectors to their lowest lows but there is one segment that is clocking impressive growth, thanks to healthy underlying demand.

Fertiliser sales were up 47 percent in April, brokerage firm Prabhudas Lilladher has said in a report.

""Total industry volume up 47 percent to 3.7 million tonne, driven by preponement of purchase, healthy underlying demand and low base. Urea/NPK/DAP sales are at 2 million tonne/5.9 million tonne/7 million tonne, up 27 percent/102 percent/95 percent, respectively. SSP volumes up 51 percent to 2.7 million tonne,"" the brokerage said.

Among the players, Coromandel International's volumes were up 194 percent YoY, Chambal up 69 percent and GSFC's volumes were 15 percent higher, the report said.

Demand to remain healthy

The sector is likely to see positive growth due to healthy underlying demand as India's agriculture sector has not been hit as badly as the industry by the coronavirus outbreak.

Besides, both the Centre and state governments have been responding to the challenges in agriculture value chain posed by the COVID-19 outbreak, which is a positive.

The government has taken several steps to ensure that the farm sector remains on track and a good rabi season has resulted in a spike in receivables of most agrochemical players.

The outlook for the Kharif season is also positive with the met department predicting a normal monsoon.

""IMD's forecast indicates that India's seasonal monsoon rainfall is likely to be normal (96-104 percent) of the long period average, with a likelihood of above-normal rain in August and September 2020. Rabi harvesting has been encouraging, with nearly 40 percent of the crop already purchased by the government and other private institutions and disbursements being transferred to the farmers,"" brokerage firm Kotak Institutional Equities said.

The challenges

The biggest challenge for the fertiliser industry is the liquidity crunch in the rural sector.

Timely disbursements are critical to mitigate tight these conditions and enable robust offtake for agri-inputs for Kharif.

""Cash flows of farmers have taken a hit as several mandis remain closed due to the lockdown. Dip in realisation of produce has further worsened woes. However, procurement by the government at MSP rates is likely to ease their liquidity woes,"" said Edelweiss Securities.

The brokerage expects surplus production to improve farmer's overall income.

Experts highlight that the fertiliser players may not see a similar magnitude of sales in Rabi season due to stretched working capital.

""The increase in volume in April sales was due to the higher acreage of sowing, especially in paddy and cereals. But the sector has very limited companies that will be able to see a similar level of sales in Rabi season due to stretched working capital,"" said Sameer Kalra, Founder, Target Investing.

Stocks to buy

Brokerage firm Prabhudas has buy recommendations on Bayer Cropscience, Dhanuka Agritech, Godrej Agrovet, Insecticides India and UPL.

Brokerage firm Edelweiss Securities has buy recommendations on Dhanuka Agritech and Coromandel International among the agro-chem players.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/fertiliser-sales-up-47-in-april-demand-to-remain-healthy-5-stocks-to-buy-5248981.html
"May 12, 2020 07:04 PM IST",2,,Ideas For Profit | Here's why investors should consider Security & Intelligence Services India,"Security and Intelligence Services India Ltd, a market leader in security solutions, facility management and cash logistics segment, has an edge over its peers due to its strong brand positioning and ability to provide end-to-end services.
Despite high competition and growth pangs of an unorganised market, SIS has been able to increase its market share.
The management also expects the demand to increase in the future due to the COVID-19 outbreak.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyIn this edition of Ideas For Profit, we tell you why investors should look at company from a long-term perspective.","Despite high competition and growth pangs of an unorganised market, SIS has been able to increase its market share.","Security and Intelligence Services India Ltd, a market leader in security solutions, facility management and cash logistics segment, has an edge over its peers due to its strong brand positioning and ability to provide end-to-end services.

Despite high competition and growth pangs of an unorganised market, SIS has been able to increase its market share. The management also expects the demand to increase in the future due to the COVID-19 outbreak.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

In this edition of Ideas For Profit, we tell you why investors should look at company from a long-term perspective.",https://www.moneycontrol.com/news/business/companies/ideas-for-profit-heres-why-investors-should-consider-security-intelligence-services-india-5256681.html
"May 12, 2020 01:20 PM IST",-2,Sunil Matkar,Piramal Enterprises share price tanks 10% on weak Q4 earnings,"Piramal Enterprises share price fell 10 percent intraday on May 12, day after the company reported a loss of Rs 1,702 crore in the quarter ended March 2020 on higher provisions and tax adjustments.
It was quoting at Rs 850.85, down Rs 81.40, or 8.73 percent, on the BSE at 1238 hours.
Piramal Enterprises has reported a fourth quarter loss at Rs 1,702 crore against a profit of Rs 455 crore in the year-ago period, as the company provisioned for the likely impact of the coronavirus impact.
Piramal Enterprises in January sold healthcare insights and analytics business Decision Resources Group (DRG) to Clarivate Analytics for $950 million.
Revenue from operations during the quarter stood at Rs 3,341 crore, falling 2 percent compared to Rs 3,408.52 crore in same period last year.","The company has reported a loss of Rs 1,702 crore in the quarter ended March 2020.","Piramal Enterprises share price fell 10 percent intraday on May 12, day after the company reported a loss of Rs 1,702 crore in the quarter ended March 2020 on higher provisions and tax adjustments.

The stock lost more than 56 percent of its value in one year. It was quoting at Rs 850.85, down Rs 81.40, or 8.73 percent, on the BSE at 1238 hours.

Piramal Enterprises has reported a fourth quarter loss at Rs 1,702 crore against a profit of Rs 455 crore in the year-ago period, as the company provisioned for the likely impact of the coronavirus impact.

The company reported expected credit loss on financial assets (including commitments) at Rs 2,019 crore for the quarter against Rs 107.05 crore in the same period last year.

""The group has estimated and recognised an additional expected credit loss of Rs 1,903 crore on certain financial assets, on account of the anticipated effect of the global health pandemic,"" Piramal said in its BSE filing.

“As a result of the uncertainties resulting from COVID-19, the impact of this pandemic may be different from those estimated as on the date of approval of these financial results and the Group will continue to monitor any changes to the future economic conditions.”

In addition, there was one-time accounting write-off of Rs 1,758 crore of deferred tax asset (DTA) and reversal of minimum alternate tax (MAT) credit, as the company opted for a lower-tax rate under the new corporate tax regime.

There was a gain of Rs 658.39 crore from its discontinued operations. Piramal Enterprises in January sold healthcare insights and analytics business Decision Resources Group (DRG) to Clarivate Analytics for $950 million.

Hence, the company said the normalised net profit stood at Rs 807 crore for the quarter.

Revenue from operations during the quarter stood at Rs 3,341 crore, falling 2 percent compared to Rs 3,408.52 crore in same period last year.

""The last few quarters have been challenging for the Indian economy. The situation has further worsened due to the COVID-19 pandemic, with a subsequent economic recovery likely to be long-drawn,"" Chairman Ajay Piramal said.

He said pharma business continued to be operational despite COVID-19 lockdowns and delivered a healthy revenue growth of 13 percent YoY to Rs 5,419 crore and an EBITDA margin of 26 percent for FY20.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

""We have consciously shrunk wholesale loan book by 12 percent and more importantly, reduced large single borrower exposure by Rs 4,200 crore over the past year,"" Piramal added.",https://www.moneycontrol.com/news/business/markets/piramal-enterprises-share-price-tanks-10-on-weak-q4-earnings-5254711.html
"May 12, 2020 04:43 PM IST",-2,Rakesh Patil,"Taking Stock: Modi's speech announcement helps recoup some losses; Nifty closes below 9,200","The S&P BSE Sensex recovered more than 500 points from the day's low and the Nifty closed a shade below 9,200.
The final tally on D-Street: the S&P BSE Sensex fell 190 points to 31,371 while the Nifty ended 42 points lower at 9,196.
On the broader markets front, the BSE Midcap index fell 0.75 percent while the S&P BSE Smallcap index was down 0.58 percent.
Stocks & SectorsSectorally, the S&P BSE Telecom index rose 4.2 percent followed by the S&P BSE Power index rose 2.3 percent and the S&P BSE Metal index was up 1.3 percent.
Profit-taking was seen in the S&P BSE Energy index which fell 5 percent, followed by the S&P BSE Oil & Gas index that was down 2.6 percent and the S&P BSE Capital Goods index fell 0.75 percent.","Announcement of PM address to the nation at 8 pm Tuesday led to short covering in the last hour of the trade, say experts.","The bulls helped the Nifty recoup some of its losses in the last hour of the trade on May 12 but not enough to push the index back in the green. The S&P BSE Sensex recovered more than 500 points from the day's low and the Nifty closed a shade below 9,200.

The announcement that Prime Minister Narendra Modi would address to the nation at 8 pm led to short covering in the last hour of the trade, say experts.

It raised hopes of a fiscal package to help the economy that has been wrecked by the coronavirus outbreak and the lockdown which will complete 50 days on May 13.

The final tally on D-Street: the S&P BSE Sensex fell 190 points to 31,371 while the Nifty ended 42 points lower at 9,196.

Sectorally, profit-taking was seen in sectors like energy, oil & gas, capital goods, as well as healthcare stocks, while value-buying was seen in telecom, power, metals and IT stocks.

On the broader markets front, the BSE Midcap index fell 0.75 percent while the S&P BSE Smallcap index was down 0.58 percent.

“Tuesday recovery can be attributed to the short-covering ahead of the Prime Minister's address,” Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory, Chartviewindia.in, told Moneycontrol.

“Failure of today's intraday breakdown is hinting that market might have chalked out a new reading range between 9,400–9,100 kinds of levels with its price behaviour in the last five trading sessions,” he said.

Top Nifty gainers included Bharti Airtel, ITC, NTPC, and Vedanta.

Top Nifty losers included Kotak Mahindra Bank, followed by Cipla, Asian Paints, GAIL India and RIL.

“Technically, the Nifty has rebounded after breaching the 9,140 level. This bounce could take it up towards 9,380 in the near term,” said Deepak Jasani, Head, Retail Research, HDFC Securities.

“Hopes of the announcement of a fiscal package in or after the 8 pm address by the PM today raised hopes among market participants,” he said.

Stocks & Sectors

Sectorally, the S&P BSE Telecom index rose 4.2 percent followed by the S&P BSE Power index rose 2.3 percent and the S&P BSE Metal index was up 1.3 percent.

Profit-taking was seen in the S&P BSE Energy index which fell 5 percent, followed by the S&P BSE Oil & Gas index that was down 2.6 percent and the S&P BSE Capital Goods index fell 0.75 percent.

A volume spike of more than 100 percent was seen in stocks like UPL, Sun TV, Exide Industries, Bandhan Bank, Vedanta, Ramco Cements and NCC.

Long Buildup was seen in stocks like Exide Industries, Vedanta, Bajaj Auto, and Bajaj Finserv.

Short Buildup was seen in stocks like Bandhan Bank, RIL, Nestle India, Tata Steel, and Kotak Bank.

Top companies that will report their results for the March quarter on May 13 include ABB Ltd, Godrej Consumer Products, Kotak Mahindra Bank, Maruti Suzuki, Mphasis and Siemens.

More than 130 stocks dropped to a 52-week low. It includes GE Power, AU Small Finance Bank, SBI, Quess Corp, DCB Bank, IIFL Holdings, DB Corp, and India Hotels.

Stocks in news

IRCTC | Indian Railway Catering & Tourism Corp (IRCTC) share price ended at 5 percent upper circuit after online bookings for passenger train services opened a day earlier.

Asian Paints | The stock was down almost 3 percent on growth worries. Goldman Sachs also downgraded the stock to sell with a target at Rs 1,111 per share.

Bandhan Bank | The share price was down over a percent with the bank reporting a 20 percent decline in Q4 profit to Rs 517 crore on additional COVID-19 provisions.

Piramal Enterprises | The share shed more than 3 percent after the company reported a net loss of Rs 1,702.59 crore in the quarter ended March 31, mainly on the back of additional provisioning for challenges posed by the COVID-19 pandemic.

IndusInd Bank | The stock was up 3 percent on reports that Japanese insurance major Nippon Life was in discussion with the bank for a strategic investment.

Reliance Industries | The share price was down over 6 percent on profit booking. The stock will turn ex-rights on May 13. The company has fixed May 14 as the record date.

Technical View

The Nifty formed a Doji kind of indecisive formation, as it smartly recoiled from an intraday low

The key technical development, which has gone in favour of bears, from price action can be the breach of 200-day simple moving average placed at 9,240.

A close below 9,100 could trigger a fresh bout of selling, with bigger targets close to 8,500.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Considering the current volatile phase, traders are advised to remain neutral on the index, whereas fresh selling opportunity can be considered on a close below 9,100, say experts.",https://www.moneycontrol.com/news/business/markets/taking-stock-modis-speech-announcement-helps-recoup-some-losses-nifty-closes-below-9200-5255991.html
"May 12, 2020 10:22 AM IST",-2,Sandip Das,Maruti shares fall 4% despite operations resuming at Manesar plant; brokerages expect fall in Q4 profit,"Maruti Suzuki share price fell over 4 percent in the morning trade on May 12 as the auto major restarted its manufacturing operations at its Manesar plant.
The stock price has been under pressure and has fallen over 32 percent in the last 3 months.
It was quoting at Rs 4,715.50, down Rs 216.45, or 4.39 percent at 09:48 hours and is the top index loser.
Net profit of Maruti is expected to decline 17 percent YoY to Rs 1,496 crore.
Maruti Suzuki is seeing a supply side constraint currently, he said.","Maruti restarted its manufacturing operations at its Manesar plant with one shift and manpower permission of up to 75 percent. It is one of the most active stocks on NSE in terms of value with 6,31,989 shares being traded.","Maruti Suzuki share price fell over 4 percent in the morning trade on May 12 as the auto major restarted its manufacturing operations at its Manesar plant. The company after almost 2 months of lockdown has been allowed to start with one shift and manpower permission of up to 75 percent.

The stock price has been under pressure and has fallen over 32 percent in the last 3 months. It was quoting at Rs 4,715.50, down Rs 216.45, or 4.39 percent at 09:48 hours and is the top index loser. It is also one of the most active stocks on NSE in terms of value with 6,31,989 shares being traded at 09:59 hours.

Maruti Suzuki is scheduled to come out with its March quarter earnings numbers on May 13 and to recommend dividend, if any, on equity shares of the company for the financial year 2019-20, the company said in a filing to the exchanges.

According to Kotak Institutional Equities, revenues are likely to decline by 12 percent YoY to Rs 18,846.7 crore in Q4 FY20, led by 16 percent YoY decline in volumes and 1 percent YoY increase in ASPs.

Profit may also dip 28 percent YoY to Rs 1,293.5 crore. The brokerage firm expects EBITDA to decline by 20 percent in the quarter under study led by 12 percent YoY decline in revenues and 80 bps decline in EBITDA margin driven by negative operating leverage.

Japanese research firm Nomura is of the view that Maruti's revenues may decline around 13 percent YoY on the back of volume drop while EBITDA margins is expected to remain flat sequentially. Revenue may fall 13 percent YoY to Rs 18,596.5 crore. Net profit of Maruti is expected to decline 17 percent YoY to Rs 1,496 crore.

In an interview to CNBC-TV18, RC Bhargava, Chairman at Maruti Suzuki said that the company is starting in a small way with limited number of models with only one shift allowed now and manpower permission up to 75 percent. Working hours have come down to 6.5 from 8 hours/shift due to safety measures adding that dealerships have recently started opening up.

Maruti Suzuki is seeing a supply side constraint currently, he said. There could be labour related issues once production picks up adding that the company has given cash advance against supplies to many of its vendors. The auto industry could end up with 20-25 percent less sales compared to last year.

According to According to Moneycontrol SWOT Analysis powered by Trendlyne, Maruti Suzuki's RoCE has been declining in the last two years while the momentum is weak with price trading below the short, medium and long term averages. The technical rating is also very bearish.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/maruti-shares-fall-4-as-manesar-plant-restarts-operation-brokerages-expect-fall-in-q4-profit-5253861.html
"May 12, 2020 03:06 PM IST",2,Sandip Das,"D-Street Buzz: Telecom stocks rally led by Bharti Airtel; RIL most active, volumes surge 168%","Among the sectors, Nifty Energy is down almost a percent dragged by Reliance Industries which shed over 3 percent followed by GAIL India and ONGC.
Among the banking names, Kotak Mahindra Bank shed over 3 percent while Bandhan Bank, HDFC Bank and Federal Bank were the other losers.
Stocks which moved the most with respect to volumes included Vodafone Idea where 35,98,93,279 shares were traded followed by Vedanta, Tata Motors, ICICI Bank, State Bank of India, ICICI Bank and Reliance Industries.
Telecom stocks are trading on a handsome note with Bharti Airtel jumping over 4 percent followed by Vodafone Idea which spiked over 7 percent while Bharti Infratel and Tata Communications are the other gainers.
Download a copy: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.","Stocks which moved the most with respect to volumes included Vodafone Idea where 35,98,93,279 shares were traded followed by Vedanta, Tata Motors, ICICI Bank, State Bank of India, ICICI Bank and Reliance Industries.","The Indian stock market continues trading in the red but has regained some lost ground with Sensex is down 123.10 points or 0.39% at 31438.12, and the Nifty down 25.85 points or 0.28% at 9213.35.

Experts feel the index can fall up to 8,800 and if that also breaks in coming days, then there could be sharp selling pressure.

Among the sectors, Nifty Energy is down almost a percent dragged by Reliance Industries which shed over 3 percent followed by GAIL India and ONGC.

RIL witnessed spurt in volume by more than 2.50 times and was trading with volumes of 2,530,267 shares, compared to its five day average of 967,447 shares, an increase of 161.54 percent.

Among the banking names, Kotak Mahindra Bank shed over 3 percent while Bandhan Bank, HDFC Bank and Federal Bank were the other losers.

Over 300 stocks hit lower circuit on BSE including names like AU Samll Finance Bank, Mahindra CIE, IIFL Holdings and Avas Financiers among others.

Stocks which moved the most with respect to volumes included Vodafone Idea where 35,98,93,279 shares were traded followed by Vedanta, Tata Motors, ICICI Bank, State Bank of India, ICICI Bank and Reliance Industries.

India VIX is marginally up 0.05 percent at 38.06 level.

Telecom stocks are trading on a handsome note with Bharti Airtel jumping over 4 percent followed by Vodafone Idea which spiked over 7 percent while Bharti Infratel and Tata Communications are the other gainers.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-telecom-stocks-rally-led-by-bharti-airtel-ril-most-active-volumes-surge-168-5255261.html
"May 12, 2020 10:22 AM IST",-2,Kshitij Anand,Investors lose Rs 36 lakh crore since Jan; experts say allocate 35-60% portfolio to equities,"So what is Asset Allocation?
In simple words, asset allocation centers on diversification of a portfolio among different asset classes such as equities, fixed income, gold, and some cash in hand.
Can asset allocation be the same for all age groups of investors?
This tool will suggest an asset allocation for you across different asset classes based on your level of risk capacity and risk tolerance.
Before deciding the percentage of the allocation to different financial instruments one should consider the below factors.","Asset allocation centers on diversification of a portfolio among different asset classes such as equities, fixed income, gold, and some cash in hand.","Since January 2020, when both Nifty and Sensex both hit a record high, investors have lost Rs 36 lakh crore in the market in terms of market capitalisation on the BSE.

If you are a new investor, following the discipline of asset allocation is all the more important, especially at a time when the economy is unlikely to do well for at least a year, earnings will remain muted for more than 2 quarters thanks to the lockdown, and interest rates are heading lower which also means that your fixed deposits might not give you attractive returns.

So what is Asset Allocation? In simple words, asset allocation centers on diversification of a portfolio among different asset classes such as equities, fixed income, gold, and some cash in hand.

He objective of asset allocation is to minimize risk and maximize returns. Can asset allocation be the same for all age groups of investors? Well, the answer to that would be ‘no'.

The asset allocation strategy would be dependent on your risk profile. For starters, you could do with a small amount but then as portfolio size increases investors are advised to seek professional help.

Try Asset Allocation Calculator on Moneycontrol. This tool will suggest an asset allocation for you across different asset classes based on your level of risk capacity and risk tolerance.

https://www.moneycontrol.com/personal-finance/tools/asset-allocation-calculator.html

Amid the COVID-19 fall which has wiped out more than Rs 30 lakh in terms of market capitalisation on the BSE and most of the bluechip names are down 20-50 percent in the same period suggest that there are plenty of good quality beaten-down stocks which investors could look at.

Before deciding the percentage of the allocation to different financial instruments one should consider the below factors. The investor should have a clear financial goal which will help in deciding either to invest in the growth-oriented or income-oriented class, suggest experts.

Cash flows, or source of cash, as well as the time horizon for both investment as well as to fulfill the financial goal is of utmost importance. Risk appetite will decide the investor's ability to take the risk and returns associated with the investments

“Asset allocation is a simple strategy to mitigate the risk and to maximize the returns which meet the financial goals of the investors. The investor has a wide range of options to choose between various instruments like equity, debt, gold, cash, and real estate,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor told Moneycontrol.",https://www.moneycontrol.com/news/business/markets/investors-lose-rs-36-lakh-crore-since-jan-experts-say-allocate-35-60-portfolio-to-equities-5249021.html
"May 12, 2020 04:49 PM IST",2,Subhash Helgaokar,Buy Swaraj Engines; target of Rs 1313: East India Securities,"East India Securities' research report on Swaraj EnginesSwaraj Engines (SWE) reported a lower single-digit volume decline in Q4FY20, far better than ~12% de-growth in the tractor industry.
Based on our recent survey, we believe Swaraj tractors continue to enjoy strong brand equity.
Swaraj Engines reported a top-line of Rs 1,751mn (down 8.5% YoY & up 3.0% QoQ), in-line with our estimate.
PAT witnessed a small fall of 4.9% YoY to Rs 158mn.
Considering COVID impact and rising competition, we have lower down our target price to Rs 1,313 with Buy rating as we believe tractor sector would outperform in auto industry with government focus on agriculture and construction activities.","East India Securities is bullish on Swaraj Engines has recommended buy rating on the stock with a target price of Rs 1313 in its research report dated May 11, 2020.","East India Securities' research report on Swaraj Engines

Swaraj Engines (SWE) reported a lower single-digit volume decline in Q4FY20, far better than ~12% de-growth in the tractor industry. Based on our recent survey, we believe Swaraj tractors continue to enjoy strong brand equity. Swaraj Engines reported a top-line of Rs 1,751mn (down 8.5% YoY & up 3.0% QoQ), in-line with our estimate. This was on account of engine volume degrowth of 4.3% YoY. Blended realization declined by about 4.4% YoY. The company witnessed an EBITDA margin contraction of 97bps YoY to 11.6%, however there was a jump of 177bps QoQ in margin. PAT witnessed a small fall of 4.9% YoY to Rs 158mn. Considering COVID impact and rising competition, we have lower down our target price to Rs 1,313 with Buy rating as we believe tractor sector would outperform in auto industry with government focus on agriculture and construction activities.

Outlook

By looking at the present uncertain situation and intensifying competition in tractor industry, we have lower down our multiple to 18x FY22E (~17% discount to its six-year average) to arrive at a target price of Rs 1,313 per share, which indicates 34% upside from the current levels. Hence, we have Buy rating.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-swaraj-engines-target-of-rs-1313-east-india-securities-5255931.html
"May 12, 2020 11:57 AM IST",-2,Sandip Das,Asian Paints falls 2% on growth worries; Goldman Sachs downgrades stock,"Asian Paints share price was down almost 3 percent intraday on May 12, hitting a 7-week low.
Global research firm Goldman Sachs also downgraded the stock to sell with a target at Rs 1,111 per share.
Goldman Sachs forecasts FY22E and FY23 volume growth to be 1.5x real GDP growth (lower than the long-term average of 1.7x).
It expects volume growth to slow to an average of 6 percent over the next three years.
According to Glodman Sachs, the stock is pricing in 23 percent average volume growth (3.3x of real GDP) in FY22-24E, leaving limited upside from current levels.","According to Glodman Sachs, the stock is pricing in 23 percent average volume growth (3.3x of real GDP) in FY22-24E, leaving limited upside from current levels.","Asian Paints share price was down almost 3 percent intraday on May 12, hitting a 7-week low. Global research firm Goldman Sachs also downgraded the stock to sell with a target at Rs 1,111 per share.

The stock has fallen over 17 percent in the last 15 days and was quoting at Rs 1,536.50, down Rs 32.75, or 2.09 percent, at 11:00 hours on May 12.

According to the research firm, there are significant risks to sales growth as it expects consumers to down trade and extend the re-painting cycle given the macroeconomic slowdown.

Goldman Sachs forecasts FY22E and FY23 volume growth to be 1.5x real GDP growth (lower than the long-term average of 1.7x). It expects volume growth to slow to an average of 6 percent over the next three years.

Asian Paints sales CAGR of 3 percent (FY19-22E) is among the lowest in its coverage, it added.

According to Glodman Sachs, the stock is pricing in 23 percent average volume growth (3.3x of real GDP) in FY22-24E, leaving limited upside from current levels.

While Asian Paints will benefit from the pullback in input costs and can re-invest the same to drive volume growth, it assumes 7 percent average higher volume growth in FY22/23E (at 2.3-2.5x real GDP growth), equates to an implied valuation suggesting 32 percent downside, the research firm said.

According to Moneycontrol SWOT Analysis powered by Trendlyne, MFs have decreased their shareholding last quarter. The momentum is weak with price below short, medium and long term averages.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/asian-paints-falls-2-on-growth-worries-goldman-sachs-downgrades-stock-5254061.html
"May 12, 2020 09:53 AM IST",2,Rakesh Patil,Biocon share price rises on GMP compliance,"Biocon share price rose more than 1 percent in early trade on May 12 after the company received EU GMP Certification for its Bengaluru facility.
Biocon Biologics India Ltd., a subsidiary of the company has received the certificate of GMP compliance from EMA represented by the competent authority of Germany for its Biologics Drug Substance (DS), facilities at Hosur Road, Bengaluru.
These facilities are used for the manufacturing of drug substance of Pegfilgrastim and Recombinant Human Insulin and manufacturing related activities for Insulin Glargine and Insulin Aspart.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAt 09:21 hrs Biocon was quoting at Rs 351.25, down Rs 0.35, or 0.10 percent on the BSE.","The inspection was inspected by the regulatory agency between January 20 and 23, 2020.","Biocon share price rose more than 1 percent in early trade on May 12 after the company received EU GMP Certification for its Bengaluru facility.

Biocon Biologics India Ltd., a subsidiary of the company has received the certificate of GMP compliance from EMA represented by the competent authority of Germany for its Biologics Drug Substance (DS), facilities at Hosur Road, Bengaluru.

The inspection was done by the regulatory agency between January 20 and 23, 2020.

These facilities are used for the manufacturing of drug substance of Pegfilgrastim and Recombinant Human Insulin and manufacturing related activities for Insulin Glargine and Insulin Aspart.

This certification will enable us to continue addressing the growing needs of patients in the EU markets and enhance access to our high-quality biosimilars. We remain committed to global standards of quality and compliance, said by the company spokesperson.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:21 hrs Biocon was quoting at Rs 351.25, down Rs 0.35, or 0.10 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/biocon-share-price-rises-on-gmp-compliance-5253431.html
"May 12, 2020 08:43 PM IST",-2,Sunil Matkar,Rakesh and Rekha Jhunjhunwala cut stake in Agro Tech Foods,"Rakesh and Rekha Jhunjhunwala pared their stakes in Agro Tech Foods by 1.66 percent in quarter ended March 2020.
As per the shareholding pattern of March quarter, Rakesh held 2.67 percent stake in the company and Rekha 3.08 percent, taking their combined stake to 5.75 percent which was reduced from December quarter.
They both held 7.41 percent stake in the company in December quarter - Rakesh had 4.74 percent shareholding and his wife 2.67 percent.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAgro Tech Foods is engaged in the business of marketing food and food ingredients to consumers and institutional customers.",They both held 7.41 percent stake in the company in December quarter - Rakesh had 4.74 percent shareholding and his wife 2.67 percent.,"Rakesh and Rekha Jhunjhunwala pared their stakes in Agro Tech Foods by 1.66 percent in quarter ended March 2020.

As per the shareholding pattern of March quarter, Rakesh held 2.67 percent stake in the company and Rekha 3.08 percent, taking their combined stake to 5.75 percent which was reduced from December quarter.

They both held 7.41 percent stake in the company in December quarter - Rakesh had 4.74 percent shareholding and his wife 2.67 percent.

Their stake was also further reduced in December quarter from 8.22 percent held in September quarter.

On May 12, it closed at Rs 521.05 on the BSE, up 5.34 percent.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Agro Tech Foods is engaged in the business of marketing food and food ingredients to consumers and institutional customers.",https://www.moneycontrol.com/news/business/markets/rakesh-jhunjhunwala-and-rekha-jhunjhunwala-cut-stake-in-agro-tech-foods-5257511.html
"May 12, 2020 10:00 AM IST",2,Rakesh Patil,IRCTC share price locked at upper circuit for 2nd day after railway bookings start,"Indian Railway Catering & Tourism Corp (IRCTC) share price locked at upper circuit for the second day on May 12 after online bookings for passenger train services have opened yesterday.
Bookings for passenger train services have opened on May 11 on the IRCTC website, while the train services will start in a graded manner from May 12.
The passenger train services, including suburban trains, had been suspended following the prime minister's call for a nationwide lockdown on March 24.
At 09:24 hrs IRCTC - Indian Railway Catering & Tourism Corp was quoting at Rs 1,367.95, up Rs 65.10, or 5.00 percent.
Also Read - COVID-19 impact | IRCTC books reservations for over 54,000 passengers within hoursMoneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.",The share price rose 46 percent over the last six months.,"Indian Railway Catering & Tourism Corp (IRCTC) share price locked at upper circuit for the second day on May 12 after online bookings for passenger train services have opened yesterday.

Bookings for passenger train services have opened on May 11 on the IRCTC website, while the train services will start in a graded manner from May 12.

The passenger train services, including suburban trains, had been suspended following the prime minister's call for a nationwide lockdown on March 24.

Also Read - List of trains resuming from May 12, how and where to book tickets, travel SOPs and other questions answered

The share price rose 46 percent over the last six months.

At 09:24 hrs IRCTC - Indian Railway Catering & Tourism Corp was quoting at Rs 1,367.95, up Rs 65.10, or 5.00 percent.

Also Read - COVID-19 impact | IRCTC books reservations for over 54,000 passengers within hours

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

There were pending buy orders of 71,652 shares, with no sellers available.",https://www.moneycontrol.com/news/business/stocks/irctc-share-price-locked-at-upper-circuit-for-2nd-day-after-railway-bookings-start-5253731.html
"May 12, 2020 04:50 PM IST",2,Subhash Helgaokar,Buy ICICI Bank; target of Rs 444: YES Securities,"YES Securities' research report on ICICI BankICICI Bank delivered a better-than-expected core operating performance (adj.
Core NII grew 24% yoy and core PPOP grew 25% yoy on a balance sheet growth of 14% yoy.
Liability-side strength was reflected in deposit mobilization (up 8% qoq and 18% yoy), texture (avg.
Expect bank to deliver 13-14% RoE in FY22 with healthy capital levels if the Covid spread peaks soon.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","YES Securities is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 444 in its research report dated May 10, 2020.","YES Securities' research report on ICICI Bank

ICICI Bank delivered a better-than-expected core operating performance (adj. for treasury/lumpy income and int. on IT refund). Core NII grew 24% yoy and core PPOP grew 25% yoy on a balance sheet growth of 14% yoy. Fees grew 13% despite Covid impact. Liability-side strength was reflected in deposit mobilization (up 8% qoq and 18% yoy), texture (avg. CASA stable at 42%) and funding cost (fell 50bps qoq on computed basis). Reported NIM was at multi-year high of 3.9%, up 10 bps qoq.

Outlook

Retain BUY with a 12m TP of Rs.444. Expect bank to deliver 13-14% RoE in FY22 with healthy capital levels if the Covid spread peaks soon. Stand-alone bank trades at 1.2x/8x FY22 ABV/EPS.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-icici-bank-target-of-rs-444-yes-securities-5255911.html
"May 12, 2020 04:25 PM IST",1,Rakesh Patil,"D-Street Buzz: Vedanta jumps 12%, but down 36% in 3 months","The company's share price has though declined 36 percent in the last 3 months.
According to Moneycontrol SWOT Analysis powered by Trendlyne, Vedanta showed a decline in its quarterly net profit.
Vedanta share price ended at Rs 89.30, up Rs 9.70, or 12.19 percent on the BSE.
The share touched its 52-week high Rs 179.95 and 52-week low Rs 60.30 on 27 June, 2019 and 30 March, 2020, respectively.
The latest book value of the company is Rs 209.51 per share.","The share touched its 52-week high Rs 179.95 and 52-week low Rs 60.30 on 27 June, 2019 and 30 March, 2020, respectively.","Mining giant Vedanta has set up a dedicated Rs 100 crore fund that will cater to three specific areas – livelihood of the daily wage worker, employees & contract workers, preventive health care and will provide timely help to communities in and around various plant locations of the company (Image: Moneycontrol)

Vedanta share price jumped more than 12 percent during Tuesday's trading session. The Nifty metal index rose over 1 percent against selling seen in the overall equity market.

The company's share price has though declined 36 percent in the last 3 months.

According to Moneycontrol SWOT Analysis powered by Trendlyne, Vedanta showed a decline in its quarterly net profit. Also, mutual funds decreased their shareholding in the last quarter. The company has zero promoter pledge.

The company's PE ratio is at 8.94X higher than the industry PE of 6.66X, data showed.

The technical rating on Moneycontrol is bullish.

Vedanta share price ended at Rs 89.30, up Rs 9.70, or 12.19 percent on the BSE.

The share touched its 52-week high Rs 179.95 and 52-week low Rs 60.30 on 27 June, 2019 and 30 March, 2020, respectively.

Currently, it is trading 50.38 percent below its 52-week high and 48.09 percent above its 52-week low.

The company's trailing 12-month (TTM) EPS was at Rs 9.67 per share. (Dec, 2019).

The latest book value of the company is Rs 209.51 per share. At current value, the price-to-book value of the company was 0.43.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The dividend yield of the company was 21.11 percent.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-vedanta-jumps-12-but-down-36-in-3-months-5255791.html
"May 12, 2020 04:51 PM IST",1,Subhash Helgaokar,Buy Lupin; target of Rs 978: Prabhudas Lilladher,"Prabhudas Lilladher's research report on LupinWe assigned 24x PE (earlier 22x) on FY22E due to better earnings visibility from the US market led by easing of regulatory issues.
We believe regulatory resolution would allow LPC to make a strong comeback in the US market where pricing environment has been stabilized and trade-war concerns between US and China could provide an opportunity to Indian Gx.
OutlookWe upgrade LPC to 'Buy' (earlier Reduce) with TP of Rs978 (earlier Rs685).
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 978 in its research report dated May 10, 2020.","Prabhudas Lilladher's research report on Lupin

We assigned 24x PE (earlier 22x) on FY22E due to better earnings visibility from the US market led by easing of regulatory issues. We increase our EE by 31% for FY21E-22E led by US revenue growth of 10-15% constant currency (earlier 5-7%) and EBITDA margin expansion of 200bps due to savings from remediation cost and change in business mix. We believe regulatory resolution would allow LPC to make a strong comeback in the US market where pricing environment has been stabilized and trade-war concerns between US and China could provide an opportunity to Indian Gx.

Outlook

We upgrade LPC to 'Buy' (earlier Reduce) with TP of Rs978 (earlier Rs685).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-lupin-target-of-rs-978-prabhudas-lilladher-5255921.html
"May 12, 2020 12:44 PM IST",1,Subhash Helgaokar,Buy USDINR; target of 76.00 - 76.20 : ICICI Direct,"ICICI Direct's currency report on USDINRSpot CurrencyThe rupee moved higher towards 76 levels as the number of Covid-19 cases continued to rise in India.
Strengthening of the Dollar index and negative domestic equities weighed on investor sentiment • The Dollar index started the week on optimistic note and moved above 100 levels.
However, last week it faced difficulty at higher levels.
The open interest fell by almost 2.5% during the last session • The US$INR pair is likely to move higher as Covid-19 cases are increasing.
The Dollar index is trading in a range.","ICICI Direct The USDINR pair is likely to move higher as Covid-19 cases are increasing. The Dollar index is trading in a range. If it manages to close above 100.60 levels, most EM currencies will further depreciate.","ICICI Direct's currency report on USDINR

Spot Currency

The rupee moved higher towards 76 levels as the number of Covid-19 cases continued to rise in India. Strengthening of the Dollar index and negative domestic equities weighed on investor sentiment • The Dollar index started the week on optimistic note and moved above 100 levels. However, last week it faced difficulty at higher levels. We feel the range can be broken only if it closes above 100.60 levels.

Currency futures on NSE

The dollar-rupee contract on the NSE was at 75.94 in the last session. The open interest fell by almost 2.5% during the last session • The US$INR pair is likely to move higher as Covid-19 cases are increasing. The Dollar index is trading in a range. If it manages to close above 100.60 levels, most EM currencies will further depreciate.

Intra-day strategy

US$INR May futures contract (NSE) View: Bullish on US$INR Buy US$ in the range of 75.70-75.80 Market Lot: US$1000 Target: 76.00/ 76.20 Stop Loss: 75.6 Support: 75.34/75.6 Resistance: 76.00/76.20

The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-usdinr-target-of-76-00-76-20-icici-direct-5254561.html
"May 11, 2020 04:32 PM IST",-2,Kshitij Anand,"Small, midcap stocks may witness selling pressure at higher levels: Gaurav Garg","edited excerpt:Q) It seems like the markets seem to have witnessed profit-taking at higher levels.
Global market trends turned positive following attempts to defuse tensions around the US-China trade talks, which ultimately led to the recovery of the domestic markets.
The partial relaxation granted to less affected areas from lockdown will be helpful in reviving the economy in certain aspects and therefore investors seem to accumulate these stocks, but selling pressure likely at higher levels in small & midcap space.
Small and midcap stocks may witness selling pressure at higher levels.
There are supply-side challenges but the overall outlook is positive and hence investors can add these stocks (at dip) to their basket.","Nifty's movement next week may depend on the progress in the COVID-19 vaccine, hopes of a bigger fiscal stimulus from the government, expectations of a decline in daily novel Coronavirus cases.","The partial relaxation granted to less affected areas from lockdown will be helpful in reviving the economy in certain aspects and therefore investors seem to be accumulating these stocks, but selling pressure likely at higher levels in small & midcap space, Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor, said in an interview with Moneycontrol's Kshitij Anand.

edited excerpt:

Q) It seems like the markets seem to have witnessed profit-taking at higher levels. What led to a sharp sell-off on D – street and then some recovery to the close of the week?

A) Indian stock markets fell on both local as well as global cues. On the global front, the US President Donald Trump criticizing China's handling of the Coronavirus pandemic unnerved investors, and on the domestic front, an extension of the nationwide lockdown dampened the sentiment.

Stocks dropped globally after the US President on Sunday said that Beijing misled the world about COVID-19.

On the domestic front, earnings and the economy would take time to revive even if all restrictions are lifted. The government may not ease the curbs anytime soon considering the number of new cases we are seeing every day.

All the above factors turned the investor's sentiments negative fuelled by global tensions which eventually led to the downfall of Nifty.

Global market trends turned positive following attempts to defuse tensions around the US-China trade talks, which ultimately led to the recovery of the domestic markets. Markets seem to be awaiting the announcement of a stimulus package from the government.

A) The market has been trying to move up, and now with global markets also bouncing back, investors are now feeling that the time for value buying has arrived.

The partial relaxation granted to less affected areas from lockdown will be helpful in reviving the economy in certain aspects and therefore investors seem to accumulate these stocks, but selling pressure likely at higher levels in small & midcap space.

A) Nifty's movement next week may depend on the progress in the COVID-19 vaccine, hopes of a bigger fiscal stimulus from the government, expectations of a decline in daily novel Coronavirus cases.

There is likely to be some stock-specific action due to earnings. Volatility may remain higher in the coming week. Small and midcap stocks may witness selling pressure at higher levels.

A) The oil giant company has a firm belief that the data will be the next oil and it has been focusing more on the same platform.

With the introduction of Reliance Jio which had disrupted the telecom business, it had been continuously entering different sectors and making progress aggressively.

Many companies struggle to raise funds and for them, it might take years but that is not the case with Reliance Jio which is among one of the high values companies in India.

Within a short span of time, it has raised more than Rs. 60,000 cr. The latest deal is with the Vista Equity Partners for a stake of 2.32 percent which is valued around Rs. 11,000 cr.

The deals with tech giant Facebook which they combined planning to enter to the various businesses especially focusing on UPI payment platform and retail has boosted the valuation of the Reliance Industries.

We recommend investors to hold their position for the long term as the stock is expected to outperform the index.

Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

A) In November 2019 Moody's has downgraded India's outlook from stable to negative with respect to the lower economic growth.

On Friday, in revision to that Moody's stated that “India's rating outlook reflects the rising risk of slower GDP growth, low policy effectiveness.”

The already slow economic growth, less job creation, high debt burdens, and credit crunch among NBFC and others have highly contributed, in addition to that the outbreak of Coronavirus and the extension of lockdown had been highly impacted the economy of India.

On Friday, the benchmark indices have ended at 9521.50 or 0.57 percent positive. From the day's performance, we may conclude that the market has already discounted the Moody's rating about India and investors are still in hope for another stimulus package and closely watching various treatment and vaccine options to the COVID-19.

A) With a growing number of cases of COVID 19 and the situation not getting under control, it looks like the lockdown will be extended in many parts of the country which are getting COVID-19 cases on a regular basis.

The situation is very dire, with no medicine/vaccine, and lockdown seems to be the only available and possible way to flatten the curve. This makes the probability of lockdown extension very high, at least for the affected areas.

Lockdown has already taken a toll on the economy. However, the lockdown may be relaxed in certain places and this would have mixed effects on markets and would make market choppier.

A) The COVID-19 panic has set pharma stocks on fire. Countries at present are halting exports of essential drugs, but this is only temporary. In the long term, the risk from protectionism on India's low-cost export model will be countered by its sheer price competitiveness.

After this pandemic, there could be significantly higher spending both by the government and private sector on healthcare, specialty chemicals, and pharmaceuticals.

There are supply-side challenges but the overall outlook is positive and hence investors can add these stocks (at dip) to their basket.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/small-midcap-stocks-may-witness-selling-pressure-at-higher-levels-gaurav-garg-5246951.html
"May 11, 2020 03:16 PM IST",2,Sandip Das,Slideshow | Angel Broking picks 17 stocks that can return up to 32%,"Reliance Industries | Company has built up a dominant telecom business and has already attained market leader status with 38.5 crore subscribers at the end of Q3FY20.
Telecom business to witness robust growth over the next few years due to tariff hikes and shift of subscribers from Vodafone Idea to other telecom players.
RIL has also built a very strong retail business which is the largest organized retailing company in India.
Angel Broking expects the retail business to be a key value driver for Reliance over the long run though there would be some impact on business in FY21 due to the COVID-19 outbreak.
Upside: 11% Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd",Here are the 17 portfolio stock ideas from Angel Broking that can return 12-32 percent upside.,Reliance Industries | Company has built up a dominant telecom business and has already attained market leader status with 38.5 crore subscribers at the end of Q3FY20. Telecom business to witness robust growth over the next few years due to tariff hikes and shift of subscribers from Vodafone Idea to other telecom players. RIL has also built a very strong retail business which is the largest organized retailing company in India. Angel Broking expects the retail business to be a key value driver for Reliance over the long run though there would be some impact on business in FY21 due to the COVID-19 outbreak. Refining and petrochemicals business would be a stable low growth business for RIL going forward but will be a major cash generator for the company as there will be negligible capex requirements. The cash flows would be used to fund expansion into other businesses. Upside: 11% Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd,https://www.moneycontrol.com/news/business/stocks/slideshow-angel-broking-picks-17-stocks-that-can-return-up-to-32-5249801.html
"May 11, 2020 01:43 PM IST",2,Subhash Helgaokar,Buy Hindalco; target of Rs 179: Motilal Oswal,"Motilal Oswal 's research report on HindalcoHindalco's (HNDL) subsidiary Novelis' 4QFY20 results highlight the company's strength in its high-margin business with EBITDA/t of USD436/t.
We lower our FY21/FY22E EBITDA estimates by 7%/4% due to lower-than-expected volumes in Novelis on account of COVID-19.
However, we reiterate our Buy rating given the attractive valuation (5x FY22E EV/EBITDA) and ~75% EBITDA contribution from the non-LME business (Novelis and Aleris), which provides more stability to earnings.
OutlookThe stock trades at an attractive valuation of 5.0x EV/EBITDA and 6x P/E on FY22E.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Motilal Oswal is bullish on Hindalco has recommended buy rating on the stock with a target price of Rs 179 in its research report dated May 07, 2020.","Motilal Oswal 's research report on Hindalco

Hindalco's (HNDL) subsidiary Novelis' 4QFY20 results highlight the company's strength in its high-margin business with EBITDA/t of USD436/t. We lower our FY21/FY22E EBITDA estimates by 7%/4% due to lower-than-expected volumes in Novelis on account of COVID-19. However, we reiterate our Buy rating given the attractive valuation (5x FY22E EV/EBITDA) and ~75% EBITDA contribution from the non-LME business (Novelis and Aleris), which provides more stability to earnings.

Outlook

The stock trades at an attractive valuation of 5.0x EV/EBITDA and 6x P/E on FY22E. We value it at INR179/share based on SOTP. Re-iterate Buy.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hindalco-target-of-rs-179-motilal-oswal-5250091.html
"May 11, 2020 09:56 AM IST",1,Sandip Das,VIP Industries share price jumps 6% after Rakesh Jhunjhunwala raises stake,"VIP Industries share price surged almost 7 percent in the morning trade on May 11 after ace investor Rakesh Jhunjhunwala raised his stake by 2.85 lakh shares during the January-March quarter of FY20, BSE data showed.
In Q4FY20, Jhunjhunwala held 75,00,400 shares of VIP Industries against 72,15,400 shares held at the end of Q3.
In percentage terms, Jhunjhunwala now holds 5.31 percent shares of the company, data showed.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAccording to Moneycontrol SWOT Analysis, powered by Trendlyne, VIP Industries has zero promoter pledge with the book value per share improving for the last two years but the technical rating is very bearish.","The stock volume grew 1.56 times and was trading with volumes of 32,835 shares, compared to its five-day average of 13,203 shares, an increase of 148.69 percent.","VIP Industries share price surged almost 7 percent in the morning trade on May 11 after ace investor Rakesh Jhunjhunwala raised his stake by 2.85 lakh shares during the January-March quarter of FY20, BSE data showed.

In Q4FY20, Jhunjhunwala held 75,00,400 shares of VIP Industries against 72,15,400 shares held at the end of Q3.

In percentage terms, Jhunjhunwala now holds 5.31 percent shares of the company, data showed.

The stock volume jumped more than 1.56 times and was trading with volumes of 32,835 shares, compared to its five-day average of 13,203 shares, an increase of 148.69 percent.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

According to Moneycontrol SWOT Analysis, powered by Trendlyne, VIP Industries has zero promoter pledge with the book value per share improving for the last two years but the technical rating is very bearish.",https://www.moneycontrol.com/news/business/stocks/vip-industries-share-price-jumps-6-after-rakesh-jhunjhunwala-raises-stake-5248841.html
"May 11, 2020 10:07 AM IST",1,Rakesh Patil,Inox Wind share price rises 5% on order win from Continuum Power Trading,"Inox Wind share price rose 5 percent intraday on May 11 after company had won an order from Continuum Power Trading.
The company has signed definitive agreements with Continuum Power Trading (TN) Private Limited to supply, erect and commission 250 MW of wind power projects (in two phases of 126 MW and 124 MW) comprising of a mix of 2 MW and 3 MW turbines.
As a part of the turnkey order, company will provide Continuum Power with end to end solutions from development and construction to commissioning and providing long term operations and maintenance services.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAt 09:52 hrs Inox Wind was quoting at Rs 25, up Rs 0.90, or 3.73 percent on the Bombay Stock Exchange (BSE).",The company will provide Continuum Power with end to end solutions from development and construction to commissioning and providing long term operations and maintenance services.,"Inox Wind share price rose 5 percent intraday on May 11 after company had won an order from Continuum Power Trading.

The company has signed definitive agreements with Continuum Power Trading (TN) Private Limited to supply, erect and commission 250 MW of wind power projects (in two phases of 126 MW and 124 MW) comprising of a mix of 2 MW and 3 MW turbines.

Upon the receipt of certain advances, Inox Wind has started execution of the first phase of the project comprising of 126 MW which is scheduled to be commissioned by Q3 of FY 2021 at Dayapar, District Bhuj in the State of Gujarat on a turnkey basis.

As a part of the turnkey order, company will provide Continuum Power with end to end solutions from development and construction to commissioning and providing long term operations and maintenance services.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:52 hrs Inox Wind was quoting at Rs 25, up Rs 0.90, or 3.73 percent on the Bombay Stock Exchange (BSE).",https://www.moneycontrol.com/news/business/stocks/inox-wind-share-price-rises-5-on-order-win-from-continuum-power-trading-5248891.html
"May 11, 2020 01:45 PM IST",1,Sunil Matkar,IRCTC locked in upper circuit as online booking for passenger train starts,"Shares of Indian Railway Catering & Tourism Corporation (IRCTC) were locked in 5 percent upper circuit on May 11 as the online booking for passenger train operations started.
Today it was quoting at Rs 1,302.85, up Rs 62.00, or 5 percent on the BSE at 1307 hours IST.
Also read: Here is a list of trains Indian Railways will be starting from May 12The tickets for trains are available only through IRCTC website.
""Ticket booking counters at the railway stations shall remain closed and no counter tickets (including platform tickets) shall be issued.
Catering business contributed 55 percent to FY19 revenue of IRCTC, tourism 23.5 percent and Rail Neer around 9 percent.","The tickets for trains are available only through IRCTC website. Ticketing business contributed 12.4 percent to total revenue of IRCTC and according to Prabhudas Lilladher, is expected to contribute 26 percent to total revenue in FY20.","Shares of Indian Railway Catering & Tourism Corporation (IRCTC) were locked in 5 percent upper circuit on May 11 as the online booking for passenger train operations started.

The stock corrected 58 percent in past month from its high seen in February due to COVID-19 crisis, but rallied 60 percent from its closing low of March.

Today it was quoting at Rs 1,302.85, up Rs 62.00, or 5 percent on the BSE at 1307 hours IST. There were pending buy orders of 134,304 shares, with no sellers available.

The Indian Railways will be gradually starting passenger train operations from May 12, initially, with 15 pairs of trains (30 return journeys), the government has said on Sunday.

The booking for reservation in these trains will start from May 11 at 4 pm, the government has said, adding that the booking option will be available only on IRCTC website.

Also read: Here is a list of trains Indian Railways will be starting from May 12

The tickets for trains are available only through IRCTC website. Ticketing business contributed 12.4 percent to total revenue of IRCTC and according to Prabhudas Lilladher, is expected to contribute 26 percent to total revenue in FY20.

""Ticket booking counters at the railway stations shall remain closed and no counter tickets (including platform tickets) shall be issued. Only passengers with valid confirmed tickets will be allowed to enter the railway stations,"" the government has said.

Catering business contributed 55 percent to FY19 revenue of IRCTC, tourism 23.5 percent and Rail Neer around 9 percent.

Prabhudas Lilladher expects company to report a 17.6 percent sequential decline in adjusted profit, 15 percent in revenue and 17 percent in EBITDA for the quarter ended March 2020, largely due to COVID-19-led shutdown.

COVID-led shutdown is expected to lead to a revenue loss of 15-20 days in March quarter, the brokerage said, adding IRCTC's fixed monthly operating expenses burn is in the region of Rs 42-52 crore.

But IRCTC is debt-free and had cash balance of Rs 1,160 crore as of December 2019. Thus, Prabhudas Lilladher believes company can meet its fixed cost obligations from current cash pile without any strain on balance sheet.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/irctc-locked-in-upper-circuit-as-online-booking-for-passenger-train-starts-5250201.html
"May 11, 2020 01:43 PM IST",1,Subhash Helgaokar,Buy Hindustan Unilever Limited target of Rs 2305: Sharekhan,"Sharekhan's research report on Hindustan Unilever LimitedThe GSK Group sold 5.7% stake (13.37 crore shares) in Hindustan Unilever (HUL) through multiple block deals in the open market.
HUL's stock price has corrected by ~16% from its recent high factors in the sluggish performance in Q4FY2020.
With 50-55% of business catering to essential categories and the company's strong direct distribution reach, we expect HUL to recover rapidly post the pandemic situation.
We maintain our Buy recommendation on the stock with unchanged PT of Rs.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on Hindustan Unilever Limited has recommended buy rating on the stock with a target price of Rs 2305 in its research report dated May 08, 2020.","Sharekhan's research report on Hindustan Unilever Limited

The GSK Group sold 5.7% stake (13.37 crore shares) in Hindustan Unilever (HUL) through multiple block deals in the open market. This has reduced the supply overhang in the stock. The merger of GSK Consumer Healthcare's business with HUL will make the latter one of the largest players in the domestic foods space and would lead to earnings accretion of 4-8% over FY2021/FY2022. HUL's stock price has corrected by ~16% from its recent high factors in the sluggish performance in Q4FY2020. With 50-55% of business catering to essential categories and the company's strong direct distribution reach, we expect HUL to recover rapidly post the pandemic situation.

Outlook

HUL has a strong balance sheet with robust cash flows and goods dividend payout which makes it a safest bet in the uncertain environment. We maintain our Buy recommendation on the stock with unchanged PT of Rs. 2,305.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hindustan-unilever-limited-target-of-rs-2305-sharekhan-2-5250111.html
"May 11, 2020 01:42 PM IST",1,Subhash Helgaokar,Buy Shree Cement target of Rs 20660: Sharekhan,"Sharekhan's research report on Shree CementDuring Q4FY2020, Shree Cement reported better-than-expected operational performance, backed by higher realisation and reduced cost of production.
Shree Cement will not undertake any new capacity expansion plan for atleast a year, as cement demand is expected to decline during FY2021.
However, cement demand is likely to bounce back in FY2022.
2,400 crore would aid in maintaining healthy liquidity profile and better working capital management in the near term.
OutlookWe reiterate our Buy rating on Shree Cement Limited (Shree Cement) with a revised PT of Rs.","Sharekhan is bullish on Shree Cement has recommended buy rating on the stock with a target price of Rs 20660 in its research report dated May 08, 2020.","Sharekhan's research report on Shree Cement

During Q4FY2020, Shree Cement reported better-than-expected operational performance, backed by higher realisation and reduced cost of production. Cement volumes were affected by COVID-19-led lockdown. Shree Cement will not undertake any new capacity expansion plan for atleast a year, as cement demand is expected to decline during FY2021. However, cement demand is likely to bounce back in FY2022. Shree Cement's recent fund raising of Rs. 2,400 crore would aid in maintaining healthy liquidity profile and better working capital management in the near term.

Outlook

We reiterate our Buy rating on Shree Cement Limited (Shree Cement) with a revised PT of Rs. 20,660,considering its strong balance sheet, efficient operations, and scarcity premium (relatively low absolute free float).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-shree-cement-target-of-rs-20660-sharekhan-5250131.html
"May 11, 2020 01:44 PM IST",1,Subhash Helgaokar,Buy ICICI Bank target of Rs 454: Sharekhan,"Sharekhan's research report on ICICI BankICICI Bank posted mixed numbers for Q4FY20 in a difficult environment, wherein operating performance was in line, while large provisions (partly due to one large account and COVID-19) affected PAT.
GNPA/ NNPA ratio decreased sequentially by 35 bps / 6 bps to 6.04% / 1.54% respectively, but high slippages and ~30% of book under moratorium are dampeners.
OutlookWe maintain our Buy rating on the stock with a revised price target (PT) of Rs.
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 454 in its research report dated May 08, 2020.","Sharekhan's research report on ICICI Bank

ICICI Bank posted mixed numbers for Q4FY20 in a difficult environment, wherein operating performance was in line, while large provisions (partly due to one large account and COVID-19) affected PAT. GNPA/ NNPA ratio decreased sequentially by 35 bps / 6 bps to 6.04% / 1.54% respectively, but high slippages and ~30% of book under moratorium are dampeners. We are cutting our estimates and target multiple considering the dynamic environment.

Outlook

We maintain our Buy rating on the stock with a revised price target (PT) of Rs. 454.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-icici-bank-target-of-rs-454-sharekhan-5250121.html
"May 11, 2020 10:38 AM IST",1,Nishant Kumar,"RIL share price climbs over 3%, looks to extend gains into 5th consecutive session","Reliance Industries (RIL) share price jumped more than 3 percent in the morning trade on BSE on May 11, looking to extend its winning streak into the fifth consecutive session.
The oil-to-retail major has been gaining after brokerages and analysts reacted positively on Reliance Industries' Jio Platforms securing three back-to-back deals.
The three investments in Jio Platforms are expected to fast-track RIL's target of emerging net debt-free on a net cash basis by March 2021.
On April 30, RIL announced India's biggest rights issue of Rs 53,125 crore at Rs 1,257 per share.
Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",Reliance Industries has been gaining after it secured three back-to-back investment deals for its Jio Platforms.,"Reliance Industries (RIL) share price jumped more than 3 percent in the morning trade on BSE on May 11, looking to extend its winning streak into the fifth consecutive session.

The oil-to-retail major has been gaining after brokerages and analysts reacted positively on Reliance Industries' Jio Platforms securing three back-to-back deals.

The three investments in Jio Platforms are expected to fast-track RIL's target of emerging net debt-free on a net cash basis by March 2021.

On April 22, Facebook announced its decision to invest Rs 43,574 crore in Jio Platforms for a 9.99 percent stake.

Silver Lake on May 4 said it would invest Rs 5,655.75 crore for a 1.15 percent stake at an equity value of Rs 4.90 lakh crore. Four days later, Vista Equity Partners picked a 2.32 percent stake for Rs 11,367 crore.

Overall, experts remain bullish on the stock given its current and expected growth in telecom and digital business and the company's deleveraging plan. They feel the deal with Facebook will boost Reliance Retail's business and help RIL grow much faster.

On April 30, RIL announced India's biggest rights issue of Rs 53,125 crore at Rs 1,257 per share.

In a BSE filing on May 9, the company announced May 14 as the ‘Record Date' for the purpose of the rights issue.

At 1010 hours, the stock was trading 2.47 percent up at Rs 1,600.40 on BSE.

Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/ril-share-price-climbs-over-3-looks-to-extend-gains-into-5th-consecutive-session-5248921.html
"May 11, 2020 03:56 PM IST",-1,Sandip Das,D-Street Buzz: Bank Nifty ends 2% lower dragged by ICICI Bank; SBI hits 52-week low on BSE,"The other losers included Kotak Mahindra Bank, IndusInd Bank, Punjab National Bank and RBL Bank which ended 1-2 percent lower.
ICICI Bank, HDFC Bank, Axis Bank and State Bank of India were among the most active stocks on NSE in terms of value.
About 8,36,56,578 shares were traded in ICICI Bank while 1,42,72,411 share were traded in HDFC Bank and 5,45,61,254 shares were traded in State Bank of India.
Shah feels many of the topline stocks in Bank Nifty are going to make lower lows.
The company's revenue for the quarter though was up 21 percent at Rs 2,510 crore from Rs 2,076 crore.","Apart from ICICI Bank, other banking names including Kotak Mahindra Bank, IndusInd Bank, Punjab National Bank and RBL Bank ended 1-2 percent lower.","The Indian stock market have closed in the red after profit booking dragged the market with Bank Nifty being the top sectoral losers down over 2 percent.

The top losers from the banking space included ICICI Bank which fell over 5 percent after the bank set aside Rs 2,725 crore as specific provisions towards the impact of the COVID-19 induced lockdown.

The other losers included Kotak Mahindra Bank, IndusInd Bank, Punjab National Bank and RBL Bank which ended 1-2 percent lower.

ICICI Bank, HDFC Bank, Axis Bank and State Bank of India were among the most active stocks on NSE in terms of value. About 8,36,56,578 shares were traded in ICICI Bank while 1,42,72,411 share were traded in HDFC Bank and 5,45,61,254 shares were traded in State Bank of India.

Gautam Shah, Founder and Chief Strategist at Goldilocks Premium Research in an interview to CNBC-TV18 said, Bank Nifty plunged 45 percent against 37 percent fall seen in Nifty 50 during February 19-March 23 period when the maximum sell-off had taken place globally due to COVID-19 crisis and FII outflow. Shah feels many of the topline stocks in Bank Nifty are going to make lower lows.

Gautam Shah expects the Bank Nifty to fall towards 19,500 levels in the immediate. And if that gets violated then one could see the drop all the way to 18,300 and possibly even 17,000, he feels.

Share price of Au Small Finance Bank was down 5 percent lower circuit on BSE. Japanese research firm Nomura has downgraded the stock to neutral with a target price of Rs 500. It expects assets under management to moderate to 10 per cent and 22 per cent by FY21 and FY22, respectively.

Share price of State Bank of India hit 52-week low on BSE with the PSU major's Q4 profit down to Rs 83.5 crore from Rs 249 crore in the year-ago period, reported CNBC-TV18. The company's revenue for the quarter though was up 21 percent at Rs 2,510 crore from Rs 2,076 crore.

Also, three promoters of Ram Dev International, recently booked by the CBI for allegedly cheating a consortium of six banks to the tune of Rs 411 crore, have already fled the country before the State Bank of India reached the agency with the complaint, officials said on Saturday. According to the complaint filed by SBI, the account had become non-performing asset (NPA) on January 27, 2016.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-bank-nifty-ends-2-lower-dragged-by-icici-bank-sbi-hits-52-week-low-on-bse-5251001.html
"May 11, 2020 11:55 AM IST",1,Sandip Das,"D-Street Buzz: Nifty Auto ends 4% higher led by Maruti, Tata Motors, Hero MotoCorp; Bajaj Auto jumps 6%","Among the sectors, the auto index jumped 4 percent led by Maruti Suzuki, Tata Motors, Bajaj Auto and Hero MotoCorp which jumped 6 percent each.
Hero MotoCorp on May 10 said it has resumed operations across 1,500 touch-points, including authorised dealerships, across the country.
Around 10,000 units of motorcycles and scooters have already been sold since the reopening of these customer touch-points, Hero MotoCorp said in a statement.
It prefers companies that have a strong balance sheet and cash position and are leaders in their segments such as Hero MotoCorp and Exide Industries.
Shabbir Kayyumi, Head of Technical Research at Narnolia Financial Advisors recommends buying Tata Motors around Rs 78 with target at Rs 92.","Maruti Suzuki and Tata Motors were among the most active stocks on NSE in terms of value with 31,76,498 shares and 15,25,92,033 shares traded respectively.","The Indian stock market ended in the red after profit booking on May 11.

Sensex was down 81.48 points or 0.26% at 31561.22, while Nifty was down 12.30 points or 0.13% at 9239.20. About 1084 shares have advanced, 1280 shares declined, and 186 shares are unchanged.

Among the sectors, the auto index jumped 4 percent led by Maruti Suzuki, Tata Motors, Bajaj Auto and Hero MotoCorp which jumped 6 percent each.

After being shut for more than 40 days, two-wheeler, car and commercial vehicle showrooms are finally beginning to open in areas that were lesser impacted by the COVID-19 pandemic.

Hero MotoCorp on May 10 said it has resumed operations across 1,500 touch-points, including authorised dealerships, across the country. Around 10,000 units of motorcycles and scooters have already been sold since the reopening of these customer touch-points, Hero MotoCorp said in a statement.

Maruti Suzuki and Tata Motors were among the most active stocks on NSE in terms of value with 31,76,498 shares and 15,25,92,033 shares traded respectively at 15:30 hours.

Tata Motors has been a steady performer in the last 1 month with the stock gaining over 27 percent.

According to broking house, Sharekhan, Eicher Motors and Maruti Suzuki are its top largecap picks. It prefers companies that have a strong balance sheet and cash position and are leaders in their segments such as Hero MotoCorp and Exide Industries.

Shabbir Kayyumi, Head of Technical Research at Narnolia Financial Advisors recommends buying Tata Motors around Rs 78 with target at Rs 92. Daily chart of the stock reveals that demand is increasing and supply is diminishing as stock is taking support from line of the parity showing a rebound from its lower levels, he said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-auto-stocks-rally-led-by-maruti-tata-motors-hero-motocorp-motherson-sumi-jump-5-6-5249441.html
"May 12, 2020 07:30 AM IST",2,Nishant Kumar,"Hot Stocks | Sun Pharma, Lupin, Torrent Pharma are three short-term ideas","Daily DMI Indicator has also reached the contraction zone after the positive move, which indicates weakness in the short-term trend.
Bearish markets are likely to be headed by the banking and finance sector, while pharma and IT would remain outperformers.
Lupin | Buy | LTP: Rs 852.80 | Target price: Rs 920 | Stop loss: Rs 809 | Upside: 8%After a few days of consolidation, the stock has resumed its primary uptrend.
Torrent Pharmaceuticals | Buy | LTP: Rs 2,506 | Target price: Rs 2,725 | Stop loss: Rs 2,350 | Upside: 9%The stock has given a symmetrical triangle pattern breakout on the daily charts.
The primary trend has been bullish with higher tops and higher bottoms on the daily and weekly charts.","After bearish development on the short-term charts, Nifty has not seen follow up selling. The level of 9,100 has been acting as strong support for the index.","Vinay Rajani

For the last five sessions, Nifty has been trying to sustain above 9,100 and has been consolidating in the narrow range of 9,200 and 9,270 on a closing basis.

After bearish development on the short-term charts, Nifty has not seen follow up selling. The level of 9,100 has been acting as strong support for the index.

Any level below 9,116 could result in selling momentum in the Nifty.

Below 9,116, the index could slide to the next supports of 8,980 and 8,700, which happens to be 38.2 percent and 50 percent retracement of the entire rise seen from 7,511 to 9,889.

On the upside, the range of 9,500-9,550 could act as a resistance, where calls have been written and an 'Island' unfilled gap is placed.

Daily MACD Indicator has been struggling to move above its zero line. Daily DMI Indicator has also reached the contraction zone after the positive move, which indicates weakness in the short-term trend.

Breadth Indicators on the Nifty500 daily chart is giving the sign of market weakening. New high low index and MCclellan Summation Index have turned bearish on the daily chart.

This has happened for the first time after March 5, 2020, when the bullish signal was generated by the same indicators.

It is advisable to remain cautious on the market. Any level below 9,116 could bring momentum selling in the Nifty, which could drag it towards 8,980 and 8,700 targets.

Pullbacks and rallies should be utilised to lighten long commitments. However, the market would remain stock and sector-specific. Bearish markets are likely to be headed by the banking and finance sector, while pharma and IT would remain outperformers.

Here are three stock ideas for the next 3-4 weeks:

Sun Pharma | Buy | LTP: Rs 465.50 | Target price: Rs 510 | Stop loss: Rs 437 | Upside: 10%

The primary trend of the stock has been bullish as it has been forming higher tops and higher bottoms since March 2020.

The stock is trading above its 50, 100 and 200-DMA. It has reversed north from the previous top support on the weekly charts.

The relative strength of the stock has been significantly higher as compared to Nifty for the last many weeks. Weekly RSI and MACD have reached above their previous peaks and are showing strength in the trend.

The pharma sector looks strongest amongst the sectors.

Lupin | Buy | LTP: Rs 852.80 | Target price: Rs 920 | Stop loss: Rs 809 | Upside: 8%

After a few days of consolidation, the stock has resumed its primary uptrend. In the month of April 2020, it broke out from a long-term downward sloping trend line on the monthly charts.

This month, the stock should see follow up buying. It is placed above all important moving averages. Indicators and Oscillators are also showing strength in the trend.

Torrent Pharmaceuticals | Buy | LTP: Rs 2,506 | Target price: Rs 2,725 | Stop loss: Rs 2,350 | Upside: 9%

The stock has given a symmetrical triangle pattern breakout on the daily charts. It is very near to its all-time high.

The primary trend has been bullish with higher tops and higher bottoms on the daily and weekly charts. This stock is one of the best-performing stocks from the pharma sector.

Volumes have been rising along with the price rise for the last 4 sessions.

(The analyst is Senior Technical & Derivative Analyst at HDFC securities)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​​",https://www.moneycontrol.com/news/business/markets/hot-stocks-sun-pharma-lupin-torrent-pharma-are-three-short-term-ideas-5251081.html
"May 11, 2020 01:43 PM IST",1,Subhash Helgaokar,Buy RBL Bank; target of Rs 180: Motilal Oswal,"Motilal Oswal 's research report on RBL BankRBK reported weak business trends, weighed by decline in wholesale assets and deposit outflows.
Higher provisions impacted earnings, but slippages moderated on a sequential basis, enabling improvement in the coverage ratio.
Asset quality is expected to remain under watch as 33% of the loan book availed moratorium, with management guiding for elevated credit costs in credit cards/MFI/MSME portfolio.
OutlookThis may pose a risk as the business environment remains weak, thus prolonging the slippage trend in the Wholesale portfolio.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Motilal Oswal is bullish on RBL Bank has recommended buy rating on the stock with a target price of Rs 180 in its research report dated May 07, 2020.","Motilal Oswal 's research report on RBL Bank

RBK reported weak business trends, weighed by decline in wholesale assets and deposit outflows. Higher provisions impacted earnings, but slippages moderated on a sequential basis, enabling improvement in the coverage ratio. Asset quality is expected to remain under watch as 33% of the loan book availed moratorium, with management guiding for elevated credit costs in credit cards/MFI/MSME portfolio. We cut our PAT estimate for FY21/FY22 by 6%/5%, primarily as we factor in moderation in fee income, led by reduced economic activity / lockdown. Maintain Buy.

Outlook

This may pose a risk as the business environment remains weak, thus prolonging the slippage trend in the Wholesale portfolio. We revise our TP to INR180 (0.9x FY22E ABV). Maintain Buy.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-rbl-bank-target-of-rs-180-motilal-oswal-5250101.html
"May 11, 2020 01:42 PM IST",1,Subhash Helgaokar,Buy Jindal Steel and Power; target of Rs 150: Motilal Oswal,"Motilal Oswal 's research report on Jindal Steel and PowerJSPL produced 550kt steel and related products during Apr'20 (up 5% YoY).
This was on the back of record high production from the Angul Blast Furnace, which produced 298kt hot metal, clocking 10kt daily.
Apr'20 sales stood at 335kt, of which 248kt (74% of total) were exports.
The balance production in Apr'20 is at the ports, waiting to be exported out; sales would be booked in May'20.
We value JSPL stock using SoTP methodology and value the steel business at 4.0x.","Motilal Oswal is bullish on Jindal Steel and Power has recommended buy rating on the stock with a target price of Rs 150 in its research report dated May 05, 2020.","Motilal Oswal 's research report on Jindal Steel and Power

JSPL produced 550kt steel and related products during Apr'20 (up 5% YoY). This was on the back of record high production from the Angul Blast Furnace, which produced 298kt hot metal, clocking 10kt daily. Other related products include granulated pig iron and other intermediary products. Though domestic demand remained dry during the month, production was boosted by large export orders, primarily of billets from China due to the shortage of intermediates there. Apr'20 sales stood at 335kt, of which 248kt (74% of total) were exports. Exports were up 109% MoM while implied domestic sales were down ~80% MoM. The balance production in Apr'20 is at the ports, waiting to be exported out; sales would be booked in May'20. We note that while these export volumes would earn lower EBITDA margins (likely ~INR5,000/t), it is still positive as this should help recover fixed costs if plants earn positive cash flows, which is critical in this environment.

Outlook

At CMP, the stock trades at 4.1x FY22E EV/EBITDA. We value JSPL stock using SoTP methodology and value the steel business at 4.0x. The power business is valued using DCF method. We arrive at a target price of INR150/share.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-jindal-steel-and-power-target-of-rs-150-motilal-oswal-5250081.html
"May 11, 2020 11:52 AM IST",2,Sunil Matkar,"Reliance Industries reclaims Rs 10 lakh crore m-cap intraday, 2.6% away from record high","Reliance Industries, owner of the country's largest telecom operator Jio by subscriber base, has reclaimed Rs 10 lakh crore mark in market capitalisation intraday on May 11, but it closed slightly below that mark.
The index is 2.6 percent away from its record high of Rs 1,617.80 seen on December 20 last year.
After the company announced its deleveraging plan in the AGM last year, the stock had picked up momentum and hit a record high in December.
As a part of debt reduction, Reliance on April 30th also announced India's biggest rights issue of Rs 53,125 crore, with a ratio of 1:15 and a price of Rs 1,257 per share.
Download a copy: 'Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.'","The index is 2.6 percent away from its record high of Rs 1,617.80 seen on December 20 last year.","Reliance Industries, owner of the country's largest telecom operator Jio by subscriber base, has reclaimed Rs 10 lakh crore mark in market capitalisation intraday on May 11, but it closed slightly below that mark. Last it hit the level was on January 17, 2020.

The stock gained 0.96 percent to close at Rs 1,576.75, with a market cap of Rs 9,99,565.43 crore, after hitting an intraday high of Rs 1,614.85, taking total gains to 78 percent from closing lows of March, outperforming equity benchmark indices which gained around 21 percent from March lows.

The index is 2.6 percent away from its record high of Rs 1,617.80 seen on December 20 last year.

After the company announced its deleveraging plan in the AGM last year, the stock had picked up momentum and hit a record high in December.

However, it also fell sharply along with market turmoil in February-March due to COVID-19 crisis, but rebounded quite sharply than any other largecaps in April-May following strong growth in Reliance Jio and stake sale in Jio Platforms, the 100 percent subsidiary of RIL.

Reliance announced three back to back deals with private equity investors (Vista and Silver Lake) and Whatsapp's owner Facebook Inc, and garnered Rs 60,596.37 crore by selling 13.47 percent stake in Jio Platforms in less than three weeks.

""In the midst of all the chaos, Reliance Industries seems to have created its own bull market territory through a V-Shaped recovery by concerted efforts to bring quality investors, reduce its net debt and streamline its balance sheet,"" Jimeet Modi, Founder & CEO at SAMCO Securities & StockNote told Moneycontrol.

RIL having the highest weight in Nifty50 is also keeping markets on a better footing which in a way is helping to neutralize negative sentiments and is good for the current pandemic-stricken economy, he said.

As a part of debt reduction, Reliance on April 30th also announced India's biggest rights issue of Rs 53,125 crore, with a ratio of 1:15 and a price of Rs 1,257 per share.

With strong visibility to these equity infusions, RIL is set to achieve net-zero debt status ahead of its own aggressive timeline (March 2021), Reliance said.

And in spite of the COVID-19 crisis and the lockdowns, the due-diligence by Saudi Aramco for the planned investment in the O2C business is on track as both the parties are committed and actively engaged, it added.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: 'Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.'",https://www.moneycontrol.com/news/business/markets/reliance-industries-ril-reclaims-rs-10-lakh-crore-market-cap-again-nears-record-high-5249391.html
"May 11, 2020 01:32 PM IST",-1,Sunil Matkar,"HDFC AMC falls 4% after weak Q4 earnings, Narnolia downgrades to hold","Shares of HDFC Asset Management Company fell nearly 4 percent intraday on May 11 after weak earnings in Q4FY20 following decline in equity markets.
equity oriented QAAUM excluding index funds stood at Rs 1,57,400 Cr as on March 2020 with a market share of 15.2 percent.
Equity AUM composition to the total AUM declined to 38 percent in Q4FY20 as against 46 percent last quarter (closing AUM basis).
""HDFC AMC's business franchise is seen remaining strong with substantial market share of 14-15 percent and strong operational performance (39-40 bps).
HDFC Asset Management Company share price was quoting at Rs 2,571.80, down Rs 50.55, or 1.93 percent on the BSE at 1258 hours IST.","Revenue in Q4 fell 2.1 percent YoY (down 9.3 percent QoQ) to Rs 476 crore due to low AUM growth, fall in equity oriented assets as well as less fee income on PMS.","Shares of HDFC Asset Management Company fell nearly 4 percent intraday on May 11 after weak earnings in Q4FY20 following decline in equity markets.

Company's profit in March quarter degrew by 9.6 percent year-on-year (down 29.4 percent QoQ) to Rs 250 crore mainly on the account of lower revenue and one off impact on other income.

Revenue in Q4 fell 2.1 percent YoY (down 9.3 percent QoQ) to Rs 476 crore due to low AUM growth, fall in equity oriented assets as well as less fee income on PMS.

Quarterly Average Assets under Management (QAAUM) grew by 8 percent YoY (down 3 percent QoQ) mainly due to fall in equity oriented assets on the account of fall in markets. QAAUM in actively managed equity oriented funds i.e. equity oriented QAAUM excluding index funds stood at Rs 1,57,400 Cr as on March 2020 with a market share of 15.2 percent.

Equity AUM composition to the total AUM declined to 38 percent in Q4FY20 as against 46 percent last quarter (closing AUM basis). This fall had impact on the revenue of the company as it being the high margin segment but management is optimistic of the recovery in equity AUM going ahead.

""AUM growth has been lowest in Q4FY20 as against that of in last 8 quarters almost. SIP book declined. Along with that company had performance issue in its larger funds causing the decline in market share. Operating expenses are expected to remain under control,"" Narnolia Financial Services said.

On the account of macroeconomic factors (COVID-19 impact on the market) along with the performance of the company, the brokerage downgraded its rating on the stock to hold from buy, but maintained target price at Rs 2,703.

As per the management after the recent event in Mutual Fund industry the debt investors are more or less moving to liquid and overnight funds.

ICICI Direct feels given elevated economic uncertainty, amid COVID-19, its business model is preferred involving least credit risk. Hence, the brokerage maintained its buy rating on the stock with a target price of Rs 3,000 per share.

""Near term outlook remains uncertain but structural changes, including increase in financial savings, remain positive. It is expected to maintain its leadership through healthy AUM growth. Focus on strong operating efficiency & higher proportion of equity AUM is seen aiding profitability. MTM decline led to schemes falling in low value slab, enabling higher TER cushioning declining revenue,"" ICICI Direct said.

""HDFC AMC's business franchise is seen remaining strong with substantial market share of 14-15 percent and strong operational performance (39-40 bps). Hence, its strong positioning & superior earnings profile deserve premium valuations,"" it added.

HDFC Asset Management Company share price was quoting at Rs 2,571.80, down Rs 50.55, or 1.93 percent on the BSE at 1258 hours IST. Before today's fall, it was up 25 percent from its March-end.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hdfc-amc-falls-4-after-weak-q4-earnings-narnolia-downgrades-to-hold-5249981.html
"May 11, 2020 10:25 AM IST",1,Kshitij Anand,COVID-19 presents an opportunity to invest in MNCs; 18 firms worth looking at,"The COVID-19-led price correction in stocks presents a unique opportunity for Indian investors to invest in the Multi-National Corporations (MNCs) listed in India, Standard Chartered Securities India Limited said in a report.
The strong parentage backing and strategic shift of their production base to India presents a unique opportunity for long-term growth.
There are 18 stocks which fit the criteria and that include names like Blue Dart, Akzo Nobel, Abbott India, Cummins India, HUL, Castrol India, and OFSS, etc.
MNC Outperformance:Historical evidence suggests MNCs companies have delivered superior returns over a long-term period, said the note.
The MNC companies have also outperformed the broader market benchmarks over a longer period.",MNCs are usually well-capitalized with low debt exposure and good dividend policies. Most of the MNCs have market leadership in their category of operations and strong brand equity.,"The COVID-19-led price correction in stocks presents a unique opportunity for Indian investors to invest in the Multi-National Corporations (MNCs) listed in India, Standard Chartered Securities India Limited said in a report.

The strong parentage backing and strategic shift of their production base to India presents a unique opportunity for long-term growth.

The international brokerage house is of the view that MNC companies tend to outperform the broader market over a long period as evidenced by the comparative study between the Nifty MNC index and prominent benchmarks.

“We have filtered our MNC universe of 43 stocks basis profitability ratios (ROE & ROCE) higher than 15 percent for the past three fiscal years. There are 18 stocks which fit the criteria and that include names like Blue Dart, Akzo Nobel, Abbott India, Cummins India, HUL, Castrol India, and OFSS, etc. among others,” said the note.

Why MNC?

MNC's are professionally driven by strong corporate governance. They are known for their technological proficiency and asset-light business models.

Standard Chartered Securities India is of the view that in the post-COVID world, business models of MNCs are likely to lead the growth backed by innovation and faster adoption to changing consumer behaviour.

MNCs are usually well-capitalized with low debt exposure and good dividend policies. Most of the MNCs have market leadership in their category of operations and strong brand equity.

The report highlighted that MNCs are also likely to be key beneficiaries of structural changes such as formalisation of the Indian economy, the abolition of the Dividend Distribution Tax for corporates (as proposed in the recent budget), and India's quest for Make-in-India to be successful.

MNC Outperformance:

Historical evidence suggests MNCs companies have delivered superior returns over a long-term period, said the note.

The MNC companies have also outperformed the broader market benchmarks over a longer period. Over a five-year period, the Nifty MNC has outperformed the Nifty50 index by 1.5 percent CAGR and the BSE 500 by 1.8 percent CAGR.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-presents-an-opportunity-to-invest-in-mncs-18-firms-worth-looking-at-5247581.html
"May 11, 2020 09:40 AM IST",1,Rakesh Patil,ICICI Bank share price falls post Q4 nos; brokerages maintain buy,"Dolat Capital | Rating: Buy | Target: Rs 420The disappointment on asset quality was driven by high corporate slippages, led by two overseas exposures.
HDFC Securities | Rating: Buy | Target: Rs 435Banks Gross NPAs dipped (-10.5/4.7% YoY/QoQ) to Rs 414.1 billion (5.53%, -117/42bps) facilitated by higher reductions as gross slippages at Rs 53.1 billion (3.3% ann.
Total deposits grew 18.1/7.6% to Rs 7.71 trillion, driven by 29% YoY growth in term deposits.
Average CA deposits grew 15% YoY and average SA deposit grew 11% YoY.
Motilal Oswal | Rating: Buy | Target: Rs 475Broking firm expect loan growth to moderate given the weak macro environment, weighed by the COVID-19 outbreak.","The domestic loan growth was at 13 percent YoY in March quarter, driven by 16 percent growth in retail segment that contributed about 53.3 percent to total loan book.","ICICI Bank share price fell over 1 percent in the early trade on May 11 after the company posted better-than-expected numbers for the March quarter.

The company on May 9 reported a 26 percent year-on-year growth in standalone profit at Rs 1,221.36 crore in quarter ended March 2020 against Rs 969.06 crore.

The bank had made COVID-19 related provisions of around Rs 2,725 crore against standard assets to further strengthen balance sheet.

Net interest income for the quarter grew by 17.1 percent year-on-year to Rs 8,926.89 crore with 10 percent loan growth and 18 percent increase in deposits year-on-year (YoY).

The domestic loan growth was at 13 percent YoY in March quarter, driven by 16 percent growth in retail segment that contributed about 53.3 percent to total loan book.

Also Read - ICICI Bank tags $100 mn Singapore Hin Leong exposure as NPA, makes provisions

Arihant Capital | Rating: Accumulate | Target: Rs 385

ICICI Bank is poised to do well in terms of NIMs and PPOPs for the next few quarters due to excessive liquidity in hand, fallen interest rates and highly regulated sanctioning of new loans towards both retail and corporate segment.

The bank's insurance subsidiaries however will not be paying dividends, thereby declining in dividend income for the year ahead.

Dolat Capital | Rating: Buy | Target: Rs 420

The disappointment on asset quality was driven by high corporate slippages, led by two overseas exposures.

Substantial provisions on these however ensured PCR was sequentially stable. Margins showed healthy trends despite a sequential 500 bps decline in CD ratio.

HDFC Securities | Rating: Buy | Target: Rs 435

Banks Gross NPAs dipped (-10.5/4.7% YoY/QoQ) to Rs 414.1 billion (5.53%, -117/42bps) facilitated by higher reductions as gross slippages at Rs 53.1 billion (3.3% ann. versus 2.8% QoQ and 2.5% YoY) increased.

Total deposits grew 18.1/7.6% to Rs 7.71 trillion, driven by 29% YoY growth in term deposits. Average CA deposits grew 15% YoY and average SA deposit grew 11% YoY. The CASA ratio was 45.1% (versus 47.0% QoQ and 49.6% YoY).

Prabhudas Lilladher | Rating: Buy | Target: Rs 436

The broking house unable to foresee hits on asset quality as yet but see high probability of rising stress, hence conservatively build 2.5% slippage ratio and 180bps of credit cost in FY21 with residual flow in FY22 as well.

The bank remains best placed in amongst banking sector.

Motilal Oswal | Rating: Buy | Target: Rs 475

Broking firm expect loan growth to moderate given the weak macro environment, weighed by the COVID-19 outbreak.

As a prudent measure, the bank has made additional provisions of Rs 27.2b toward COVID-19-related stress; furthermore, lower exposure to the SME segment (3.5% of loans) and high granularity in the BB and below book provides some comfort.

Motilal Oswal increase credit cost estimate to 2.2% in FY21E and cut FY21/22E earnings by 8%/3% and estimate bank to deliver RoA/RoE of 1.3%/12.4% in FY22.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:20 hrs ICICI Bank was quoting at Rs 334.70, down Rs 3.05, or 0.90 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/icici-bank-share-price-falls-post-q4-nos-brokerages-maintain-buy-5248471.html
"May 10, 2020 02:04 PM IST",-2,Subhash Helgaokar,Sell ICICI Securities; target of Rs 316: HDFC Securities,"HDFC Securities' research report on ICICI SecuritiesHightened market volatility and ADTVs in Mar-20 resulted in higher core $QFY20 broking revenues (+25.6/27.9% YoY/QoQ) driving total adj.
revenues to Rs 4.5bn (+22.0/15.8% YoY/QoQ, +14.6% vs.
and APAT to Rs 1.6bn (+76.8/13.6% YoY/QoQ, +18.8% vs.
OutlookWe increase our FY21E/22E earnings estimates by 12.7/10.8% but continue to rate ISEC a SELL with an increased TP of Rs 316 (P/E of 18x FY22E).
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","HDFC Securities is bearish on ICICI Securities has recommended buy rating on the stock with a target price of Rs 316 in its research report dated May 08, 2020.","HDFC Securities' research report on ICICI Securities

Hightened market volatility and ADTVs in Mar-20 resulted in higher core $QFY20 broking revenues (+25.6/27.9% YoY/QoQ) driving total adj. revenues to Rs 4.5bn (+22.0/15.8% YoY/QoQ, +14.6% vs. est.) and APAT to Rs 1.6bn (+76.8/13.6% YoY/QoQ, +18.8% vs. est.).

Outlook

We increase our FY21E/22E earnings estimates by 12.7/10.8% but continue to rate ISEC a SELL with an increased TP of Rs 316 (P/E of 18x FY22E).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/sell-icici-securities-target-of-rs-316-hdfc-securities-5247221.html
"May 10, 2020 02:05 PM IST",1,Subhash Helgaokar,Hold Cyient; target of Rs 225: ICICI Direct,"Revenues declined 3.8% QoQ mainly led by 5.6% QOQ decline in services revenues.
The decline in services revenues was led by 24.7% QoQ decline in E&U vertical and 22.3% QoQ decline in semiconductor IoT and Analytics.
Reported PAT declined 58% QoQ.
However, adjusting for one off expenses, adjusted PAT declined 30.3%.
OutlookAccordingly, we revise our PE multiple downwards to 8x (from 9x) on FY22E EPS leading to a revised target price of Rs 225.","ICICI Direct recommended hold rating on Cyient with a target price of Rs 225 in its research report dated May 08, 2020.","ICICI Direct's research report on Cyient

Cyient Ltd (Cyient) reported a poor set of Q4FY20 numbers. Revenues declined 3.8% QoQ mainly led by 5.6% QOQ decline in services revenues. The decline in services revenues was led by 24.7% QoQ decline in E&U vertical and 22.3% QoQ decline in semiconductor IoT and Analytics. Normalised margins fell 118 bps due to lower utilisation and pricing pressure. Reported PAT declined 58% QoQ. However, adjusting for one off expenses, adjusted PAT declined 30.3%.

Outlook

Accordingly, we revise our PE multiple downwards to 8x (from 9x) on FY22E EPS leading to a revised target price of Rs 225. We maintain HOLD rating on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-cyient-target-of-rs-225-icici-direct-5247231.html
"May 10, 2020 02:04 PM IST",2,Subhash Helgaokar,Buy HCL Technologies; target of Rs 565: HDFC Securities,"HDFC Securities' research report on HCL TechnologiesMaintain BUY on HCL Tech (HCLT) based on relative out performance, in-line 4Q rev, operational improvement and business durability (large deals, infra services, software business).
HCLT's software portfolio and strong presence in infra services (cloud migration, virtual workplace, endpoint management) will mitigate the near-term headwinds of volume/price compression & deferrals.
OutlookOur TP of Rs 565, values HCLT at a modest 12x FY22E EPS (3-6% EPS increase).
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","HDFC Securities is bullish on HCL Technologies has recommended buy rating on the stock with a target price of Rs 565 in its research report dated May 08, 2020.","HDFC Securities' research report on HCL Technologies

Maintain BUY on HCL Tech (HCLT) based on relative out performance, in-line 4Q rev, operational improvement and business durability (large deals, infra services, software business). HCLT's software portfolio and strong presence in infra services (cloud migration, virtual workplace, endpoint management) will mitigate the near-term headwinds of volume/price compression & deferrals.

Outlook

Our TP of Rs 565, values HCLT at a modest 12x FY22E EPS (3-6% EPS increase).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hcl-technologies-target-of-rs-565-hdfc-securities-5247211.html
"May 10, 2020 02:04 PM IST",2,Subhash Helgaokar,Buy ICICI Bank; target of Rs 420: Dolat Capital,"Dolat Capital's research report on ICICI BankCOVID related provisions of `27bn and lower other income led to weaker than expected PAT for ICICI Bank.
The disappointment on asset quality was driven by high corporate slippages, led by two overseas exposures.
While we see weakness in core metrics across the banking sector, ICICI's strong subsidiary profile and best-in-class liability franchise provide valuation comfort.
OutlookWe maintain our BUY recommendation and value the standalone bank at 1.5x FY22E ABV, with a SOTP-based TP of ` 420 implying 2.1x of FY22E P/ABV.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Dolat Capital is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 420 in its research report dated May 10, 2020.","Dolat Capital's research report on ICICI Bank

COVID related provisions of `27bn and lower other income led to weaker than expected PAT for ICICI Bank. The disappointment on asset quality was driven by high corporate slippages, led by two overseas exposures. Substantial provisions on these however ensured PCR was sequentially stable. Margins showed healthy trends despite a sequential 500 bps decline in CD ratio. We factor in near-doubling of slippages in FY21E but high contingency buffers of ~`45bn (including all STD asset provisions except for general provisions) and superior PCR limit credit costs to 220 bps, resulting in RoA of 1.1%. While we see weakness in core metrics across the banking sector, ICICI's strong subsidiary profile and best-in-class liability franchise provide valuation comfort.

Outlook

We maintain our BUY recommendation and value the standalone bank at 1.5x FY22E ABV, with a SOTP-based TP of ` 420 implying 2.1x of FY22E P/ABV.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-icici-bank-target-of-rs-420-dolat-capital-5247191.html
"May 10, 2020 02:03 PM IST",2,Subhash Helgaokar,Buy Persistent Systems Limited target of Rs 650: Sharekhan,"Sharekhan's research report on Persistent Systems LimitedPSL delivered steady performance in a tough environment; revenue declined by 1.8% q-o-q owing to drop in IP-led revenue, while margin expanded by 41bps q-o-q, led by lower marketing expenses and rupee depreciation.
Growth momentum in Technology Services Unit (TSU) would continue on account of new logo addition and a healthy deal pipeline.
Cash and cash equivalents account for 38% of its current market capitalisation; reasonable valuation and high cash and cash equivalents are expected to provide downside support to the stock price.
OutlookWe retain our Buy rating on Persistent Systems Limited (PSL) with a revised PT of Rs.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on Persistent Systems Limited has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 06, 2020.","Sharekhan's research report on Persistent Systems Limited

PSL delivered steady performance in a tough environment; revenue declined by 1.8% q-o-q owing to drop in IP-led revenue, while margin expanded by 41bps q-o-q, led by lower marketing expenses and rupee depreciation. Growth momentum in Technology Services Unit (TSU) would continue on account of new logo addition and a healthy deal pipeline. Cash and cash equivalents account for 38% of its current market capitalisation; reasonable valuation and high cash and cash equivalents are expected to provide downside support to the stock price.

Outlook

We retain our Buy rating on Persistent Systems Limited (PSL) with a revised PT of Rs. 650, given its reasonable valuation.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-persistent-systems-limited-target-of-rs-650-sharekhan-5247171.html
"May 10, 2020 11:14 AM IST",-1,Kshitij Anand,Investors have already factored in slower GDP growth amid coronavirus pandemic: Ritesh Asher,"But speculations over various stimulus packages for stressed industries from the government has contributed to this end of the week recovery.
For the coming week, investors should look out for Q4 FY2020 earnings and growth rate of coronavirus cases in India and across the world, as it plays a crucial role in directing further economic actions.
What are your views and estimates on the stock and what should investor's do – buy, sell or hold?
Q. Moody's says India's negative rating outlook reflects a rising risk of slower GDP growth.
Investors have already factored in slower GDP growth with the ongoing COVID-19 pandemic and its effect on the economy.","For this week, investors should look out for Q4 FY2020 earnings and growth rate of COVID-19 cases in India and across the world, KIFS Trade Capital's Chief Strategic Officer Ritesh Asher, told Moneycontrol.","Investors have already factored in slower Gross Domestic Product (GDP) growth due to the novel coronavirus pandemic and its impact on the economy, and it seems that the market has already discounted this news when hit a 52-week low, Ritesh Asher - Chief Strategic Officer (CSO) at KIFS Trade Capital, said in an interview with Moneycontrol's Kshitij Anand.

Here are edited excerpts from the interview:

Q. It looks like the markets seem to have witnessed profit-taking at higher levels. What led to the sharp sell-off on D-Street and then some recovery towards the close of the week?

A. The market witnessed a bounce back from the bottom of 7,500 largely on the back of relief measures introduced by the government.

Muted earnings season also weighed on sentiments of traders recently which lead to a sharp selloff. But speculations over various stimulus packages for stressed industries from the government has contributed to this end of the week recovery.

Q. Any factors which investors should watch out for in the coming week?

A. For the coming week, investors should look out for Q4 FY2020 earnings and growth rate of coronavirus cases in India and across the world, as it plays a crucial role in directing further economic actions.

Also read: 10 key factors that will keep traders busy this week

Q. Another mega-deal in RIL's Jio Platforms. What are your views and estimates on the stock and what should investor's do – buy, sell or hold?

A. Reliance Industries' Jio had a back-to-back deal in the span of less than a month from Facebook followed by Silver Lake Partners and this is the third deal in a row for by US-based company Vista Equity Partners making it the fourth largest company in India, in terms of valuation.

These deals will help RIL reduced its debt which was acting as a black spot for the reputation of the company. Reliance Industries has great potential and we recommend investors follow a buy on dips strategy and hold it if you already have it in your portfolio.

Q. Small & Midcaps outperformed in the week gone by. Looks like investors are slowly accumulating beaten down names?

A. Fundamentally, many stocks were available at favourable valuations and investors seem to have taken advantage of this opportunity. It has been observed that after front liners, the pullback was seen in the small and midcap space.

Q. Moody's says India's negative rating outlook reflects a rising risk of slower GDP growth. Do you think this is already factored in or will it weigh on markets and investor decision making?

A. Investors have already factored in slower GDP growth with the ongoing COVID-19 pandemic and its effect on the economy. It seems that the market had already discounted this news previously when the market made a 52-week low.

Now, market sentiments or investors' decision will depend on the future aspect of this ongoing situation based on how government and industries will take measures to overcome this negative impact.

Q. Do you think the lockdown could get extended beyond May 17? If yes, what is the kind of impact it could have on markets?

A. No, we do not think that the lockdown may get extended further for the whole country, but there might be a few states which could extend the lockdown depending on the spread.

We also do not expect things to go back to normal as it was before. The government may lift the lockdown slowly and gradually, which will act as a relief for industries that are out of business since March.

This will slowly start generating income and cash flow for drying out the economy resulting in positive impact on the market.

Q. Specialty chemicals, pharma best-placed sectors do ride out of COVID-19 storm. But, after a swift rally, are these still a good buy at current levels? What should investors do?

A. If we talk on the investment perspective, pharma is good to bet from 2017 till early 2020. The pharma sector has corrected about 45 percent, the recent recovery was around 15 percent lead by good accumulation on institutional front.

There is still a lot of space left for the sector so investors are advised to buy on dips and accumulate fundamentally sound pharma stocks for better returns.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Reliance Industries Ltd, which owns Jio, is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/investors-have-already-factored-in-slower-gdp-growth-amid-coronavirus-pandemic-ritesh-asher-5245111.html
"May 10, 2020 11:03 AM IST",2,Subhash Helgaokar,Buy Shree Cement; target of Rs 23500: ICICI Direct,"However, on the revenue front, the company reported 2% YoY decline in revenues to Rs 3,218 crore (vs. I-direct estimate: Rs 3,036 crore) owing to demand weakness in the ending weeks of March 2020.
Blended realisations increased 3.5% YoY to Rs 4.656/t (vs. I-direct estimate of Rs 4,780/t).
Thus, EBITDA saw 27% growth YoY to Rs 1,079 crore (I-direct estimate: Rs 856 crore).
Thus, PAT increased 83% YoY to Rs 588 crore YoY (vs. I-direct estimate of Rs 297 crore).
Thus, we maintain our positive stance on the company with a BUY rating and an unchanged target price of Rs 23,500.","ICICI Direct is bullish on Shree Cement has recommended buy rating on the stock with a target price of Rs 23500 in its research report dated May 09, 2020.","ICICI Direct's research report on Shree Cement

Shree Cements continued to maintain its cost leadership in the industry with overall cost of production declining 7.3% YoY during the quarter to Rs 3095/t, which along with better pricing resulted in 34.4% YoY growth in EBITDA/t to Rs 1561/t during the quarter. However, on the revenue front, the company reported 2% YoY decline in revenues to Rs 3,218 crore (vs. I-direct estimate: Rs 3,036 crore) owing to demand weakness in the ending weeks of March 2020. Volumes for Q4FY20 dipped 5.3% YoY to 6.9 MT. Blended realisations increased 3.5% YoY to Rs 4.656/t (vs. I-direct estimate of Rs 4,780/t). Due to higher realisations and a reduction in total costs/tonne by 6% YoY, EBITDA margins expanded 772 bps YoY to 33.5% (I-direct estimate: 28.3%). Thus, EBITDA saw 27% growth YoY to Rs 1,079 crore (I-direct estimate: Rs 856 crore). Further, with proceeds from QIP being parked in liquid investments, other income is almost 2x YoY. Thus, PAT increased 83% YoY to Rs 588 crore YoY (vs. I-direct estimate of Rs 297 crore).

Outlook

Shree Cement added capacities and entered non-core regions without jeopardising its profitability and return ratios. The company has maintained leadership on the cost front led by continued focus on cost rationalisation. We expect the company to continue its leadership on the costs, profitability and, thus, return front. Thus, we maintain our positive stance on the company with a BUY rating and an unchanged target price of Rs 23,500.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-shree-cement-target-of-rs-23500-icici-direct-2-5246731.html
"May 10, 2020 11:02 AM IST",2,Subhash Helgaokar,Buy Kansai Nerolac Paints; target of Rs 415: ICICI Direct,"ICICI Direct's research report on Kansai Nerolac PaintsKansai Nerolac reported its Q4FY20 performance wherein revenue and earnings declined ~14% and 23% YoY, respectively.
While the company's decorative segment grew in double digits in January-February, the lockdown from the last week of March hurt overall decorative volume offtake in Q4FY20.
However industrial segment (~40-45% of revenue) performance remained muted in Q4 owing to lower volume offtake from automotive industry.
The company is well placed to face near term challenges of Covid-19 related slowdown due to its strong fundamentals (No.
Considering a strong revival in paint demand from FY22E, we reiterate our BUY rating on the stock with a revised target price of Rs 415/share.","ICICI Direct is bullish on Kansai Nerolac Paints has recommended buy rating on the stock with a target price of Rs 415 in its research report dated May 09, 2020.","ICICI Direct's research report on Kansai Nerolac Paints

Kansai Nerolac reported its Q4FY20 performance wherein revenue and earnings declined ~14% and 23% YoY, respectively. While the company's decorative segment grew in double digits in January-February, the lockdown from the last week of March hurt overall decorative volume offtake in Q4FY20. However industrial segment (~40-45% of revenue) performance remained muted in Q4 owing to lower volume offtake from automotive industry. On the margin front, while benign raw material prices helped improve gross margins of the company (by 220 bps YoY, 100 bps QoQ) in Q4FY20, EBITDA margins stayed flat at 13% owing to lower operating leverage. Finally, higher depreciation charges, lower other income dragged PAT down 23% YoY to ~Rs 71 crore. Further, despite various challenges in FY20E, the company's balance sheet position remained strong (with zero debt, efficient working capital management).Going ahead, while FY21E will be a challenging year for company (~45 days sales loss due to lockdown), we expect a strong recovery in FY22E led by decorative paints segment.

Outlook

KNPL is a leading paint manufacturer with a strong promoter pedigree. The company is well placed to face near term challenges of Covid-19 related slowdown due to its strong fundamentals (No. 3 decorative player with a pan-India dealer network and zero debt balance sheet). Considering a strong revival in paint demand from FY22E, we reiterate our BUY rating on the stock with a revised target price of Rs 415/share.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-kansai-nerolac-paints-target-of-rs-415-icici-direct-5246701.html
"May 10, 2020 02:02 PM IST",2,Subhash Helgaokar,Buy HCL Technologies target of Rs 620: Sharekhan,"Sharekhan's research report on HCL TechnologiesRevenue was inline and margins were ahead of our expectations; Q4FY2020 order bookings were the highest in FY2020.
Management expects revenue would decline significantly in Q1FY2021 owing to some supply disruption, deferral of discretionary spends and price discounts; expects gradual recovery in demand from H2FY2021.
Strong demand for infrastructure business and emergence of new business models for deeply impacted verticals is expected to create new growth opportunities.
OutlookWe maintain our Buy rating on HCL Technologies (HCL Tech) with a revised PT of Rs.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on HCL Technologies has recommended buy rating on the stock with a target price of Rs 620 in its research report dated May 07, 2020.","Sharekhan's research report on HCL Technologies

Revenue was inline and margins were ahead of our expectations; Q4FY2020 order bookings were the highest in FY2020. Management expects revenue would decline significantly in Q1FY2021 owing to some supply disruption, deferral of discretionary spends and price discounts; expects gradual recovery in demand from H2FY2021. Strong demand for infrastructure business and emergence of new business models for deeply impacted verticals is expected to create new growth opportunities.

Outlook

We maintain our Buy rating on HCL Technologies (HCL Tech) with a revised PT of Rs. 620.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hcl-technologies-target-of-rs-620-sharekhan-5247161.html
"May 10, 2020 02:04 PM IST",1,Subhash Helgaokar,Hold Persistent Systems; target of Rs 563: Arihant Capital,"Arihant Capital 's research report on Persistent SystemsPersistent Systems Q4FY20 beat our revenue estimates.
Consolidated revenue for the quarter stood at Rs 9,264 mn, registering growth of +11.4% YoY/+0.4% QoQ, EBITDA stood at Rs 1,269 mn, up 5.1% YoY/+2.8% QoQ and consolidated PAT for the quarter stood at Rs 838 mn, down -4.7% YoY/ 0.8% QoQ.
The company saw the imminent threat posed by Covid-19 and started WFH before India started its lockdown as a safeguard measure for its employees.
OutlookWe marginally raised our target P/E multiple from 12.3x to 13.0x for its FY22E earnings and arrive at a target price of 563 per share, and maintain our HOLD rating.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Arihant Capital recommended hold rating on Persistent Systems with a target price of Rs 563 in its research report dated May 08, 2020.","Arihant Capital 's research report on Persistent Systems

Persistent Systems Q4FY20 beat our revenue estimates. Consolidated revenue for the quarter stood at Rs 9,264 mn, registering growth of +11.4% YoY/+0.4% QoQ, EBITDA stood at Rs 1,269 mn, up 5.1% YoY/+2.8% QoQ and consolidated PAT for the quarter stood at Rs 838 mn, down -4.7% YoY/ 0.8% QoQ. The company saw the imminent threat posed by Covid-19 and started WFH before India started its lockdown as a safeguard measure for its employees. Company anticipate some degree of a U shaped recovery when it comes to COVID19.

Outlook

We marginally raised our target P/E multiple from 12.3x to 13.0x for its FY22E earnings and arrive at a target price of 563 per share, and maintain our HOLD rating.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-persistent-systems-target-of-rs-563-arihant-capital-5247201.html
"May 10, 2020 11:02 AM IST",2,Subhash Helgaokar,Buy TCI Express; target of Rs 850: ICICI Direct,"ICICI Direct's research report on TCI ExpressTCI Express (TCIEL) reported revenues, profitability below I-direct estimates.
Revenue de-grew 10.5% YoY driven by 11.5% volume de-growth amid a challenging business environment.
EBITDA margins fell 149 bps to 11.2% mainly due to lower operating leverage (employee & other expense).
Hence, absolute EBITDA de-grew 21% YoY to Rs 27 crore.
OutlookWe value TCIEL at 29x P/E with a target price of Rs 850 and a BUY recommendation.","ICICI Direct is bullish on TCI Express has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 09, 2020.","ICICI Direct's research report on TCI Express

TCI Express (TCIEL) reported revenues, profitability below I-direct estimates. Revenue de-grew 10.5% YoY driven by 11.5% volume de-growth amid a challenging business environment. EBITDA margins fell 149 bps to 11.2% mainly due to lower operating leverage (employee & other expense). Hence, absolute EBITDA de-grew 21% YoY to Rs 27 crore. PAT de-grew 12.5% YoY to Rs 19 crore, mainly due to a below expected operational performance (negated up to a certain limit by lower tax rate of 25.5% vs. 33.8%).

Outlook

We value TCIEL at 29x P/E with a target price of Rs 850 and a BUY recommendation.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-tci-express-target-of-rs-850-icici-direct-5246711.html
"May 10, 2020 11:00 AM IST",1,Subhash Helgaokar,Hold HCL Technologies; target of Rs 548: Prabhudas Lilladher,"Prabhudas Lilladher's research report on HCL TechnologiesHCLT reported in-line sequential revenue growth of 0.8% and 13.5% YoY CC.
Revenue growth was led by strong growth in Mode 2 revenues, which grew 7.1% in c/c, aiding healthy 1.6% growth in IT services.
Products revenues were flat (-0.1% QoQ growth) while ER&D services declined by 1.8% QoQ.
EBIT margin at 20.9% was up 70 bps QoQ aided by one-off improvement in Mode 2 margins, rupee depreciation (50 bps) and lower subcontracting costs (down 140 bps).
IBM business revenues has steadily improved to US$160mn(Q3FY20: US$140mn,Q2FY20:US$ 106mn).","Prabhudas Lilladher recommended hold rating on HCL Technologies with a target price of Rs 548 in its research report dated May 08, 2020.","Prabhudas Lilladher's research report on HCL Technologies

HCLT reported in-line sequential revenue growth of 0.8% and 13.5% YoY CC. Revenue growth was led by strong growth in Mode 2 revenues, which grew 7.1% in c/c, aiding healthy 1.6% growth in IT services. Products revenues were flat (-0.1% QoQ growth) while ER&D services declined by 1.8% QoQ. IBM business added US$160mn in Q4FY20. EBIT margin at 20.9% was up 70 bps QoQ aided by one-off improvement in Mode 2 margins, rupee depreciation (50 bps) and lower subcontracting costs (down 140 bps). FCF of US$451.7 mn was strong at 104.7% of net profit. IBM business revenues has steadily improved to US$160mn(Q3FY20: US$140mn,Q2FY20:US$ 106mn). FY21 will be a critical year for the products business as focus shifts to new business acquisition. Stickiness of the product portfolio is a tailwind for renewals in the current environment. HCLT has stopped guiding due to the uncertain environment following the epidemic. Management's base case is a sharp revenue decline in 1QFY21, followed by stable revenues in 2QFY21 and growth recovery in 2HFY21.

Outlook

We marginally fine tune our estimates & now value HCLT on 12X (earlier 11x) to arrive at a changed target price of Rs.548. Stock currently trades at attractive multiple of 11.3x on FY22E. Maintain HOLD.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-hcl-technologies-target-of-rs-548-prabhudas-lilladher-5246671.html
"May 10, 2020 11:01 AM IST",1,Subhash Helgaokar,Hold NIIT Technologies; target of Rs 1330: ICICI Direct,"ICICI Direct's research report on NIIT TechnologiesNIIT Technologies (NIITT) reported 2.3% QoQ growth in dollar revenues mainly led by insurance vertical and Wishworks, partially offset by 4.7% QoQ decline in the travel vertical.
The fresh order book remains in the range of $180 million.
The QoQ dip in the fresh order book was mainly due to the higher base in the last quarter.
Digital revenues increased 8.0% QoQ & 42.1% YoY and now accounts for 38% of total revenues.
The company is in the process of changing its name to Coforge Ltd.OutlookHence, we maintain our HOLD rating on the stock with a revised target price of Rs 1330 per share (15x P/E on FY22E EPS).","ICICI Direct recommended Hold rating on NIIT Technologies with a target price of Rs 1330 in its research report dated May 06, 2020.","ICICI Direct's research report on NIIT Technologies

NIIT Technologies (NIITT) reported 2.3% QoQ growth in dollar revenues mainly led by insurance vertical and Wishworks, partially offset by 4.7% QoQ decline in the travel vertical. The fresh order book remains in the range of $180 million. The QoQ dip in the fresh order book was mainly due to the higher base in the last quarter. Digital revenues increased 8.0% QoQ & 42.1% YoY and now accounts for 38% of total revenues. The company is in the process of changing its name to Coforge Ltd.

Outlook

Hence, we maintain our HOLD rating on the stock with a revised target price of Rs 1330 per share (15x P/E on FY22E EPS).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-niit-technologies-target-of-rs-1330-icici-direct-5246691.html
"May 10, 2020 02:01 PM IST",2,Subhash Helgaokar,Buy ICICI Bank; target of Rs 436: Prabhudas Lilladher,"Prabhudas Lilladher's research report on ICICI BankICICIBC's PPOP was good on better NII (10bps improvement in NIMs) and steady other income & costs.
Although, bank missed its earnings as provisions were up on few large NPAs in corporate and provision buffer on COVID-19 related crisis.
At of end Apr'20, 30% of loans were under moratorium along with Rs27.25bn of provisions (incl 5% directed by RBI).
OutlookWe retain BUY with revised TP of Rs436 (from Rs509) based on 1.8x (from 2.0x) FY22 ABV and remains best placed in amongst banking sector.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Prabhudas Lilladher is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 436 in its research report dated May 10, 2020.","Prabhudas Lilladher's research report on ICICI Bank

ICICIBC's PPOP was good on better NII (10bps improvement in NIMs) and steady other income & costs. Although, bank missed its earnings as provisions were up on few large NPAs in corporate and provision buffer on COVID-19 related crisis. At of end Apr'20, 30% of loans were under moratorium along with Rs27.25bn of provisions (incl 5% directed by RBI). We continue to keep faith in its strong brand franchise, while high PCR of +75%, strong CASA & pricing power will help it to mitigate adverse impact from COVID-19. We are unable to foresee hits on asset quality as yet but see high probability of rising stress, hence conservatively build 2.5% slippage ratio and 180bps of credit cost in FY21 with residual flow in FY22 as well.

Outlook

We retain BUY with revised TP of Rs436 (from Rs509) based on 1.8x (from 2.0x) FY22 ABV and remains best placed in amongst banking sector.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-icici-bank-target-of-rs-436-prabhudas-lilladher-5247141.html
"May 11, 2020 07:34 AM IST",2,Nishant Kumar,"Hot Stocks | Sun Pharma, HDFC Life are buys for short term","Sameet ChavanNifty ended last week tad above 9,200, shedding over 6 percent as compared to the previous weekly close.
In fact, in the last couple of trading sessions, price action was extremely lethargic and the market completely looked directionless.
This stock as well has shown strong outperformance and recently it has rallied from the levels of Rs 388 to Rs 500.
Volume analysis indicates an increase in volume during upmove as compared to volume during correction which suggests accumulation in the stock.
HDFC Life Insurance Company | Buy | LTP: Rs 521.65 | Target price: Rs 585 | Stop loss: Rs 487 | Upside: 12%This stock has confirmed a bullish continuation ‘Pennant' breakout on the daily chart.","Once we see Nifty surpassing the higher boundary of 9,450, we would see a good broad-based participation in the market.","Sameet Chavan

Nifty ended last week tad above 9,200, shedding over 6 percent as compared to the previous weekly close.

Although it appears to be a sharp cut when compared to the previous week's close, the overall trading action during the week was muted.

In fact, in the last couple of trading sessions, price action was extremely lethargic and the market completely looked directionless.

Neither bulls had the strength to overcome the sturdy wall of 9,400-9,450 nor bears were dominant enough to violate the 9,100-mark.

Hence, this week, 9,450 to 9,100 remains to be an immediate range. Only a sustainable breakout on either side would confirm the next path of action.

Traders holding existing longs should maintain their positions as long as 9,100 is successfully defended.

At present, traders are advised to stay light and should ideally continue focusing on individual stocks.

Although we are completely not out of the woods when it comes to coronavirus pandemic, we remain hopeful till the time above-mentioned key support is not violated.

Once we see Nifty surpassing the higher boundary of 9,450, we would see good broad-based participation in the market.

Here are two trading ideas for the next 3-4 weeks:

Sun Pharmaceutical Industries | Buy | LTP: Rs 470 | Target price: Rs 510 | Stop loss: Rs 447 | Upside: 8.5%

Pharma stocks are buzzing, showing signs of outperformance after a phase of slumber of more than four years.

This stock as well has shown strong outperformance and recently it has rallied from the levels of Rs 388 to Rs 500.

On the daily chart, after some correction, prices seem to have resumed the uptrend by forming a bullish candlestick.

Volume analysis indicates an increase in volume during upmove as compared to volume during correction which suggests accumulation in the stock.

Prices are well above the key averages and oscillators are positively placed supporting the buy call.

HDFC Life Insurance Company | Buy | LTP: Rs 521.65 | Target price: Rs 585 | Stop loss: Rs 487 | Upside: 12%

This stock has confirmed a bullish continuation ‘Pennant' breakout on the daily chart.

The said breakout is supported by a good increase in volume and a bullish candlestick pattern.

On the daily chart, prices have closed above 89-EMA which was previously acting as resistance and now indicates a change in polarity.

In addition, momentum oscillator RSI, after forming a base around 50 level, has started northward journey, supporting the bullish view on this counter.

(The author is Chief Technical & Derivatives Analyst at Angel Broking)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/hot-stocks-sun-pharma-hdfc-life-are-buys-for-short-term-5243231.html
"May 10, 2020 11:01 AM IST",2,Subhash Helgaokar,Hold Rallis India; target of Rs 240: ICICI Direct,"ICICI Direct's research report on Rallis IndiaRallis reported muted topline growth of 2% YoY to Rs 346 crore.
The delay in dispatches for the domestic market remained at Rs 16 crore while the same for the international market was at Rs 53 crore.
The crop protection segment posted growth of 1.2% YoY to Rs 322 crore while the seed business remained at Rs 24 crore (+4.3% YoY).
Crop protection EBITDA remained at Rs 6 crore against Rs 20 crore in Q4FY19 while the same for the seed business was a loss of Rs 19 crore against a loss of Rs 14 crore in Q4FY19.
Adjusting gain on sale of flats to the tune of Rs 11.4 crore, bottomline was at a loss of Rs 10.7 crore against profit of Rs 1.4 crore In Q4FY19.","ICICI Direct recommended Hold rating on Rallis India with a target price of Rs 240 in its research report dated May 06, 2020.","ICICI Direct's research report on Rallis India

Rallis reported muted topline growth of 2% YoY to Rs 346 crore. Growth was hampered by a delay in dispatches for both domestic and international market post lockdown. The delay in dispatches for the domestic market remained at Rs 16 crore while the same for the international market was at Rs 53 crore. The crop protection segment posted growth of 1.2% YoY to Rs 322 crore while the seed business remained at Rs 24 crore (+4.3% YoY). Higher other expenses due to one-time Covid-19 related charges along with forex MTM impacted EBITDA, which came in at a loss of Rs 10 crore against profit of Rs 7 crore in Q4FY19. Crop protection EBITDA remained at Rs 6 crore against Rs 20 crore in Q4FY19 while the same for the seed business was a loss of Rs 19 crore against a loss of Rs 14 crore in Q4FY19. Adjusting gain on sale of flats to the tune of Rs 11.4 crore, bottomline was at a loss of Rs 10.7 crore against profit of Rs 1.4 crore In Q4FY19.

Outlook

We value the company at 19x PER of FY22E earnings estimates (implied EV/EBITDA 12x FY22E). We arrive at a target price of Rs 240. We have a HOLD recommendation on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-rallis-india-target-of-rs-240-icici-direct-5246681.html
"May 10, 2020 02:03 PM IST",2,Subhash Helgaokar,Accumulate HCL Technologies; target of Rs 560: Dolat Capital,"Dolat Capital's research report on HCL TechnologiesHCLT reported 0.8% QoQ growth in CC terms (our estimate: 1.4%) led by 7.1% QoQ growth in Mode 2 covering up for 0.4%/1% QoQ decline in Mode 1/Mode 3.
HCLT expects growth to come in H2 as ramp up of deals (14 transformational deals wins in Q4) will begin only in Q2.
OutlookWith strong lead indicators and expectations of performance revival in H2, we largely retain our estimates building in CC revenue and EPS CAGR of ~5%/5% over FY20-22E.
We have an Accumulate rating on the stock with TP of `560 valued at 12.5x PER on FY22E EPS (10% disc.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Dolat Capital recommended accumulate rating on HCL Technologies with a target price of Rs 560 in its research report dated May 08, 2020.","Dolat Capital's research report on HCL Technologies

HCLT reported 0.8% QoQ growth in CC terms (our estimate: 1.4%) led by 7.1% QoQ growth in Mode 2 covering up for 0.4%/1% QoQ decline in Mode 1/Mode 3. OPM improved by 60bps to 20.9% (DE: 20.3%) driven by one-off margins gains in Mode 2 (Q4:18.1% up ~290bps QoQ)  HCLT didn't offer guidance for FY21 due to uncertainty in environment despite 12% order book growth YoY (Order pipeline soften in April but reviving now). HCLT expects growth to come in H2 as ramp up of deals (14 transformational deals wins in Q4) will begin only in Q2.

Outlook

With strong lead indicators and expectations of performance revival in H2, we largely retain our estimates building in CC revenue and EPS CAGR of ~5%/5% over FY20-22E. We have an Accumulate rating on the stock with TP of `560 valued at 12.5x PER on FY22E EPS (10% disc. to Infy).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/accumulate-hcl-technologies-target-of-rs-560-dolat-capital-5247181.html
"May 10, 2020 11:01 AM IST",2,Subhash Helgaokar,Buy Kansai Nerolac Paints; target of Rs 486: Prabhudas Lilladher,"Although near term outlook remains uncertain due to lockdown impact on sales and sentiments, we expect smart recovery from 2HFY21 given low base in Auto and impact of J&K from 2Q20.
Although KNPL has passed on input costs benefits in auto and industrials, we expect improved gross margins due to sharp decline in input costs.
OutlookThe stock trades at 28xFY22 EPS which is at 33% discount to Asian paints.
We value the stock at 38xFY22 EPS and retain BUY with a target price of Rs486, a 35% upside.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Prabhudas Lilladher is bullish on Kansai Nerolac Paints has recommended buy rating on the stock with a target price of Rs 486 in its research report dated May 08, 2020.","Prabhudas Lilladher's research report on Kansai Nerolac Paints

KNPL 4Q Mgt commentary reinforced our positive stance on the company given 1) successful launch of soldier in economy segment in emulsions 2) foray in coil coatings, floor coatings and rebar coatings 3) strong free cash flow with cash/investments of Rs4.7bn and 4) sustained higher than industry growth in decorative segment. Although near term outlook remains uncertain due to lockdown impact on sales and sentiments, we expect smart recovery from 2HFY21 given low base in Auto and impact of J&K from 2Q20. Although KNPL has passed on input costs benefits in auto and industrials, we expect improved gross margins due to sharp decline in input costs.

Outlook

The stock trades at 28xFY22 EPS which is at 33% discount to Asian paints. We value the stock at 38xFY22 EPS and retain BUY with a target price of Rs486, a 35% upside.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-kansai-nerolac-paints-target-of-rs-486-prabhudas-lilladher-5246661.html
"May 10, 2020 02:02 PM IST",2,Subhash Helgaokar,Buy Hindustan Unilever Limited target of Rs 2305: Sharekhan,"Sharekhan's research report on Hindustan Unilever LimitedThe GSK Group sold 5.7% stake (13.37 crore shares) in Hindustan Unilever (HUL) through multiple block deals in the open market.
HUL's stock price has corrected by ~16% from its recent high factors in the sluggish performance in Q4FY2020.
With 50-55% of business catering to essential categories and the company's strong direct distribution reach, we expect HUL to recover rapidly post the pandemic situation.
We maintain our Buy recommendation on the stock with unchanged PT of Rs.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on Hindustan Unilever Limited has recommended buy rating on the stock with a target price of Rs 2305 in its research report dated May 08, 2020.","Sharekhan's research report on Hindustan Unilever Limited

The GSK Group sold 5.7% stake (13.37 crore shares) in Hindustan Unilever (HUL) through multiple block deals in the open market. This has reduced the supply overhang in the stock. The merger of GSK Consumer Healthcare's business with HUL will make the latter one of the largest players in the domestic foods space and would lead to earnings accretion of 4-8% over FY2021/FY2022. HUL's stock price has corrected by ~16% from its recent high factors in the sluggish performance in Q4FY2020. With 50-55% of business catering to essential categories and the company's strong direct distribution reach, we expect HUL to recover rapidly post the pandemic situation.

Outlook

HUL has a strong balance sheet with robust cash flows and goods dividend payout which makes it a safest bet in the uncertain environment. We maintain our Buy recommendation on the stock with unchanged PT of Rs. 2,305.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hindustan-unilever-limited-target-of-rs-2305-sharekhan-5247151.html
"May 08, 2020 09:41 PM IST",2,Nishant Kumar,Rakesh Jhunjhunwala raises stake in VIP Industries during March quarter,"One of India's most successful investors, Rakesh Jhunjhunwala, raised his stake by 2.85 lakh shares in VIP Industries during the January-March quarter of FY20, data available with BSE showed.
In Q4FY20, Rakesh Jhunjhunwala held a total of 75,00,400 shares of VIP Industries against a total of 72,15,400 shares of the company held at the end of Q3.
In percentage terms, Jhunjhunwala now holds 5.31 percent shares of the company, data showed.
Shares of VIP Industries fell 44.45 percent during the March quarter.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","In Q4FY20, Rakesh Jhunjhunwala held a total of 75,00,400 shares of VIP Industries against a total of 72,15,400 shares of the company held at the end of Q3","One of India's most successful investors, Rakesh Jhunjhunwala, raised his stake by 2.85 lakh shares in VIP Industries during the January-March quarter of FY20, data available with BSE showed.

In Q4FY20, Rakesh Jhunjhunwala held a total of 75,00,400 shares of VIP Industries against a total of 72,15,400 shares of the company held at the end of Q3.

In percentage terms, Jhunjhunwala now holds 5.31 percent shares of the company, data showed.

Shares of VIP Industries fell 44.45 percent during the March quarter.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The company's net sales stood at Rs 432.35 crore in December 2019, up 0.53 percent year-on-year. Net profit came in at Rs 34.21 crore in December 2019, up 43.56 percent YoY.",https://www.moneycontrol.com/news/business/markets/rakesh-jhunjhunwala-raises-stake-in-vip-industries-during-march-quarter-5243771.html
"May 08, 2020 11:26 AM IST",2,Subhash Helgaokar,Buy NIIT Technologies; target of Rs 1340: Prabhudas Lilladher,"Prabhudas Lilladher's research report on NIIT TechnologiesNITEC posted strong USD revenues growth of +2.3% QoQ (+12.2% YoY) to $154.8mn higher than our estimates (Ple: USD149.1.mn, Cons: USD 150mn).
Strongest Commentary among the peers- management expects single digit decline in Q1, growth in Q2 & YoY growth in FY21E.
Constant currency revenue growth despite COVID crisis.
OutlookWe upgrade NIIT Tech to Buy from HOLD on account strong commentary, better deal wins despite COVID crisis.
We value now NIIT Tech at 14x (earlier:12X) to arrive at a TP of Rs.1340 (earlier: Rs.1029).","Prabhudas Lilladher is bullish on NIIT Technologies has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated May 06, 2020.","Prabhudas Lilladher's research report on NIIT Technologies

NITEC posted strong USD revenues growth of +2.3% QoQ (+12.2% YoY) to $154.8mn higher than our estimates (Ple: USD149.1.mn, Cons: USD 150mn). EBIT margin remained flat at 14% (+13bps QoQ) (Ple: 13.5%, Cons: 13.7%). Revenue & margin performance was better than we estimated. Strongest Commentary among the peers- management expects single digit decline in Q1, growth in Q2 & YoY growth in FY21E. Constant currency revenue growth despite COVID crisis.

Outlook

We upgrade NIIT Tech to Buy from HOLD on account strong commentary, better deal wins despite COVID crisis. Stock trades at attractive valuation of 12.4X earnings which is 20%/12% discount to peers MTCL/LTI. We value now NIIT Tech at 14x (earlier:12X) to arrive at a TP of Rs.1340 (earlier: Rs.1029).

Note: The earlier version of the report from Prabhudas Lilladher had an error. Prabhudas Lilladher has issued a correction which has been updated in the copy.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-niit-technologies-target-of-rs-1340-prabhudas-lilladher-5240451.html
"May 09, 2020 08:12 AM IST",-2,Kshitij Anand,"'More pain left, bear markets have lasted for a minimum of 18 months'","Traditionally, bear markets have lasted for a minimum of 18 months and this time it isn't expected to be different, Umesh Mehta, Head of Research, Samco Securities, says in an interview to Moneycontrol's Kshitij Anand.
A) As per statistics, Indian markets and the US have shown the highest correlation in the past month compared to the last decade.
Hence, Monday was no different when Indian markets reacted in line with its global peers and witnessed crack in prices.
Traditionally, bear markets have lasted for a minimum of 18 months and this time isn't expected to be different.
Post the lockdown, the ground-level pain will be a key data point that might lead investors to react in the markets.","Investors should, therefore, patiently wait and get into sectoral leaders to prevent wealth erosion in the coming months, says Umesh Mehta.","Traditionally, bear markets have lasted for a minimum of 18 months and this time it isn't expected to be different, Umesh Mehta, Head of Research, Samco Securities, says in an interview to Moneycontrol's Kshitij Anand.

Edited excerpts:

Q) It seems markets have witnessed profit-taking at higher levels. What led to the sharp selloff on D-Street and then some recovery towards the close of the week?

A) As per statistics, Indian markets and the US have shown the highest correlation in the past month compared to the last decade. Hence, Monday was no different when Indian markets reacted in line with its global peers and witnessed crack in prices.

However, the latter half was comparatively buoyant since heavyweights such as Reliance Industries managed to keep markets afloat.

Additionally, sentiments were guided by the opening of factories in certain states, which helped recovery on D-Street towards the end of the week.

Q) Any factors that investors should watch out for in the coming week?

A) Until the lockdown ends, the situation at the ground will not be known, till then markets are expected to continue in a narrow range. Indices should take another 2-3 months to show significant cracks once again.

Markets will continue to be lackluster unless there is a fiscal stimulus announced which will indeed be accepted by the Street with open arms.

Q) Another mega deal for RIL's Jio platform. What are your views and estimates on the stock and what should investors do?

A) Reliance Industries is playing its cards very smartly as it has single-handedly formed its own bull path. When the entire market is in a state of chaos, (Mukesh) Ambani announced three back-to-back deals along with a rights issue.

The future of Reliance Jio will depend on how effectively these deals help the platform to grow and achieve the scale it plans. However, for now, investors can hold the stock until the rights issue and dividend record date to capitalise on the gains.

A) Broader markets have substantially recovered but not all stocks would prove to be outstanding wealth-creators in the long run. A crack in the larger weights will eventually trickle down to the small and midcaps, taking them lower in times to come.

Traditionally, bear markets have lasted for a minimum of 18 months and this time isn't expected to be different. Hence, there is still more pain left.

Investors should, therefore, patiently wait and get into sectoral leaders to prevent wealth erosion in the coming months.

Q) Moody's says India's negative rating outlook reflects a rising risk of slower GDP growth. Do you think this is factored in or will it weigh on markets and investors?

A) Markets seem to have factored in the pain, for now, given that despite the rise in daily COVID cases or negative outlook markets moved higher.

Post the lockdown, the ground-level pain will be a key data point that might lead investors to react in the markets. These reactions will be negative and ugly if the lockdown lasts longer.

Q) Do you think the lockdown will be extended beyond May 17? If yes, what will it do to the market?

A) An extension of the lockdown seems unlikely since the economy is bleeding. Currently, markets are expecting the lockdown to be lifted on May 17, however, any further extension will cause a downward movement.

Even if Mumbai and other metro cities remain in extended lockdown, the effect will be extremely negative for the economy.

Q) Specialty chemicals and pharma sectors are best placed do ride out the COVID-19 storm but, after a swift rally, are they still a good buy?

A) The pharmaceutical sector was in a long-term downtrend and faced massive pressure for the past few years. Since this is a health hazard, any positive news will take the pharma stocks zooming.

However, they can turn out to be bull traps, which we witnessed last week. Hence, investors should wait for the earnings to assess the impact of the situation on these companies.

Specialty chemicals, on the other hand, can be good from a long-term perspective since the supply from China may be shifted and Indian players are expected to gain a place in the specialty space on the world map.

However, only investors who are aggressive risk-takers should buy fundamentally stronger specialty chemical stocks.

Though current valuations are lower and they have remained so for quite sometime, only a rerating of earnings multiple will bring excellent gains in the specialty sector, which, in turn, depends on the actual bargaining power of Indian companies in the global spectrum.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/more-pain-left-bear-markets-have-lasted-for-a-minimum-of-18-months-5242971.html
"May 08, 2020 03:10 PM IST",2,Sandip Das,"D-Street Buzz: 250 stocks hit upper circuit on BSE; volumes of RIL, HUL top the charts","The Indian stock market is trading in the green largely helped by Reliance Industries which jumped 4 percent and is the top Sensex gainer.
The top gainers included HUL, Reliance Industries, Tech Mahindra, Nestle India and Sun Pharma while NTPC, Mahindra & Mahindra, Axis Bank, State Bank of India and Maruti Suzuki remained the top losers.
263 stocks hit upper circuit on BSE including Future Retail, Vakrangee, Infibeam, Ruchi Soya, Future Lifestyle and Edelweiss Financial.
On the other hand DR Reddy's Labs, Venus Remedies and Uttam Value Steel hit new 52-week high on BSE.
The most active stocks in terms of volumes included Vodafone Idea, Laurus Labs, RBL Bank, State Bank of India, YES Bank, IndusInd Bank, ICICI Bank and Reliance Industries among others.","The most active stocks in terms of volumes included Vodafone Idea, Laurus Labs, RBL Bank, State Bank of India, YES Bank, IndusInd Bank, ICICI Bank and Reliance Industries among others.","The Indian stock market is trading in the green largely helped by Reliance Industries which jumped 4 percent and is the top Sensex gainer.

RIL share price rose more than 4 percent after a US-based private equity fund said it is going to pick a stake in the company's digital unit.

Share price of Hindustan Unilever added over 3 percent Societe Generale had bought 1.29 crore shares of the company at Rs 1,902 per share. Global research firm Credit Suisse has maintained its outperform call on the stock with target at Rs 2,400 per share, as reported by CNBC-TV18.

Sensex is up 273.75 points or 0.87% at 31717.13, and the Nifty up 75.70 points or 0.82% at 9274.75.

The top gainers included HUL, Reliance Industries, Tech Mahindra, Nestle India and Sun Pharma while NTPC, Mahindra & Mahindra, Axis Bank, State Bank of India and Maruti Suzuki remained the top losers.

263 stocks hit upper circuit on BSE including Future Retail, Vakrangee, Infibeam, Ruchi Soya, Future Lifestyle and Edelweiss Financial. On the other hand DR Reddy's Labs, Venus Remedies and Uttam Value Steel hit new 52-week high on BSE.

The most active stocks in terms of volumes included Vodafone Idea, Laurus Labs, RBL Bank, State Bank of India, YES Bank, IndusInd Bank, ICICI Bank and Reliance Industries among others.

Despite the sharp correction over a period, HDFC Securities maintained its reduce rating with a target of Rs 136, given elevated risks and sub-par expected return ratios. India VIX is down 3.93 percent and is trading at 38.36 level. Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/d-street-buzz-250-stocks-hit-upper-circuit-on-bse-volumes-of-ril-hul-top-the-charts-5242031.html
"May 08, 2020 11:00 AM IST",2,Subhash Helgaokar,Buy USDINR; target of 76.10 - 76.30: ICICI Direct,"ICICI Direct's currency report on USDINRSpot CurrencyThe rupee further depreciated by almost 9 paise and ended at 75.76 whereas the US$INR May future ended above 76 levels.
Weakness in the rupee was largely due to strengthening of the dollar and US-China trade war fears • After three days of winning streak, the Dollar Index ended negative for the first time in the week.
Currency futures on NSEThe dollar-rupee contract on the NSE was at 76.03 in the last session.
The open interest fell almost 3.2% during the last session • The US$INR pair managed to close above 76 levels as US Dollar index moved near 100 levels.
Negative domestic equities and selling by FIIs are likely to keep the rupee move in check.",ICICI Direct The USDINR pair managed to close above 76 levels as US Dollar index moved near 100 levels. Negative domestic equities and selling by FIIs are likely to keep the rupee move in check.,"ICICI Direct's currency report on USDINR

Spot Currency

The rupee further depreciated by almost 9 paise and ended at 75.76 whereas the US$INR May future ended above 76 levels. Weakness in the rupee was largely due to strengthening of the dollar and US-China trade war fears • After three days of winning streak, the Dollar Index ended negative for the first time in the week. However, it remained near the important level of 100.

Currency futures on NSE

The dollar-rupee contract on the NSE was at 76.03 in the last session. The open interest fell almost 3.2% during the last session • The US$INR pair managed to close above 76 levels as US Dollar index moved near 100 levels. Negative domestic equities and selling by FIIs are likely to keep the rupee move in check.

Intra-day strategy

US$INR May futures contract (NSE) View: Bullish on US$INR Buy US$ in the range of 75.80-75.90 Market Lot: US$1000 Target: 76.10/ 76.30 Stop Loss: 75.70 Support: 75.50/75.80 Resistance: 76.20/76.40

The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-usdinr-target-of-76-10-76-30-icici-direct-5240321.html
"May 09, 2020 09:24 AM IST",-2,Kshitij Anand,Profit taking hits D-Street; nearly 90 stocks in BSE500 fell 10-30% in a week,"A volatile week for Indian markets which started off on a weak note, but witnessed mild recovery towards the close of the week.
Benchmark indices closed below their crucial support levels while small and mid-caps outperformed on a relative basis.
The Nifty50 plunged 6.17 percent while the S&P BSE Sensex was down 6.15 percent for the week ended May 8 compared to 4.9 percent fall seen in the S&P BSE Mid-cap index, and 4.17 percent drop in the S&P BSE Small-cap index in the same period.
“Broader markets have substantially recovered but not all stocks would prove to be outstanding wealth creators in the long run.
“But, speculations over various stimulus packages for stressed industries from the government has contributed to this end of the week recovery,” he said.",Markets witnessed a bounce back from the bottom over-optimism on relief measures introduced by government but continuous rise in COVID-19 cases and bad earning season weighed on the sentiments.,"A volatile week for Indian markets which started off on a weak note, but witnessed mild recovery towards the close of the week. Benchmark indices closed below their crucial support levels while small and mid-caps outperformed on a relative basis.

The Nifty50 plunged 6.17 percent while the S&P BSE Sensex was down 6.15 percent for the week ended May 8 compared to 4.9 percent fall seen in the S&P BSE Mid-cap index, and 4.17 percent drop in the S&P BSE Small-cap index in the same period.

Small and Mid-caps outperform on a relative basis, but profit-taking was seen across the board as market participants preferred to book profits at higher levels after a sharp rally seen in the previous week.

There are as many as 87 stocks in the S&P BSE 500 index which fell 10-30 percent for the week ended May 8 that include names like Power Finance Corp., Motherson Sumi, Quess Corp, Tata Motors, ITC, Maruti Suzuki, Havells India, Titan, SIS, Reliance Power, and AU Small Finance Bank.

The Nifty50 rose over 14 percent in April, and more than 7 percent in the last week of April; hence, some profit-taking was on cards.

“Broader markets have substantially recovered but not all stocks would prove to be outstanding wealth creators in the long run. A crack in the larger weights will eventually trickle down to the small and mid-caps taking them lower in times to come,” Umesh Mehta, Head of Research, Samco Securities told Moneycontrol.

Weak global cues, muted economic activity, rise in COVID-19 related cases, weak numbers from India Inc. for March quarter, and fears of extension in lockdown weighed on sentiment.

“Markets witnessed a bounce back from the bottom over-optimism on relief measures introduced by government but continuous rise in COVID-19 cases and bad earning season weighed on the sentiments which lead to a sharp selloff,” Ritesh Asher - Chief Strategic Officer(CSO) told Moneycontrol.

“But, speculations over various stimulus packages for stressed industries from the government has contributed to this end of the week recovery,” he said.",https://www.moneycontrol.com/news/business/markets/profit-taking-hit-d-street-nearly-90-stocks-in-bse500-fell-10-30-in-a-week-5244741.html
"May 08, 2020 07:34 PM IST",2,Sunil Matkar,"Jio-Vista deal: RIL m-cap near Rs 10 lakh crore, stock up 77% from March lows","RIL is back near its Rs 10 lakh crore market capitalisation (m-cap).
On April 22, Facebook announced its decision to invest Rs 43,574 crore in Jio Platforms for a 9.99 percent stake.
Silver Lake on May 4 decided to invest Rs 5,655.75 crore for a 1.15 percent stake, at an equity value of Rs 4.90 lakh crore.
On April 30, RIL announced India's biggest rights issue of Rs 53,125 crore at Rs 1,257 per share.
Last week, RIL informed the exchanges it expects to complete the capital raising programme totalling over Rs 1.04 lakh crore by Q1 FY21.","All credit goes to three back-to-back deals that took place in Jio Platforms, the 100 percent subsidiary of Reliance Industries","Oil-telecom-to-retail major Reliance Industries (RIL) was the only big gainer among Nifty constituents on May 8.

The index heavyweight shot up 76.7 percent from its March lows and is just 3.6 percent away from its record high of Rs 1,617.8 now, whereas the Nifty is up only 20 percent from its March lows.

The stock had fallen 45.5 percent in three months from its record high seen in December last year, but took only a month-and-a- half to recover almost all gains.

RIL is back near its Rs 10 lakh crore market capitalisation (m-cap). As per its May 8 closing price, the company's m-cap stood at 9,90,088.02 crore.

All credit goes to the three back-to-back deals that took place in Jio Platforms, the 100 percent subsidiary of RIL. This is as per its deleveraging plan, or target of emerging net debt free on a net cash basis by March 2021.

On April 22, Facebook announced its decision to invest Rs 43,574 crore in Jio Platforms for a 9.99 percent stake.

Silver Lake on May 4 decided to invest Rs 5,655.75 crore for a 1.15 percent stake, at an equity value of Rs 4.90 lakh crore. On May 8, Vista Equity Partners said it would invest Rs 11,367 crore for a 2.32 percent equity stake.

Jio Platforms has now raised Rs 60,596.37 crore from leading technology investors in less than three weeks.

On April 30, RIL announced India's biggest rights issue of Rs 53,125 crore at Rs 1,257 per share.

Overall experts remain bullish on the stock given its current and expected growth in telecom as well as digital business, and its strong deleveraging plan. They feel the deal with Facebook will boost Reliance Retail's business and help RIL grow much faster in coming years.

Umesh Mehta, Head of Research, Samco Securities, advises investors to hold the stock till the rights issue and dividend record date to capitalise on the gains.

Last week, RIL informed the exchanges it expects to complete the capital raising programme totalling over Rs 1.04 lakh crore by Q1 FY21. ""This includes investment by Facebook in Jio Platforms, the upcoming rights issue and the previous investment by British Petroleum in FY20.""

Disclaimer: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

'Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.'",https://www.moneycontrol.com/news/business/markets/jio-vista-deal-ril-m-cap-near-rs-10-lakh-crore-stock-up-77-from-march-lows-5243411.html
"May 10, 2020 10:40 AM IST",-2,Kshitij Anand,Investing for a comeback: 88% Nifty stocks trading below 10-year average,"Like in cricket, playing the right players for the right pitch is most important, so is choosing the right market segment to take advantage of a comeback.
Thereafter, equity markets witnessed a strong rally in April 2009 and the Nifty returned 37 percent in six months from its October lows.
The recovery in the BSE Mid Small cap index was however much lower at 22 percent.
Similarly, in CY2011, Nifty contained its worst drawdown to 24 percent versus 36 percent for the S&P BSE Mid Small cap index.
Going deeper into Nifty constituents, we see that 88 percent of the Nifty stocks are trading below their 10-year average valuations on one-year forward earnings.","About 88 percent of the Nifty stocks are trading below their 10-year average valuations on one-year forward earnings. Of these, roughly 65 percent stocks are below their one standard deviation.","Sumit Agrawal

Indian markets have joined global peers in a massive equity sell-off led by fears of a sudden and swift economic slowdown, given the novel coronavirus pandemic.

We have deployed enormous humanitarian and economic efforts to manage and recover from one of the biggest health crisis of our time.

From an investor's perspective, the sharp fall offers an opportunity to have an equity exposure from a medium to long-term perspective. Historically, markets have always behaved extreme in the short run to any adverse developments led by aggressive investor reactions.

Only when the dust settles, and sanity returns, the prices tend to re-adjust to the new economic realities. In 2008, while the market corrected by 60 percent from its January high, the Nifty EPS for CY2009 was only about 20 percent lower than CY2007.

What followed in CY2009 was a strong 75 percent rally in the Nifty.

Likewise, positioning portfolios accordingly to take advantage of any mispricing and possible recovery, is going to be a key call for any investor today.

Like in cricket, playing the right players for the right pitch is most important, so is choosing the right market segment to take advantage of a comeback.

A realistic assessment of the current situation points to only a gradual recovery after a weaker near-term moderation in growth.

In this context, the large-cap segment of the market seems to be the best positioned to limit drawdowns and recover earlier as normalcy returns.

This is primarily driven by its ability to navigate the near-term cyclical slowdown and at the same time be resilient enough when things improve.

In the year 2008, the Nifty made a bottom in October, quite ahead of BSE Mid Small cap index which made a bottom only in March 2009.

Thereafter, equity markets witnessed a strong rally in April 2009 and the Nifty returned 37 percent in six months from its October lows. The recovery in the BSE Mid Small cap index was however much lower at 22 percent.

Similarly, in CY2011, Nifty contained its worst drawdown to 24 percent versus 36 percent for the S&P BSE Mid Small cap index. This reflects well about the ability of large caps to limit the drawdowns and stage a quicker comeback as well.

After the steep fall from the recent highs in January this year, valuation in the large-cap space has become favourable after a long time.

The 40 percent fall in the Nifty from its January highs to the March lows, took its one year forward P/E to a level close to 11x.

These are the similar valuation levels that acted as the market bottom in the three significant market declines in the past 15 years, except the global financial crisis of 2008, where the market bottomed at about 8x one year forward P/E.

It would also be wise to do a similar analysis based on trailing earnings. Nifty trailing P/E hit a low of 14.7x in March, which is roughly one standard deviation below its 20-year average. Similarly, on a P/B basis, the valuations are closer to its 18-year low.

Going deeper into Nifty constituents, we see that 88 percent of the Nifty stocks are trading below their 10-year average valuations on one-year forward earnings. Of these, roughly 65 percent of the stocks are below their one standard deviation.

Generally, investments at such valuation levels in the past have yielded high teens annualized returns on a two-year horizon. While timing the market bottom has been a holy grail forever, we believe these are attractive valuation levels from a risk-reward framework.

Historically, sector-leading companies are found to be more resilient when in a recovery stage, and hence increasing equity allocation here would be a wiser decision at this juncture.

Lastly, for investors, in such times, it is far more important how we behave rather than how our investments behave.

Not reacting to panic, sticking to asset allocation, timely rebalancing, and positioning portfolios in companies with sustainable competitive advantage would go a long way in minimizing the damage and using volatility to our benefit.

Note: Mutual fund investments are subject to market risks, read all scheme related documents carefully.

(The author is Vice President – Fund Management (Equity) at IDFC AMC)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/investing-for-a-comeback-88-nifty-stocks-trading-below-10-year-average-5244931.html
"May 08, 2020 02:23 PM IST",2,Kshitij Anand,Be selective while picking midcaps: Over 20 stocks on buy list of brokerages,"Indian market rallied over 14 percent in April which many would have thought was the resumption of a bull market rally.
The Nifty Mid-cap 100 was up 15.4 percent in Apr'20, as against the Nifty's rise of 14.7 percent.
In the last 12 months, mid-caps were down 23% as against Nifty's decline of 16 percent.
The statistics look compelling to investors who are looking for a better return, but the reality could be very different.
Not all midcaps which are trading below their intrinsic value or are beaten down are top buys, caution experts.","The Nifty Mid-cap 100 was up 15.4 percent in Apr'20, as against the Nifty's rise of 14.7 percent. In the last 12 months, mid-caps were down 23% as against Nifty's decline of 16 percent.","Indian market rallied over 14 percent in April which many would have thought was the resumption of a bull market rally. But given the fact that we are just 2 months in the bear market, these swift rallies can be categorized as bear market rallies.

The Nifty50 is still down over 20 percent from January high, and with many states across India under lockdown, economic activity is virtually shut and that is likely to impact earnings of India Inc. for the June and September quarter.

The Nifty Mid-cap 100 was up 15.4 percent in Apr'20, as against the Nifty's rise of 14.7 percent. In the last 12 months, mid-caps were down 23% as against Nifty's decline of 16 percent.

Notably, over the last 5 years, mid-caps have underperformed by 15%. The Nifty Mid-cap100 P/E ratio now trades at 14.4x from 20.2x in Mar'19 while mid-caps are currently trading at 25% discount to large-caps, said a Motilal Oswal strategy report.

The statistics look compelling to investors who are looking for a better return, but the reality could be very different. Not all midcaps which are trading below their intrinsic value or are beaten down are top buys, caution experts.

“Along with growth shock, there is another challenge for Small and Midcaps equity. Credits are getting re-priced in this environment and it will also impact these companies' ability to get funding,” Sameer Kaul, MD and CEO, TrustPlutus Wealth Managers (India) Pvt. Ltd told Moneycontrol.

“Unavailability of credit and uncertain growth environment will create too much risk for investment at this point in time. Hence, we suggest being cautious before investing in the Mid and Small-cap businesses,” he said.

Irrespective of the market cap of the company, investors should focus on key monitorable such as management pedigree, growth potential, uniqueness of the product, as well as operational efficiencies.

“One should be cautious in all caps I would say, as now only the most resilient will survive the onslaught of the undergoing economic crisis. Companies with a sound business model, along with the capability to adapt to such fast-changing dynamic business environments, will emerge stronger and richer,” Aamar Deo Singh, Head Advisory, Angel Broking Ltd told Moneycontrol.

“And even large caps resting on their past laurels could get hit. But true, one should do a thorough and in-depth analysis before investing in small and midcaps. Now, the quality of management of companies will also be put to test, and it will be interesting to see those who emerge from the current churn,” he said.

Experts advise investors to be selective while choosing midcaps. We have collated a list of midcaps from various brokerage firms that they are recommending amid COVID-19 fall:

Brokerage Firm: Kotak Securities

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/be-selective-while-picking-midcaps-over-20-stocks-on-buy-list-of-brokerages-5235041.html
"May 09, 2020 08:10 AM IST",-2,Kshitij Anand,The biggest financial lesson from the COVID-19 crisis: ‘always diversify',"And turns out that the biggest financial lesson from the current crisis is also the simplest: always diversify your investments.
(Here, equity represents Sensex returns, debt represents 10-year G-sec return, gold represents domestic gold spot price returns as on March 31, 2020).
Market conditions that cause one asset category to do well, often cause another asset category to have average or poor returns.
By investing in more than one asset category, you'll reduce the risk of losing money and your portfolio's overall investment returns will have a smoother ride.
If one asset category's investment return falls, you'll be in a position to counteract your losses in that asset category with better returns in another asset category.","By investing in more than one asset category, you'll reduce the risk of losing money and your portfolio's overall investment returns will have a smoother ride.","Chirag Mehta

Yes, 2020 has been a treacherous year, so far, for most investment portfolios. And yes, external factors that were beyond your control are mainly to blame.

But, what if we were to tell you that there was something you could have done better too. Don't fret. They say it's okay to make mistakes as long as you learn from them.

And turns out that the biggest financial lesson from the current crisis is also the simplest: always diversify your investments.

Here's why.

If you had an all-equity portfolio worth Rs 1,00,000 at the start of 2020, you're probably down a painful 28 percent to Rs 72,000 as of March-end, which means you'll need a whopping 39 percent gain to recover from the recent carnage.

And based on how unpredictable and bearish things are at the moment, you'd agree that those kinds of spectacular gains are far out in the future.

On the flip side, if your portfolio at the start of 2020 was divided between equities, debt and gold in 40:40:20 ratio, the current value would be 92k, requiring a much lower 8.7 percent gain to be whole again.

Pretty good, right? (Here, equity represents Sensex returns, debt represents 10-year G-sec return, gold represents domestic gold spot price returns as on March 31, 2020).

So, how exactly does this diversification work?

Let's take a day-to- day example. Have you ever noticed that street vendors often sell seemingly unrelated products-- umbrellas and sunglasses? Initially, that may seem odd. After all, when will someone buy both the items at the same time?

Probably never--and that's the point. Vendors know that when it rains, it's easier to sell umbrellas but harder to sell sunglasses and when it's sunny, the reverse is true.

By selling both items- in other words, by diversifying the product line--the vendor can reduce the risk of losing money on any given day. If that makes sense, you've got a great start on understanding asset allocation and diversification.

Unfortunately, unlike the vendor, who knows that monsoons follow summer and summer follows monsoons, investors don't deal with predictable economic cycles.

Economies go through ups and downs and these more often than not are unforeseeable.

Assets in our portfolio, due to their differing risk and return characteristics, respond differently to these ups and downs. You'd agree that equities run-up when the economy is doing well and gold tends to shine when the economy is down.

In essence, because it is difficult to predict the future of the economy, it is also difficult to determine the best-performing asset class. That's where asset allocation and diversification come in handy.

Asset allocation is a time-tested approach to portfolio management. It means spreading your investments among multiple asset classes such as stocks and bonds.

By including asset categories with investment returns that move up and down differently under different market conditions within a portfolio, an investor can limit significant losses.

Market conditions that cause one asset category to do well, often cause another asset category to have average or poor returns. By investing in more than one asset category, you'll reduce the risk of losing money and your portfolio's overall investment returns will have a smoother ride.

If one asset category's investment return falls, you'll be in a position to counteract your losses in that asset category with better returns in another asset category.

The concluding point is that diversification, whilst offering no guarantees of portfolio performance or complete protection against risk, increases the possibility of an investor's portfolio withstanding the elements in a financial atmosphere experiencing both man-made and natural disasters on an almost daily basis.

We did some number crunching to substantiate our point.

(The author is Senior Fund Manager - Alternative Investments, Quantum Mutual Fund)",https://www.moneycontrol.com/news/business/markets/the-biggest-financial-lesson-from-the-covid-19-crisis-always-diversify-5242831.html
"May 08, 2020 11:27 AM IST",2,Subhash Helgaokar,Accumulate Rallis India; target of Rs 246: Prabhudas Lilladher,"Prabhudas Lilladher's research report on Rallis IndiaRallis India's results were disappointing due to lost sales from COVID (RS 692 mn), forex loss (Rs 99 mn) and other one-off items.
Impact on the international business was more than domestic.
Plants are operating at low utilization; hence the company is giving priority to domestic business over international before the onset of peak season in Kharif.
International business growth will be driven by capacity creation for Metribuzin (Phase 2).
Maintain Accumulate rating with revised target price of Rs 246 (Previous- 240).","Prabhudas Lilladher recommended accumulate rating on Rallis India with a target price of Rs 246 in its research report dated May 06, 2020.","Prabhudas Lilladher's research report on Rallis India

Rallis India's results were disappointing due to lost sales from COVID (RS 692 mn), forex loss (Rs 99 mn) and other one-off items. Impact on the international business was more than domestic. Lockdown has impacted the operations but there is gradual improvement every passing day in limping back to normalcy. Plants are operating at low utilization; hence the company is giving priority to domestic business over international before the onset of peak season in Kharif. Despite weak results and near term blip in business due to COVID, outlook on Rallis remains robust. Domestic business growth will be driven by new launches, addition of new trade partners, relaxation in credit policies, commencement of new capacity and rosy outlook for the domestic agchem industry. International business growth will be driven by capacity creation for Metribuzin (Phase 2).

Outlook

We have marginally revised our EBITDA/PAT estimates downwards for FY21E by 4.6%/1.1% and for FY22E by 5.1%/3.3% but increase our target multiple from 17x to 18x. Maintain Accumulate rating with revised target price of Rs 246 (Previous- 240).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/accumulate-rallis-india-target-of-rs-246-prabhudas-lilladher-5240441.html
"May 08, 2020 02:49 PM IST",-2,Sunil Matkar,RBL Bank share price tanks over 6% after Q4 nos; analysts remain bearish,"RBL Bank share price fell 6.6 percent intraday on May 8 after the private lender reported a sharp drop in Q4 profit and muted loan and deposit growth.
Most analysts remain bearish on the stock on account of the coronavirus outbreak hitting business.
Despite the sharp correction, HDFC Securities maintained its reduce rating with a target of Rs 136, given elevated risks and sub-par expected return ratios.
Asset quality and growth trends in Cards, MFI and LAP segments critical to valuation,"" said Yes Securities.
""Around 33 percent of the loan portfolio availed moratorium; thus, we expect credit cost trends to remain elevated at 3.6 percent for FY21.","While retaining reduce call with a target price of Rs 135, Yes Securities said it cut FY21/22 earnings estimates by 88/44 percent due to sharp adjustments to loan growth, fee growth and credit cost.","RBL Bank share price fell 6.6 percent intraday on May 8 after the private lender reported a sharp drop in Q4 profit and muted loan and deposit growth. Most analysts remain bearish on the stock on account of the coronavirus outbreak hitting business.

The stock, which has fallen more than 80 percent in the last one year, was quoting at Rs 120.70, down 6.36 percent on the BSE at 1358 hours.

Despite the sharp correction, HDFC Securities maintained its reduce rating with a target of Rs 136, given elevated risks and sub-par expected return ratios.

""RBL Bank's Q4 earnings were higher versus estimates on account of sharper-than-expected margin expansion (not sustainable) and lower than expected loan loss provisions (elevated nevertheless, to persist), but balance sheet growth was constrained as deposits dipped 8 percent QoQ (1 percent YoY). RBL faces challenges on both sides of the balance sheet -- potential stress from high unsecured loan exposure and a weak deposit franchise,"" the brokerage said.

The private sector lender reported a 53.7 percent year-on-year (YoY) decline in standalone profit at Rs 114.36 crore due to 207.1 percent jump in provisions.

Net interest income grew by 38.2 percent to Rs 1,020.98 crore YoY with advances book growth at 7 percent YoY (down 3 percent QoQ), but total deposits reduced 1 percent YoY (down 8 percent QoQ).

Asset quality also weakened with gross non-performing assets (NPA) as a percentage of gross advances rising 29 basis points QoQ to 3.62 percent, but net NPA declined 2 basis points QoQ to 2.05 percent as of March 2020.

""Gross NPLs increases by 30 bps, with slippages staying elevated at annualised 5 percent (corporate book clean-up and portfolio mix change).

Credit cost was high at annualised 4.2 percent, also driven by accelerated provision on recognized corporate stress (PCR up 600 bps) and Rs 115 crore COVID-related (included full 10 percent provisions on standard-but-overdue accounts, 100 percent provisions on cards NPLs and contingent provisions on retail portfolio),” said Yes Securities.

It said asset quality risks include 33 percent of portfolio opting for moratorium till April 30; BB & Below at 6.5 percent (few lumpy exposures); BBB rated portfolio at 20 percent and 7.5 percent BBB & BB rated exposure to COVID-hit sectors.

While retaining reduce call with a target price of Rs 135, the brokerage said it cut FY21/22 earnings estimates by 88/44 percent due to sharp adverse adjustments to loan growth, fee growth and credit cost.

Key FY21 expectations of the bank are: a) cautious on growth; cards and MFI drivers in second half of FY21, b) NIMs to witness some compression due to surplus liquidity and interest reversals, c) credit cost similar or mildly higher than FY20 (3.6 percent).

""Given its portfolio complexion, the bank faces heightened near-term macro uncertainty, which will keep a check on valuation. Asset quality and growth trends in Cards, MFI and LAP segments critical to valuation,"" said Yes Securities.

Emkay believes RBL's expected business/return on assets (RoA) normalisation from FY21 could be pushed back due to COVID-19-led disruption. Hence, the brokerage retained hold rating with a target price of Rs 145 due to lower valuations and timely shoring up of capital (Tier I over 15 percent) but retained underweight rating in its Emkay Alpha Portfolio.

Motilal Oswal said the asset quality would continue to remain under pressure, with concerns over retail as the COVID-19 outbreak would impact delinquency trends in the portfolios of credit cards/MFI and MSME.

""Around 33 percent of the loan portfolio availed moratorium; thus, we expect credit cost trends to remain elevated at 3.6 percent for FY21.

Furthermore, the bank's BBB-/BB-rated exposures to COVID-19-impacted sectors stood at 5.6/1.8 percent. This may pose a risk as the business environment remains weak, thus prolonging the slippage trend in the Wholesale portfolio,"" it said.

The brokerage cut its PAT estimate for FY21/FY22 by 6/5 percent, as it factored in moderation in fee income led by reduced economic activity and lockdown but maintained a buy call with a target of Rs 180 per share.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/rbl-bank-share-price-tanks-over-6-after-q4-nos-analysts-remain-bearish-5241961.html
"May 10, 2020 11:00 AM IST",2,Subhash Helgaokar,Buy Hindalco Industries; target of Rs 170: Prabhudas Lilladher,"Prabhudas Lilladher's research report on Hindalco IndustriesNovelis delivered better than expected Q4FY20 earnings on the back of better than expected margins in spite of lower volumes.
South American/Asian operations drove the show with 13%/24% YoY growth in EBITDA at USD112mn/USD56mn on the back of better scrap spreads and higher premiums.
European operations posted 54% growth in EBITDA at USD86mn, benefitted by income of USD29mn on the contract having Take/Pay terms.
While, EBITDA in North American operations fell 22% YoY at USD122mn due to lower share of margin rich auto volumes.
In wake of attractive valuations, comfortable B/S and better earnings outlook, we reiterate BUY with TP of Rs170, EV/EBITDA of 5.7x FY21e.","Prabhudas Lilladher is bullish on Hindalco Industries has recommended buy rating on the stock with a target price of Rs 170 in its research report dated May 08, 2020.","Prabhudas Lilladher's research report on Hindalco Industries

Novelis delivered better than expected Q4FY20 earnings on the back of better than expected margins in spite of lower volumes. Adj. EBITDA grew by 1% YoY to USD361mn (PLe:345mn), led by 9% growth in unitary margins partially offset by 7% YoY dip in volumes at 811kt. South American/Asian operations drove the show with 13%/24% YoY growth in EBITDA at USD112mn/USD56mn on the back of better scrap spreads and higher premiums. European operations posted 54% growth in EBITDA at USD86mn, benefitted by income of USD29mn on the contract having Take/Pay terms. While, EBITDA in North American operations fell 22% YoY at USD122mn due to lower share of margin rich auto volumes.

Outlook

However, niche product basket and higher infra spending in US would revive earnings in FY22e. In wake of attractive valuations, comfortable B/S and better earnings outlook, we reiterate BUY with TP of Rs170, EV/EBITDA of 5.7x FY21e.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-hindalco-industries-target-of-rs-170-prabhudas-lilladher-5246721.html
"May 08, 2020 10:46 AM IST",1,Sandip Das,"Dr Reddy's Labs share price jumps 4%, hits 52-week high after US FDA EIR for its Srikakulam unit","Pharma major Dr Reddy's Laboratories share prices gained over 4 percent intraday on May 8 after the company said that it had received EIR from US FDA for Srikakulam (CTO VI) unit.
According to Moneycontrol SWOT Analysis powered by Trendlyne Dr Reddy's Labs has zero promoter pledge with rising net cash flow and cash from operating activity.
The technical rating is also very bullish according to moneycontrol technical analysis.
Dr Reddy's Labs is one of the most active stock on NSE in terms of value with 9,29,265 shares being traded.
We look forward to future opportunities with this company,"" Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.","The stock movement shows strong momentum with price above short, medium and long term moving averages.","Pharma major Dr Reddy's Laboratories share prices gained over 4 percent intraday on May 8 after the company said that it had received EIR from US FDA for Srikakulam (CTO VI) unit.

""With regards to the audit of our API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI), we would like to inform you that we have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as ""Voluntary Action Indicated"" (VAI), the company said in a filing to the exchanges.

The stock has been a steady performer in the last 1 year with the scrip jumping over 57 percent in the last 9 months. It was quoting at Rs 4,016, up Rs 181.65, or 4.74 percent at 10:20 hours and has touched a 52-week high of Rs 4,099.90.

According to Moneycontrol SWOT Analysis powered by Trendlyne Dr Reddy's Labs has zero promoter pledge with rising net cash flow and cash from operating activity. The stock movement shows strong momentum with price above short, medium and long term moving averages. The technical rating is also very bullish according to moneycontrol technical analysis.

Dr Reddy's Labs is one of the most active stock on NSE in terms of value with 9,29,265 shares being traded. It witnessed spurt in volume by more than 1.28 times and was trading with volumes of 32,633 shares, compared to its five day average of 29,746 shares, an increase of 9.71 percent.

The company on May 6 launched generic Desmopressin Acetate injection indicated for treatment of hemophilia, in the US. ""The launch of desmopressin injection demonstrates a strong, growing collaboration with SunGen Pharma. We look forward to future opportunities with this company,"" Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/dr-reddys-labs-share-price-jumps-4-hits-52-week-high-after-us-fda-eir-for-its-srikakulam-unit-5240161.html
"May 08, 2020 11:41 AM IST",2,Rakesh Patil,Slideshow | Brokerages bet on these 10 stocks for 15-66% returns,"On May 7, the Indian indices ended in the red amid volatility.
Sensex plunged more than 200 points and Nifty50 slipped below 9,200 levels.
Here are 10 stocks where brokerages maintained buy call with an upside of 15-66 percent.",Here are the 10 stocks in which brokerages maintained buy call and expecting upside between 15-66 percent.,"On May 7, the Indian indices ended in the red amid volatility. Sensex plunged more than 200 points and Nifty50 slipped below 9,200 levels. Here are 10 stocks where brokerages maintained buy call with an upside of 15-66 percent.",https://www.moneycontrol.com/news/business/stocks/slideshow-brokerages-bet-on-these-10-stocks-for-15-66-retruns-5239701.html
"May 09, 2020 01:38 PM IST",1,Rakesh Patil,RSI pull back in Tata Motors suggests a buying opportunity,"RSI PBB is Pull Back Buy setup which indicates, once RSI turns its tail upside after taking support from zone of 45-55 levels, target is previous swing high of RSI which was 80 or previous swing high of prices (Rs 94).
Currently, Tata Motors is going through this setup and we expect higher price movement towards previous high Rs 94-98 levels in coming days.
After marking high of 80, RSI is retracing towards 50 towards mid-line standing around 50 mark.3.
Profit Booking:Whenever price candle will be near previous swing high which is near Rs 94-98 levels.
Conclusion:We recommend buying Tata Motors around Rs 81-80 levels with a stop loss of Rs 73 on a closing basis for higher targets of Rs 94 and Rs 98 levels as indicated in above chart.","In Tata Motors, RSI had given a breakout by moving above 50 levels from below and then it made a high of 80 then after that it is moving lower or retracing towards the centre line placed at 50 level, this behavior calls for a ‘RSI Pull Back Buy'.","Shabbir Kayyumi

RSI stands for Relative Strength Index. It is a momentum oscillator used to identify trend reversal.

RSI was invented by Welles Wilder Jr. The default look-back period for RSI is 14, however, this can be lowered to increase sensitivity or raised to decrease sensitivity. RSI calculates strength of a stock's trend and helps to predict their reversals.

Why to buy Tata Motors?

There are a lot of trading strategies using RSI; below mentioned is one of the most popular among trading community which involves Buy after completing retracement for higher movement.

In the past few days, RSI had given a breakout by moving above 50 levels from below and then it made a high of 80 then after that it is moving lower or retracing towards the centre line placed at 50 level, this behavior is called as ‘RSI PBB' setup.

RSI PBB is Pull Back Buy setup which indicates, once RSI turns its tail upside after taking support from zone of 45-55 levels, target is previous swing high of RSI which was 80 or previous swing high of prices (Rs 94).

Currently, Tata Motors is going through this setup and we expect higher price movement towards previous high Rs 94-98 levels in coming days.

1. Recent RSI gave a breakout and reached swing top around 80 levels.2. After marking high of 80, RSI is retracing towards 50 towards mid-line standing around 50 mark.3. Strong bullish candle formation near buying zone has given us confirmation of retracement complete and original trend begin.4. Mid- term moving average 50 DMA placed around 79 levels defines mid-term trend very well augurs with bulls as prices are sustained and trading above it.

5. Decent volume participation while forming a bullish candle will also give additional confirmation.

Profit Booking:

Whenever price candle will be near previous swing high which is near Rs 94-98 levels.

Stop Loss:

Entire bullish view negates on breaching of a swing low and one should exit from long position.

Conclusion:

We recommend buying Tata Motors around Rs 81-80 levels with a stop loss of Rs 73 on a closing basis for higher targets of Rs 94 and Rs 98 levels as indicated in above chart.

The author is Head - Technical & Derivative Research, Narnolia Financial Advisors.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/rsi-pull-back-in-tata-motors-suggests-a-buying-opportunity-5245061.html
"May 08, 2020 11:26 AM IST",1,Subhash Helgaokar,Hold Marico; target of Rs 318: Prabhudas Lilladher,"Prabhudas Lilladher's research report on MaricoMRCO 4Q results displayed the impact of COVID lockdown and pantry stocking in Saffola even as VAHO and Parachute suffered.
MRCO has extended several incentives to trade and expects strong growth in Saffola and gradual stabilization in Parachute and VAHO.
We believe non-essential products like Parachute, VAHO and personal care will recover after a while and impact of lockdown will be visible in IBD for 1HFY21.
OutlookWe estimate 7.2% PAT CAGR over FY20-22 and 11.3% PAT growth in FY22.
We value the stock at 35xFY22 EPS and arrive at target price of Rs318 (Rs329 based on 36xFY22 EPS earlier).","Prabhudas Lilladher recommended hold rating on Marico with a target price of Rs 318 in its research report dated May 04, 2020.","Prabhudas Lilladher's research report on Marico

MRCO 4Q results displayed the impact of COVID lockdown and pantry stocking in Saffola even as VAHO and Parachute suffered. MRCO has extended several incentives to trade and expects strong growth in Saffola and gradual stabilization in Parachute and VAHO. Input costs and benign and provide a lever to MRCO to reduce prices and gain share from unorganized players. However, we believe that current momentum in Saffola is led by sustained pantry stocking by consumers and is unsustainable. We believe non-essential products like Parachute, VAHO and personal care will recover after a while and impact of lockdown will be visible in IBD for 1HFY21.

Outlook

We estimate 7.2% PAT CAGR over FY20-22 and 11.3% PAT growth in FY22. MRCO is currently trading at 31.1xFY22 EPS which reflects uncertainty over growth and limited new product success over the years. We value the stock at 35xFY22 EPS and arrive at target price of Rs318 (Rs329 based on 36xFY22 EPS earlier). Retain Hold.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-marico-target-of-rs-318-prabhudas-lilladher-5240421.html
"May 08, 2020 01:35 PM IST",2,Nishant Kumar,Pharma sector in a sweet spot: Axis Capital picks 6 winners in the sector,"A strong demand environment and a depreciating currency have put the pharma sector in a sweet spot.
Some brokerages and market experts believe COVID-19 will bring about a change in market leadership and pharma will emerge stronger.
On the other hand, despite near-term challenges, domestic-focused companies' growth is seen steady over the medium-term.
Axis Capital continues to like domestic-focused companies for sustainable growth and margin and the ability to generate free cash flows.
Download a copyThe views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.",Some brokerages and market experts believe the COVID-19 will bring about a change in market leadership and pharma will emerge stronger.,"At a time when COVID-19 has hit businesses hard, pharma has emerged as a bright spot.

A strong demand environment and a depreciating currency have put the pharma sector in a sweet spot.

Some brokerages and market experts believe COVID-19 will bring about a change in market leadership and pharma will emerge stronger.

""After almost 4 years of underperformance, pharma seems to have regained its lost 'mojo' in the last 2 months as focus globally turns towards this sector. We think Indian pharma stocks will be the leaders of the next bull run for the next 2/3 years as earnings, volumes & growth will see outperform. Also, the need for medicine stocking may be more psychological which could drive higher volumes both globally & locally,"" Sanjiv Bhasin, Director at IIFL, said in an interview with Moneycontrol.

Brokerage firm Axis Capital points out tailwinds emerging in the US generic business.

""With tailwinds emerging in US generics after COVID-19, we expect negative operating leverage (high CAPEX and R&D coupled with slower approvals/ USFDA issues) which had compressed return ratios to improve over near to medium term,"" said Axis Capital.

The brokerage has raised EPS and PE for US-focused companies.

On the other hand, despite near-term challenges, domestic-focused companies' growth is seen steady over the medium-term.

Axis Capital continues to like domestic-focused companies for sustainable growth and margin and the ability to generate free cash flows.

Axis has a buy recommendation on Aurobindo, Cadila, Biocon, Alembic, Eris Lifesciences and Natco Pharma.

On the earnings front, brokerages expect the domestic formulations segment to see a healthy Q4 with 9-12 percent year-on-year (YoY) organic growth for the sector, with the limited impact of COVID-19 on domestic sales for the quarter, given most companies have a cut-off date of around March 20 for book sales.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/pharma-sector-in-a-sweet-spot-axis-capital-picks-6-winners-in-the-sector-5241121.html
"May 08, 2020 11:26 AM IST",1,Subhash Helgaokar,Hold Titan Company; target of Rs 844: Prabhudas Lilladher,"Our Channel checks suggest significant pressure on demand and likely rush to offload jewellery post lockdown ends and need to improve designing in a post compulsory hallmarking scenario as purity plank might not work to advantage of Tanishq.
OutlookWe believe TTAN will continue to enjoy premium valuations and value the stock at 43xFY22 EPS and arrive at a target price of Rs844 (Rs1264 earlier).
We retain hold and recommend accumulation on declines for long term gains given possibility of near term PE de-rating.
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Prabhudas Lilladher recommended hold rating on Titan Company with a target price of Rs 844 in its research report dated May 05, 2020.","Prabhudas Lilladher's research report on Titan Company

We are cutting FY20, FY21 and FY22 EPS estimates by 7.1%, 43.7% and 28.1% as current confluence of 1) store closures due to lockdown 2) expected cut in discretionary spends by consumer 3) 20% higher gold prices 4) 54% less wedding dates in FY21 and washout of 1Q wedding season (68% of FY21 wedding season) and 5) lower new store openings shows its impact on Jewellery sales. Our Channel checks suggest significant pressure on demand and likely rush to offload jewellery post lockdown ends and need to improve designing in a post compulsory hallmarking scenario as purity plank might not work to advantage of Tanishq.

Outlook

We believe TTAN will continue to enjoy premium valuations and value the stock at 43xFY22 EPS and arrive at a target price of Rs844 (Rs1264 earlier). We retain hold and recommend accumulation on declines for long term gains given possibility of near term PE de-rating.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-titan-company-target-of-rs-844-prabhudas-lilladher-5240431.html
"May 08, 2020 10:48 AM IST",1,,"RIL share price gains 4% on Vista Equity investment; stock 4% away from 52-week high of Rs 1,617","The stock is just 4.5 percent away from its record high of Rs 1,617 registered on December 20, 2019.
Vista Equity Partners will pick up a 2.32 percent stake in the company's Jio Platforms for Rs 11,367 crore at an equity value of Rs 4.91 lakh crore and an enterprise value of Rs 5.16 lakh crore.
They believe in the transformative power of technology to be the key to an even better future for everyone,"" said Mukesh Ambani, Chairman and Managing Director - Reliance Industries.
At 10:48 hrs Reliance Industries was quoting at Rs 1,567.50, up Rs 60.25, or 4.00 percent on the BSE.
Download a copy: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",Vista's investment is at 12.5 percent premium over the Facebook deal announced in April.,"Reliance Industries (RIL) share price rose more than 4 percent intraday on May 8 after a US-based private equity fund said it is going to pick a stake in the company's digital unit.

The stock is just 4.5 percent away from its record high of Rs 1,617 registered on December 20, 2019.

The stock has rallied about 40 percent since April.

Vista Equity Partners will pick up a 2.32 percent stake in the company's Jio Platforms for Rs 11,367 crore at an equity value of Rs 4.91 lakh crore and an enterprise value of Rs 5.16 lakh crore.

The US-based private equity firm that runs the world's largest exclusively tech-focused fund.

Vista's investment is at 12.5 percent premium over the Facebook deal announced in April. The investment by Silver Lake Partners in Jio announced earlier this week was also at a similar premium to the Facebook deal.

""Like our other partners, Vista also shares with us the same vision of continuing to grow and transform the Indian digital ecosystem for the benefit of all Indians. They believe in the transformative power of technology to be the key to an even better future for everyone,"" said Mukesh Ambani, Chairman and Managing Director - Reliance Industries.

At 10:48 hrs Reliance Industries was quoting at Rs 1,567.50, up Rs 60.25, or 4.00 percent on the BSE.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/ril-to-open-higher-on-investment-from-vista-equity-stock-7-away-from-52-week-high-5239621.html
"May 08, 2020 11:25 AM IST",2,Subhash Helgaokar,Buy SBI Life Insurance Company; target of Rs 880: Prabhudas Lilladher,"Prabhudas Lilladher's research report on SBI Life Insurance CompanySBI Life's NBP growth weakened to 20% YoY while seeing a tepid APE growth of 11% in FY20 and targets single digit growth for FY21.
Though Protection biz growth moderated to 27% YoY it still continues to be the core focus while ULIPs performed better than peers.
OutlookOverall operating metrics like persistency, margins, costs etc.
expected to remain steady while growth is expected to slow down a bit going ahead.
We retain BUY with revised TP of Rs 880 (from Rs 1,127) based on 2.4x (from 3.2x) Mar-22 P/EV.","Prabhudas Lilladher is bullish on SBI Life Insurance Company has recommended buy rating on the stock with a target price of Rs 880 in its research report dated May 06, 2020.","Prabhudas Lilladher's research report on SBI Life Insurance Company

SBI Life's NBP growth weakened to 20% YoY while seeing a tepid APE growth of 11% in FY20 and targets single digit growth for FY21. Though Protection biz growth moderated to 27% YoY it still continues to be the core focus while ULIPs performed better than peers. Margins continued to improve with 100bps YoY ending at 18.7% on back of favorable mix but were weaker than expected on conservative assumptions on future risks. Persistency continued to improve across all cohorts with ULIPs having largely stable experience, while NPar showed improvement.

Outlook

Overall operating metrics like persistency, margins, costs etc. expected to remain steady while growth is expected to slow down a bit going ahead. We retain BUY with revised TP of Rs 880 (from Rs 1,127) based on 2.4x (from 3.2x) Mar-22 P/EV.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-sbi-life-insurance-company-target-of-rs-880-prabhudas-lilladher-5240401.html
"May 08, 2020 03:20 PM IST",-2,Sunil Matkar,Cyient locked in lower circuit on weak guidance; HDFC Sec downgrades stock,"Shares of Cyient, the global engineering and technology solutions company, were locked in a 10 percent lower circuit on May 8 on weak revenue growth guidance for Q1FY21.
HDFC Securities downgraded its rating on Cyient to reduce from add post a weak performance and bleak growth outlook.
""Services growth and margin performance in Q4 were disappointing.
Services margin stood at 9.6 percent down 100bps QoQ.
HDFC Securities expects USD revenue growth of down 20/up 7.8 percent and EBIT percent of 7.8/8.8 percent for FY21/22.","Cyient's revenue stood at $149.2 million, down 3.9/9.7 percent QoQ/YoY against HDFC Securities' estimates of $153 million, while constant currency revenue degrowth was 3.7 percent QoQ.","Shares of Cyient, the global engineering and technology solutions company, were locked in a 10 percent lower circuit on May 8 on weak revenue growth guidance for Q1FY21. HDFC Securities downgraded its rating to reduce.

The stock lost 58 percent of its value in last three months. It was quoting at Rs 208.55, down 9.99 percent on the BSE at 14:33 hours IST.

HDFC Securities downgraded its rating on Cyient to reduce from add post a weak performance and bleak growth outlook.

""Services growth and margin performance in Q4 were disappointing. Growth in the first half of FY21 will be severely impacted due to a structural problem in A&D and supply-side (COVID-related) issues in Communication and Transportation verticals. Cyient's higher mix of mechanical services and elevated exposure to stressed verticals has magnified the COVID-19 impact versus its peers,"" the brokerage said.

It has reduced its EPS estimates by 16.4/13.8 percent for FY21/22. Its price target on the stock stood Rs 240, based on 9x FY22E EPS, which is at around 30 percent discount to 5-year average 1-year-forward P/E multiple.

Cyient's revenue stood at $149.2 million, down 3.9/9.7 percent QoQ/YoY against HDFC Securities' estimates of $153 million, while constant currency revenue degrowth was 3.7 percent QoQ.

Its revenue was down 4 percent YoY in constant currency (CC) terms versus growth of 12.8/1.8 percent YoY CC growth for HCL/Wipro ER&D division.

Management has indicated of a steep fall of around 15-20 percent QoQ in Q1FY21.

EBIT margin contracted 118 bps QoQ to 8.4 percent (lowest ever). Services margin stood at 9.6 percent down 100bps QoQ.

""The margin recovery will be linked to growth and Q4FY21 exit will be similar to Q4FY20. Cyient's higher mix of mechanical engineering (legacy) services explains the poor growth metrics and the lower margin structure compared to ER&D peers,"" said HDFC Securities.

The brokerage further said Cyient was struggling with issues such as (1) stress in services portfolio, (2) stress in top accounts (3) Issues in core vertical (aerospace and defence), (4) focus on lower margin DLM business and (5) lower margins structure due to investments and muted growth.

""Concerns related to slowdown in decision making, COVID-19 related uncertainty and higher mix of legacy services remain,"" it added.

HDFC Securities expects USD revenue growth of down 20/up 7.8 percent and EBIT percent of 7.8/8.8 percent for FY21/22.

Motilal Oswal also feels Cyient's Q4FY20 revenue and adjusted EBIT margins were disappointing. The brokerage has a neutral call on the stock.

""Sharper disruption versus peers (e.g. HCL Tech's ER&D portfolio) is also a reflection of the company's weak execution capabilities. We anticipate a material slowdown in key verticals like A&D, Transportation and E&U (contributing around 60 percent of revenue) over the next 12-18 months,"" it said.

""While Communications (around 23 percent of revenue) may not be heavily impacted by COVID-19, the liquidity crunch would mean low emphasis on ER&D spends. Supply-side issues in ER&D are more pronounced than in IT services given the reluctance of clients to enable Work from Home (WFH) due to concerns around plagiarism/IP theft,"" it added.

Hence, the brokerage cut its EPS estimates for FY20-22 by 31-33 percent due to the worse-than-expected results and commentary.

""Given the continued execution challenges at the company, dented visibility on earnings recovery and the one-off trail, hope of a re-rating may be too optimistic. Target price of Rs 260 is based on around 10x FY22E EPS,"" Motilal Oswal said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/cyient-locked-in-lower-circuit-on-weak-guidance-hdfc-sec-downgrades-stock-5242021.html
"May 10, 2020 10:15 AM IST",1,Kshitij Anand,Here's an ideal portfolio construction strategy for every mother,"However, I firmly believe that the portfolio shared below can help every mother tide the current financial crisis, with better management of household income.
You can easily achieve this by investing in a systematic investment plan (SIP) investing in equity mutual funds and in unit-linked insurance plans (ULIPs), offering annualised returns of 12 percent.
SIPs in equity mutual funds infuse much-needed discipline into your investments and ULIPs offer investment and protection, within a single product.
Additionally, SIPs help you better navigate through market volatility, offering a pause option to be exercised, should the need arise.
Debt mutual funds, on the other hand, prevent erosion in corpus due to market volatility.","This Mother's Day, we can urge every mother, working or non-working, to arm herself with financial knowledge, requisite to make sound investment decisions.","Rahul Jain

At a time when stock markets have nosedived, production has come to a grinding halt and being confined within four walls of our homes has became the new normal, one thing that remains constant is mother's love and care for her family.

Women around the world, continue to work and care for their families, just as they always have, for centuries.

Mothers are considered as the epitome of nurturing and usually juggle various roles in their life, managing each of them with ease and elan. Their selfless contribution to our well-being and prosperity, cannot be recompensed.

Tough balancing act

Balancing household budgets with income, managing expenses and every expectation is a daunting task. Exercising utmost precision and prudence to stretch finances just a wee bit more, a mother's knack has been legendary. And in the current situation, it is a worthy challenge for a superhero.

Adding to the mix, are possible pay cuts and job losses, school fees, and EMIs, not to mention day-to-day expenses and four square, healthy meals for her family, every single day.

The prayer on every mother's lips today is to find the right solution that allows her to balance the needs and wants of her family, without compromise and with as much relative ease as she can muster.

However, I firmly believe that the portfolio shared below can help every mother tide the current financial crisis, with better management of household income.

With this in her arsenal, she can meet essential expenses, save considerably despite limited resources and also address her own priorities, with ease.

Structure of the portfolio

Dedicated and disciplined investments in different asset classes such as equity mutual funds, unit-linked insurance plans (ULIPs) and debt mutual funds, can help every mother address two crucial needs — her children's education and the well-being of her family.

To give you a simple example, assuming you are 35-years-old with a child aged five, you would need over Rs 40 lakh, for his/her graduation.

This is assuming that the cost of graduation is approximately Rs 15 lakh, today. This would, with an annual rate of inflation of 10 percent, escalate to Rs 43 lakh, 11 years down the line.

In order to achieve this, you would need to consistently set aside a monthly investment of Rs 18,000 for 11 years, to generate an annual return of 10 percent.

You can easily achieve this by investing in a systematic investment plan (SIP) investing in equity mutual funds and in unit-linked insurance plans (ULIPs), offering annualised returns of 12 percent.

This would amount to Rs 12,600 per month, which when coupled with a monthly investment of Rs 5,400 in a debt fund offering 6 percent per annum for 11 years, can help build the above corpus.

SIPs in equity mutual funds infuse much-needed discipline into your investments and ULIPs offer investment and protection, within a single product.

Additionally, SIPs help you better navigate through market volatility, offering a pause option to be exercised, should the need arise.

In times like now, this option to pause your SIPs can come in handy. This option helps you take a brief break from your SIP payments and also allows you to restart them later, without the need for an exit given lack of funds. Debt mutual funds, on the other hand, prevent erosion in corpus due to market volatility.

ULIPs offer partial withdrawal facility after a mandatory lock-in period of five years, which comes handy to ride any liquidity crunch, especially amidst black swan events like the one we are currently witnessing.

In case of any untoward incident, the life cover kicks in, and the proceeds can help your family tide over your absence, without any financial stress

Conclusion

This Mother's Day, I would urge every mother, working or non-working, to arm herself with financial knowledge, requisite to aid, and make sound investment decisions.",https://www.moneycontrol.com/news/business/markets/mothers-day-here-is-an-ideal-portfolio-construction-strategy-for-every-mother-5246741.html
"May 07, 2020 12:17 PM IST",2,Sandip Das,"Nifty must move above recent swing high of 9,889 for further upmove; 5 stocks to bet on","VIX is likely to stabilize at current levels and bounce back from current levels.
It has bounced back to current levels and consolidating in a range of Rs 520 to Rs 450 odd levels.
It has formed bullish pole and flag pattern on the daily chart and now showing signs of breakout on the upside.
MACD line has given a negative crossover with its average on the daily chart below equilibrium level of zero.
MACD line has given a negative crossover with its average on the daily chart below equilibrium level of zero.",For market to move higher recent swing of 9889 needs to be taken out for move towards 10550 levels.,"Ashish Chaturmohta

It was a volatile session of trade for the market on May 6. After the initial weakness market rallied into the green but was unable to sustain at higher levels. The Nifty finally settled at 9,271 up 0.71% for the day. Broader market indices BSE Midcap and Smallcap also saw a gain of 0.78% and 0.49% respectively for the day. The market breadth on NSE was negative with advance-decline ratio of 4:5.

On the daily chart, the index has formed a bearish rising wedge pattern. It has retraced 50% of the decline from 12,430 to 7,511, thus, suggesting pullback rally is over. Though on last Thursday, the index witnessed breakout on upside, it has failed to sustain it, and Monday's gap down opening has formed bearish island reversal pattern. Nifty has given breakdown from wedge pattern and trading below rising trendline.

The trendline will act as resistance which comes around 9,600 levels. On the downside trading below 9,100 levels, expect further decline towards 8,800 and then 8,400 levels. However, for the market to move higher recent swing of 9,889 needs to be taken out to move towards 10,550 levels.

In Nifty May monthly expiry options, maximum open interest for Put is seen at strike price 9,000 followed by 8,500 while for Call maximum open interest is seen at 10,00 and 9,500. Nifty options distribution data is suggesting a range of 9,500 and 9,000 for now.

India VIX measure of volatility had seen a sharp decline from 86 to 33 odd levels. Now it is again seeing a bounce back from lower levels and leading to selling pressure in the market. VIX is likely to stabilize at current levels and bounce back from current levels.

Here are the top 5 stocks which can give % return in next 1-3 months:

SRF: Buy | CMP: Rs 3655 | Stop loss: Rs 3,460 | Target: Rs 4,260 | Return: 16%

The stock witnessed a sharp decline from an all-time high of 4,260 in February this year to a low of Rs 2,467. Overall, the chemical industry has seen recovery from lows including SRF. The stock has crossed key Fibonacci 61.8% retracement of fall 4,260-2,467 which comes at 3,574. The rally has been on bullish body candles indicating buying interest in the stock.

Currently, the stock is consolidating in a narrow range after the up move that typically happens in an uptrend. Price has crossed short as well as long-term averages on the daily chart and trading above it. Relative strength index has given positive crossover with its average on the weekly chart. Thus, the stock can be bought at current levels and on dips to Rs 3600 with stop loss below Rs 3,460 for a target of Rs 4,260 levels.

HDFC Life Insurance Company: Buy | CMP: Rs 491 | Stop loss: Rs 465 | Target: Rs 565 | Return: 15%

The stock had seen a major decline from all-time high of Rs 646 in this January to recent low Rs 340 in March. Price has taken support around its previous consolidation low of Rs 340. It has bounced back to current levels and consolidating in a range of Rs 520 to Rs 450 odd levels. The 20-day moving average was acting as resistance for the stock which has been crossed by stock and consolidating above it. Relative strength index has given positive crossover with its average on daily as well on the weekly chart.

Thus, the stock can be bought at current levels and on dips to Rs 482 with stop loss below Rs 465 for target of Rs 565 levels.

Escorts: Buy | CMP: Rs 716 | Stop loss: Rs 680 | Target: Rs 825 | Return: 15%

On the long term monthly chart, the stock seems to be forming bullish inverted head and shoulders pattern with right shoulder in progress. The recent decline which is part of this larger reversal pattern was on below-average volumes than previous up move high volumes. After the bounce back from Rs 526 to Rs 793, the price has corrected to current levels.

It has formed bullish pole and flag pattern on the daily chart and now showing signs of breakout on the upside. Relative strength index and Stochastic have given positive crossover with their respective averages on the daily chart. Thus, stock can be bought at current levels and on dips to Rs 705 with stop loss below Rs 680 for a target of Rs 825 levels.

Axis Bank: Sell | CMP: Rs 395 | Stop loss: Rs 415 | Target: Rs 335 | Return: 18%

The stock has seen a major decline from Rs 760 to Rs 324 odd levels in February-March months. Recent bounce back rally has retraced 38.2% Fibonacci levels and seen reversal down. Price has broken the rising trend line connecting the bounce back lows. MACD line has given a negative crossover with its average on the daily chart below equilibrium level of zero.

Thus, the stock can be sold at current levels and on the rise to Rs 402 with stop loss above Rs 415 for a target of Rs 335 levels.

Havells India: Sell | CMP: Rs 513 | Stop loss: Rs 539 | Target: Rs 435 | Return: 18%

The stock is in downtrend forming a lower top and lower bottom on the daily and weekly chart. Recent bounce back has been facing resistance at Rs 560 odd levels and failed to move above on the second attempt. Last few days of decline is suggesting bounce back rally is over. The stock is suggesting a resumption of the downtrend.

MACD line has given a negative crossover with its average on the daily chart below equilibrium level of zero. Thus, stock can be sold at current levels and on the rise to Rs 520 with stop loss above Rs 539 for a target of Rs 435 levels.

The author is Head of Technical and Derivatives, Sanctum Wealth Management.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/nifty-must-move-above-recent-swing-high-of-9889-for-further-upmove-5-stocks-to-bet-on-5235071.html
"May 07, 2020 02:51 PM IST",2,Subhash Helgaokar,Buy Adani Ports and Special Economic Zone; target of Rs 360: Dolat Capital,"Dolat Capital's research report on Adani Ports and Special Economic ZoneQ4 results were an operational miss.
Lower SEZ income affecting revenues and margins.
Margins came lower at 56.3% vs 62.7% YoY.
FY20 margins at 63.7% vs 64.7% YoY.
Given the sharp price correction, we move rating to Buy with a DCF based TP of ` 360.","Dolat Capital is bullish on Adani Ports and Special Economic Zone has recommended buy rating on the stock with a target price of Rs 360 in its research report dated May 06, 2020.","Dolat Capital's research report on Adani Ports and Special Economic Zone

Q4 results were an operational miss. Revenue declined by ~5% YoY to ` 29.2bn. Lower SEZ income affecting revenues and margins. Adj EBITDA was at ` 16.4Bn, down 15% YoY. Margins came lower at 56.3% vs 62.7% YoY. FY20 margins at 63.7% vs 64.7% YoY. APAT stood at ` 13.4bn, up 14% YoY. PAT was impacted by a ` 10bn forex on the P&L.  The management guidance: (1) Evaluating the situation, No volume guidance for FY21 ; may give one when there is better visibility post lockdown (2) SEZ income to be ` 8-10Bn; (3) Ports margin to range between 68-70% (4) Snowman deal viability under review; (5) Capex guidance for FY21 reduced to ` 20Bn vs ` 40Bn earlier; (6) net debt to equity of 2.9x is within limits while it has a cover for its entire debt servicing of FY21.(7) Promoter pledge to be 0% by next 12-18 months,

Outlook

With April volumes down 25% from normal, we factor in a gradual recovery leading to a 6% volume decline in FY21. This leads to an EPS cut of 19%/11% in FY21/22 vs earlier estimates. Relatively less impacted under COVID, with a 60% sticky cargo as base volume, new ports in its fold, improving utilisation, better volumes on DFC connect to Mundra as some of the triggers for the stock. Given the sharp price correction, we move rating to Buy with a DCF based TP of ` 360. Key risk remains economic slowdown, which impact volumes.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-adani-ports-and-special-economic-zone-target-of-rs-360-dolat-capital-5236071.html
"May 07, 2020 02:52 PM IST",-2,Subhash Helgaokar,Sell NIIT Technologies; target of Rs 950: Dolat Capital,"Dolat Capital's research report on NIIT TechnologiesNITEC reported 3% QoQ CC revenue growth (our estm: 2%) largely driven by traction in Insurance (up 6% QoQ) and Others Vertical (up 11% QoQ) that covered up for decline in Travel vertical (-3.8% QoQ).
PAT stood at ` 1.1Bn below estm due to provisioning related exceptional loss of ` 128mn.
 It has added $180mn in TCV including 3 large deals (2 in BFSI) during the quarter.
The 12M executable order book stood at $468mn up 20% YoY basis.
OutlookWe expect revenue/earnings CAGR of 8%/5% over FY20-22E but believes that current valuations of 15x FY22E earnings are stretched given the potential risk in Travel vertical and thus maintain our Sell rating, with a TP of `950 valued at 12x FY22E EPS (inline to 10yr mean).","Dolat Capital is bearish on NIIT Technologies has recommended sell rating on the stock with a target price of Rs 950 in its research report dated May 06, 2020.","Dolat Capital's research report on NIIT Technologies

NITEC reported 3% QoQ CC revenue growth (our estm: 2%) largely driven by traction in Insurance (up 6% QoQ) and Others Vertical (up 11% QoQ) that covered up for decline in Travel vertical (-3.8% QoQ). OPM was in-line with our estimates at 14%. PAT stood at ` 1.1Bn below estm due to provisioning related exceptional loss of ` 128mn.  It has added $180mn in TCV including 3 large deals (2 in BFSI) during the quarter. Deal TCV on TTM basis is up 16% at $749mn. The 12M executable order book stood at $468mn up 20% YoY basis.  NIITTech expects FY21 growth to be positive given order book position, strong execution on deal ramp-up (not impacted as transitioned to WFH mode) and robust performance on BFS and Insurance vertical. It expects decline in revenues in Q1 and growth revival starting Q2 onwards. The company has also guided sub100bps decline in OPM.

Outlook

We expect revenue/earnings CAGR of 8%/5% over FY20-22E but believes that current valuations of 15x FY22E earnings are stretched given the potential risk in Travel vertical and thus maintain our Sell rating, with a TP of `950 valued at 12x FY22E EPS (inline to 10yr mean).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/sell-niit-technologies-target-of-rs-950-dolat-capital-5236081.html
"May 08, 2020 09:16 AM IST",1,,Why HCL Tech is a good addition with a new normal around the corner,"We would advise investors to add HCL Tech on every market correction as the long-term proposition remains strong and the company is likely to be a winner in the post Covid-19 era of new normal.
@moneycontrolcom Madhuchanda Dey",We would advise investors to add HCL Tech on every market correction as the long-term proposition remains strong and the company is likely to be a winner in the post Covid-19 era of new normal.,"We would advise investors to add HCL Tech on every market correction as the long-term proposition remains strong and the company is likely to be a winner in the post Covid-19 era of new normal.

@moneycontrolcom Madhuchanda Dey",https://www.moneycontrol.com/news/business/moneycontrol-research/why-hcl-tech-is-a-good-addition-with-a-new-normal-around-the-corner-5239311.html
"May 08, 2020 10:06 AM IST",1,Rakesh Patil,Biocon share price up 2% on receiving EIR from USFDA,"Biocon share price added 2 percent intraday on May 8 after the company received EIR from the USFDA.
The company has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the pre-approval and GMP inspection of its Small Molecules API Manufacturing facility at Biocon Park SEZ, Bommansandra, Bengaluru.
The EIR has been closed with a VAI classification for the observations.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAt 09:51 hrs Biocon was quoting at Rs 353.25, up Rs 3.60, or 1.03 percent on the BSE.","The inspection was conducted between January 20 and January 24, 2020.","Biocon share price added 2 percent intraday on May 8 after the company received EIR from the USFDA.

The company has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the pre-approval and GMP inspection of its Small Molecules API Manufacturing facility at Biocon Park SEZ, Bommansandra, Bengaluru.

The inspection was conducted between January 20 and January 24, 2020.

At the conclusion of the inspection, the agency had issued a Form 483, with five observations, which are being addressed by the company.

The EIR has been closed with a VAI classification for the observations.

We remain committed to global standards of quality and compliance, said company spokesperson.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:51 hrs Biocon was quoting at Rs 353.25, up Rs 3.60, or 1.03 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/biocon-share-price-up-2-on-receiving-eir-from-usfda-5240061.html
"May 07, 2020 05:01 PM IST",-2,,Ideas For Profit | Adani Ports Q4: Should investors turn cautious?,"For port operators like Adani Ports & SEZ, problems have multiplied due to the domestic lockdown and uncertainties related to Exim trade.
The stock has fallen by 29 percent from Rs 380 (52-week high of Rs 430) to current Rs 270 a share.
While the decline can be partially controlled, investors should adopt a cautious approach.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyIn this edition of Ideas For Profit, Moneycontrol's Sakshi Batra tells us what lies ahead for the company and its investors.","In this edition of Ideas For Profit, Moneycontrol's Sakshi Batra tells us what lies ahead for the company and its investors.","For port operators like Adani Ports & SEZ, problems have multiplied due to the domestic lockdown and uncertainties related to Exim trade. During the March quarter, the company reported close to a 5 percent decline in the consolidated revenue. The stock has fallen by 29 percent from Rs 380 (52-week high of Rs 430) to current Rs 270 a share.

While the decline can be partially controlled, investors should adopt a cautious approach.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

In this edition of Ideas For Profit, Moneycontrol's Sakshi Batra tells us what lies ahead for the company and its investors.",https://www.moneycontrol.com/news/business/markets/ideas-for-profit-adani-ports-q4-should-investors-turn-cautious-5236341.html
"May 07, 2020 12:47 PM IST",2,Sunil Matkar,"Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets","""Earnings momentum will continue in pharma space.
The Nifty Pharma index gained half a percent on May 6, taking total gains to around 45 percent since March 23.
""Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare are our top picks, but as the risk-reward turned unfavourable for Lupin, we downgraded rating to sell from outperform,"" said CLSA.
Indian pharma stocks would lead the bull run for the next two to three years as earnings, volumes and growth will rise.
Jefferies expects Sun Pharma to report 21 percent earnings CAGR over FY20-22 against 14 percent for Dr Reddy's Labs.","The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.","Pharma stocks have been on buyers' radar with governments across the world focusing on healthcare following the coronavirus outbreak that has killed more than 263,000 people and infected more than 3.7 million globally.

In the last few days, India has seen a spike in infections with confirmed cases inching close to 53,000. The death toll is at 1,783.

There is no cure for COVID-19, the respiratory illness caused by the virus. Human trials for vaccines and drugs are on but a definitive treatment seems to be months, if not years, away.

For now, drugs that control fever and anti-malarial drugs are being prescribed to treat the symptoms or for emergency use.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Companies that produce hydroxychloroquine, an anti-malarial drug, and other pharma firms have done well over the last two months. There is expected to be a huge demand for the pharma sector in the coming years, analysts say.

""Earnings momentum will continue in pharma space. We prefer a stock-specific approach after the broad-based rally,"" said CLSA, which raised earnings estimates for the sector by 5-7 percent for FY21-22.

The Nifty Pharma index gained half a percent on May 6, taking total gains to around 45 percent since March 23.

""Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare are our top picks, but as the risk-reward turned unfavourable for Lupin, we downgraded rating to sell from outperform,"" said CLSA. It also lowered Abbott India to outperform from buy.

But the brokerage has significantly raised target price of all stocks under its coverage.

""We raise target for Lupin to Rs 780 from Rs 660 per share, Abbott to Rs 20,320 from Rs 16,850, Torrent Pharma to Rs 2,600 from Rs 2,010, Dr Reddy's Labs to Rs 4,250 from Rs 3,170, Sun Pharma to Rs 590 from Rs 520, Aurobindo Pharma to Rs 790 from Rs 520, Cipla to Rs 720 from Rs 480 and Cadila Healthcare to Rs 400 from Rs 350 per share,"" it said.

After almost four years of under-performance, pharma seemed to have regained its mojo in the last two months, Sanjiv Bhasin of IIFL said.

Indian pharma stocks would lead the bull run for the next two to three years as earnings, volumes and growth will rise. ""Also the need for medicine stocking may be more psychological which could drive higher volumes both globally and locally,"" he said.

Jefferies expects Sun Pharma to report 21 percent earnings CAGR over FY20-22 against 14 percent for Dr Reddy's Labs.

""Business mix for Sun Pharma is superior and key earnings drivers are India, while Dr Reddy Labs is more reliant on US generic launches where risks are high,"" Jefferies said.

Dr Reddy was trading at historical valuations but with cost rationalisation behind, execution in US/India must improve for the company, while Sun Pharma was trading at discount to peers and expectations were low, it added.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/pharma-index-up-45-from-march-lows-clsa-says-earnings-momentum-to-continue-raises-targets-5235161.html
"May 08, 2020 10:02 AM IST",1,Sandip Das,"HUL share prices jump 3% after Societe Generale buys 1.29 cr shares, Credit Suisse retains outperform call","FMCG major Hindustan Unilever (HUL) share prices jumped over 3 percent in the morning trade on May 8 after Societe Generale had bought 1.29 crore shares of the company at Rs 1,902 per share.
Global research firm Credit Suisse has maintained its outperform call on the stock with target at Rs 2,400 per share.
It expects total EPS growth of over 20 percent in Hindustan Unilever.
Sumit Bilgaiyan, Founder of Equity99 is of the view, ""Hindustan Unilever results were certainly weak.
According to Moneycontrol SWOT Analysis powered by Trendlyne Hindustan Unilever has zero promoter pledge with growth in quarterly net profit and increasing profit margin (YoY).","Credit Suisse has maintained its outperform call on the stock with target at Rs 2,400 per share.","FMCG major Hindustan Unilever (HUL) share prices jumped over 3 percent in the morning trade on May 8 after Societe Generale had bought 1.29 crore shares of the company at Rs 1,902 per share.

The stock is among the most active stocks on NSE in terms of value with 23,62,605 shares being traded at 09:30 hours. The stock is quoting at Rs 2,056.40, up Rs 63.90, or 3.21 percent. It has touched an intraday high of Rs 2,070 and an intraday low of Rs 2,040.15.

British drugmaker GlaxoSmithKline Pte and Horlicks Limited sold 5.69 percent stake in the company via block deals on May 7, 2020. The price band is at a discount of 3-8 percent to the closing price of the HUL stock of Rs 2,010.2 per share on May 6 on the National Stock Exchange (NSE).

Global research firm Credit Suisse has maintained its outperform call on the stock with target at Rs 2,400 per share. It is of the view that GSK's 5.7 percent stake sale removes the key overhang adding that premium to Britannia Industries and Dabur India has narrowed to 5-15 percent after the recent correction, according to a report by CNBC-TV18.

On the other hand, after the correction, discount to Nestle India has widened to 25 percent, it said. Morgan Stanley feels that diversified brand portfolio and track record of execution makes it a better risk reward while the company is likely to deliver flat revenues in core business in FY21. It expects total EPS growth of over 20 percent in Hindustan Unilever.

The stock has seen a steady decline in the last 5 days with GSK selling stake in HUL on May 7, 2020, a deal which will be valued roughly between USD 3.2-3.4 billion, according to a Business Standard report.

Sumit Bilgaiyan, Founder of Equity99 is of the view, ""Hindustan Unilever results were certainly weak. We would recommend adding on dips as these are defensives and essential products, demand of which might not be impacted in the downturn.""

According to Moneycontrol SWOT Analysis powered by Trendlyne Hindustan Unilever has zero promoter pledge with growth in quarterly net profit and increasing profit margin (YoY). However, the technical rating remains very bearish.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hul-share-prices-jump-3-after-societe-generale-buys-1-29-cr-shares-credit-suisse-retains-outperform-call-5240021.html
"May 07, 2020 02:56 PM IST",1,Rakesh Patil,Salasar Techno share price rises nearly 8% on order win of Rs 29 crore,"Salasar Techno Engineering share price rose nearly 8 percent intraday on May 7 after the company bagged an order from Haryana Vidyut Prasaran Nigam Limited.
The company has secured order for construction of 220 & 66 KV Transmission lines in Yamuna Nagar & Ambala Area on turnkey basis received from Haryana Vidyut Prasaran Nigam Limited.
At 14:22 hrs Salasar Techno Engineering was quoting at Rs 83.85, up Rs 6.00, or 7.71 percent on the BSE.
The share touched its 52-week high Rs 213.35 and 52-week low Rs 68.80 on 29 May, 2019 and 30 March, 2020, respectively.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","The share touched its 52-week high Rs 213.35 and 52-week low Rs 68.80 on 29 May, 2019 and 30 March, 2020, respectively.","Salasar Techno Engineering share price rose nearly 8 percent intraday on May 7 after the company bagged an order from Haryana Vidyut Prasaran Nigam Limited.

The company has secured order for construction of 220 & 66 KV Transmission lines in Yamuna Nagar & Ambala Area on turnkey basis received from Haryana Vidyut Prasaran Nigam Limited.

The order size is Rs 28.65 crore and to be executed by August 2021.

At 14:22 hrs Salasar Techno Engineering was quoting at Rs 83.85, up Rs 6.00, or 7.71 percent on the BSE.

The share touched its 52-week high Rs 213.35 and 52-week low Rs 68.80 on 29 May, 2019 and 30 March, 2020, respectively.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Currently, it is trading 60.7 percent below its 52-week high and 21.87 percent above its 52-week low.",https://www.moneycontrol.com/news/business/stocks/salasar-techno-share-price-rises-nearly-8-on-order-win-of-rs-29-crore-5236041.html
"May 07, 2020 11:55 AM IST",-2,Kshitij Anand,Drop airlines! Here are top 10 stocks based on Warren Buffett's investment methodology,"Warren Buffett exited the positions after the coronavirus pandemic which could alter the way airlines function once the lockdown opens.
The following stocks were filtered with the highest Master Score and RS (Relative Strength) rating.
Master Score is a proprietary filter created by MarketSmith that highlights great earnings potential and strong price performance of a stock.
The Relative Strength rating is the result of calculating a stock's percentage price change over the last 12 months.
Here are 10 stocks according to the above-mentioned parameters that one should look at (they are filtered based on Market Score).",Warren Buffett once again showed investors as to how one can cut losses and preserve cash. The investing phenomenon is dynamic in nature and usually changes over a period of time based on the prevailing trend.,"Berkshire Hathaway confirmed that in April it sold its “entire positions” in the four largest carriers - American Airlines Group Inc, Delta Air Lines Inc, Southwest Airlines Co, and United Airlines Holdings Inc, Warren Buffett told investors last weekend.

The legendary investor sold his stake in the ""big four"" US airlines at a loss in April, going against his own advice. But, it does suggest that investors should not wait, and cut losses at the earliest.

Warren Buffett exited the positions after the coronavirus pandemic which could alter the way airlines function once the lockdown opens. Buffett said he “made a mistake” investing in the sector, which the pandemic has changed “in a very major way” with no fault of the airlines.

Also read: Warren Buffett offloads US airline stocks: Time to sell Indigo & Spicejet?

Warren Buffett once again showed investors as to how one can cut losses and preserve cash, and one should just build a portfolio based on the investment climate. The investing phenomenon is dynamic in nature and usually changes over a period of time based on prevailing trends, suggest experts.

“There are few cyclical sectors which see ups and downs over the course of the business cycle, and to capitalize from their undervaluation it is imperative to catch the bottom which is technically difficult,” Dinesh Rohira is a Founder & CEO of 5nance.com told Moneycontrol.

“Nevertheless, the long term investor can still capitalize from such valuation gaps of quality names through a staggered investment approach at different price levels and stick to the core fundamentals of investing. The challenges in the economy are likely to persist for an extended period due to the current pandemic which might remain even for 1 or 2 years from now,” he said.

What to buy:

Warren Buffett, a former student of Benjamin Graham, is noted as a legendary value investor. He emphasizes on stocks that are trading at reasonable prices.

Making the job simpler for investors in picking stocks conforming to the values of Buffett, we have taken data from MarketSmith powered by William O'Neil.

The following stocks were filtered with the highest Master Score and RS (Relative Strength) rating. Master Score is a proprietary filter created by MarketSmith that highlights great earnings potential and strong price performance of a stock.

On the other hand, RS rating is a technical tool that is the most popular way to see the market's top performers. The Relative Strength rating is the result of calculating a stock's percentage price change over the last 12 months.

A 40 percent weight is assigned to the latest three-month period; the remaining three quarters each receive 20 percent weight. All stocks are arranged in order of greatest price percentage change and assigned a percentile rank from 99 (highest) to 1 (lowest).

The filter is applied to look for companies with long-term past and potential future growth. Of the stocks returned by the screen, Buffett most likely would emphasize on those trading at reasonable prices.

The stocks having a market capitalisation greater than Rs 500 crore and Average Rupee Volume greater than 10,000 crores are considered to filter stocks for the list.

Here are 10 stocks according to the above-mentioned parameters that one should look at (they are filtered based on Market Score). The stocks having market capitalization greater than Rs 500 crore and Average Rupee Volume greater than 10,000 crores are considered to filter stocks for the list:

Abbott India: Master Score 85

Sanofi India: Master Score 78

Indraprastha Gas: Master Score 75

Amrutanjan Health Care: Master Score 74

Bharat Rasayan: Master Score 70

Honeywell Automation: Master Score 69

Relaxo Footwear: Master Score 69

Britannia Industries: Master Score 68

Balkrishna Industries: Master Score 66

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/drop-airlines-here-are-top-10-stocks-based-on-warren-buffetts-investment-methodology-5229831.html
"May 07, 2020 02:11 PM IST",-1,Nishant Kumar,"A longer period of pain for consumer durables and capital goods, but brokerages see strong growth in 5 stocks","For the consumer durable companies, Q4FY20 started on a strong note with strong volume growth in January and February 2020.
Here are 5 stocks from the above two sectors that, as per brokerages, look attractive for a long-term perspective.
The current order book stands at Rs 2,1000 crore, while order inflow for FY20 is seen at Rs 11,000 crore (down 22 percent YoY).
With continued strong demand for new launches, market leadership and robust distribution network, we expect Crompton's earnings to clock 16 percent CAGR through FY19-22E,"" said the analyst.
Amber Enterprises | Buy | LTP: Rs 1,124 | Target price: Rs 1,437 | Upside: 28%As per the brokerage, Amber has gradually emerged as a contract manufacturer for domestic room ACs.","While some sectors of the economy may see some relief after the lockdown ends, there are some, such as capital goods and consumer durables, that may have to wait for a longer time to see normalcy return to them.","The COVID-led disruption has been unprecedented for the business and economy.

While some sectors of the economy may see some relief after the lockdown ends, there are some, such as capital goods and consumer durables, that may have to wait for a longer time to see normalcy returning.

Brokerages point out that the capital goods sector has seen lower order inflow in the last couple of quarters especially from the private sector due to factors, including overcapacity and land acquisition issues.

In the aftermath of the slowdown in the investment cycle for the last few years, COVID-19 is likely to prove to be the last nail in the coffin for the sector.

For the consumer durable companies, Q4FY20 started on a strong note with strong volume growth in January and February 2020. However, their volume was affected towards the end of March owing to the COVID-led nationwide lockdown.

""The companies which were experiencing supply-side issues from China during January-February 2020 period, now face demand issues across product categories,"" said Arafat Saiyed, Assistant Vice President at Reliance Securities.

COVID-19 is expected to have a significant impact on the capex cycle, which has already been muted for the last couple of years.

""The government's priority now is providing the basic necessities for survival, while capex and infrastructure development will be delayed by at least 6-9 months. The companies having a healthy balance sheet, strong cash and long-term scalability throughout disruptions will pass this phase rather easily,"" said Saiyed.

Here are 5 stocks from the above two sectors that, as per brokerages, look attractive for a long-term perspective. Take a look:

Analyst: Arafat Saiyed, Assistant Vice President at Reliance Securities

KEC International | Buy | LTP: Rs 208.60 | Target price: Rs 328 | Upside: 57%

Shares of KEC international have corrected about 45 percent in the last 2 months owing to COVID-led disruptions, which, as per the analyst, offers a fresh buying opportunity, as the company has already received approvals from the respective authorities to start operations at a few of its sites albeit in a phased manner.

The current order book stands at Rs 2,1000 crore, while order inflow for FY20 is seen at Rs 11,000 crore (down 22 percent YoY).

Domestic orders contribute 62 percent to the order book, while international projects account for about 38 percent.

As per the analyst, the management has guided that the revenue is expected to decline marginally (Rs 300 crore) in Q4FY20.

Larsen & Toubro | Buy | LTP: Rs 839 | Target price: Rs 1,670 | Upside: 99%

The analyst expects Larsen & Toubro to report an order inflow of Rs 66,000 crore in Q4FY20 as the company has already announced orders worth about Rs 50,000 crore to the exchanges.

For FY20, the company has guided for order inflow growth of 10-12 percent.

""We continue to view Larsen & Toubro as a proxy play of CAPEX revival in India considering a huge opportunity, proven execution track record and strong diversification,"" said the analyst.

Crompton greaves Consumer | Buy | LTP: Rs 208 | Target price: Rs 344 | Upside: 65%

Crompton has a relatively low share of seasonal products and healthy cash balance which enables the company to stay strong in the downturn.

The analyst expects Crompton's competitive positioning to remain strong with new entrants facing pricing and working-capital challenges.

""COVID-19 will impact Q4FY20 and Q1FY21 performance. The strong balance sheet will help tide over the lockdown period with support to vendors and channels. With continued strong demand for new launches, market leadership and robust distribution network, we expect Crompton's earnings to clock 16 percent CAGR through FY19-22E,"" said the analyst.

Brokerage: Anand Rathi Shares & Stock Brokers

Dixon Technologies | Buy | LTP: Rs 4,409.70 | Target price: Rs 5,392 | Upside: 22%

The brokerage highlights that the company is well placed to cater to mounting demand across multiple categories in the rapidly growing Indian consumer durables sector.

""Dixon's scale and size give it an edge. With robust aspirational demand in India, customs-duty structures being inverted to support Make-in-India, and GST rates rationalised, Dixon's growth seems to be aligned with strategic steps. Further reduction in GST rates would eventually result in deeper penetration,"" said the brokerage.

With manufacturing operations in India ramping up, established domestic and global brands in India are looking at lowering imports in a phased manner. This would help in adding clients and ramping up volumes in existing and forthcoming product categories.

""We model 24 percent and 32 percent CAGR over FY20-22 in respectively revenue and PAT, resulting in the RoCE expanding from 26 percent in FY19 to about 36 percent in FY21 and FY22,"" said the brokerage.

Amber Enterprises | Buy | LTP: Rs 1,124 | Target price: Rs 1,437 | Upside: 28%

As per the brokerage, Amber has gradually emerged as a contract manufacturer for domestic room ACs. It is set to emerge stronger after COVID-19 as rising financial pressure on OEMs might compel them to increase the outsourcing of components as well as fully-assembled ACs.

Its customers now include most OEMs, domestic and MNCs, as well as white-label brands of leading e-commerce portals and chain stores, courtesy its service portfolio capable of providing end-to-end solutions. This, its key strength should help it emerge stronger after this black-swan event, said the brokerage.

""Anticipating shrinking demand from OEMs, we lower our FY20e PAT 4 percent, and about 18 percent for FY21 and FY22. We now model consolidated revenue/PAT CAGRs of 15 percent/18 percent over FY20-22, resulting in the RoCE expanding from 19 percent to 20 percent,"" said the brokerage.

The brokerage believes Amber is well placed to emerge stronger from this unprecedented event, considering that its contract manufacturing abilities would be further strengthened by rising deemed exports in FY21 and FY22.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/a-longer-period-of-pain-for-consumer-durables-and-capital-goods-but-brokerages-see-strong-growth-in-5-stocks-5228821.html
"May 07, 2020 04:35 PM IST",2,Sunil Matkar,"Analysts retain buy on Persistent Systems after Q4 numbers, expect 24-45% return","Persistent Systems: Persistent Systems promoters increased have their stake in the company to 31.91 percent from 30.47 in the previous year.
""We retain our buy rating on Persistent Systems with a revised price target of Rs 650 (potential upside of 28.7 percent), given its reasonable valuation,"" Sharekhan said.
Persistent Systems delivered a steady performance in a tough environment, with better-than-expected performance in both revenue and operating profitability.
Post Q4FY20, we model Persistent Systems USD revenue growth/(decline) at (3.8)/8.7 percent for FY21/FY22 (versus (2)/8.5 percent modelled earlier).
We maintain hold, with a revised target price of Rs 550 (versus Rs 540 earlier) based on an unchanged 10x FY22E EPS.","Persistent Systems delivered a steady performance in a tough environment, with better-than-expected performance in both revenue and operating profitability.","6. Persistent Systems: Persistent Systems promoters increased have their stake in the company to 31.91 percent from 30.47 in the previous year. The stock has given 8.49 percent return YTD (Image Source: Moneycontrol)

Persistent Systems share price gained 5 percent on May 7 as most brokerages retained their buy rating on the stock given the steady growth in Q4FY20 and reasonable valuation after recent fall.

The stock fell 36.5 percent from its January peak till March 23. It is still down around 29 percent from its January highs. It closed at Rs 531.50, up 5.34 percent, on the BSE on May 7.

""We retain our buy rating on Persistent Systems with a revised price target of Rs 650 (potential upside of 28.7 percent), given its reasonable valuation,"" Sharekhan said.

Cash and cash equivalents account for 38 percent of its current market capitalisation; reasonable valuation and high cash and cash equivalents are expected to provide downside support to the stock price, according to the brokerage house.

While maintaining buy call with a target at Rs 730 (the highest among brokerages, potential upside of 45 percent), Motilal Oswal also feels despite the disruption due to COVID-19, Persistent's strong performance within the services segment (around 15/11 percent in 4Q/FY20, YoY) reflected its steady progress on turnaround.

""As the pandemic situation is expected to increase the uptake of digital services, we expect Persistent's portfolio to benefit. High exposure to salesforce consulting and verticals such as Technology, Healthcare, and BFSI gives us this confidence,"" the brokerage said.

Find All Earnings Related News Here

The company's robust performance in 4Q (barring IP), healthy deal pipeline, and cautiously optimistic outlook indicate the near-term COVID-19 disruption would not be as bad as we initially anticipated, it added.

Persistent Systems delivered a steady performance in a tough environment, with better-than-expected performance in both revenue and operating profitability. USD revenue came at $127.1 million, down by 1.8 percent QoQ, attributed to significant 24.3 percent QoQ decline in IP-led revenue due to weak seasonality and lower revenue re-seller business because of COVID-19 outbreak. PAT declined 4.7 percent QoQ mainly due to lower forex gain.

However, the sharp decline in IP revenue was partially offset by 3.8 percent QoQ growth in Technology Services Unit (TSU, 73.7 percent of total revenue), driven by strong 7 percent QoQ growth in digital revenue.

""IP revenue should continue to be an overhang. Historically, execution challenges and volatility in the IP portfolio have led to inconsistency in the company's performance. However, the recent improvement witnessed in execution and a higher focus on annuity revenue should address this issue to some extent,"" said Motilal Oswal.

The brokerage upgraded its EPS estimates over FY20–22 by 20–22 percent. ""While material delay in clients' discretionary spends is a monitorable risk, subdued multiples offer adequate margin for safety,"" it said.

EBITDA margin improved by 41 bps QoQ to 13.8 percent despite lower IP revenue and bad provisions in the wake of COVID-19, led by lower sales and marketing expenses, decline in purchase/royalty expenses, and rupee benefits (50 bps).

Management expects margin to improve in FY21 on account of lower sales and marketing expenses and completion of rebranding activities.

""We assume FY21 is going to be a weak year, given anticipated material deterioration in the demand environment. However, growth is likely to recover in FY22 once the situation normalises,"" Sharekhan said.

Meanwhile, Persistent expanded its partnership with Dassault Systèmes to strengthen digital transformation capabilities in Europe.

""This agreement brings industrial OEMs and suppliers to the Dassault Systèmes 3DEXPERIENCE platform where clients can reduce costs, improve supplier collaboration, drive agility and gather better field insights for future product iterations and customer support,"" company said in its BSE filing.

ICICI Direct

In a post COVID-19 world, we expect digital technologies to gain traction. Persistent is expected to be a key beneficiary of this digital acceleration. In addition, the focus of the new management on large annuity oriented deals, increase in deal sizes and less reliance on top client bodes well for services growth in the long term (which is also visible in the near term quarterly performance).

In addition, the company also has substantial cash on its balance sheet (around 24 percent of market cap), which can be used for acquisition (to fuel growth). Further, considering multiple levers for cost rationalisation, we expect margins to see an improved trajectory in the long term. This, coupled with reasonable valuation of 10x P/E on FY22 EPS, prompts us to remain optimistic on the stock. Hence, we maintain buy rating on the stock with a revised target price of Rs 625 per share (potential upside of 23.8 percent).

Anand Rathi

Taking into account potential weakness in contract renewals and smaller accounts, we cut FY21 and FY22 respectively around 12 percent and 7 percent. However, we believe that current valuations factor in the risks and, on free cash flow basis, the stock can generate 14 percent yield. Maintain buy with target of Rs 630 (potential upside of 24.8 percent).

Centrum Broking

We believe Persistent delivering steady growth in Enterprise segment could enable address larger opportunity as well as stabilize performance. Post Q4FY20, we model Persistent Systems USD revenue growth/(decline) at (3.8)/8.7 percent for FY21/FY22 (versus (2)/8.5 percent modelled earlier).

We trim EPS estimates by 9/4 percent for FY21/FY22E led revenue, margin downgrade. Stock trades at 9.6x FY22E EPS and valuations are reasonable. We reduce our target price by 4 percent to Rs 650 (potential upside 28.7 percent). Retain buy.

Emkay

The company's senior leadership has taken 20-25 percent salary cuts as a temporary measure to protect margins. We note that cash generation improved in the March 2020 quarter after the weakness in 9MFY20 on account of changes in the internal finance systems.

We raise FY21/22 estimates by 5/2 percent on higher-margin assumptions but retain revenue estimates broadly. We introduce FY23 EPS at around Rs 60. We maintain hold, with a revised target price of Rs 550 (versus Rs 540 earlier) based on an unchanged 10x FY22E EPS.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/analysts-retain-buy-on-persistent-systems-after-q4-numbers-expect-24-45-return-5236691.html
"May 07, 2020 02:53 PM IST",2,Subhash Helgaokar,Accumulate Marico; target of Rs 320: Dolat Capital,"Dolat Capital's research report on MaricoMarico's Q4FY20 revenue and EBITDA came below our estimate but APAT was in line.
India business reported 3% volume de-growth while overall volume de-growth was 4%.
Volume growth would have been mid-single digit excluding lock down impact.
Parachute and value added hair oils (VAHO) reported volume and value decline due to significant drop in sales in second half of March.
We also believe that Parachute volumes would recover fast, as the secondary sales continues to remain positive.","Dolat Capital recommended accumulate rating on Marico with a target price of Rs 320 in its research report dated May 04, 2020.","Dolat Capital's research report on Marico

Marico's Q4FY20 revenue and EBITDA came below our estimate but APAT was in line. India business reported 3% volume de-growth while overall volume de-growth was 4%. Volume growth would have been mid-single digit excluding lock down impact. Parachute and value added hair oils (VAHO) reported volume and value decline due to significant drop in sales in second half of March. Saffola continues to outperform with 25% value/volume growth. Domestic gross margin improved +50bps YoY, primarily due to a decline in copra prices. Going ahead, we expect mild inflation in copra prices in the ensuing quarters. We also believe that Parachute volumes would recover fast, as the secondary sales continues to remain positive.

Outlook

We lower our FY21E and FY22E EPS estimates at ` 8.5 and ` 9.1 respectively. Valuing the stock at 35x FY22E EPS to arrive at a TP of `320. Maintain Accumulate.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/accumulate-marico-target-of-rs-320-dolat-capital-5236101.html
"May 08, 2020 07:07 AM IST",2,Nishant Kumar,"Hot Stocks | Bharti Airtel, United Spirits, IGL buy recommendations for short term","Apart from this, certain buying opportunities exist and could fetch 7 to 10 percent returns in the short term.
RSI is in a bullish zone after two months of consolidation and other momentum indicators are also supporting the bullish bias.
Long positions can be initiated in the stock at Rs 527 and on any dips till Rs 510 for short-term gains.
Momentum indicators are on the verge of breaking out and could result in a decent rally in the short term.
United Spirits | Buy | LTP: Rs 504 | Target price: Rs 545 | Stop loss: Rs 478 | Upside: 8%After a decent correction from higher levels, the stock has formed a bullish “Doji” candlestick pattern at the support levels.","Nifty is trading in a short-term range of 9,380 to 8,900 and considering the time cycle, we could see major moves in the coming days if Nifty trades on either side of the above-mentioned levels.","Manali Bhatia

There is a very popular saying on Dalal Street - Sell in May and go away. But the question for now is - are the price patterns reflecting this trend?

The phrase has not always proved to be correct but May and October are the two significant months as far as the time cycle of the market is concerned.

If one axis of the chart in technical analysis studies the information regarding price, the other one deals with the time which is often ignored.

As per the time cycle, the month of May has seen major movements in the market but was not always on the downside.

We witnessed two upper freezes in the year 2,009. To be precise, the major moves that were registered as per the time cycle have taken place between 16th and 20th May (most of the time) and traders need to be cautious to avoid damages.

Looking at the current scenario, we can say that Nifty is trading in a short-term range of 9,380 to 8,900, and considering the time cycle, we could see major moves in the coming days if Nifty trades on either side of the above-mentioned levels.

Levels of 10,000 can be witnessed in the current month in case of higher range trades. On the flip side, 8,000 can be seen quite easily if 8,900 gets traded on a closing basis.

As of now, wait and watch policy needs to be adopted. Let prices and time cycle decide the next leg of the market.

Apart from this, certain buying opportunities exist and could fetch 7 to 10 percent returns in the short term.

Here are three buy calls for the next 3-4 weeks:

Bharti Airtel | Buy | LTP: Rs 528 | Target price: Rs 580 | Stop loss: Rs 500 | Upside: 10%

Bulls are having an upper hand as the bullish cup and handle formation has been witnessed in the counter.

The weekly chart is trading with higher top and higher bottom formation and bullish breakout on the daily chart indicating that the next leg of the up move is on the cards.

RSI is in a bullish zone after two months of consolidation and other momentum indicators are also supporting the bullish bias.

Long positions can be initiated in the stock at Rs 527 and on any dips till Rs 510 for short-term gains.

Indraprastha Gas | Buy | LTP: Rs 468.50 | Target price: Rs 500 | Stop loss: Rs 445 | Upside: 7%

Bullish momentum is building up in the counter and positive crossover of major short term and medium term moving averages has been witnessed on the daily chart.

Momentum indicators are on the verge of breaking out and could result in a decent rally in the short term.

United Spirits | Buy | LTP: Rs 504 | Target price: Rs 545 | Stop loss: Rs 478 | Upside: 8%

After a decent correction from higher levels, the stock has formed a bullish “Doji” candlestick pattern at the support levels.

Range shift in RSI has been witnessed on a daily chart from the bearish zone to the sideways zone indicating that phase of downside has abated and a new trend could emerge from the current levels.

The stock is placed at a decent risk-reward level and offering lucrative buying opportunity from the short term perspective

(The author is Senior Research Analyst at Rudra Shares & Stock Brokers)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/markets/hot-stocks-bharti-airtel-united-spirits-igl-buy-recommendations-for-short-term-5237471.html
"May 07, 2020 02:53 PM IST",2,Subhash Helgaokar,Accumulate Persistent Systems; target of Rs 550: Dolat Capital,"Dolat Capital's research report on Persistent SystemsPersistent reported 1.8% QoQ decline in revenues as US$127mn (in line with our estimates) as Alliance Business de-grew 28% QoQ, partially off-set by 3.8% QoQ growth in Services (Technology+ Digital) Segment.
OPM for the quarter improved 50bps QoQ to 9.2% (our estimate: 8.1%) led by lower volumes in reseller business in Q4.
Technology & Digital segment (collectively 74% of revenues) continue to drive topline growth with 2.2% and 7% QoQ growth.
PSYS expects these segments to outperform based on positive client interactions, strong pipeline and increased need for Digital services.
OutlookWe expect Persistent to continue to deliver strong performance in the Tech-services business led by its micro-focus approach in select capabilities and verticals.","Dolat Capital recommended accumulate rating on Persistent Systems with a target price of Rs 550 in its research report dated May 07, 2020.","Dolat Capital's research report on Persistent Systems

Persistent reported 1.8% QoQ decline in revenues as US$127mn (in line with our estimates) as Alliance Business de-grew 28% QoQ, partially off-set by 3.8% QoQ growth in Services (Technology+ Digital) Segment. OPM for the quarter improved 50bps QoQ to 9.2% (our estimate: 8.1%) led by lower volumes in reseller business in Q4. Technology & Digital segment (collectively 74% of revenues) continue to drive topline growth with 2.2% and 7% QoQ growth. PSYS expects these segments to outperform based on positive client interactions, strong pipeline and increased need for Digital services. Alliance Business turnaround is expected to be gradual as it is continuing its' focus on new tech areas – (closed new deals with Red Hat). Profitability is expected to be under pressure as client discounts and requested delays in implementation are in the talks. Persistent has taken senior team pay cuts (20-25%), variable cuts and also has scope to leverage S&M costs (systemic rationalization of 100-200bps here).

Outlook

We expect Persistent to continue to deliver strong performance in the Tech-services business led by its micro-focus approach in select capabilities and verticals. We have built in revenue/earnings CAGR of 7%/6% over FY20-22E and maintain our Accumulate rating on the stock with TP of `550, valued at 11x on FY22E earnings (implies 1.5x on PEG).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/accumulate-persistent-systems-target-of-rs-550-dolat-capital-5236091.html
"May 07, 2020 12:46 PM IST",1,Sunil Matkar,"Jefferies initiates coverage on 5 realty stocks, Godrej Properties top pick","The BSE Realty index has gained just 0.9 percent from its March lows though the benchmark Sensex gained 20 percent during the period.
Jefferies initiated coverage on five stocks with a buy rating with Godrej Properties as its top pick.
The brokerage advised buying DLF with target at Rs 186, Godrej Properties with target at Rs 945, Oberoi Realty with target at Rs 423, Prestige Estates with target at Rs 246 and Sobha with price target at Rs 311 per share.
Godrej Properties had during the lockdown in April added two new projects in Worli and Matunga East, Mumbai.
Also just a few days before the lockdown began on March 25, Godrej Properties acquired 100 percent issued and paid-up share capital of the Ceear Lifespaces Private Limited.","Though the BSE realty index has fallen 47% in three months, Jefferies says only the strong will survive and make gains.","The BSE Realty index has gained just 0.9 percent from its March lows though the benchmark Sensex gained 20 percent during the period. Even if one was to calculate returns from its January high, the index is still down 47 percent in more than three months.

The demonetisation, GST, and RERA increasingly made real estate norms stricter, resulting in a dramatic drop in cash transactions. Also, the demand for real estate was low due to high prices.

To revive demand, the government took some steps in 2019. The RBI, too, stepped in by reducing interest rates, but the lockdown has dealt a huge blow to the employment-generating sector.

Stocks were down 44-60 percent from their 2020 peak, pricing in a 20 percent plus capital value decline but the seven-year-long weak residential cycle set a good base to bounce back, CNBC-TV18 quoted Jefferies as saying.

Survivors would make disproportionate gains and consolidation would get a boost as disruptions weeded out the weak hands, it said.

Many companies in the last several years either shut down their operations or sold projects to other companies.

Jefferies initiated coverage on five stocks with a buy rating with Godrej Properties as its top pick.

The brokerage advised buying DLF with target at Rs 186, Godrej Properties with target at Rs 945, Oberoi Realty with target at Rs 423, Prestige Estates with target at Rs 246 and Sobha with price target at Rs 311 per share.

Godrej Properties had during the lockdown in April added two new projects in Worli and Matunga East, Mumbai.

Also just a few days before the lockdown began on March 25, Godrej Properties acquired 100 percent issued and paid-up share capital of the Ceear Lifespaces Private Limited.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/jefferies-initiates-coverage-on-5-realty-stocks-godrej-properties-top-pick-5235341.html
"May 07, 2020 10:26 AM IST",-2,Sandip Das,HUL share price falls 2% as GSK sells around 5% stake; brokerages optimistic,"The price band is at a discount of 3-8 percent to the closing price of the HUL stock of Rs 2,010.2 per share on May 6 on the National Stock Exchange (NSE).
According to Moneycontrol SWOT Analysis powered by Trendlyne, Hindustan Unilever witnessed degrowth in quarterly revenue and profit in recent results.
Credit Suisse has an 'outperform' call with a target price of Rs 2,400, according to CNBC-TV18.
It raised the target price to Rs 2,650 from Rs 2,350 but cited that the uncertainty on demand will persist.
At 10:10 hrs Hindustan Unilever was quoting at Rs 1,966.20, down Rs 43.65, or 2.17 percent.",Analysts are of the view that the merger of HUL and GSK Consumer will have substantial revenue and cost synergies in the next three to five years.,"Share price of FMCG major Hindustan Unilever fell over 2 percent in morning trade on May 7 after British drugmaker GlaxoSmithKline Pte and Horlicks Limited sold 5.69 percent stake in the company via block deals.

GSK sold the stake on May 7, 2020, and the expected settlement date for the transaction is May 11. The deal will be valued roughly between Rs 247.5 million and Rs 260.9 million ($3.2-3.4 billion), according to a Business Standard report. Around 13,37,72,044 shares totalling 5.69 percent of total shares outstanding as of April 21, 2020, were offloaded through block deals.

The price band is at a discount of 3-8 percent to the closing price of the HUL stock of Rs 2,010.2 per share on May 6 on the National Stock Exchange (NSE).

Morgan Stanley, HSBC, JPMorgan are the advisors to the deal.

According to Moneycontrol SWOT Analysis powered by Trendlyne, Hindustan Unilever witnessed degrowth in quarterly revenue and profit in recent results. The scrip is showing weak momentum with price below short, medium and long term averages with the technical rating being bearish.

Hindustan Unilever is the most active stock on NSE in terms of value with 15,99,60,670 shares being traded.

Analysts are of the view that the merger of HUL and GSK Consumer will have substantial revenue and cost synergies in the next three to five years.

Global brokerages are, however, optimistic. Credit Suisse has an 'outperform' call with a target price of Rs 2,400, according to CNBC-TV18. HSBC has a buy rating on HUL. It raised the target price to Rs 2,650 from Rs 2,350 but cited that the uncertainty on demand will persist.

At 10:10 hrs Hindustan Unilever was quoting at Rs 1,966.20, down Rs 43.65, or 2.17 percent. It has touched an intraday high of Rs 1,975.00 and an intraday low of Rs 1,902.30.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hul-share-price-falls-2-as-gsk-sells-around-5-stake-brokerages-optimistic-5234681.html
"May 07, 2020 03:32 PM IST",1,Sunil Matkar,Aster DM Healthcare gains 10% as arm starts COVID-19 RT-PCR confirmatory test service,"Shares of Aster DM Healthcare rallied 10 percent intraday on May 7 as its subsidiary started providing RT-PCR confirmatory test service for COVID-19 in Bengaluru.
Diagnostics subsidiary Aster Clinical Lab LLP has set up its pathology reference laboratory at Bengaluru.
biochemistry, haematology, microbiology, molecular diagnostics, cytogenetics, digital histopathology etc, company said in its BSE filing.
""It has a state of the art molecular diagnostics department with accreditation from NABL and approval from ICMR, to start full-fledged testing of COVID-19 RT-PCR confirmatory test,"" it added.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.",Diagnostics subsidiary Aster Clinical Lab LLP has set up its pathology reference laboratory at Bengaluru.,"Shares of Aster DM Healthcare rallied 10 percent intraday on May 7 as its subsidiary started providing RT-PCR confirmatory test service for COVID-19 in Bengaluru.

Diagnostics subsidiary Aster Clinical Lab LLP has set up its pathology reference laboratory at Bengaluru.

The laboratory is fully equipped with advanced instruments to serve routine & specialized investigation e.g. biochemistry, haematology, microbiology, molecular diagnostics, cytogenetics, digital histopathology etc, company said in its BSE filing.

""It has a state of the art molecular diagnostics department with accreditation from NABL and approval from ICMR, to start full-fledged testing of COVID-19 RT-PCR confirmatory test,"" it added.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The stock gained nearly 20 percent in last one-and-half-month period. It was quoting at Rs 97.75, up 2.89 percent on the BSE at 1509 hours IST.",https://www.moneycontrol.com/news/business/markets/aster-dm-healthcare-gains-10-as-arm-starts-covid-19-rt-pcr-confirmatory-test-service-5236461.html
"May 07, 2020 08:49 PM IST",2,Sunil Matkar,"Societe Generale buys Rs 2,453 crore HUL shares, Anamudi Real ups stake in Sobha","Horlicks and GSK sold over 13.37 crore shares of HUL in the range of Rs 1,902.18-1,913.8, deals data available on the National Stock Exchange reveal.
However, Societe Generale was the major buyer, acquiring 1.29 crore HUL shares worth Rs 2,453.58 crore at Rs 1,902 per share.
As per the scheme of amalgamation between GSK Consumer Healthcare and HUL, GSK and Horlicks had received 5,40,83,698 shares of HUL (representing 2.3 percent of its total paid-up equity) and 7,96,88,346 shares (3.39 percent stake), respectively, in April.
On May 5 and 6, he bought 1,25,000 and 1,51,000 shares at Rs 309.98 and Rs 315.01, respectively.
The firm acquired 5,52,000 shares and 5,58,000 on May 7 and April 8 at Rs 180.26 and Rs 168.71, respectively.","Promoter Sameer Gupta continued to buy Apollo Pipes shares for the third consecutive session, acquiring a 1,44,476 shares at Rs 323.73 per share","Hindustan Unilever was the stock of the day on May 7 as Horlicks and GlaxoSmithKline (GSK) sold their stake in the company through several bulk deals in opening trade.

Horlicks and GSK sold over 13.37 crore shares of HUL in the range of Rs 1,902.18-1,913.8, deals data available on the National Stock Exchange reveal.

However, Societe Generale was the major buyer, acquiring 1.29 crore HUL shares worth Rs 2,453.58 crore at Rs 1,902 per share.

As per the scheme of amalgamation between GSK Consumer Healthcare and HUL, GSK and Horlicks had received 5,40,83,698 shares of HUL (representing 2.3 percent of its total paid-up equity) and 7,96,88,346 shares (3.39 percent stake), respectively, in April.

Among other deals, promoter Sameer Gupta continued to buy Apollo Pipes shares for the third consecutive session, further acquiring 1,44,476 shares at Rs 323.73 per share.

On May 5 and 6, he bought 1,25,000 and 1,51,000 shares at Rs 309.98 and Rs 315.01, respectively.

Anamudi Real Estates raised its stake in south-based real estate company Sobha. The firm acquired 5,52,000 shares and 5,58,000 on May 7 and April 8 at Rs 180.26 and Rs 168.71, respectively.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Consolidated Infrastructure Company purchased 53,73,128 shares in Gammon Infrastructure at Rs 0.34 per share, while Saudi Arabian Monetary Authority sold 3,24,863 shares of Just Dial at Rs 339.85 per share.",https://www.moneycontrol.com/news/business/markets/societe-generale-buys-rs-2453-cr-hul-shares-anamudi-real-ups-stake-in-sobha-5238311.html
"May 07, 2020 10:58 AM IST",2,Subhash Helgaokar,Buy USDINR; target of 76.20 - 76.40: ICICI Direct,"ICICI Direct's currency report on USDINRSpot CurrencyThe rupee further depreciated by almost 9 paise and closed at 75.76 whereas the US$INR May future ended above 76 levels.
Weakness in the rupee was largely due to strengthening of dollar and US-China trade war fear • The Dollar index managed to reclaim the crucial level of 100 yesterday.
The US private sector shed 20 million jobs during last month but the dollar managed to keep buying interest alive as news came of opening US economy gradually.
Currency futures on NSEThe dollar-rupee contract on the NSE was at 76.03 in the last session.
The open interest fell almost 3.2% during the last session • The US$INR pair managed to close above 76 levels as the US Dollar index moved near 100 levels.",ICICI Direct The USDINR pair managed to close above 76 levels as the US Dollar index moved near 100 levels. Negative tic equities and selling by FIIs are likely to keep the rupee move in check.,"ICICI Direct's currency report on USDINR

Spot Currency

The rupee further depreciated by almost 9 paise and closed at 75.76 whereas the US$INR May future ended above 76 levels. Weakness in the rupee was largely due to strengthening of dollar and US-China trade war fear • The Dollar index managed to reclaim the crucial level of 100 yesterday. The US private sector shed 20 million jobs during last month but the dollar managed to keep buying interest alive as news came of opening US economy gradually.

Currency futures on NSE

The dollar-rupee contract on the NSE was at 76.03 in the last session. The open interest fell almost 3.2% during the last session • The US$INR pair managed to close above 76 levels as the US Dollar index moved near 100 levels. Negative domestic equities and selling by FIIs are likely to keep the rupee move in check.

Intra-day strategy

US$INR May futures contract (NSE) View: Bullish on US$INR Buy US$ in the range of 75.90-76.00 Market Lot: US$1000 Target: 76.20/ 76.40 Stop Loss: 75.80 Support: 75.50/75.80 Resistance: 76.20/76.40

The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-usdinr-target-of-76-20-76-40-icici-direct-5234841.html
"May 06, 2020 10:19 AM IST",-2,Rakesh Patil,"HPCL, BPCL, IOC slip 7-13% after govt hikes excise on petrol, diesel","The oil marketing companies HPCL, BPCL and IOC remained under pressure in early trade after the government hiked the excise duty on petrol and diesel.
The government on May 5 hiked excise duty on petrol and diesel by Rs 10 and Rs 13 respectively.
However, the MRP of petrol and diesel will continue to remain the same, said the official.
The recent marketing margins were never sustainable for a long time and we thus expect marketing margins to drop substantially from recent levels, recovering a bit over mid-term, provided oil prices remain at current levels, it added.
Indian Oil Corporation (IOC) touched 52-week low of Rs 72.85, and was quoting at Rs 73.85, down Rs 4.90, or 6.22 percent.","The move will not impact consumers and price hike will be absorbed by OMCs, a government official said","The oil marketing companies HPCL, BPCL and IOC remained under pressure in early trade after the government hiked the excise duty on petrol and diesel.

The government on May 5 hiked excise duty on petrol and diesel by Rs 10 and Rs 13 respectively. However, the MRP of petrol and diesel will continue to remain the same, said the official.

These duty rate changes will come into effect from May 6 and will take away the gains from falling global crude oil prices.

However, the move will not impact consumers and price hike will be absorbed by OMCs, a government official said.

Also Read - Petrol sales down 61%, diesel 56.5% in April; slight pick-up in 2nd half, more expected in May

According to Ashika Institutional Equity the hike in excise duty would be absorbed by OMCs which will take another big hit on marketing margins with demand slowdown.

The recent marketing margins were never sustainable for a long time and we thus expect marketing margins to drop substantially from recent levels, recovering a bit over mid-term, provided oil prices remain at current levels, it added.

Indian Oil Corporation (IOC) touched 52-week low of Rs 72.85, and was quoting at Rs 73.85, down Rs 4.90, or 6.22 percent.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Bharat Petroleum Corporation was quoting at Rs 324.20, down Rs 22.60, or 6.52 percent and Hindustan Petroleum Corporation was quoting at Rs 193.30, down Rs 21.35, or 9.95 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/hpcl-bpcl-ioc-slip-7-13-after-govt-hikes-excise-on-petrol-diesel-5228711.html
"May 06, 2020 02:58 PM IST",2,Sunil Matkar,"Analysts bullish on SBI Life after FY20 earnings, expect 20-36% upside","However, given the COVID-19 disruption, SBI Life expects growth to slow down to single digits.
ICICI Direct also feels SBI Life seems to be well placed to stem the tide, though lockdown and economic slowdown is expected to make FY21 a challenging fiscal.
ICICI Direct expects SBI Life's business growth at around 11 percent CAGR and VNB margins at 17-17.5 percent in FY21-22.
We expect SBI Life to deliver strong FY20-22 VNB CAGR of 23.3 percent and RoEVs of around 13.4/15.1 percent.
We rate SBI Life a buy with a TP of Rs 975.","JM Financial, which has a buy rating with price target at Rs 860, believes SBI Life is better placed to weather the COVID-19 disruption given significant brand equity, an expansive multi-channel, pan India distribution network, cost leadership and access to parent's huge client base.","SBI Life Insurance Company share price gained 4.4 percent intraday on May 6 on growth numbers in FY20 despite disruption due to COVID-19 in the last 10 days of March.

The stock shot up 38.5 percent since March 23's closing, while today, it was quoting at Rs 745, up Rs 29.35 or 4.10 percent on the BSE at 13:34 hours IST.

Brokerages are bullish on the stock and expect 20-36 percent potential upside on likely steady growth in operating parameters in coming years, though there could be slowdown in overall business in first half of FY21 due to COVID-19.

The insurance company closed FY20 with an embedded value (EV) of Rs 26,300 crore aided by 30 percent YoY growth in embedded value operating profit (EVOP) mainly coming from a) healthy new business value (NBV) growth (17 percent), b) jump in persistency variance (Rs 240 crore versus Rs 5 crore last year) from steady product level persistency and modification in the treatment of group renewable business and c) other operating variances (Rs 190 crore versus Rs 6 crore) owing to release of risk margins baked in last year.

Margins improved 100bps YoY to 18.7 percent in FY20 aided by a) rising share of non PAR (7 percent of APE versus 0.4 percent last year) and protection (9 percent versus 7 percent) and b) 135-265bps YoY improvement in 25th-61st bucket regular persistency.

JM Financial, which has a buy rating with price target at Rs 860, believes SBI Life is better placed to weather the COVID-19 disruption given significant brand equity, an expansive multi-channel, pan India distribution network, cost leadership and access to parent's huge client base.

The brokerage expects an 18 percent embedded value CAGR over FY20-22E with 17-18 percent operating return on embedded value (RoEVs) with key risks being growth, persistency and unfavourable yield movement.

Prabhudas Lilladher also retained its buy rating with a revised price target of Rs 880 (from Rs 1,127 earlier) as it expects overall operating metrics like persistency, margins, costs etc to remain steady, though growth is expected to slow down a bit going ahead.

Annual premium equivalent (APE) for FY20 increased 11 percent YoY – inline with the industry, with a market share of 11 percent making it the largest private life insurer.

However, given the COVID-19 disruption, SBI Life expects growth to slow down to single digits. This was reflected in the (1.3 percent) hit to new business value (NBV) margins from operating assumption change to reflect negative operating leverage in FY21, JM Financial said.

Distribution wise, others (digital, Mconnect, YONO) recorded a 60 percent YoY growth in new business premium in FY20 with channel share at 20 percent, up 5 percentage points YoY.

Solvency ratio as of March 2020 stood at 194 percent, down 35 percent QoQ impacted by weak equity markets. In line with IRDA directive, the insurer cancelled dividend for FY20.

ICICI Direct also feels SBI Life seems to be well placed to stem the tide, though lockdown and economic slowdown is expected to make FY21 a challenging fiscal.

""Change in product mix, excellent operating efficiency, competitive position in individual protection business remain key drivers. Steady persistency, strong banca partnership, focus on improving digital footprint is seen supporting growth as well as earnings,"" said the brokerage.

ICICI Direct expects SBI Life's business growth at around 11 percent CAGR and VNB margins at 17-17.5 percent in FY21-22.

""Preferring to stay with businesses having lower balance sheet (unlike banks) and healthy fundamentals, we remain structurally positive on the stock,"" said the brokerage which maintained its buy rating on the stock with a target price of Rs 850 per share (earlier Rs 800).

Sharp movement in capital/debt market or significant claims remains a risk, it feels.

The private life insurer reported a 15.9 percent year-on-year rise in its March quarter (Q4) profit at Rs 530.67 crore, while its net investment income stood at a negative of Rs 6,677.19 crore in Q4 as against investment income of Rs 4,150.73 crore in the year-ago period.

SBI Life's net premium income stood at Rs 11,862.98 crore in Q4FY20, showing a 4.7 percent YoY increase. Company has made an additional reserve of Rs 60 crore for novel coronavirus (COVID-19) pandemic over and above the policy level liabilities.

The life insurer had set aside a provision of Rs 107.26 crore in Q4 for diminution in value of investments and provisions for standard, non-standard assets.

SBI Life's solvency ratio stood at 1.95 in Q4 compared to 2.13 in the year-ago period and as against regulatory requirement of 1.50.

In Q4FY20 protection APE was at Rs 320 crore (up 28.0/39.1 percent YoY/QoQ, 11.8 percent share). Retail/group protection grew 6.2/66.7 percent YoY.

Emkay view

We assume coverage on SBI Life with a buy rating (overweight in NBFC Emkay Alpha Portfolio) and a revised target of Rs 892 at 2.5x March'22E EV (earlier Rs 1,100).

We believe that SBI Life's margin will improve owing to a gradual rise in protection plans' share along with the elevated share of non-par products. However, management needs to re-price its existing protection plans amid a rise in prices for reinsurance. We expect VNB margins to improve to around 19.6 percent by FY22 against around 18.7 percent during FY20.

HDFC Securities view

SBI Life's Q4FY20 performance was marginally below expectations, as NBP/APE declined 11.8/12.6 percent YoY due to the lockdown, while VNBM sustained at 20.7 percent (+90bps YoY). Despite SBI Life's ambition to post APE growth in FY21, given the macros, we remain skeptical.

Growth in Mar/Apr-20 has been severely impacted. Business is expected to decline over Q1FY21, however SBILIFE still believes that a single digit APE growth is possible in FY21E.

Over FY21, we expect COVID-19 and changes in personal taxation to cause significant disruption to insurance sales. We however take a longer term view on the business and appreciate the strong distribution footprint of its parent SBI (24k+ branches), improving protection share (FY20: 8.9 percent, up 212bps YoY), lowest operating cost ratios (9.9 percent), and improving margins (VNBM: 20.7 percent). We expect SBI Life to deliver strong FY20-22 VNB CAGR of 23.3 percent and RoEVs of around 13.4/15.1 percent.

We rate SBI Life a buy with a TP of Rs 975. Lower growth, renewals, and protection share are key risks to our call.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/earnings/analysts-bullish-on-sbi-life-after-fy20-earnings-expect-20-36-upside-5230311.html
"May 06, 2020 02:22 PM IST",2,Sandip Das,"D-Street Buzz: Over 200 stocks hit upper circuit on BSE; ITC top index loser, HDFC twins gain","Shares of banking names moved higher in the afternoon session led by HDFC Bank and ICICI Bank which jumped over 4 percent followed by RBL Bank, Kotak Mahindra Bank and Bandhan Bank.
The most active shares included Reliance Industries, Axis Bank, Bajaj Finance, HDFC Bank and ICICI Bank.
210 stocks hit upper circuit on BSE including names like Mahindra CIE, Ruchi Soya, Spandana Sphoorty Financial, JMT Auto, Dwarikesh Sugar and Balrampur Chini Mills among others.
The top gainers included Bajaj Finance which jumped 5 percent followed by HDFC Bank, ICICI Bank, Bharti Airtel and HDFC.
Download a copy: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.","The most active shares included Reliance Industries, Axis Bank, Bajaj Finance, HDFC Bank and ICICI Bank.","The Indian stock market is trading in the green with Sensex up 297.35 points or 0.95% at 31750.86, and the Nifty gained 82.10 points or 0.89% at 9287.70.

Nifty FMCG was the underperforming sector, down over a percent dragged by ITC which fell over 6 percent after media report stated that the Centre is reportedly looking to raise Rs 22,000 crore by selling its stake in ITC (7.94 pecent) which it holds through the Specified Undertaking of the Unit Trust of India (SUUTI), in a bulk deal on the exchanges.

The other losers included Emami, Godrej Consumer and United Breweries.

Shares of banking names moved higher in the afternoon session led by HDFC Bank and ICICI Bank which jumped over 4 percent followed by RBL Bank, Kotak Mahindra Bank and Bandhan Bank.

The most active shares included Reliance Industries, Axis Bank, Bajaj Finance, HDFC Bank and ICICI Bank.

210 stocks hit upper circuit on BSE including names like Mahindra CIE, Ruchi Soya, Spandana Sphoorty Financial, JMT Auto, Dwarikesh Sugar and Balrampur Chini Mills among others.

There were pending buy orders of 43,465 shares in Ruchi Soya, with no sellers available. On the other hand, in Mahindra CIE, there were pending buy orders of 61,311 shares, with no sellers available.

The top gainers included Bajaj Finance which jumped 5 percent followed by HDFC Bank, ICICI Bank, Bharti Airtel and HDFC.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-over-200-stocks-hit-upper-circuit-on-bse-itc-top-index-loser-hdfc-twins-gain-5229991.html
"May 06, 2020 09:39 PM IST",1,,Ideas For Profit | Here's why this IT company should be on the radar of investors,"Despite deriving a significant share of its revenue from traveland transportation industry, the company has reported industryleading revenue performance in Q4.
The reason behind NIIT coming out relatively unscathed is two-fold.
On the supply side, it had better preparedness and seamlessly moved the entire workforce to work-from-home with minimum revenue loss.
On the demand side, barring travel and transportation, other segments stayed supportive.
In this edition of Ideas For Profit, we dissect the financials of the IT company.",The stock has corrected by 41 percent in the past three months against 24 percent decline in Nifty and 16 percent of the IT index.,"NIIT Technologies has proved its mettle amid challenging times.

Despite deriving a significant share of its revenue from travel

and transportation industry, the company has reported industry

leading revenue performance in Q4.

The reason behind NIIT coming out relatively unscathed is two-fold. On the supply side, it had better preparedness and seamlessly moved the entire workforce to work-from-home with minimum revenue loss. On the demand side, barring travel and transportation, other segments stayed supportive.

In this edition of Ideas For Profit, we dissect the financials of the IT company.",https://www.moneycontrol.com/news/business/markets/ideas-for-profit-heres-why-this-it-company-should-be-on-the-radar-of-investors-5232411.html
"May 07, 2020 08:38 AM IST",-2,,Why investors should say no to Yes Bank,"The ride ahead is bumpy for Yes Bank and hence, best avoided especially since a lot of high quality peers are now available at a bargain in the ongoing correction.
@moneycontrolcom Madhuchanda Dey","The ride ahead is bumpy for Yes Bank and hence, best avoided especially since a lot of high quality peers are now available at a bargain in the ongoing correction.","The ride ahead is bumpy for Yes Bank and hence, best avoided especially since a lot of high quality peers are now available at a bargain in the ongoing correction.

@moneycontrolcom Madhuchanda Dey",https://www.moneycontrol.com/news/business/moneycontrol-research/why-investors-should-say-no-to-yes-bank-5233831.html
"May 06, 2020 06:51 PM IST",2,Subhash Helgaokar,Buy Marico; target of Rs 350: Motilal Oswal,"Motilal Oswal 's research report on MaricoMarico's (MRCO) 4QFY20 sales were marginally below estimates on account of the COVID-19 led lockdown headwinds.
However, EBITDA and margins were above estimates due to benign commodity costs and lower ad spends.
We believe that MRCO's relatively resilient portfolio of products should help it weather the impact on sales and earnings decline in FY21, unlike several of its peers.
Valuations appear attractive at 32x FY22E EPS, below 3/5/10-year average for a business that has better earnings visibility compared to peers.
OutlookNevertheless, valuations appear attractive at 32x FY22E EPS, below 3/5/10- year average of 44.9x/43x/35.5x, for a business that has better earnings visibility compared to peers.","Motilal Oswal is bullish on Marico has recommended buy rating on the stock with a target price of Rs 350 in its research report dated May 04, 2020.","Motilal Oswal 's research report on Marico

Marico's (MRCO) 4QFY20 sales were marginally below estimates on account of the COVID-19 led lockdown headwinds. However, EBITDA and margins were above estimates due to benign commodity costs and lower ad spends. Further, lower-than-expected tax rate led to the PAT beat. We believe that MRCO's relatively resilient portfolio of products should help it weather the impact on sales and earnings decline in FY21, unlike several of its peers. Valuations appear attractive at 32x FY22E EPS, below 3/5/10-year average for a business that has better earnings visibility compared to peers. Maintain Buy.

Outlook

Nevertheless, valuations appear attractive at 32x FY22E EPS, below 3/5/10- year average of 44.9x/43x/35.5x, for a business that has better earnings visibility compared to peers. Maintain Buy with TP of INR350.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-marico-target-of-rs-350-motilal-oswal-5230481.html
"May 06, 2020 06:51 PM IST",2,Subhash Helgaokar,Buy AU Small Finance Bank; target of Rs 675: Motilal Oswal,"Motilal Oswal 's research report on AU Small Finance BankAU Small Finance Bank (AUBANK) reported subdued earnings, impacted by higher provisions (INR1.4b) toward SMA accounts.
Overdue loans stood at INR23b (8.5% of loans) as of April'20 v/s INR36b as of 1st Mar'20.
29% of customers (25% of the loan book) availed moratorium, which would be the key monitorable in the near term.
On the business front, loan growth moderated, while deposits stood healthy.
We cut our earnings estimate for FY21/22 by 18%/10% as we factor in high credit cost and moderation in business growth.","Motilal Oswal is bullish on AU Small Finance Bank has recommended buy rating on the stock with a target price of Rs 675 in its research report dated May 04, 2020.","Motilal Oswal 's research report on AU Small Finance Bank

AU Small Finance Bank (AUBANK) reported subdued earnings, impacted by higher provisions (INR1.4b) toward SMA accounts. Overdue loans stood at INR23b (8.5% of loans) as of April'20 v/s INR36b as of 1st Mar'20. 29% of customers (25% of the loan book) availed moratorium, which would be the key monitorable in the near term. On the business front, loan growth moderated, while deposits stood healthy. Margins were stable on a sequential basis despite excess liquidity buildup, with management suggesting spreads would improve further. We cut our earnings estimate for FY21/22 by 18%/10% as we factor in high credit cost and moderation in business growth. Maintain Buy.

Outlook

We estimate loan growth trends to remain soft at 15% in FY21 (20% AUM growth), while credit cost would increase to 1.7% in FY21E, as we build in higher slippages, driving an 18%/10% cut in our FY21/FY22 earnings. We thus revise our TP to INR675 (3.5x FY22E BV). Maintain Buy.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-au-small-finance-bank-target-of-rs-675-motilal-oswal-5230501.html
"May 06, 2020 01:26 PM IST",2,Sunil Matkar,"Analysts retain 'buy' on Varun Beverages but cut target, earnings estimates on lockdown impact","Varun Beverages share price gained 3.1 percent intraday on May 6 as most brokerages remained bullish on the stock but slashed price target and earnings estimates taking into account the impact of the lockdown.
The company maintained its operating margin on benign raw material costs and an easy base for the International business (last year Q1 margin was impacted by translation provisions).
Its revenue increased 23.3 percent year-on-year to Rs 1,676.4 crore, impacted by lockdown in the last 10 days of March.
Revenue growth lagged volume growth on higher salience of packaged water, characterised by lower realisations.
Consolidated volume grew 26.7 percent aided by the acquisition of PepsiCo's South and West territories and healthy performance in international geographies (7 percent volume growth).","Despite disruptions, the company maintained its operating margin on benign raw material costs and an easy base for the International business.","Varun Beverages share price gained 3.1 percent intraday on May 6 as most brokerages remained bullish on the stock but slashed price target and earnings estimates taking into account the impact of the lockdown.

The stock has gained 20 percent in the last one month following a recovery in market recovery. It was quoting at Rs 625.05, up 0.83 percent, on the BSE at 1230 hours.

While retaining the “buy” call on the franchise of PepsiCo with a price target at Rs 760 from Rs 860, JM Financial said Varun posted resilient numbers amid disruption led by COVID-19.

""Varun Beverages' Q1CY20 result was better than our expectations driven by higher volume contribution from acquired territories and resilient performance from International geographies. Organic domestic volume performance (declined 13.7 percent) was a bit disappointing, though, as COVID-19 related lockdown had an adverse impact in the month of March (accounts for disproportionately higher volume share),"" it said.

The company maintained its operating margin on benign raw material costs and an easy base for the International business (last year Q1 margin was impacted by translation provisions).

The carbonated soft drinks and non-carbonated beverages maker reported a whopping 50 percent year-on-year growth in Q1 CY20 consolidated profit at Rs 60.06 crore, supported by tax writeback. Its revenue increased 23.3 percent year-on-year to Rs 1,676.4 crore, impacted by lockdown in the last 10 days of March.

Revenue growth lagged volume growth on higher salience of packaged water, characterised by lower realisations. Consolidated volume grew 26.7 percent aided by the acquisition of PepsiCo's South and West territories and healthy performance in international geographies (7 percent volume growth).

On the operating front, its earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 24.2 percent year-on-year to Rs 271.15 crore in the quarter ended March 2020.

""Operating performance was better than our estimates as weak domestic organic volume growth was offset by healthy contribution from newly acquired territories and resilient International business,"" said JM Financial.

EBITDA margin was flattish as sharp gross profit margin gains (up 281bps) on lower commodity prices was negated by adverse operating leverage (SG&A grew 32 percent).

The management withdrew its volume guidance for the year on demand uncertainties amidst the pandemic but was confident of maintaining operating margin, said JM Financial.

Benign raw material prices and reduction in trade/marketing spends would help negate the adverse impact from lower throughput, it said.

Net debt was largely maintained at Rs 3,200-3,300 crore sequentially and the management expects near-term debt maturities (Rs 450 crore) to be financed by operating cash flows. It also has unutilised credit lines of Rs 480 crore.

""This coupled with improved revenue trajectory post relaxation of lockdown recently should help navigate any liquidity related challenges in the near-term. Our confidence on business delivering healthy free cash flow to the firm (FCFF - Rs 1,000 crore) in CY20 and consequent net debt reduction drives our positive bias,"" JM Financial said.

Global brokerage house CLSA also maintained “buy” rating on the stock but reduced price target to Rs 745 from Rs 766 as it cut 2020 EPS estimates by 60 percent.

""There was sharp impact in India as lockdown extended, but there are multiple growth levers beyond 2020,"" said the brokerage, adding the company had 70 percent urban exposure and large OOH consumption (40 percent of sales).

However, ICICI Direct remained cautious and downgraded its rating to reduce with a revised price target at Rs 580 per share.

Unlike other FMCG companies, the company would be severely impacted by the lockdown, as manufacturing and supply chains were completely derailed, it said.

""Moreover, it also does not have advertising and promotion lever to reduce the cost at the time of crisis to protect margins. Though the management is confident of maintaining operating margins, we believe the recovery would be painful and prolonged,"" it said.

Moreover, higher interest cost was likely to impact earnings in CY20, it added.

In a conference call, compiled by JM Financial, the company said all plants were operational and Varun Beverages was meeting consumer demand. ""Inventory pile-up at March-end has been largely cleared in April,"" it said.

""30-40 percent of beverage demand is on-the-go impulse consumption and 10 percent is institutional; contribution from which is expected to remain negligible in the near term.""

International geographies like Nepal and Sri Lanka also witnessed lockdown in April, which would impact revenues in Q2CY20, the company said.

But EBITDA margin and EBITDA per case would be largely maintained in CY20. ""Softening in commodity prices (pet chips, sugar), lower schemes and promotions and savings in administrative overheads will help in this regard,” it said.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/analysts-retain-buy-on-varun-beverages-but-cut-target-earnings-estimates-on-lockdown-impact-5229691.html
"May 06, 2020 11:43 AM IST",-2,Sandip Das,ITC shares tumble 6% on reports of govt offloading entire stake in the company,"The government is looking to complete the transaction by end of the first or second week of May, says a report by The Economic Times.
The report adds that mutual fund (MF) houses and the Life Insurance Corporation of India (LIC) are also expected to participate.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAccording to Moneycontrol SWOT Analysis powered by Trendlyne ITC witnessed a decline in net profit with a falling profit margin (QoQ).
It also indicates weak momentum with price below short, medium and long term averages with the technical rating being very bearish.","Media report stated that the Centre is reportedly looking to raise Rs 22,000 crore by selling its stake in ITC which it holds through the Specified Undertaking of the Unit Trust of India.","Share price FMCG major ITC tumbled 6 percent intraday on May 6 after media report stated that the centre is reportedly looking to raise Rs 22,000 crore by selling its stake in ITC (7.94 pecent) which it holds through the Specified Undertaking of the Unit Trust of India (SUUTI), in a bulk deal on the exchanges.

The government is looking to complete the transaction by end of the first or second week of May, says a report by The Economic Times.

The report adds that mutual fund (MF) houses and the Life Insurance Corporation of India (LIC) are also expected to participate.

Moneycontrol could not independently verify the report.

The stock witnessed a spurt in volume by more than 1.70 times and was quoting at Rs 163.70, down Rs 10.20, or 5.87 percent at 11:00 hours. It was also the top Sensex loser on May 6.

“The proposed transaction is expected at a marginal discount of 2-3 percent to underlying trading price on the transaction date,” the source told the paper, adding that the government is expected to “exit completely” from ITC.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

According to Moneycontrol SWOT Analysis powered by Trendlyne ITC witnessed a decline in net profit with a falling profit margin (QoQ). It also indicates weak momentum with price below short, medium and long term averages with the technical rating being very bearish.",https://www.moneycontrol.com/news/business/stocks/itc-shares-tumble-6-on-reports-of-govt-offloading-entire-stake-in-the-company-5228971.html
"May 07, 2020 09:53 AM IST",-2,Rakesh Patil,"Investors overlook widening losses, Yes Bank share price locked in upper circuit","Yes Bank share price was locked in 10 percent upper circuit in the early trade on May 7, even though a day earlier it posted a weak set of numbers for the March quarter.
If that amount were to be adjusted with the profit after tax (PAT) figure, the bank would show a profit of Rs 2,628 crore.
Net NPAs stood at 5.03% compared with 5.97 percent in the December quarter and 1.86 percent in the year-ago period.
The bank's deposits shrunk to Rs 1.05 lakh crore, down 54 percent compared with Rs 2.27 lakh crore in the year-ago quarter while advances declined 29 percent year on year to Rs 1.7 lakh crore from Rs 2.4 lakh crore.
Download a copyAt 0934 hours, Yes Bank was quoting at Rs 28.95, up Rs 2.60, or 9.87 percent on the BSE.",Net NPAs in the March quarter stood at 5.03% compared with 5.97 percent in the December quarter and 1.86 percent in the year-ago period.,"Yes Bank share price was locked in 10 percent upper circuit in the early trade on May 7, even though a day earlier it posted a weak set of numbers for the March quarter.

The bank reported a net loss of Rs 3,668 crore in the quarter ended March 2020 on account of higher provisions, or the money set aside to cover risky loans.

The private lender, recently bailed out by a consortium of banks, showed an extraordinary income of Rs 6,297 crore (net of tax) from the writedown of additional tier- 1 (AT1) bonds in its profit and loss account. If that amount were to be adjusted with the profit after tax (PAT) figure, the bank would show a profit of Rs 2,628 crore.

The gross non-performing assets (GNPAs), or bad loans, stood at 16.8 percent compared with 3.22 percent a year ago. Compared with the previous quarter, the gross NPAs eased up from 18.87 percent in December.

Net NPAs stood at 5.03% compared with 5.97 percent in the December quarter and 1.86 percent in the year-ago period.

The bank's deposits shrunk to Rs 1.05 lakh crore, down 54 percent compared with Rs 2.27 lakh crore in the year-ago quarter while advances declined 29 percent year on year to Rs 1.7 lakh crore from Rs 2.4 lakh crore.

There were pending buy orders of 49,347 shares, with no sellers available.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 0934 hours, Yes Bank was quoting at Rs 28.95, up Rs 2.60, or 9.87 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/investors-overlook-widening-losses-yes-bank-share-price-locked-in-upper-circuityes-bank-shrugs-off-widening-losses-share-price-locked-in-upper-circuit-5234121.html
"May 06, 2020 10:39 AM IST",-2,Kshitij Anand,70 stocks in BSE500 decline over 50% since January: 7 rules to buy beaten-down stocks,"The other way could be to analyse the reason behind the fall and then make an informed decision to either buy or sell.
“This (COVID-19 & impact on sectors) will impact the long-term growth prospects of companies in the various sectors for better or worse.
In tough times, a lot of discretionary spending will be pushed forward or maybe down traded and thus growth may actually come down significantly.
Expert: Dinesh Rohira, Founder and CEO, 5nance.com Growth prospects: In the current environment, there are some businesses that will benefit.
De-leveraged companies: Companies with lower levels of debt are always in a better position to tide through tough times.",Experts feel that there are a few factors which investors should keep in mind while buying beaten-down stocks especially at a time when the COVID-19 outbreak has virtually halted the economic activity.,"Nearly 90 percent of the top 500 companies on the BSE have given negative returns since January 20 when the S&P BSE Sensex hit a record high. 71 of those firms have fallen more than 50 percent in the same period. One way to look at the fall is – stocks are available at a 50-80% discount from the price which they were trading at just 3 months back. The other way could be to analyse the reason behind the fall and then make an informed decision to either buy or sell. Close



The 71 companies in the S&P BSE 500 index that fell over 50 percent include Canara Bank, Dish TV, Delta Corp, Future Retail, Gayatri Projects, RBL Bank, Repco Home Finance, and Prestige Estate. Note: The list is for reference only and not a buy or sell recommendations related news Trade Setup for Wednesday: Top 14 things to know before Opening Bell

Technical View: Nifty forms Doji pattern after sharp recovery, 9,250 crucial for upside

Taking Stock: Modi's speech announcement helps recoup some losses; Nifty closes below 9,200







Many sectors and companies might undergo a sea-change in the post-COVID-19 world. The outbreak of the COVID-19 virus will have a subsequent effect on the physical and economic ecosystem, and the consumption pattern of the entire world will have a noticeable change, suggest experts.



For instance, work from home could become a normal practice, virtual markets will be strengthened further, defense systems against viruses would see more capital allocation, traveling patterns will change drastically, overall deleveraging etc., they say.



“This (COVID-19 & impact on sectors) will impact the long-term growth prospects of companies in the various sectors for better or worse. Although valuations have taken a beating, it is important to check these valuations in the context of the entire ecosystem,” Dinesh Rohira, Founder and CEO, 5nance.com told Moneycontrol.



“Buying into the future should be selective and done prudently judging the impact on consumption patterns, it is even more important during such volatile times. The near term will see a drop in growth due to the lockdown and social distancing, hence opportunities to buy can be plenty as volatility will continue. The idea is to remain prepared and invest in a staggered manner,” he said.



Rules to buy beaten-down stocks:



Experts feel that there are few factors which investors should keep in mind while buying beaten-down stocks especially at a time when the COVID-19 outbreak has virtually halted economic activity in most countries across the globe.



“As of now the extent of restrictive phase even after the opening of lockdown and the overall impact is very uncertain and thus one should invest only in companies, which are beaten down merely due to FII selling pressure but have an otherwise robust business model, or are low-cost producer, have no balance sheet risk and cater to the essential need of the consumers,” said Sameer Kaul, MD & CEO, TrustPlutus Wealth Management Services told Moneycontrol.



Here are the factors which one should keep in mind -





Expert: Sameer Kaul, MD & CEO, TrustPlutus Wealth Management Services



Study the balance sheet:



Few factors should be considered before hunting in such a volatile period. First and foremost is to look at the balance sheet risk in a tough period and see if the company has high leverage and high fixed cost. If that's the case, it will be difficult for the company to service the obligations.



Free Cash Flow Generation:Does the company's business generate free cash flow to sustain or survive its current obligations or will it require more capital as given that capital will be available easily in the current scenario? Does the company produce an essential commodity: Are the company's products essential in nature or are they luxury or discretionary? In tough times, a lot of discretionary spending will be pushed forward or maybe down traded and thus growth may actually come down significantly. Expert: Dinesh Rohira, Founder and CEO, 5nance.com Growth prospects: In the current environment, there are some businesses that will benefit. These are the companies with products that have non-discretionary demand and low elasticity to price. Management dynamism: Many companies that can change quickly with the times will be at an advantage. Adapting products and services to the environment is key, such that it can benefit consumers. Valuations: Across the board, valuations have become reasonable. Still, recent financials can have a bearing on the continuing performance. Sometimes very low valuations can also mean that poor fundamentals are expected to remain or further deteriorate. De-leveraged companies: Companies with lower levels of debt are always in a better position to tide through tough times. They are the ones that have more capacity to survive and change according to the requirement. Technologically-driven businesses: Many companies implement technology to their advantage. It is even more critical during such times as social distancing could mean more virtual dependence. Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/70-stocks-in-bse500-decline-over-50-since-january-7-rules-to-buy-beaten-down-stocks-5224191.html
"May 06, 2020 10:52 AM IST",2,Sandip Das,Astec Lifesciences shares surge 20% after robust profit growth; volumes zoom almost 3000%,"Sales rose 35 percent to Rs 180.57 crore in the quarter ended March 2020 as against Rs 133.76 crore during the previous quarter ended March 2019, the company said in a filing to the exchanges.
It was trading with volumes of 17,540 shares, compared to its five day average of 579 shares, an increase of 2,928.31 percent.
According to Moneycontrol SWOT Analysis powered by Trendlyne Astec Lifesciences has zero promoter pledge with low debt.
It is a high growth stock with promoters increasing shareholding with the technical rating being very bullish.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","There were pending buy orders of 12,033 shares, with no sellers available. It was trading with volumes of 17,540 shares, compared to its five day average of 579 shares, an increase of 2,928.31 percent.","Share price of agrochemicals and pharmaceutical intermediates Astec Lifesciences surged 20 percent hitting upper circuit of Rs 519.75 per share on the BSE after the company's net profit zoomed 145.13 percent to Rs 31.18 crore in the quarter ended March 2020 as against Rs 12.72 crore during the previous quarter.

Sales rose 35 percent to Rs 180.57 crore in the quarter ended March 2020 as against Rs 133.76 crore during the previous quarter ended March 2019, the company said in a filing to the exchanges.

The stock has gained over 31 percent in the last 5 days and was quoting at Rs 519.75, up Rs 86.60, or 19.99 percent at 10:29 hours. There were pending buy orders of 12,033 shares, with no sellers available. It was trading with volumes of 17,540 shares, compared to its five day average of 579 shares, an increase of 2,928.31 percent.

According to Moneycontrol SWOT Analysis powered by Trendlyne Astec Lifesciences has zero promoter pledge with low debt. It is a high growth stock with promoters increasing shareholding with the technical rating being very bullish.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The Board of Directors at its meeting recommended a final dividend of 15 percent on the equity share capital of the company, i.e., Rs 1.50 per equity share of the face value of Rs 10 each for the financial year ended March 31, 2020, subject to the approval of the shareholders, it said in a filing to the exchanges.",https://www.moneycontrol.com/news/business/stocks/astec-lifesciences-shares-surge-20-after-robust-profit-growth-volumes-zoom-almost-3000-5228871.html
"May 06, 2020 12:36 PM IST",-2,Kshitij Anand,'Sell in May and go away' theory is going to apply in 2020: Shrikant Chouhan,"Edited excerpt:A) This time, of course, the ""sell in May and go away"" theory is going to apply.
Levels of 9000 to 8900 below 9300 are important for the Nifty.
If the Nifty breaks the level of 8900, it could fall to 8700, 8500 or even 8000.
A) It is underperforming heavily and whenever there is a fresh round of selling in the market, the NiftyBank bleeds first.
The Nifty had touched the level of the entire fall to 50%, while NiftyBank managed to reach only up to 40 percent.","Index rollovers were also on the lowest side (81%), which shows traders were not comfortable when the market was hitting the levels of 9900 on the day of expiry.","Levels of 9,000 to 8,900 below 9,300 are important for the Nifty, and if the Nifty breaks the level of 8,900, it could fall to 8,700, 8,500 or even 8,000, Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities, said in an interview with Moneycontrol's Kshitij Anand.

Edited excerpt:

A) This time, of course, the ""sell in May and go away"" theory is going to apply. Levels of 9000 to 8900 below 9300 are important for the Nifty. If the Nifty breaks the level of 8900, it could fall to 8700, 8500 or even 8000.

The main reason behind this is that the Nifty has completed a pullback trend and once again it is now ready to convert in trending fall once again.

A) It is underperforming heavily and whenever there is a fresh round of selling in the market, the NiftyBank bleeds first. The Nifty had touched the level of the entire fall to 50%, while NiftyBank managed to reach only up to 40 percent.

Weakness is more likely and the index could fall to 17000 maximum, and below that 15000 or 14400 is also possible.

In the year 2008, when the market crashed due to the crises of “subprime” at that time as well the Nifty recovered after forming higher bottom whereas the NiftyBank made lower low (newer low) before recovering.

A) Based on rollover statistics, Reality, Consumer Durables, and Infra Capital Goods sectors are more likely to underperform. Based on Technicals, NBFCs and PSU banks should also underperform.

A) Index rollovers were also on the lowest side (81%), which shows traders were not comfortable when the market was hitting the levels of 9900 on the day of expiry.

However, they failed to take a short-selling bet at the exact technical level 9900(50% of the entire fall). However, technically, we feel that the Nifty would spend more time between the levels of 9000 and 9600 before falling to the levels of 8000.

Be short-seller around 9500/9600 levels or keep on reducing weak long positions.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/sell-in-may-and-go-away-theory-is-going-to-apply-in-2020-shrikant-chouhan-5225621.html
"May 06, 2020 06:49 PM IST",2,Subhash Helgaokar,Buy Axis Bank target of Rs 540: Sharekhan,"Sharekhan's research report on Axis BankAxis Bank posted mixed numbers for Q4FY2020.
While operating results were in line, elevated provisions (especially provisions related to the COVID-19 impact) caused the bank to post a loss.
We believe that while Axis Bank's is being prudent, the COVID-19 impact is likely to impact both growth and credit costs for the banking sector including Axis Bank.
We are fine-tuning our estimates and target multiple considering the dynamic environment.
OutlookWe maintain our Buy rating on the stock with a revised price target (PT) of Rs.","Sharekhan is bullish on Axis Bank has recommended buy rating on the stock with a target price of Rs 540 in its research report dated April 28, 2020.","Sharekhan's research report on Axis Bank

Axis Bank posted mixed numbers for Q4FY2020. While operating results were in line, elevated provisions (especially provisions related to the COVID-19 impact) caused the bank to post a loss. We believe that while Axis Bank's is being prudent, the COVID-19 impact is likely to impact both growth and credit costs for the banking sector including Axis Bank. We are fine-tuning our estimates and target multiple considering the dynamic environment. However considering the business strengths we expect the bank to ride over the medium term challenges.

Outlook

We maintain our Buy rating on the stock with a revised price target (PT) of Rs. 540.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-axis-bank-target-of-rs-540-sharekhan-5230451.html
"May 06, 2020 06:48 PM IST",2,Subhash Helgaokar,Buy Tata Consultancy Services target of Rs 1920: Sharekhan,"Sharekhan's research report on Tata Consultancy ServicesRevenue missed estimates owing to Covid-19 impact, while EBIT margin matched our expectations.
Management expects peak negative revenue impact in Q1FY2021E as demand environment deteriorates significantly, which could be at the similar level of revenue decline during global financial crisis (GFC).
OutlookWe maintain our Buy rating on TCS with a revised PT of Rs.
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on Tata Consultancy Services has recommended buy rating on the stock with a target price of Rs 1920 in its research report dated April 16, 2020.","Sharekhan's research report on Tata Consultancy Services

Revenue missed estimates owing to Covid-19 impact, while EBIT margin matched our expectations. Management expects peak negative revenue impact in Q1FY2021E as demand environment deteriorates significantly, which could be at the similar level of revenue decline during global financial crisis (GFC). We believe that revenue would plunge during H1FY2021E followed by gradual improvement in H2FY2021E. Expect normalized revenue growth in FY2022E.

Outlook

We maintain our Buy rating on TCS with a revised PT of Rs. 1,920, given its strong business model.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-tata-consultancy-services-target-of-rs-1920-sharekhan-5230431.html
"May 06, 2020 10:15 AM IST",2,Sandip Das,NIIT Tech shares hit 10% upper circuit after Q4 results; Board declares dividend,"It said strong tech capabilities and sharp execution helped the company in winning large deals.
The company had posted a net profit of Rs 102 crore in January-March 2019 quarter, NIIT Technologies said in a statement.
Its consolidated revenue grew 19 percent to Rs 1,109.3 crore in the quarter under review from Rs 931.9 crore in the year-ago period, it added.
According to Moneycontrol SWOT Analysis powered by Trendlyne NIIT Tech has low debt with zero promoter pledge.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","The company's board declared a third interim dividend of Rs 11 per share, and the record date for the same has been fixed for May 15, 2020.","Share price of NIIT Technologies surged 10 percent intraday on May 6 after the company reported a 11.4 percent rise in consolidated net profit to Rs 113.6 crore for the March 2020 quarter.

It said strong tech capabilities and sharp execution helped the company in winning large deals.

The company had posted a net profit of Rs 102 crore in January-March 2019 quarter, NIIT Technologies said in a statement.

Its consolidated revenue grew 19 percent to Rs 1,109.3 crore in the quarter under review from Rs 931.9 crore in the year-ago period, it added.

The company's board declared a third interim dividend of Rs 11 per share, and the record date for the same has been fixed for May 15, 2020.

According to Moneycontrol SWOT Analysis powered by Trendlyne NIIT Tech has low debt with zero promoter pledge. However, Moneycontrol's technical rating has a neutral call on the stock.

The stock hit the upper circuit with pending buy orders of 966 shares, with no sellers available.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

""The firm recorded one of its best annual performances ever in FY'20, which has come on the back of a similarly strong performance delivered in the preceding year,"" NIIT Technologies CEO Sudhir Singh said.",https://www.moneycontrol.com/news/business/stocks/niit-tech-shares-hit-10-upper-circuit-after-q4-results-board-declares-dividend-5228631.html
"May 05, 2020 10:37 PM IST",2,,COVID-19 | Market analysis and investments strategies with Udayan Mukherjee,"The unprecedented disruption caused by novel coronavirus, or COVID-19, may have a longer-than-expected impact on the economy and markets.
But has the stock market hit bottom?
Which are the sectors that could brave the COVID-19 storm?
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyLet's take a deep dive with CNBC-TV18's consulting editor Udayan Mukherjee to understand.",Let's take a deep dive with CNBC-TV18's consulting editor Udayan Mukherjee to understand.,"The unprecedented disruption caused by novel coronavirus, or COVID-19, may have a longer-than-expected impact on the economy and markets.

But has the stock market hit bottom? Will government stimulus help markets? Which are the sectors that could brave the COVID-19 storm?

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Let's take a deep dive with CNBC-TV18's consulting editor Udayan Mukherjee to understand.",https://www.moneycontrol.com/news/business/earnings/covid-19-market-analysis-and-investments-strategies-with-udayan-mukherjee-5226551.html
"May 06, 2020 09:00 AM IST",2,,"SBI Life reports mixed performance, should investors bet on the stock?","To view the full content of this article, you have to be a Pro:Already a Moneycontrol Pro subscriber?
Or Open in AppNot a Moneycontrol Pro subscriber yet?
Subscribe to Moneycontrol Pro:What's included:",,"To view the full content of this article, you have to be a Pro:

Already a Moneycontrol Pro subscriber? Or Open in App

Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:







What's included:",https://www.moneycontrol.com/news/business/moneycontrol-research/sbi-life-reports-mixed-performance-should-investors-bet-on-the-stock-5228111.html
"May 05, 2020 01:41 PM IST",2,Sunil Matkar,"Pick auto stocks with lower COVID-19 impact, strong balance sheets, say brokerages","Most auto companies, for the first time, reported zero sales in April, due to the nationwide lockdown.
M&M, TVS Motor, Bajaj Auto and Eicher Motors managed to export some vehicles.
Hence, the Pantnagar plant being operational does not help,"" Motilal Oswal said after talking to Bajaj Auto.
Leading agencies such as CRISIL and the World Bank have slashed India's FY21 economic growth forecast to 1.5-2.8 percent from 4.8-5.2 percent.
Further, dealer support from auto companies may also impact their margins in the near term.","The Nifty Auto Index has corrected by about 21 percent in the past two months, compared to an18 percent decline in the Nifty.","Most auto companies, for the first time, reported zero sales in April, due to the nationwide lockdown.

With factories and dealerships shut during the month, original equipment manufacturers (OEMs) Mahindra & Mahindra (automotive segment), Bajaj Auto, TVS Motor, Hero MotoCorp and Maruti Suzuki reported almost no business.

However, as the government allowed agricultural activities (except in the containment zones), M&M and Escorts sold a few tractors. M&M, TVS Motor, Bajaj Auto and Eicher Motors managed to export some vehicles.

As it announced the third phase of lockdown that began on May 4, the Centre has allowed companies to start operations and dealers to reopen business, with the permission of state governments, in the areas that are coronavirus-free.

In an interaction with brokerage houses, OEMs indicated they were evaluating the possibility of restarting operations and waiting for permissions from state governments. Most of them have inventories of three to eight weeks.

Even after recommencing operations in some plants with a minimum manpower due to social distancing, getting spare parts would be difficult as most auto ancillary plants are in red zones or the coronavirus hot spots.

For instance, Bajaj Auto's two plants, including in one in Pantnagar, are operational. ""30 percent of Bajaj Auto's dealers are located in the green zone and 50 percent are in green/orange zone. Hardly 2-3 percent of its dealerships have reopened for business, and hence, there is near-zero demand for vehicles or spares. Hence, the Pantnagar plant being operational does not help,"" Motilal Oswal said after talking to Bajaj Auto.

M&M told the brokerage that tractor plants have not restarted yet, as the company had enough inventories (for around eight weeks) in the system, even at the plant level. ""Auto plants have started at Nashik, Haridwar and Igatpuri (engines). Chakan plant is yet to start,"" it said.

Hence, given the uncertainty due to COVID-19 crisis, brokerages expect the recovery to take longer time and all companies to see negative growth in FY21 against FY20 but there could be recovery in FY20 on low base of FY21.

""The COVID-19 pandemic has not only put the brakes on the initial signs of recovery seen in 2Ws/PVs but has also brought in uncertainty considering the several unknowns associated with its impact. This potentially deepens the impact of BS6 related price increase on FY21 demand,"" Motilal Oswal said.

Given the lockdown of nearly two months, the economy will likely take time to reach normalcy, say brokerages.

Leading agencies such as CRISIL and the World Bank have slashed India's FY21 economic growth forecast to 1.5-2.8 percent from 4.8-5.2 percent.

""Slower economic growth is likely to impact discretionary purchases such as automobiles and we expect the demand to remain under pressure in the near term. We expect recovery from FY2022 as long-term growth triggers, such as lower vehicle penetration and favourable demographics, are intact,"" Sharekhan said.

Moreover, pent-up demand (automotive volumes have been under pressure for the past six quarters) and pick-up in economic growth (post normalisation) would lead to a recovery from FY2022, it feels.

The Nifty Auto Index has corrected by about 21 percent in the past two months (compared to a correction of 18 percent in the Nifty) after the COVID-19 outbreak and the lockdown.

Most automotive stocks have also corrected sharply and are trading at 15-45 percent below their historical long-term average multiples.

Given the weak demand going ahead and attractive valuations, brokerages prefer to pick quality names less impacted by COVID-19 and have strong balance-sheet position.

""The demand is expected to remain under pressure in the near term on account of a slowdown in economic growth. Further, dealer support from auto companies may also impact their margins in the near term. Hence, we stay neutral on the automobile sector and prefer a selective approach,"" Sharekhan said.

The brokerage likes companies that are relatively less impacted by COVID-19 such as Balkrishna Industries and M&M (67 percent and 35 percent revenue from agriculture, respectively).

It also prefers companies that have a strong balance sheet and cash position and are leaders in their segments such as Hero MotoCorp, Exide Industries and Mayur Uniquoters.

Motilal Oswal also said valuations appeared attractive across companies but given the uncertain macro environment and threat of a possible prolonged impact of the coronavirus, it preferred stocks offering higher visibility of demand recovery, better competitive positioning, scope of higher operating leverage and strong balance sheet.

Eicher Motors and Maruti Suzuki are its top largecap picks, among mid-caps, it preferred Endurance Technologies.

Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/pick-auto-stocks-with-lower-covid-19-impact-strong-balance-sheets-say-brokerages-5223821.html
"May 05, 2020 01:56 PM IST",-2,Kshitij Anand,"D-Street Talk podcast | Bulls aren't back, it was just a ‘Dead Cat Bounce': Amar Deo Singh","Major levels to track on the downside would be 8,900, and below that crucial support is placed at 8600-8650 zone.
Some of the indicators were in oversold territory so some pullback was expected, but again at higher levels markets would get sold into and that's what we saw on Monday,” explains Singh.
(Tune in to the podcast for more)Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copy: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Major levels to track on the downside would be 8900, and below that crucial support is placed at 8600-8650 zone. On the upside, resistance is seen at 9600, followed by 10,000 levels.","The Nifty50 recovered almost 50 percent of the entire fall from 12,430, but experts suggest investors remain cautious as we are just 2 months in the bear market, and what we witnessed in April was a ‘Dead Cat Bounce'.

What we saw in April was a Bear market rally and that is why it was fast and swift and might have got many off guard in the month of May, Amar Deo Singh, Head Advisory, Angel Broking Ltd said in a podcast ‘D-Street Talk' with Moneycontrol.

Major levels to track on the downside would be 8,900, and below that crucial support is placed at 8600-8650 zone. On the upside, resistance is seen at 9600, followed by 10,000 levels.

“If we look at the markets on the monthly charts – most of the indicators are extremely negative. Some of the indicators were in oversold territory so some pullback was expected, but again at higher levels markets would get sold into and that's what we saw on Monday,” explains Singh.

(Tune in to the podcast for more)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/podcast/d-street-talk-podcast-bulls-arent-back-it-was-just-a-dead-cat-bounce-amar-deo-singh-5223421.html
"May 06, 2020 09:03 AM IST",2,Subhash Helgaokar,Buy Federal Bank target of Rs 80: Sharekhan,"Sharekhan's research report on Federal BankInitial signs indicate that COVID-19 outbreak may result in higher delinquencies and lower credit offtake for BFSI companies, including Federal Bank.
Federal Bank has a 51% wholesale book and ~37% of NRE deposits, which are expected to see COVID-19 related impact.
We have fine tuned our estimates and revised our target multiple in light of the dynamic environment.
OutlookWe maintain our Buy rating on the stock with a revised price target of Rs.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","Sharekhan is bullish on Federal Bank has recommended buy rating on the stock with a target price of Rs 80 in its research report dated April 23, 2020.","Sharekhan's research report on Federal Bank

Initial signs indicate that COVID-19 outbreak may result in higher delinquencies and lower credit offtake for BFSI companies, including Federal Bank. Federal Bank has a 51% wholesale book and ~37% of NRE deposits, which are expected to see COVID-19 related impact. We have fine tuned our estimates and revised our target multiple in light of the dynamic environment. However, post market correction, we opine most negatives are factored in the price.

Outlook

We maintain our Buy rating on the stock with a revised price target of Rs. 80.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-federal-bank-target-of-rs-80-sharekhan-5228091.html
"May 05, 2020 01:28 PM IST",1,Sandip Das,Bharat Forge jumps 3% on resuming operations at Baramati plant,"Share price of auto component maker Bharat Forge jumped over 3 percent intraday on May 5 after the company partially resumed manufacturing operations at its Baramati plant.
""We wish to inform that Bharat Forge Limited is gearing up to commence partial operations at its Baramati plant as per the guidelines stipulated by the Ministry of Home Affairs of the Government of India after obtaining permission from the local district authority (MIDC, Baramati),"" the company said in a filing to the exchanges.
According to Moneycontrol SWOT Analysis powered by Trendlyne, Bharat Forge has zero promoter pledge with FII/FPI or institutions increasing their shareholding.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyThe company's other manufacturing facilities in the country would remain closed till further notice, Bharat Forge said.","Bharat Forge is commencing operations in a graded manner with the Baramati facility reopening from May 5 and we expect production to commence by end of the week, the company said.","Share price of auto component maker Bharat Forge jumped over 3 percent intraday on May 5 after the company partially resumed manufacturing operations at its Baramati plant.

""We wish to inform that Bharat Forge Limited is gearing up to commence partial operations at its Baramati plant as per the guidelines stipulated by the Ministry of Home Affairs of the Government of India after obtaining permission from the local district authority (MIDC, Baramati),"" the company said in a filing to the exchanges.

""Bharat Forge is commencing operations in a graded manner with the Baramati facility reopening from May 5 and we expect production to commence by end of the week, post completion of mandatory safety check and training of personnel on physical distancing, health and hygiene,"" it added.

The stock price jumped over 27 percent in the last 1 month and was quoting at Rs 279.35, up Rs 9.50, or 3.52 percent at 13:10 hours.

According to Moneycontrol SWOT Analysis powered by Trendlyne, Bharat Forge has zero promoter pledge with FII/FPI or institutions increasing their shareholding.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The company's other manufacturing facilities in the country would remain closed till further notice, Bharat Forge said.",https://www.moneycontrol.com/news/business/stocks/bharat-forge-jumps-3-on-resuming-operations-at-baramati-plant-5224011.html
"May 05, 2020 03:30 PM IST",2,Subhash Helgaokar,Buy HDFC Bank; target of Rs 1100: ICICI Direct,"ICICI Direct's research report on HDFC BankThe bank reported steady asset quality with sequential fall in GNPA at Rs 12650 crore & ~16 bps reduction in GNPA ratio to 1.26%.
Excluding moratorium provided by RBI, GNPA would have been up 10 bps at 1.36%, still prudent.
Slippages were Rs 3150 crore (~0.3% of advances).
Accordingly, we maintain BUY and maintain target price at Rs 1100 valuing the bank at ~ 15x FY22E EPS (2.74x FY22E ABV).
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","ICICI Direct is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated April 20, 2020.","ICICI Direct's research report on HDFC Bank

The bank reported steady asset quality with sequential fall in GNPA at Rs 12650 crore & ~16 bps reduction in GNPA ratio to 1.26%. Excluding moratorium provided by RBI, GNPA would have been up 10 bps at 1.36%, still prudent. Till now only low single digit proportion availed moratorium and it can rise. Slippages were Rs 3150 crore (~0.3% of advances).

Outlook

The bank continues to remain a portfolio stock and maintains premium valuations. Accordingly, we maintain BUY and maintain target price at Rs 1100 valuing the bank at ~ 15x FY22E EPS (2.74x FY22E ABV). We include Rs 75 per share for HDB Financial Services.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

",https://www.moneycontrol.com/news/business/stocks/buy-hdfc-bank-target-of-rs-1100-icici-direct-5223541.html
"May 05, 2020 03:31 PM IST",2,Subhash Helgaokar,Buy ACC; target of Rs 1380: ICICI Direct,"Revenues fell 10.8% YoY to Rs 3,433 crore (vs. I-direct estimate of Rs 3,331 crore) led by a decline in cement volumes as the industry saw weak offtake in the quarter.
Blended realisations were at Rs 5,233/t, up 1.4% YoY (in line with I-direct estimate of Rs 5,225/t).
EBITDA/t for the quarter was at Rs 789/tonne (vs. I-direct estimate: Rs 706/tonne), up 27.4% YoY.
PAT declined 6.6% YoY to Rs 323 crore (vs. I-direct estimate: Rs 304 crore).
Thus, we maintain BUY on ACC, valuing the company at 12x CY21E EV/EBITDA to arrive at a target price of Rs 1,380 (implying an EV/t of ~$80).","ICICI Direct is bullish on ACC has recommended buy rating on the stock with a target price of Rs 1380 in its research report dated April 22, 2020.","ICICI Direct's research report on ACC

ACC surprised positively in Q1CY20, beating our estimates on all fronts. Revenues fell 10.8% YoY to Rs 3,433 crore (vs. I-direct estimate of Rs 3,331 crore) led by a decline in cement volumes as the industry saw weak offtake in the quarter. Cement volumes for the quarter were at 6.56 MT (vs. I-direct estimate: 6.4 MT), down 12.1% YoY while RMC volumes fell marginally from 0.94 cum in Q1CY19 to 0.93 cum in Q1CY20. Blended realisations were at Rs 5,233/t, up 1.4% YoY (in line with I-direct estimate of Rs 5,225/t). ACC saw healthy EBITDA growth on the back of improvement in profitability. EBITDA/t for the quarter was at Rs 789/tonne (vs. I-direct estimate: Rs 706/tonne), up 27.4% YoY. Thus, despite a steep drop in volumes, the EBITDA increased 12% YoY to Rs 518 crore (vs. I-direct estimate: Rs 450 crore) while EBITDA margins expanded 308 bps YoY to 15.1% The growth in operating performance is not reflected in PAT owing to steeply lower other income YoY, as the base quarter included a one-off to the tune of Rs 99 crore. PAT declined 6.6% YoY to Rs 323 crore (vs. I-direct estimate: Rs 304 crore).

Outlook

While ACC would face challenges on the P&L front in the near term, it is one of the few companies with no debt on its books and is expected to remain net cash positive despite capital expenditure on capacity addition. Return ratios are also expected to stay healthy despite a reduction in profitability. The recent correction puts ACC in a comfortable position on the valuation front. Thus, we maintain BUY on ACC, valuing the company at 12x CY21E EV/EBITDA to arrive at a target price of Rs 1,380 (implying an EV/t of ~$80).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

",https://www.moneycontrol.com/news/business/stocks/buy-acc-target-of-rs-1380-icici-direct-5223601.html
"May 06, 2020 09:40 AM IST",1,Rakesh Patil,Adani Ports share price rises 3% post weak Q4 result; Morgan Stanley remains overweight,"The company's Q4 net profit fell 74 percent at Rs 334 crore versus Rs 1,285 crore, while revenue fell 5 percent at Rs 2,921 crore versus Rs 3,082 crore, YoY, reported CNBC-TV18.
Earnings before interest, tax, depreciation and amortisation (EBITDA) was down 15 percent at Rs 1,644 crore against Rs 1,932 crore.
The company has reported a forex loss at Rs 1,004 crore versus a gain of Rs 109.1 crore, YoY.
Rail traffic from ports moving efficiently, enabling the company to convert road to rail traffic, it added further.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","According to research house, the soft realisations and higher opex in Q4 have driven the miss.","Adani Ports share price rose 3 percent in early trade on May 6 despite the company reporting a weak set of numbers for the quarter ended March 2020 (Q4FY20).

The company's Q4 net profit fell 74 percent at Rs 334 crore versus Rs 1,285 crore, while revenue fell 5 percent at Rs 2,921 crore versus Rs 3,082 crore, YoY, reported CNBC-TV18.

Earnings before interest, tax, depreciation and amortisation (EBITDA) was down 15 percent at Rs 1,644 crore against Rs 1,932 crore. The EBITDA margin was down 700 bps at 56 percent versus 63 percent, YoY.

The company has reported a forex loss at Rs 1,004 crore versus a gain of Rs 109.1 crore, YoY.

Morgan Stanley has remained overweight on the stock with a target at Rs 274 per share.

According to the research house, the soft realisations and higher operational expenditure in Q4 have driven the miss.

Also, the acquisition closures have been pushed back by two quarters. However, there is no explicit guidance, but recovery likely from Q2, it added.

Dolat Capital maintained accumulate rating on the stock.

Expecting slow pick up in cargo volume in Q2FY21, and a V-shape recovery possible in H2 F21 post complete lifting of lockdown, it added.

Availability of manpower to be a challenge and this will impact productivity in the short term. Rail traffic from ports moving efficiently, enabling the company to convert road to rail traffic, it added further.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:24 hrs, Adani Ports and Special Economic Zone was quoting at Rs 269.05, up Rs 5.90, or 2.24 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/adani-ports-share-price-rises-3-post-weak-q4-result-morgan-stanley-remains-overweight-5228041.html
"May 06, 2020 09:03 AM IST",1,Subhash Helgaokar,Hold Tata Consultancy Services; target of Rs 2055: ICICI Direct,"ICICI Direct's research report on Tata Consultancy ServicesTata Consultancy Services (TCS) reported a poor set of Q4FY20 numbers on the back of challenges posed by Covid-19.
The decline in BFSI was due to supply side challenges and lower client approval on work from home.
On the deal front, TCS won TCV worth US$8.9 billion in this quarter on the back of two large deals won in previous quarter (US$1.5 billion in Phoenix, US$1.7 billion from Walgreens).
Hence, we maintain HOLD with a revised target price of Rs 2055 (22x FY22E EPS).
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","ICICI Direct recommended Hold rating on Tata Consultancy Services with a target price of Rs 2055 in its research report dated April 17, 2020.","ICICI Direct's research report on Tata Consultancy Services

Tata Consultancy Services (TCS) reported a poor set of Q4FY20 numbers on the back of challenges posed by Covid-19. Revenues across geographies declined QoQ. Vertical wise, revenue declined in BFSI, retail and manufacturing. The decline in BFSI was due to supply side challenges and lower client approval on work from home. On the deal front, TCS won TCV worth US$8.9 billion in this quarter on the back of two large deals won in previous quarter (US$1.5 billion in Phoenix, US$1.7 billion from Walgreens).

Outlook

Hence, we stay positive on the stock from a long-term perspective. However, current valuations factor in most positives. Hence, we maintain HOLD with a revised target price of Rs 2055 (22x FY22E EPS).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-tata-consultancy-services-target-of-rs-2055-icici-direct-5228051.html
"May 06, 2020 09:03 AM IST",1,Subhash Helgaokar,Hold Marico; target of Rs 300: ICICI Direct,"However, Saffola being part of the essential portfolio saw strong 25% growth on the back of stocking up by consumers & retailers.
The growth was led by heightened media spend & in-store promotion at the start of the quarter.
OutlookWe expect Marico to see 4.3% decline in sales in FY21E mainly impacted by loss of sales during lockdown period.
However, we believe parachute & hair oil portfolio is facing structural growth issues with entire category saturating.
Though Marico has a presence in food and healthy proposition product portfolio, it is still too small to make any significant difference to the growth.","ICICI Direct recommended Hold rating on Marico with a target price of Rs 300 in its research report dated May 05, 2020.","ICICI Direct's research report on Marico

Marico reported a dismal set of Q4FY20 numbers with 3% decline in India business volumes largely impacted by Parachute & Value Added Hair Oil (VAHO) with 8% & 11% volume dip, respectively. However, Saffola being part of the essential portfolio saw strong 25% growth on the back of stocking up by consumers & retailers. Despite the current scenario, Saffola would have grown in double digits. The growth was led by heightened media spend & in-store promotion at the start of the quarter. Bangladesh & Vietnam, which remained bulk of international operations, witnessed growth of 6% & 5%, respectively. Operating margins improved 60 bps led by 110 bps cut in marketing spend and stable commodity cost, which helped cover an uptick in overhead expense to sales. Adjusting for tax write-back in the base quarter, net profit declined 6.5%.

Outlook

We expect Marico to see 4.3% decline in sales in FY21E mainly impacted by loss of sales during lockdown period. We estimate 17.8% growth in FY22E largely recouping the loss of current year. However, we believe parachute & hair oil portfolio is facing structural growth issues with entire category saturating. Though Marico has a presence in food and healthy proposition product portfolio, it is still too small to make any significant difference to the growth. We maintain our HOLD rating with a target price of Rs 300/share

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-marico-target-of-rs-300-icici-direct-5228081.html
"May 05, 2020 01:59 PM IST",1,Nishant Kumar,COVID-19: ICICI Direct picks 7 'resilient' stocks that can weather the storm; do you own any?,"Despite the slowdown, the brokerage expects the company to have a CAGR growth of 17.4 percent and 19.5 percent in revenues and profitability over FY19-22E.
The brokerage expects the stock to follow the same rhythm and resolve higher, thus offering aa fresh entry opportunity to accumulate.
Coromandel International | Buy | LTP: Rs 567.35 | Target price: Rs 688 | Upside: 21%Coromandel International is India's second-largest phosphatic fertilizer player.
Ramco Cement | Buy | LTP: Rs 513 | Target price: Rs 665 | Upside: 30%While the sales volumes are being affected, rural and semi-urban areas have shown resilience.
ICICI Direct expects the stock to resolve higher and head to Rs 665 levels, as it is the 50 percent retracement of the entire decline (Rs 884-455).","These stocks may take off once the runway is clear, says the brokerage.","They say every adversity brings with it an opportunity and the equity market is no exception.

While uncertainty and gloom prevail in the market due to the coronavirus outbreak, brokerage firm ICICI Direct has identified stocks that have the ability to withstand a storm and may take off once the runway is clear.

""As the wisdom goes in the market, there are always opportunities in every adversity which exhibit bull moves even in a rough environment. We believe in the current uncertain scenario when many stocks are at multi-year lows and finding opportunities are challenging, identifying such resilient stocks and riding them in a rough environment like this will be rewarding and exciting,"" said the brokerage.

Structural turnarounds, relative strength rankings and Dow Theory bullish signals are three broad technical concepts to find the outperformers during the market decline in 2020.

As per the brokerage, under the structural turnarounds, there are stocks that have witnessed faster retracement of the entire January – March 2020 decline quicker, in April 2020, thereby, signalling a change of guard and a robust price structure.

On the other hand, the stocks that showed relative strength are ones that have remained resilient during the sharp decline of February and March 2020 and relatively outperformed the benchmarks, acting as defensive bets for investors. These stocks have steadied the portfolio performance in turbulent times, the brokerage said.

Stocks with Dow Theory bullish signals are the ones exhibiting a combination of higher high-low on yearly time frame (long-term degree) and supported by a similar signal on monthlies (medium-term degree).

""As the basic tenet of Dow Theory goes, the trend is a friend and therefore, staying invested with these companies may be rewarding,"" said the brokerage.

Here are the seven such stocks that the brokerage has termed as resilient:

Have a look:

Info Edge (India) | Buy | LTP: 2,510 | Target price: Rs 2,950 | Upside: 17.5%

In the near term, the slowdown in the economy could impact hiring activity (Naukri business) and real estate business (99 acres), leading to a deceleration in growth in the business, the brokerage said.

However, the should company to return to strong growth in the medium term, led by its leadership position in each of the above verticals.

Despite the slowdown, the brokerage expects the company to have a CAGR growth of 17.4 percent and 19.5 percent in revenues and profitability over FY19-22E.

On the technical front, the stock has been one of the major outperformers in the technology space and has seen a sharp recovery in the last three-four weeks from the decade-long rising demand line joining the major lows of CY09 (Rs 94) CY13 (Rs 276) and CY17 (Rs 796) placed around Rs 1,600 levels, said the brokerage.

Empirically, the stock went back to its life-time high after testing the key trend line. The brokerage expects the stock to follow the same rhythm and resolve higher, thus offering aa fresh entry opportunity to accumulate.

The monthly MACD is seen conversing with its nine periods average, supporting a bullish stance.

Coromandel International | Buy | LTP: Rs 567.35 | Target price: Rs 688 | Upside: 21%

Coromandel International is India's second-largest phosphatic fertilizer player. It manufactures a wide range of fertilizers and markets around 4.5 million tonnes.

""Coromandel is poised to benefit from the recent increase in SSP prices, since the company has been selling SSP of around 5.6-6 lakh tonnes every year. Further, a recent increase in the prices of DAP can also assist the company to benefit from the higher realisation of NPKs,"" said the brokerage.

With an increase in the fertiliser industry volumes ahead of the Kharif season along with higher realisations and better EBITDA/tonne after a fall in the rock phosphate and sulphur prices, Coromandel International should post decent performance, it said.

On the technical front, the stock has relatively outperformed the mid-cap index and held its key support despite a volatile market around Rs 450 marked by a breakout area of long-term contracting triangle, thereby confirming a change of polarity and a 61.8 percent retracement of the last major upmove (Rs 337-642) at Rs 453, thereby offering fresh entry opportunity with a favourable risk-reward, said the brokerage.

On the oscillator front, the weekly stochastic is marching upward after recording a bullish crossover, indicating the continuance of a positive bias.

The brokerage expects the stock to challenge its lifetime high at Rs 642 and head to Rs 688 in the coming months, as it is 123.6 percent retracement of the last two months' decline (Rs 642–443), at Rs 688.

Relaxo Footwears | Buy | LTP: Rs 612.50 | Target price: 765 | Upside: 25%

Over the years, Relaxo has consistently posted strong performance, showing the company's fundamental strength .

""While volumes have trebled over the last decade (10-year CAGR: 10 percent), the transformation from being a basic slipper company to a conglomerate of higher value-added product categories has led the average

realisation to double to Rs 125 per piece (10-year CAGR: 7 percent),"" said the brokerage.

""Relaxo has a capital-efficient business model, generating healthy asset turns of 3 times and EBITDA margins of 15 percent. Stringent control in NWC (60 days) has led to average CFO/EBITDA at 55 percent.

Subsequently, D/E ratio fell from 1 time in FY13 to 0.1 times in FY19, with RoCE of more than 20 percent. We expect Relaxo to be the beneficiary of market share gains through a shift from unorganised to organised players.""

On the technical front, the stock has seen a change of polarity, as the previous major trendline resistance joining highs of CY15 (Rs 318) and CY18 (Rs 453) has reversed its role and is acting as support currently placed at Rs 500 levels.

As per the brokerage, the current decline from the all-time high (Rs 830 - Rs 500) achieved equality in magnitude with the 2015-2016 decline (Rs 318-188) and rebounded from key support at around Rs 500.

The brokerage expects the stock to maintain a positive bias and head to Rs 765, as it is 80 percent retracement of the entire decline (Rs 830–500).

Astral Poly Technik | Buy | LTP: Rs 930.20 | Target price: Rs 1,160 | Upside: 25%

""Despite, capacity addition and increase in dealer networks, Astral's balance-sheet position has remained strong with efficient working capital management (average RoCE and RoE of 25 percent and 19 percent,

respectively),"" said the brokerage.

""While the company is likely to face near-term challenge due to lockdown, the long-term prospect of the company remained strong given the strong push of the government in the construction and infrastructure

developments.""

The company should record revenue, earnings CAGR of 18 percent and 17 percent in FY20E-22E, supported by about 15 percent volume growth in the piping segment, it said.

On the technical front, the stock has been in a secular uptrend and has been trading in a rising channel since CY17, highlighting a sustained demand at elevated levels.

""It has recently rebounded taking support at the lower band of the rising channel which also confluence with the 80 percent retracement of the previous rally (Rs 678-1,267) placed at Rs 790 levels thus provides fresh entry opportunity with a favourable risk-reward setup,"" said the brokerage.

The monthly 14 periods RSI is seen rebounding, taking support at its previous major yearly lows, thus supports the positive bias.

The brokerage expects the stock to form a base around the lower band of the channel and resume up move towards Rs 1,160, as it is 80 percent retracement of the entire decline (Rs 1,265-746).

Ramco Cement | Buy | LTP: Rs 513 | Target price: Rs 665 | Upside: 30%

While the sales volumes are being affected, rural and semi-urban areas have shown resilience.

On the pricing front, the management does not foresee a significant pressure on cement prices in the near term.

With most of the costs being variable in nature and with crude and petcoke prices seeing a significant correction, the company could see an improvement in profitability, which could partially offset lost EBITDA on account of lower volumes, ICICI Direct said.

""The debt of Rs 2,900 crore in its book which would increase further by upto Rs 500 crore to fund the capex and working capital requirement. However, we do not see this increase in debt to pose a threat to the

company's balance sheet strength, as its D/E would remain well below 0.5 times,"" said the brokerage.

On the technical front, the stock has held its key upward sloping trendline, around Rs 460, despite elevated volatility and remains an outperformer within the cement space.

A higher base formation near key support of Rs 500-520 signals a positive bias and offers a fresh entry opportunity with a favourable risk-reward for investors to accumulate the stock.

""Structurally, over the past 24 months, the stock has retraced 80 percent of preceding 26 months rally (Rs 360–879), at Rs 460. A slower pace of retracement signals robust price structure,"" said the brokerage.

ICICI Direct expects the stock to resolve higher and head to Rs 665 levels, as it is the 50 percent retracement of the entire decline (Rs 884-455).

Laurus Labs | Buy | LTP: Rs 494.25 | Target price: Rs 620 | Upside: 25%

From being an anti-AIDS API supplier, the company is rigorously diversifying its product basket by moving into some niche APIs and formulations.

""Heavy balance sheet and subdued return ratios are attributable to aggressive capex in the past few years. However, with strong clientele, good execution track record, diverse product offering and relatively better

compliance track record, things should look promising,"" said the brokerage.

As per the brokerage, the company, being the largest supplier of some of the key anti-AIDS and other APIs in the world, can also benefit from the quest for a drug for COVID-19, the respiratory illness caused by the coronavirus.

This would also likely generate better operating leverage on the back of better capacity utilisation, ICICI Direct said.

On the technical front, during the current month, the stock witnessed a faster retracement, as over the last four weeks stock entirely retraced preceding eight weeks decline (Rs 460 –295), indicating a robust price structure, in turn, suggesting structural turnaround, auguring well for next leg of the up move.

Structurally, the stock recorded a sharp rebound from the major long-term falling trend line placed around Rs 300, underpinned by positive divergence on the MACD indicator, as the price was forming lower low. Meanwhile, MACD was forming a higher low, indicating an impending positive momentum.

The brokerage expects the stock to form a higher base after the recent sharp upmove and pave the way to Rs 620, as it is near the life high of Rs 640 seen in July 2017.

Dixon Technologies India | Buy | LTP: Rs 4,590 | Target price: Rs 5,840 | Upside: 27%

The stock has formed a higher base after arresting intermediate correction near the key value area of Rs 3,000.

Structurally, the stock witnessed a faster retracement by recouping 19 months decline (Rs 4,494– 1,560) in just six months, indicating a structural turnaround.

Thereby, subsequent retracement offers fresh entry opportunities from a long-term perspective.

The brokerage expects the stock to resolve above the life high of Rs 4,895 and head to Rs 5,840, as it is 150 percent external retracement of the last two months' correction(Rs 4,895–2,990), at Rs 5,847.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/covid-19-icici-direct-picks-7-resilient-stocks-that-can-weather-the-storm-do-you-own-any-5220551.html
"May 06, 2020 09:03 AM IST",1,Subhash Helgaokar,Hold Zee Entertainment; target of Rs 150: ICICI Direct,"ICICI Direct's research report on Zee EntertainmentZee Entertainment has announced that it will invest Rs 522 crore in its subsidiary, Margo Networks (80% holding), which operates under brand name SugarBox over the next couple of years.
SugarBox operates in the content delivery network and telecommunications industry.
It provides content distribution services at places of interest (POIs) such as public transport, rural areas, public places, hospitality and residential areas by installing necessary infrastructure.
OutlookHence, we remain cautious on the SugarBox investment by Zee Entertainment.
We maintain HOLD with a target price of Rs 150, valuing it at 8x FY22E P/E.","ICICI Direct recommended Hold rating on Zee Entertainment with a target price of Rs 150 in its research report dated April 15, 2020.","ICICI Direct's research report on Zee Entertainment

Zee Entertainment has announced that it will invest Rs 522 crore in its subsidiary, Margo Networks (80% holding), which operates under brand name SugarBox over the next couple of years. SugarBox operates in the content delivery network and telecommunications industry. It provides content distribution services at places of interest (POIs) such as public transport, rural areas, public places, hospitality and residential areas by installing necessary infrastructure. The customers can use the services available through SugarBox platform even without access to the internet.

Outlook

Hence, we remain cautious on the SugarBox investment by Zee Entertainment. Zee's inventory and related party receivables remain high. We maintain HOLD with a target price of Rs 150, valuing it at 8x FY22E P/E.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-zee-entertainment-target-of-rs-150-icici-direct-5228061.html
"May 05, 2020 03:05 PM IST",1,Sandip Das,Graphite India share price jumps 3% on resumption of operations,"The share price of Graphite India was up almost 3 percent in the afternoon trade on May 5 after the company resumed manufacturing.
The company started partial operations at its graphite electrode plant in Durgapur, West Bengal, impervious graphite equipment plant in Ambad and GRP plant in Gonde, (both in Nashik, Maharashtra, it told the exchanges.
The local management of Graphite Cova GmbH German group of companies, (our wholly owned subsidiaries in Germany) has also decided to operate the speciality and coating operations in the plant,"" it added.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyAccording to Moneycontrol SWOT Analysis powered by Trendlyne, Graphite India has zero promoter pledge with low debt and has been effectively using its capital to generate profit.","The stock was trading with volumes of 148,564 shares, compared to its five-day average of 102,728, an increase of 44.62 percent.","The share price of Graphite India was up almost 3 percent in the afternoon trade on May 5 after the company resumed manufacturing.

The company started partial operations at its graphite electrode plant in Durgapur, West Bengal, impervious graphite equipment plant in Ambad and GRP plant in Gonde, (both in Nashik, Maharashtra, it told the exchanges.

""The company is taking adequate measures to protect the manpower deployed at all its plants.) The local management of Graphite Cova GmbH German group of companies, (our wholly owned subsidiaries in Germany) has also decided to operate the speciality and coating operations in the plant,"" it added.

The stock, which has jumped 41 percent in the last one month, was quoting at Rs 208.00, up Rs 6, or 2.97 percent, at 1448 hours.

The stock witnessed a spurt in volume by more than 1.82 times and was trading with volumes of 148,564 shares, compared to its five-day average of 102,728 shares, an increase of 44.62 percent.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

According to Moneycontrol SWOT Analysis powered by Trendlyne, Graphite India has zero promoter pledge with low debt and has been effectively using its capital to generate profit.",https://www.moneycontrol.com/news/business/stocks/graphite-india-share-price-jumps-3-on-resumption-of-operations-5224571.html
"May 06, 2020 09:52 AM IST",1,,NIIT Tech's strengths come to the rescue in tough times,"NIIT Tech should definitely be a part of investor's shopping list and we would recommend adding on every market correction.
@moneycontrolcom Madhuchanda Dey",NIIT Tech should definitely be a part of investor's shopping list and we would recommend adding on every market correction.,"NIIT Tech should definitely be a part of investor's shopping list and we would recommend adding on every market correction.

@moneycontrolcom Madhuchanda Dey",https://www.moneycontrol.com/news/business/moneycontrol-research/niit-techs-strengths-come-to-the-rescue-in-tough-times-5227661.html
"May 06, 2020 09:03 AM IST",1,Subhash Helgaokar,Hold IndusInd Bank; target of Rs 500: ICICI Direct,"ICICI Direct's research report on IndusInd BankSlippages run rate continued to remain elevated at Rs 2058 crore in Q4FY20 vs. Rs 1945 crore in Q3FY20.
Of this, Rs 1184 crore, was pertaining to three major accounts – a power/paper group, a tea group, a medical equipment group and a broking company.
Write-off was at Rs 843 crore, including Rs 470 crore related to a large NBFC classified as NPA.
OutlookHence, we value the stock at 0.9x FY22E ABV to arrive at a target price of Rs 500.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.","ICICI Direct recommended Hold rating on IndusInd Bank with a target price of Rs 500 in its research report dated April 28, 2020.","ICICI Direct's research report on IndusInd Bank

Slippages run rate continued to remain elevated at Rs 2058 crore in Q4FY20 vs. Rs 1945 crore in Q3FY20. Of this, Rs 1184 crore, was pertaining to three major accounts – a power/paper group, a tea group, a medical equipment group and a broking company. Write-off was at Rs 843 crore, including Rs 470 crore related to a large NBFC classified as NPA. Asset quality witnessed deterioration with GNPA ratio increasing ~27 bps QoQ to 2.45%.

Outlook

Hence, we value the stock at 0.9x FY22E ABV to arrive at a target price of Rs 500. We maintain our HOLD rating on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/hold-indusind-bank-target-of-rs-500-icici-direct-5228071.html
"May 05, 2020 03:30 PM IST",2,Subhash Helgaokar,Buy Infosys; target of Rs 750: ICICI Direct,"ICICI Direct's research report on InfosysInfosys reported a poor set of Q4FY20 numbers mainly due to Covid-19 related challenges.
The company lost ~US$30 million revenues due to Covid-19 of which majority was due to supply led concerns.
Margins dipped 80 bps due to dip in utilisation (impact of 90 bps), CSR (50 bps), visa cost (40 bps) offset by rupee depreciation (50 bps) and cost efficiency (50 bps).
Digital revenues continue to be strong (up 29.6% YoY and constitute 41.9% of overall revenues).
We remain positive on the stock and maintain our BUY rating with a target price of Rs 750/share.","ICICI Direct is bullish on Infosys has recommended buy rating on the stock with a target price of Rs 750 in its research report dated April 21, 2020.","ICICI Direct's research report on Infosys

Infosys reported a poor set of Q4FY20 numbers mainly due to Covid-19 related challenges. The company lost ~US$30 million revenues due to Covid-19 of which majority was due to supply led concerns. The revenue decline was across geographies and across vertical except manufacturing & other vertical. Margins dipped 80 bps due to dip in utilisation (impact of 90 bps), CSR (50 bps), visa cost (40 bps) offset by rupee depreciation (50 bps) and cost efficiency (50 bps). The company has won US$1.6 billion deals (up 5.1% YoY) of which 56% are net new deals. The deals won are across geographies and verticals. Digital revenues continue to be strong (up 29.6% YoY and constitute 41.9% of overall revenues). The company expects digital technologies to pick up pace post the Covid-19 crisis.

Outlook

The company has shown a visible improvement in performance since the change in management. We expect Infosys to continue to make steady improvement in financials post these near-term challenges. Digital acceleration, large deal wins vendor consolidation and cost rationalisation remains key long term drivers. Further, the company has maintained healthy cash flow generation and has a consistent dividend payout policy. We remain positive on the stock and maintain our BUY rating with a target price of Rs 750/share.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

",https://www.moneycontrol.com/news/business/stocks/buy-infosys-target-of-rs-750-icici-direct-5223551.html
"May 05, 2020 09:39 AM IST",1,Rakesh Patil,"Marico share price gains 5% despite weak Q4 nos; Jefferies maintains buy, target Rs 400","Marico share price gained 5 percent in the early trade on May 5 despite company having posted a weak set of numbers for the quarter ended in March.
Domestic revenue in Q4 declined 7.6 percent to Rs 1,146 crore and international business degrew by 5.1 percent to Rs 350 crore YoY.
Also Read - Marico Q4 profit falls over 50% to Rs 199 crore, but margin expands on lower input costsJefferiesJefferies has maintained buy call with a target at Rs 400 per share, reported CNBC-TV18.
Kotak Institutional EquitiesKotak Institutional Equities has maintained buy rating with a target at Rs 350 per share, reported CNBC-TV18.
Credit SuisseCredit Suisse has maintained neutral call on the stock and kept target at Rs 295 per share, reported CNBC-TV18.","Domestic revenue in Q4 declined 7.6 percent to Rs 1,146 crore and international business degrew by 5.1 percent to Rs 350 crore YoY.","Marico share price gained 5 percent in the early trade on May 5 despite company having posted a weak set of numbers for the quarter ended in March.

The company, on May 4, reported a massive 50.6 percent year-on-year (Y0Y) fall in consolidated profit to Rs 199 crore versus profit of Rs 403 crore.

There was an exceptional loss of Rs 10 crore during the quarter.

Domestic revenue in Q4 declined 7.6 percent to Rs 1,146 crore and international business degrew by 5.1 percent to Rs 350 crore YoY.

Earnings before interest, tax, depreciation and amortisation (EBITDA) declined 4.1 percent year-on-year to Rs 282 crore in the quarter ended March 2020.

Also Read - Marico Q4 profit falls over 50% to Rs 199 crore, but margin expands on lower input costs

Jefferies

Jefferies has maintained buy call with a target at Rs 400 per share, reported CNBC-TV18.

The Q4 was expectedly weak on topline, while margin beat drives a positive earnings surprise.

The current utilisation is at 75 percent signals a gradual stabilization.

The company expects copra price deflation which improves FY21 margin visibility and the stock offers attractive risk-reward & remains one of the top picks.

Jeffries revise up FY21 EPS forecast as it factor in higher margin.

Kotak Institutional Equities

Kotak Institutional Equities has maintained buy rating with a target at Rs 350 per share, reported CNBC-TV18.

The company continue to find the risk-reward balance attractive. The Q4 print was decent in context of COVID-led disruption.

The research house trim the FY21-22 earnings estimates by 2-4 percent.

Credit Suisse

Credit Suisse has maintained neutral call on the stock and kept target at Rs 295 per share, reported CNBC-TV18.

The India business was supported by Saffola, which grew 25 percent.

There was a steep decline in parachute & value-added hair oils. The advertisement spends is likely to be 100 bps lower in FY21.

The overall FY21 EBITDA margin is likely to be flat YoY and cut FY21-22 earnings by 1 percent, said Credit Suisse.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

At 09:18 hrs Marico was quoting at Rs 300.60, up Rs 16.20, or 5.70 percent on the BSE.",https://www.moneycontrol.com/news/business/stocks/marico-share-price-gains-5-despite-weak-q4-nos-jefferies-maintains-buy-target-rs-400-5222441.html
"May 04, 2020 06:33 PM IST",-2,Abhishek Shingare,Vinati Organics Q4 PAT may dip 19.4% YoY to Rs. 54 cr: HDFC Securities,"HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector.
The brokerage house expects Vinati Organics to report net profit at Rs.
Net Sales are expected to decrease by 10.8 percent Y-o-Y (down 28.3 percent Q-o-Q) to Rs.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 17.1 percent Y-o-Y (down 42.5 percent Q-o-Q) to Rs.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.","Net Sales are expected to decrease by 10.8 percent Y-o-Y (down 28.3 percent Q-o-Q) to Rs. 213 crore, according to HDFC Securities.","HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector. The brokerage house expects Vinati Organics to report net profit at Rs. 54 crore down 19.4% year-on-year (down 34.7% quarter-on-quarter).

Net Sales are expected to decrease by 10.8 percent Y-o-Y (down 28.3 percent Q-o-Q) to Rs. 213 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 17.1 percent Y-o-Y (down 42.5 percent Q-o-Q) to Rs. 69 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/vinati-organics-q4-pat-may-dip-19-4-yoy-to-rs-54-cr-hdfc-securities-5220211.html
"May 05, 2020 07:19 AM IST",2,Nishant Kumar,"Hot Stocks | Glaxo Pharma, M&M, Tata Comm three buy ideas for short term","In the April 2020 series, Nifty surged 14 percent, the highest in a decade.
This was the highest series to series gain since May 2009.
Though Nifty fell sharply yesterday, it is still trading above its 20-day SMA which is placed at 9,015 levels.
On the daily chart, the stock price is taking support at 20-day SMA.
On the weekly chart also, the stock price has broken out from the downward sloping trendline.",Use this sharp correction to accumulate long positons with SL of 8900 immediate resistance is seen around 9400 levels.,"Nandish Shah

Nifty plunged 566 points, or 5.74 percent, reacting to the last two days of weak global cues, and closing at 9,294 on May 4.

This is the highest single-day fall in percentage terms since March 23, the day on which Nifty made the lowest low on the closing basis during this downtrend.

From the bottom of 7,511, registered on March 24, 2020, Nifty has risen more than 31 percent to the high of 9,889 made last Thursday.

In the April 2020 series, Nifty surged 14 percent, the highest in a decade. This was the highest series to series gain since May 2009.

Though Nifty fell sharply yesterday, it is still trading above its 20-day SMA which is placed at 9,015 levels. This also coincides with the support of 8,980, which happens to be 38.2 percent retracements of the entire rise seen from 7,511 to 9,889.

The derivative market is also pointing towards the limited downside. On the derivatives front, we have seen put writing at 9,000 levels.

Moreover, lower stock futures open interest, lower leveraged positions despite 14 percent rise in the Nifty in the April series, lower open interest in the Nifty futures in terms of the number of shares (Nifty Futures OI is at fifteen-year low) and long rollover by FIIs in the index futures segment indicates that downside is limited in the market and derivative positions are not likely to be a milestone around the neck of the market.

Therefore, we believe that 8,950-9,000 levels will act as strong support, going forward.

Use this sharp correction to accumulate long positons with SL of 8900 immediate resistance is seen around 9400 levels.

Resistance was seen around 9,970 levels, which happened to be the 50 percent retracement of the entire downswing seen from 12,430 to 7,511.

To sum it up, we believe that though Nifty has fallen sharply it has not violated any important support levels.

Any correction from hereon on the back of weak global cues is a buying opportunity for the traders, we believe.

Therefore, our advice is to accumulate long positions in the Nifty with the stop loss of 8,900 levels. On the higher side 9,390 level would act as immediate resistance. Resistance is seen at 9,730 and 9,970 levels.

Here are three buy recommendations for the next 3-4 weeks:

GlaxoSmithKline Pharmaceuticals | Buy | LTP: Rs 1,483.30 | Target price: Rs 1,600 | Stop loss: Rs 1,410 | Upside: 8%

After taking support at 200-day SMA for multiple times, the stock price has broken out on the daily chart to close at three months high.

Oscillators like RSI and MFI are forming positive divergence on the daily chart. MACD line is placed above the central line Indicating bullish setup for the stock.

Mahindra & Mahindra (M&M) | Buy | LTP: Rs 361.10 | Target price: Rs 390 | Stop loss: Rs 340 | Upside: 8%

The stock has recovered more than 5 percent from the lows yesterday by taking support at the upward sloping trendline adjoining the lows of March 25 and April 28, 2020, with higher volumes.

On the daily chart, the stock price is taking support at 20-day SMA.

RSI and MFI oscillators are forming positive divergence favouring the bulls.

Tata Communications | Buy | LTP: Rs 472.05 | Target price: Rs 520 | Stop loss: Rs 450 | Upside: 10%

The stock price has broken out on the daily chart by closing above the double top resistance level of Rs 455 with higher volumes to close at three year high.

On the weekly chart also, the stock price has broken out from the downward sloping trendline.

The stock is trading above all its important moving averages.

(The author is a technical research analyst at HDFC Securities)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-glaxo-pharma-mm-tata-comm-three-buy-ideas-for-short-term-5220601.html
"May 05, 2020 01:17 PM IST",-2,Abhishek Shingare,Alkyl Amines Q4 PAT may dip 14.2% YoY to Rs. 26 cr: HDFC Securities,"HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector.
The brokerage house expects Alkyl Amines to report net profit at Rs.
Net Sales are expected to decrease by 15.4 percent Y-o-Y (down 8.5 percent Q-o-Q) to Rs.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 39.3 percent Y-o-Y (up 14.8 percent Q-o-Q) to Rs.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.","Net Sales are expected to decrease by 15.4 percent Y-o-Y (down 8.5 percent Q-o-Q) to Rs. 217 crore, according to HDFC Securities.","HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector. The brokerage house expects Alkyl Amines to report net profit at Rs. 26 crore down 14.2% year-on-year (up 50.8% quarter-on-quarter).

Net Sales are expected to decrease by 15.4 percent Y-o-Y (down 8.5 percent Q-o-Q) to Rs. 217 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 39.3 percent Y-o-Y (up 14.8 percent Q-o-Q) to Rs. 44 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/earnings/alkyl-amines-q4-pat-may-dip-14-2-yoy-to-rs-26-cr-hdfc-securities-5223971.html
"May 04, 2020 04:12 PM IST",-2,Sunil Matkar,"Kalpataru Power terminates sale of stake in Alipurduar Transmission, stock falls 4%","Shares of Kalpataru Power Transmission fell around 4 percent on May 4 after the company terminated its agreement to sell stake in a subsidiary.
""The transaction contemplated as per SPSA viz.
sale of a stake of Alipurduar Transmission held by the company to CLP India, will not materialize due to termination of SPSA,"" it added.
The Share Purchase and Shareholders Agreement for sale of a stake in a subsidiary Alipurduar Transmission was executed amongst the Kalpataru Power, its subsidiary and CLP India on July 3 last year.
Download a copyOn the BSE, the stock closed at Rs 218.85, down 3.91 percent while on the NSE, it was down percent at Rs 219.45.","Company had executed contract for stake sale in subsidiary with CLP India on July 3 last year,","Shares of Kalpataru Power Transmission fell around 4 percent on May 4 after the company terminated its agreement to sell stake in a subsidiary.

""Certain conditions precedent, as per terms of the Share Purchase and Shareholders Agreement (SPSA), could not be achieved and the company has served a notice of termination on May 1, 2020 to terminate the SPSA and accordingly SPSA stands terminated,"" company said in its BSE filing on May 3.

""The transaction contemplated as per SPSA viz. sale of a stake of Alipurduar Transmission held by the company to CLP India, will not materialize due to termination of SPSA,"" it added.

The Share Purchase and Shareholders Agreement for sale of a stake in a subsidiary Alipurduar Transmission was executed amongst the Kalpataru Power, its subsidiary and CLP India on July 3 last year.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

On the BSE, the stock closed at Rs 218.85, down 3.91 percent while on the NSE, it was down percent at Rs 219.45.",https://www.moneycontrol.com/news/business/markets/kalpataru-power-terminates-sale-of-stake-in-alipurduar-transmission-stock-falls-4-5219581.html
"May 05, 2020 09:32 AM IST",1,Rakesh Patil,"RIL share price up nearly 2% as CLSA maintains buy, target Rs 1,770","Reliance Industries (RIL) share price rose nearly 2 percent in the early trade on May 5 as research house CLSA has maintained buy call on the stock with a target at Rs 1,770 per share.
Another stake sale in Jio and progress in InvIT stake sale are the major triggers, while Aramco deal was one of the major triggers as well, it added.
At 09:24 hrs Reliance Industries was quoting at Rs 1,450.35, up Rs 14.95, or 1.04 percent on the BSE.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copy: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",According to CLSA the investment by Facebook & Silver Lake should help to positiion Jio as a tech major.,"Reliance Industries (RIL) share price rose nearly 2 percent in the early trade on May 5 as research house CLSA has maintained buy call on the stock with a target at Rs 1,770 per share.

According to CLSA, the investment by Facebook & Silver Lake should help to positiion Jio as a tech major.

The company should achieve its target to bring down net debt by Rs 1.5 lakh crore, it said.

Another stake sale in Jio and progress in InvIT stake sale are the major triggers, while Aramco deal was one of the major triggers as well, it added.

Also Read - Reliance Jio-Silver Lake deal boosts confidence; experts see re-rating of stock

The company has reported a consolidated March quarter profit at Rs 6,348 crore, dropped 45.5 percent due to the slump in oil prices triggered by coronavirus but an impressive 72.7 percent sequential growth by Jio Platforms limited the decline.

At 09:24 hrs Reliance Industries was quoting at Rs 1,450.35, up Rs 14.95, or 1.04 percent on the BSE.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/ril-share-price-up-nearly-2-as-clsa-maintains-buy-target-rs-1770-5222671.html
"May 04, 2020 03:14 PM IST",-2,Sandip Das,"D-Street Buzz: Over 450 stocks hit lower circuit on BSE; SpiceJet, Future Retail top losers","The top losers included ICICI Bank, Bajaj Finance, IndusInd Bank, HDFC and Axis Bank which fell 9-11 percent.
The most active shares on NSE included Reliance Industries, Bharti Airtel, Hindustan Unilever, Bajaj Finance and Axis Bank among others.
461 stocks hit lower circuit on BSE including names like AU Small Finance Bank, SpiceJet, Future Retail, Edelweiss Financial and Jubilant Lifesciences.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copy: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.","461 stocks hit lower circuit on BSE including names like AU Small  Finance Bank, SpiceJet, Future Retail, Edelweiss Financial and Jubilant Lifesciences.","The Indian stock market tumbled on May 4 after the government extended the lockdown for another two weeks in an attempt the arrest the spread of coronavirus.

Sensex is down 1,963.87 points or 5.82% at 31753.75, and the Nifty down 558.80 points or 5.67% at 9301.10.

If the index breaks its next crucial supports 9,300-9,200 levels then there could be further selling pressure and index may fall below 9,000 also, experts feel.

All sectoral indices barring the pharma space are trading in the red with banks and auto stocks taking the maximum hit.

The top losers included ICICI Bank, Bajaj Finance, IndusInd Bank, HDFC and Axis Bank which fell 9-11 percent.

The most active shares on NSE included Reliance Industries, Bharti Airtel, Hindustan Unilever, Bajaj Finance and Axis Bank among others.

119 stocks have hit new 52-week low on BSE including names like JM Financial, Bank of Baroda, Chalet Hotels and Godrej Industries among others.

461 stocks hit lower circuit on BSE including names like AU Small Finance Bank, SpiceJet, Future Retail, Edelweiss Financial and Jubilant Lifesciences.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-over-450-stocks-hit-lower-circuit-on-bse-spicejet-future-retail-top-losers-5219301.html
"May 05, 2020 01:22 PM IST",2,Sunil Matkar,Brokerages see over 50% upside in this PSU stock given its strong balance sheet; do you own it?,"After hitting a four-year low in March, when the market rallied in April, many PSU stocks participated.
Power plant equipment manufacturer BHEL has gained 16 percent from its March lows, outperforming peers like ABB India (up 1.8 percent), Siemens (up 9.4 percent), etc.
The rally was after the stock lost 71 percent in the last year.
Brokerages are bullish on the stock and expect the stock to rally up to 74 percent given the strong balance sheet, favourable risk-reward ratio after steep correction, and approach to attract foreign players for using its plants.
BHEL is India's largest & undisputed leader amongst Indian power plant equipment manufacturers.",Brokerages have a positive view on the stock with a target price of Rs 41 (upside potential of 74.5 percent) in medium to long term.,"After hitting a four-year low in March, when the market rallied in April, many PSU stocks participated.

Around 49 percent of stocks have gained more than 20 percent till date from March lows, while 45 percent stocks have gained 1-20 percent during the same period.

Power plant equipment manufacturer BHEL has gained 16 percent from its March lows, outperforming peers like ABB India (up 1.8 percent), Siemens (up 9.4 percent), etc. The rally was after the stock lost 71 percent in the last year.

Brokerages are bullish on the stock and expect the stock to rally up to 74 percent given the strong balance sheet, favourable risk-reward ratio after steep correction, and approach to attract foreign players for using its plants.

In an interesting development on May 4, BHEL has called for Expression of Interest (EOI) from foreign companies who wish to use its currently idle factories for manufacturing from India.

Emkay feels this could be a win-win situation for both - the foreign company and BHEL. The partnership can shorten the time to set up manufacturing facility for the incoming partner while also helping BHEL utilize its idle factories and employees.

""With BHEL offering a readymade solution in the form of factories, staff as well as pre-set vendor base and supply chain, this can open up several possibilities for BHEL in the longer term if handled well, in our view,"" said the brokerage while maintaining buy/overweight on the stock in sector Emkay Alpha Portfolio, with a target of Rs 37 (upside potential of 57.4 percent)

With power sector demand still struggling, this is a significant diversification move for BHEL, it feels. ""India has so far lagged in grabbing a share of the global supply chain shift from China to other emerging markets. One of the key reasons for this underperformance is a lack of a readymade land bank, delay in approvals, and fear of dealing with Indian bureaucracy.""

Globe Capital said as the ongoing economic disruption across the world due to COVID-19 has highlighted the dangers of manufacturing activities being concentrated in a single location, the need for diversification of supply chains & manufacturing has thrown up a huge opportunity for India which is one of the fastest-growing economies in the world and an attractive investment destination.

The government launched Make in India campaign in 2014 with the primary goal of making India a global manufacturing hub and also announced a lot of measures in terms of tax rates to attract foreign companies in 2019.

Emkay believes it is too early to comment on how much value this could add for BHEL as even in the most optimistic scenario, the first revenue contribution from such partnership will materialize only after 12-18 months.

However, it believes that the stock offers an attractive risk-reward profile with its current market cap at Rs 7,200 crore as against FY19 net cash of Rs 5,000 crore. ""BHEL's net cash position (now around 70 percent of market cap) and receivable book of around Rs 38,000 crore (5x market cap) thus provide strong valuation support.""

Globe Capital also maintained a positive view on the stock with the target price of Rs 41 (upside potential of 74.5 percent) in medium to long term as the steep stock price correction coupled with strong balance sheet strength and long term potential make for an earning upgrade, though there would be a near-term weakness with slow orders and bulging receivables.

BHEL is India's largest & undisputed leader amongst Indian power plant equipment manufacturers. It is a single source of multiple solutions for energy, industry and infrastructure segments. It is the largest contributor to the country's installed generation capacity with more than 53 percent share.

The company has 16 manufacturing units, 8 service centres. It is the second largest employer in the Indian capital goods industry. The worldwide installed base of power generating equipment supplied by the company has exceeded 185 GW.

BHEL has a healthy order book of around Rs 1,09,000 crore for execution in 2019-20 and beyond. During the year, the company booked the highest-ever N4 orders in its transportation business segment and spares and services electric locomotive to Indian Railways.

In overseas markets, despite challenging circumstances, BHEL has secured 50 orders for projects, products, systems and services from 17 countries in the current fiscal.

Attractive dividend yield of around 8.91 percent; emerging business opportunities in e-mobility segment, EV chargers, electric buses, water treatment plant, sewage treatment plant etc; and government's focus on '24x7 Power for all' are some of key triggers highlighted by Globe Capital.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/brokerages-see-over-50-upside-in-this-psu-stock-given-its-strong-balance-sheet-do-you-own-it-5220941.html
"May 05, 2020 11:38 AM IST",-1,Sunil Matkar,Cummins India share price down 2% on Jefferies downgrades,"Diesel and natural gas engines manufacturer Cummins India share price fell nearly 2 percent intraday after Jefferies downgraded rating on the stock to “underperform” from “hold”, citing a further drop in exports.
The global brokerage house also cut price target to Rs 320 from Rs 435.
Excess supply and weak domestic demand will imply continue price competition while unlisted subsidiaries are likely to take away new opportunities,"" said the brokerage.
Jefferies feels further de-rating is on the cards as medium-term return on equity dropped below 15 percent.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.",The brokerage also cut the target price and has said further de-rating is on the cards.,"Diesel and natural gas engines manufacturer Cummins India share price fell nearly 2 percent intraday after Jefferies downgraded rating on the stock to “underperform” from “hold”, citing a further drop in exports.

The global brokerage house also cut price target to Rs 320 from Rs 435.

""The company's exports could further drop post the FY20 decline. Excess supply and weak domestic demand will imply continue price competition while unlisted subsidiaries are likely to take away new opportunities,"" said the brokerage.

Jefferies feels further de-rating is on the cards as medium-term return on equity dropped below 15 percent.

The stock was trading at Rs 372.20, down 0.21 percent on the NSE at 1109 hours. It has lost 5 percent in the last one week and 40 percent since the last week of January this year.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/cummins-india-share-price-down-2-on-jefferies-downgrades-5223511.html
"May 05, 2020 11:38 AM IST",1,Sandip Das,"D-Street Buzz: Oil & gas stocks rise led by ONGC, HPCL; RIL top index contributor","The oil & gas space is the outperforming sector, up over 2 percent led by gains from HPCL and ONGC which jumped over 5 percent each followed by Reliance Industries, BPCL and Indian Oil Corporation.
ONGC and Reliance Industries are two of the top Sensex gainers with RIL being the most active stocks in NSE in terms of value as 93,58,471 stocks traded on May 5.
ONGC on the other hand was one of the most active stocks in terms of volumes on NSE with 2,96,50,342 shares being traded.
Global research firm has a buy call on Reliance Industries with target at Rs 1,770 per share.
Reliance Industries should achieve its target to bring down net debt by Rs 1.5 lakh crore, it added.","ONGC and Reliance Industries are two of the top Sensex gainers with RIL being the most active stocks in NSE in terms of value as 93,58,471 stocks traded on May 5.","The Indian stock market rebounded on May 5 following global cues with Sensex jumping 283.70 points or 0.89 percent at 31999.05, and the Nifty gained 84.20 points or 0.91 percent at 9377.70.

The oil & gas space is the outperforming sector, up over 2 percent led by gains from HPCL and ONGC which jumped over 5 percent each followed by Reliance Industries, BPCL and Indian Oil Corporation.

Oil prices climbed in early trade on Tuesday, adding to gains in the previous session, on expectations that fuel demand will begin to pick up as some US states and nations in Europe and Asia start to ease coronavirus lockdown measures, a Reuters report said.

ONGC and Reliance Industries are two of the top Sensex gainers with RIL being the most active stocks in NSE in terms of value as 93,58,471 stocks traded on May 5.

ONGC on the other hand was one of the most active stocks in terms of volumes on NSE with 2,96,50,342 shares being traded.

Global research firm has a buy call on Reliance Industries with target at Rs 1,770 per share. It is of the view that investments by Facebook and Silver Lake should help positiion Jio as a tech major. Reliance Industries should achieve its target to bring down net debt by Rs 1.5 lakh crore, it added.

Technical Analyst Sameet Chavan of Angel Broking gas a buy on ONGC with target price at Rs 92. He is of the view that the stock after marking a low around Rs 46, witnessed a decent recovery and in the process, managed to confirm a breakout from the ‘Symmetrical Triangle' pattern.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-oil-ril-top-index-contributor-5223411.html
"May 04, 2020 05:08 PM IST",1,Ritesh Presswala,"Jio's valuation is 1.7 times higher than its peers, dwarfs some key sectors","Since its launch three years ago, Jio Platforms has grown at a tremendous pace to become India India's largest telecom company.
Telecom: Within the telecom space, Reliance Jio's valuation is almost 1.7 times higher than the combined market capitalisation of Bharti Airtel and Vodafone Idea.
The Silver Lake investment values Jio Platforms among the top five listed companies in India by m-cap.
Reliance Jio's valuation is greater than that of BSE IT Index companies, excluding TCS and Infosys.
Reliance Jio's current valuation is greater than that of 23 TECK companies, excluding TCS, Infosys, Bharti Airtel and HCL Technologies.","Jio Platforms has grown at a tremendous pace to become India India's largest telecom company. Looking at its growth in valuation, let us see how some of the major Indian telecom, IT, and Sensex companies stand up in comparison","American private equity giant Silver Lake will invest Rs 5,655.75 crore in Jio Platforms, the digital unit of Reliance Industries, for a one percent stake. This investment values Jio Platforms at Rs 4.90 lakh crore, a 12.5 percent premium to that paid by Facebook on April 22 for a 9.9 percent stake (Rs 43,574 crore).

Since its launch three years ago, Jio Platforms has grown at a tremendous pace to become India India's largest telecom company. Looking at its growth in valuation, let us see how some of the major Indian telecom, IT, and Sensex companies stand up in comparison.

Telecom: Within the telecom space, Reliance Jio's valuation is almost 1.7 times higher than the combined market capitalisation of Bharti Airtel and Vodafone Idea. In terms of subscribers, Jio is leading the pack with over 388 million users.

The Silver Lake investment values Jio Platforms among the top five listed companies in India by m-cap. The top four companies by m-cap are Reliance Industries (RIL), Tata Consultancy Services (TCS), Hindustan Unilever (HUL) and HDFC Bank

Silver Lake is the global leader in large-scale technology investing. Its mission is to build and grow great companies by partnering with world-class management teams. Reliance Jio's valuation is greater than that of BSE IT Index companies, excluding TCS and Infosys.

Reliance Jio's current valuation is greater than that of 23 TECK companies, excluding TCS, Infosys, Bharti Airtel and HCL Technologies. The S&P TECK index includes media, IT, and telecom.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd)",https://www.moneycontrol.com/news/business/markets/jios-valuation-1-7-times-higher-than-its-peers-even-stand-higher-than-key-sectors-5218441.html
"May 05, 2020 01:12 PM IST",-2,Abhishek Shingare,Galaxy Surfactants Q4 PAT may dip 6.6% YoY to Rs. 45 cr: HDFC Securities,"HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector.
45 crore down 6.6% year-on-year (down 21.5% quarter-on-quarter).
Net Sales are expected to decrease by 5.7 percent Y-o-Y (down 13.5 percent Q-o-Q) to Rs.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 4.5 percent Y-o-Y (down 17.7 percent Q-o-Q) to Rs.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.","Net Sales are expected to decrease by 5.7 percent Y-o-Y (down 13.5 percent Q-o-Q) to Rs. 590 crore, according to HDFC Securities.","HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector. The brokerage house expects Galaxy Surfactants to report net profit at Rs. 45 crore down 6.6% year-on-year (down 21.5% quarter-on-quarter).

Net Sales are expected to decrease by 5.7 percent Y-o-Y (down 13.5 percent Q-o-Q) to Rs. 590 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 4.5 percent Y-o-Y (down 17.7 percent Q-o-Q) to Rs. 78 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/earnings/galaxy-surfactants-q4-pat-may-dip-6-6-yoy-to-rs-45-cr-hdfc-securities-5223911.html
"May 05, 2020 11:16 AM IST",-2,Sunil Matkar,AU Small Finance Bank locked at lower circuit for 2nd straight session after Nomura downgrade,"Shares of AU Small Finance Bank were locked in 5 percent lower circuit for the second consecutive session on May 5 after Japanese brokerage firm Nomura downgraded its rating to 'neutral' from 'buy' earlier.
The research firm also slashed price target significantly by 53 percent to Rs 500 from Rs 1,065 per share earlier as AU SFB traded at a significant premium to peer small finance banks and banks like ICICI Bank.
The stock was trading at Rs 490.75, down Rs 25.80 or 4.99 percent on the BSE at 10:53 hours.
AU Small Finance Bank's profit has grown at a muted rate of 3 percent YoY on the back of the strong provision for COVID-19 taken for Rs 151 crore.
But while maintaining buy call on the stock with a revised target of Rs 675, Motilal Oswal feels AU Small Finance Bank has reported a steady operating performance, though COVID-19 provisions have dented earnings.","Its loan growth has declined from 40 percent range, it has grown at a muted rate of 3 percent QoQ, mainly driven by the retail segment.","Shares of AU Small Finance Bank were locked in 5 percent lower circuit for the second consecutive session on May 5 after Japanese brokerage firm Nomura downgraded its rating to 'neutral' from 'buy' earlier.

The research firm also slashed price target significantly by 53 percent to Rs 500 from Rs 1,065 per share earlier as AU SFB traded at a significant premium to peer small finance banks and banks like ICICI Bank.

The stock was trading at Rs 490.75, down Rs 25.80 or 4.99 percent on the BSE at 10:53 hours. It was down 5 percent in the previous session too, especially after weak quarterly earnings.

""Near-term challenges outweighed long-term opportunity, while the company has few levers in terms of capital raise/stake sale in Aavas,"" the brokerage said.

AU Small Finance Bank's profit has grown at a muted rate of 3 percent YoY on the back of the strong provision for COVID-19 taken for Rs 151 crore. Net interest income has remained muted at 9 percent QoQ on the back of a slowdown in AUM growth of 3 percent QoQ.

Its loan growth has declined from 40 percent range, it has grown at a muted rate of 3 percent QoQ, mainly driven by the retail segment. The NIM has remained stable on the back of the decline in the incremental cost of funds.

The cost to income ratio stood elevated on the back of higher operating expenses which management has guided to taper down going forward. Gross non-performing assets (NPA) declined by 18 bps to 1.7 percent and net NPA fell by 21 bps to 0.8 percent QoQ during the quarter.

""We remain cautious on the asset quality front on the back of COVID-19 lockdown going ahead. As of April 2020, it has Rs 2,300 crore of the portfolio at stage 2, so we expect credit cost to remain elevated in the FY21,"" Narnolia Financial Advisors said.

The brokerage has reduced its FY21 estimates by 20 percent majorly on the back of overall slow down in the auto industry and higher provisioning on the back of rising default in the COVID-19 situation. It also decreased the price target to Rs 555 while having a neutral call on the stock.

But while maintaining buy call on the stock with a revised target of Rs 675, Motilal Oswal feels AU Small Finance Bank has reported a steady operating performance, though COVID-19 provisions have dented earnings.

""The bank has reported robust asset quality ratios; however, collection efficiency has declined due to the lockdown. AU SFB disclosed that moratorium has been availed for 25 percent of the loan book. Deposit growth has held strong, enabling the bank to maintain strong surplus liquidity and LCR of 133 percent, among other measures,"" the brokerage said.

Motilal Oswal estimated loan growth trends to remain soft at 15 percent in FY21 (20 percent AUM growth), while credit cost would increase to 1.7 percent in FY21, as it built in higher slippages, driving an 18/10 percent cut in FY21/FY22 earnings estimates.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/au-small-finance-bank-locked-at-lower-circuit-for-2nd-straight-session-after-nomura-downgrade-5223381.html
"May 05, 2020 10:45 AM IST",-2,Abhishek Shingare,Navin Fluorine Q4 PAT may dip 14.7% YoY to Rs. 35 cr: HDFC Securities,"HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector.
The brokerage house expects Navin Fluorine to report net profit at Rs.
Net Sales are expected to increase by 6.5 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 13.1 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.","Net Sales are expected to increase by 6.5 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 268 crore, according to HDFC Securities.","HDFC Securities has come out with its second quarter (January-March' 20) earnings estimates for the Chemical sector. The brokerage house expects Navin Fluorine to report net profit at Rs. 35 crore down 14.7% year-on-year (up 9.9% quarter-on-quarter).

Net Sales are expected to increase by 6.5 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 268 crore, according to HDFC Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 13.1 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 57 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/earnings/navin-fluorine-q4-pat-may-dip-14-7-yoy-to-rs-35-cr-hdfc-securities-5222741.html
"May 05, 2020 09:48 AM IST",1,Sandip Das,ICICI Bank share price up 3% after Board considers raising funds via debt,"The share price of ICICI Bank jumped 3 percent in the morning trade on May 5 after the board decided to meet on May 9 to consider raising funds via debt.
The Board of Directors will also consider the approval of the audited financial results for the quarter and year ended March 31, 2020.
According to Moneycontrol SWOT Analysis powered by Trendlyne, ICICI Bank has shown high TTM EPS growth.
The company has zero promoter pledge and has show growth in net profit with increasing profit margin (QoQ).
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","The Board of Directors will also consider the approval of the audited financial results for the quarter and year ended March 31, 2020 at its meeting to be held on May 9.","The share price of ICICI Bank jumped 3 percent in the morning trade on May 5 after the board decided to meet on May 9 to consider raising funds via debt.

""We wish to inform you that the Board of the Bank at its meeting scheduled on May 9, 2020 will raising fund by way of issuance of debt securities including non-convertible debentures/bonds/notes/offshore Certificate of Deposits in single/multiple tranches in any currency through public/private placement,"" the bank said in a filing to the exchanges.

The Board of Directors will also consider the approval of the audited financial results for the quarter and year ended March 31, 2020.

The stock, which has underperformed in the last one month, was quoting at Rs 345.15, up Rs 6.90, or 2.04 percent, at 0926 hours. The stock is one of most active on NSE, with 39,44,057 shares being traded.

The stock has been in the spotlight after it confirmed that it had exposure to Singapore-based Hin Leong Trading Pte, a top oil trading firm in the dock for its alleged failure to disclose hundreds of millions of dollars in losses over several years.

According to Moneycontrol SWOT Analysis powered by Trendlyne, ICICI Bank has shown high TTM EPS growth.

The company has zero promoter pledge and has show growth in net profit with increasing profit margin (QoQ). However, in terms of technical rating as per Moneycontrol it is bearish.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by experts on moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/icici-bank-share-price-up-3-after-board-considers-raising-funds-via-debt-5222801.html
"May 05, 2020 10:46 AM IST",2,Subhash Helgaokar,Buy IDFC First Bank; target of Rs 25: ICICI Direct,"ICICI Direct's research report on IDFC First BankIn an exchange notification, IDFC First Bank has informed exchanges that its board has approved raising of Rs 2000 crore equity capital by issuing ~86.24 crore shares through preferential route at Rs 23.19/share.
Promoter IDFC Ltd will subscribe to ~34.5 crore shares maintaining its holding at 40%.
Other investors include ICICI Prudential Life Insurance (~25.87 crore shares), HDFC Life Insurance (~8.6 crore shares), Bajaj Allianz Life Insurance (~8.6 crore shares) and Dayside Investment, an affiliated entity of Warburg Pincus (~8.07 crore shares).
Thus, we value the bank at ~0.8x FY22E ABV with a revised target price of Rs 25.
The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management.","ICICI Direct is bullish on IDFC First Bank has recommended buy rating on the stock with a target price of Rs 25 in its research report dated May 04, 2020.","ICICI Direct's research report on IDFC First Bank

In an exchange notification, IDFC First Bank has informed exchanges that its board has approved raising of Rs 2000 crore equity capital by issuing ~86.24 crore shares through preferential route at Rs 23.19/share. Promoter IDFC Ltd will subscribe to ~34.5 crore shares maintaining its holding at 40%. Other investors include ICICI Prudential Life Insurance (~25.87 crore shares), HDFC Life Insurance (~8.6 crore shares), Bajaj Allianz Life Insurance (~8.6 crore shares) and Dayside Investment, an affiliated entity of Warburg Pincus (~8.07 crore shares).

Outlook

Given the asset mix and the current lockdown scenario, trend in asset quality and management commentary on the business outlook continue to remain key monitorables. Restructuring of balance sheet underway has continued with increase in run rate of low cost deposits. Raising capital is positive for the bank as it instils confidence. However, it also delays our return ratio target. Thus, we value the bank at ~0.8x FY22E ABV with a revised target price of Rs 25. We maintain BUY recommendation.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/buy-idfc-first-bank-target-of-rs-25-icici-direct-5219821.html
"May 05, 2020 11:01 AM IST",2,Sunil Matkar,This stock rallied 60% in April but experts see another 20% upside,"This is to cater to future growth in the ARV-/ANDA-led formulations segment as well as in new molecules/market share in the API segment.
Accordingly, Motilal Oswal said it had raised EPS estimates by 12.7/5.2 percent for FY21/FY22 to factor in enhanced business prospects in the FDF/Synthesis/Other API segment.
In the Q4FY20, its revenue grew 32 percent YoY to Rs 840 crore (versus Motilal Oswal's estimates of Rs 730 crore).
Subsequently, the EBITDA margin, at 22.9 percent (versus Motilal Oswal's estimates of 20.6 percent), was up 520 bps YoY.
EBITDA came in at Rs 190 crore (versus Motilal Oswal's estimates Rs 150 crore), up 71 percent YoY.","Laurus reported a strong set of results for Q4FY2020 with PAT at Rs 109.6 crore, growing 154 percent YoY and slightly ahead of Sharekhan's estimates.","Laurus Labs share price has surged 60 percent since March 30, outperforming Nifty Pharma index (up 35 percent) as well as Nifty50 (up 19 percent).

Brokerages expect another 18-20 percent upside in the stock on the back of increased focus on pharma post-COVID-19, lack of participation in the previous bull run, strong earnings and expected in-licensing opportunity from Remdesivir.

""Given the strong topline growth prospects, visibility on earnings, healthy return ratios and low debt-equity ratio would support the multiple expansions. We maintain positive view on Laurus Labs and expect 18-20 percent potential upside,"" Sharekhan said.

Laurus reported a strong set of results for Q4 FY2020 with PAT at Rs 109.6 crore, growing 154 percent YoY, slightly ahead of Sharekhan's estimates.

According to the brokerage, revenues and earnings are expected to clock a sturdy 13 / 23 percent CAGR over FY20-FY22 aided by an expected impressive performance of the formulations business followed by the custom synthesis business and ARV-API's.

""Approval of Remdesivir, the patented anti-COVID-19 drug is under trials in US and if approved could potentially benefit Laurus by way of in-licensing opportunity and would result in further earnings upgrades,"" Sharekhan said.

The United States Food and Drug Administration (USFDA) on Saturday granted emergency use authorisation (EUA) for the investigational antiviral Remdesivir of Gilead Sciences, to treat COVID-19 patients.

""We will continue to work with partners across the globe to increase our supply of Remdesivir while advancing our ongoing clinical trials to supplement our understanding of the drug's profile. We are working to meet the needs of patients, their families and healthcare workers around the world with the greatest sense of urgency and responsibility,"" Daniel O'Day, Chairman and Chief Executive Officer of Gilead Sciences said.

Motilal Oswal also reiterated buy call on the stock and raised price target to Rs 615 (from Rs 520 earlier) as it expects a 23 percent earnings CAGR, primarily led by a 22 percent sales CAGR in the finished dosage forms (FDF)/Other API segment and a 31 percent sales CAGR in the Synthesis segment over FY20–22.

Laurus Labs also ended FY20 on a robust note, with 2.3x FY19 earnings and the highest ever annual PAT at Rs 260 crore. This is attributed to growth in the formulations (FDF)/synthesis business and better operating leverage.

Laurus is in the process of further building up capacity in both the FDF and API segments. This is to cater to future growth in the ARV-/ANDA-led formulations segment as well as in new molecules/market share in the API segment.

Accordingly, Motilal Oswal said it had raised EPS estimates by 12.7/5.2 percent for FY21/FY22 to factor in enhanced business prospects in the FDF/Synthesis/Other API segment.

In the Q4FY20, its revenue grew 32 percent YoY to Rs 840 crore (versus Motilal Oswal's estimates of Rs 730 crore). Revenue was led by FDF (32 percent sales), which surged to Rs 270 crore from Rs 28.2 crore YoY, primarily owing to traction in LMIC (low-and middle-income countries), North America, and the European Union.

Other API (which contributed 11 percent of sales) increased 33 percent YoY to Rs 98.9 crore and Synthesis revenue (18 percent of sales) grew 34 percent YoY to Rs 150 crore further supported growth.

However, its growth was impacted by ARV API (32 percent of sales; down 16 YoY) and Oncology API (7 percent of sales; down 17 percent YoY).

The gross margin improved 400 bps YoY to 50.1 percent owing to a superior product mix. Subsequently, the EBITDA margin, at 22.9 percent (versus Motilal Oswal's estimates of 20.6 percent), was up 520 bps YoY.

EBITDA came in at Rs 190 crore (versus Motilal Oswal's estimates Rs 150 crore), up 71 percent YoY. Profit increased around 2.5x YoY to Rs 110 crore (against Motilal Oswal's estimates of Rs 61.7 crore), led by robust sales growth, superior margins, and a lower tax rate.

Laurus expects capex to be over Rs 300 crore in FY21, spread over the FDF/API segment, and intends to spend Rs 60 crore (FY21) on de-bottlenecking and Rs 200-250 crore on brownfield expansions (FY21/22) in the formulations segment.

""Within FDF, the company guided for three ANDA approvals, two launches in Canada, and a better off-take in Europe, in addition to increased traction in the ARV segment,"" said Motilal Oswal.

Laurus has received a fixed allocation in TLD tenders, in addition to any ad hoc business for FY21. Approval for TLE 400/600 is expected in first half of FY21, the brokerage said.

The company has completed its lab work for Favipiravir and is in the process of obtaining a commercialization license. It also launched Hydroxychloroquine (HCQS), anti-malarial drug, in March 2020 through a partner.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/this-stock-rallied-60-in-april-but-experts-see-another-20-upside-5216441.html
"May 05, 2020 10:29 AM IST",1,Sandip Das,Manappuram Finance share price gains 2% after company plans to raise up to Rs 500cr,"Manappuram Finance share price gained 2 percent intraday on May 5 after it had said it would raise up to Rs 500 crore by issuing debt securities.
The company said it would issue rated, secured, redeemable non-convertible debentures on private placement basis for Rs 100 crore with an option to retain oversubscription up to Rs 400 crore aggregating to Rs 500 crore.
The stock price gained over 21 percent in the last one month and was quoting at Rs 123.05, up Rs 2.15, or 1.78 percent at 10:15 hours.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyThe company has zero promoter pledge, and has show growth in net profit with increasing profit margin (QoQ).",According to Moneycontrol SWOT Analysis powered by Trendlyne Manappuram Finance has shown high growth and high return on equity (ROE) with low PE ratio.,"Manappuram Finance share price gained 2 percent intraday on May 5 after it had said it would raise up to Rs 500 crore by issuing debt securities.

The financial resources and management committee of the board of directors will consider the proposed allotment on May 8, 2020, it said in a regulatory filing.

The company said it would issue rated, secured, redeemable non-convertible debentures on private placement basis for Rs 100 crore with an option to retain oversubscription up to Rs 400 crore aggregating to Rs 500 crore.

The stock price gained over 21 percent in the last one month and was quoting at Rs 123.05, up Rs 2.15, or 1.78 percent at 10:15 hours.

According to Moneycontrol SWOT Analysis powered by Trendlyne Manappuram Finance has shown high growth and high return on equity (ROE) with low PE ratio with book value per share improving for last two years.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The company has zero promoter pledge, and has show growth in net profit with increasing profit margin (QoQ). However, in terms of technical rating as per Moneycontrol it is neutral.",https://www.moneycontrol.com/news/business/stocks/manappuram-finance-share-price-gains-2-after-company-plans-to-raise-up-to-rs-500cr-5223121.html
"May 04, 2020 09:45 AM IST",1,Rakesh Patil,What should investors do with RIL stock post Q4 result and PE deal?,"The losses in the stock remained capped after PE firm Silver Lake invested Rs 5,656 crore in Jio Platforms.
The consolidated profit in the previous quarter was Rs 11,640 crore and Rs 10,362 crore in the year-ago period.
CLSACLSA has maintained buy rating and raised target to Rs 1,770 from Rs 1,500 per share, reported CNBC-TV18.
There is a large inventory loss & a miss in Petchem, Jio & Retail, it added.
JPMorganJPMorgan has neutral view on the stock with a target at Rs 1,375 per share, reported CNBC-TV18.","The company has announced fundraising of Rs 53,125 crore by way of a 1:15 rights issue.","Reliance Industries (RIL) share price fell 3 percent in early trade on May 4 after company announced its fourth-quarter numbers and fundraising plan via rights issue. The S&P BSE Sensex is down 5 percent.

The losses in the stock remained capped after PE firm Silver Lake invested Rs 5,656 crore in Jio Platforms.

The company on April 30 reported a consolidated profit of Rs 6,348 crore for the March quarter. The consolidated profit dropped 45.5 percent due to the slump in oil prices triggered by coronavirus but an impressive 72.7 percent sequential growth by Jio Platforms limited the decline.

Also Read - RIL Q4: Healthy growth in Jio and retail, talks with Aramco on track; 7 key takeaways

The bottom line was hit by an exceptional loss of Rs 4,267 crore due to fall in oil prices and demand destruction following the coronavirus outbreak.

Company's YoY decline in profit was 38.7 percent. The consolidated profit in the previous quarter was Rs 11,640 crore and Rs 10,362 crore in the year-ago period.

Consolidated revenue from operations for the March quarter declined 11.1 percent sequentially to Rs 1,36,240 crore and the year-on-year was 2.4 percent.

Also Read - RIL Q4: Adjusted profit at Rs 10,813 crore, Jio registers 73% net growth; GRM beats estimates

American private equity giant Silver Lake Partners has bought 1 percent of Jio Platforms for $750 million in a deal that values the digital unit of Reliance Industries Ltd (RIL) at $65 billion.

Also Read - Reliance Jio-Silver Lake deal: Key highlights

The company also said Saudi Aramco's $15-billion investment in its oil-to-chemicals business was on track. These transactions will fast track the target of achieving debt-free status ahead of the March 2021 deadline.

The company has announced fundraising of Rs 53,125 crore by way of a 1:15 rights issue.

One share will be offered for every 15 shares held at Rs 1,257, a 14 percent discount to the closing price for April 30.

Motilal Oswal

The company is moving quickly to realize its plan of becoming net debt free by end-FY21. The company is now poised to receive Rs 1,037 billion through rights issue, the Facebook-Jio deal and the Fuel retailing JV with BP in the coming quarters.

It value company at Rs 1,618/share (from earlier Rs 1,589) based on SOTP with equity values of Rs 358/share (earlier Rs 353) for the core business, Rs 500/share (earlier Rs 450) for Reliance Retail and Rs 760/share (earlier Rs 750) for RJio. Maintain Buy.

It reiterated the buy rating on the company with a revised target price of Rs 1,618 per share.

Sharekhan

The broking firm has maintained buy rating with price target of Rs 1,710.

It has marginally lowered FY2021E-FY2022E EPS to reflect lower petrochemical margin and updation of FY2020 P&L and balance sheet numbers.

The company has reported a higher-than-expected standalone EBITDA of Rs 11,343 crore in Q4FY2020 led by beat in reported GRM at USD 8.9/bbl (versus our estimate of $7.2/bbl) and higher refinery throughput of 18.3 mmt.

Prabhudas Lilladher

The broking house tweak its estimates for FY21/22E as it believe company is well placed to capitalize on growth opportunities in the digital and retail space.

The fund raising plans of Rs 1 trillion by way of right issue, stake sale to Facebook and recent BP transactions will help company to tide over the tough post Covid pandemic situation, especially in the hydrocarbons business.

It has reiterated buy rating on the stock with a target of Rs 1601 per share.

Edelweiss Securities

Edelweiss Securities retained buy call and raised target to Rs 1,645 per share, reported CNBC-TV18.

The company is on track to pare net debt to zero in FY21. It has generated positive FCF of Rs 20,000 crore in FY20.

The tariff hikes at Jio would continue to drive 22% EPS CAGR over FY22. The petchem margin plunged on pricing pressure & lower margin on gas feedstock, it added.

CLSA

CLSA has maintained buy rating and raised target to Rs 1,770 from Rs 1,500 per share, reported CNBC-TV18.

The deleveraging plan is ahead of schedule. It is a weak Q4 but huge monetisation plans should help.

There is a large inventory loss & a miss in Petchem, Jio & Retail, it added.

At 09:22 hrs Reliance Industries was quoting at Rs 1,446.40, down Rs 20.65, or 1.41 percent on the BSE.

BofAML

The research house maintained buy rating with a target at Rs 1,700 per share, reported CNBC-TV18.

The rights offer & stake sale commentary have overshadow Q4 results. The rights are marginally accretive to FY21/22 EPS if cash used for debt repayment.

The petrochemicals business see weak cracks & low demand.

The shutdown impacted the retail business but groceries offset the impact. However, the Facebook deal, a game-changing & win-win deal for both the companies.

Axis Capital

The broking house has maintained buy call with a target at Rs 1,780 per share, reported CNBC-TV18.

The rights issue provides an excellent opportunity for existing shareholders.

JPMorgan

JPMorgan has neutral view on the stock with a target at Rs 1,375 per share, reported CNBC-TV18.

The core energy business could be staring at multi-year slump, while repositioning as a consolidated /technology company should support the stock price.

Credit Suisse

The rights issue could reduce net debt by further USD 7.5 billion, reported CNBC-TV18.

Jio's ARPU increase of 1.7% QoQ is lower than expected, while full effect of tariff hike in Jio to be felt in June quarter.

The company should be able to achieve the zero net debt target.

Follow our complete coverage of the Jio Silver Lake coverage here.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/what-should-investors-do-with-ril-stock-post-q4-result-and-pe-deal-5217421.html
"May 04, 2020 08:54 AM IST",-2,Kshitij Anand,"HUL Q4 results miss estimates: Should investors buy, sell or hold the stock?","Most brokerage firms forecast fell in earnings as well as volume disruptions but they maintained a 'buy' rating on the stock.
Revenue for the March quarter dropped 9.4 percent year-on-year to Rs 9,011 crore due to a decline in volumes.
Domestic consumer growth declined by 9 percent with a decline of 7 percent in underlying volume growth,"" HUL said in its BSE filing.
Investors are advised to hold this stock from a long-term perspective,” he said.
We have collated a list of recommendations from different experts and brokerage house on HUL post-March quarter results:Brokerage: Edelweiss Securities maintained ‘buy' rating","After a 14 percent rally, most experts feel that valuations still remain high buy it is a good buy on dips stocks for the long term.","Shares of HUL gave gained over 14 percent so far in 2020, and could see some more upside even though March quarter results were below expectations as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions, suggest experts.

Most brokerage firms forecast fell in earnings as well as volume disruptions but they maintained a 'buy' rating on the stock. After a 14 percent rally, most experts feel that valuations still remain high but it is a good 'buy on dips' stock in the long term.

The company on April 30 reported a profit of Rs 1,519 crore in the fourth quarter, registering a 1.2 percent decline YoY due to the lockdown in the second half of March.

The standalone profit in the same period last year was Rs 1,538 crore.

Revenue for the March quarter dropped 9.4 percent year-on-year to Rs 9,011 crore due to a decline in volumes.

Also read: HUL Q4 misses estimates, profit dips 1% to Rs 1,519 crore, volume shrinks 7%

HUL reported a 7 percent decline in underlying volume growth in the quarter against a 7 percent growth in Q4 FY19 and 5 percent growth in Q3 FY20.

""The spread of COVID-19 impacted the business from mid-March, which culminated into scaling down of operations post the national lockdown. Domestic consumer growth declined by 9 percent with a decline of 7 percent in underlying volume growth,"" HUL said in its BSE filing.

""HUL's quarterly show missed Street estimates on an overall front and the underlying volumes contracted 7 percent as demand fell due to the COVID-19 lockdown, the highest decline since the demonetisation quarter,"" Umesh Mehta, Head of Research, Samco Securities told Moneycontrol.

“However, HUL's resilient business model, menial debt and healthy balance sheet would help the company steer through these tough times. Investors are advised to hold this stock from a long-term perspective,” he said.

We have collated a list of recommendations from different experts and brokerage house on HUL post-March quarter results:

Brokerage: Edelweiss Securities maintained ‘buy' rating",https://www.moneycontrol.com/news/business/markets/hul-q4-results-miss-estimates-should-investors-buy-sell-or-hold-the-stock-5215141.html
"May 03, 2020 11:54 AM IST",1,Sunil Matkar,"Trend reversal seen only if Nifty breaks 9,200; bet on these 3 stocks for 15-20% returns","Shabbir KayyumiAfter giving a breakout from the consolidation zone, Nifty extended its gain and managed to close above 9,800 mark last week.
Only a decisive close below the crucial support of 9,200 will be an early sign of trend reversal.
The formation of Cup and Handle pattern on weekly chart indicates the consistency of positive rhythm in the stock.
We expect the stock can perform going ahead and recommend buying in stock around Rs 175 with stop loss of Rs 159 for the target of Rs 210.
We recommend a buy Tata Steel around Rs 295 with a stop loss of Rs 270 and a target price of Rs 340.","In the very near term, after the recent sharp rally, some consolidation or small retracement as mean reversion is highly probable.","Shabbir Kayyumi

After giving a breakout from the consolidation zone, Nifty extended its gain and managed to close above 9,800 mark last week.

The index gave range breakout and moved almost 500 points in two days with a gap-up move. Weekly Heikin Ashi candlestick pattern is flat bottom with a big body candle.

Nifty has given a breakout of Cup and Handle classical technical pattern which is having a neckline around 9,200-9,300 levels and the target as per pattern is 10,500 mark. Also, recently formed ABCD harmonic pattern's D leg can extend towards 161.8 percent of AB projecting bullish price action towards 10,250 levels. So under normal circumstances, the target for the recent rally is 10,250-10,500.

In the very near term, after the recent sharp rally, some consolidation or small retracement as mean reversion is highly probable. On the downside, all-important support is at 9,200. Only a decisive close below the crucial support of 9,200 will be an early sign of trend reversal.

Banking Index rallied in the last week, however, it is halting near its previous swing high placed around 21,900 mark. Bank Nifty needs to trade decisively above 22,000 psychological levels for further upmove and would be prone to some retracements in the very short term.

Here are the three stocks which could give 15-20 percent return in short term:

ITC: Buy Around Rs 175 | Target: Rs 210 | Stop Loss: Rs 159 | Upside: 20 percent

The stock witnessed sustained sell off over the past few days, however, the strong demand zone around Rs 145-150 levels which has emerged as the support for the same.

On the weekly chart, line of polarity suggests a strong base and until this break decisively. The formation of Cup and Handle pattern on weekly chart indicates the consistency of positive rhythm in the stock.

We expect the stock can perform going ahead and recommend buying in stock around Rs 175 with stop loss of Rs 159 for the target of Rs 210.

Mahindra & Mahindra: Buy Around Rs 365 | Target: Rs 430 | Stop Loss: Rs 330 | Upside: 17 percent

Daily chart of stock reveals that demand is increasing and supply is diminishing as stock is taking support from line of parity showing rebound from its lower levels.

Price has been trading above the consolidation phase after giving breakout for last few days and also forming Cup and Handle price pattern indicating strength from bottom.

With the chart looking attractive and decent volume participation witnessed, we recommend a buy around Rs 365 in this stock for an upside target of Rs 430, keep a stop loss of Rs 330.

Tata Steel: Buy Around Rs 295 | Target: Rs 340 | Stop Loss: Rs 270 | Upside: 15 percent

Stock has formed a double bottom price pattern on the daily chart, which should resolve on the upside after its brief consolidation.

The momentum oscillator RSI is in positive territory and entering into a trending phase. The MACD too indicates good momentum-trend follow-through.

We recommend a buy Tata Steel around Rs 295 with a stop loss of Rs 270 and a target price of Rs 340.

(The author is Head of Technical Research at Narnolia Financial Advisors.)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/trend-reversal-seen-only-if-nifty-breaks-9200-bet-on-these-3-stocks-for-15-20-returns-5216041.html
"May 04, 2020 01:49 PM IST",-2,Kshitij Anand,Warren Buffett offloads US airline stocks: Time to sell Indigo & Spicejet?,"Chairman Warren Buffett said on Saturday at the company's annual meeting that the “the world has changed” for the aviation industry.
The 89-year-old Buffett, popularly known as ‘Oracle of Omaha' is followed by investors across the globe including India.
A complete selloff could also turn investors back in India slightly cautious about the airline sector, suggest experts.
There is a likelihood of prices moving higher, and demand for travel is expected to remain low amid COVID-19 fears.
“With the mounting challenges ahead with subdued demand, short term investors should ideally exit or reduce to extreme levels from airline stocks to be invested in defensive play,” he said.","Experts advise investors to bring down their exposure in the airline. If they are long term investor then they could hold the stock, they say.","When Berkshire Hathaway Inc. sold its entire stake in the four largest US airlines in April, it dropped a hint to investors in other parts that the investment climate for the airline stocks might have change amid COVID-19 outbreak.

Chairman Warren Buffett said on Saturday at the company's annual meeting that the “the world has changed” for the aviation industry. The conglomerate had held sizeable positions in the airlines, including an 11 percent stake in Delta Air Lines, 10 percent of American Airlines Co., 10 percent of Southwest Airlines Co., and 9 percent of United Airlines at the end of 2019, according to its annual report and company filings, Reuters reported.

Buffett said he “made a mistake” investing in the sector, which the pandemic has changed “in a very major way” with no fault of the airlines, leaving limited upside for investors, a Reuters report quoted.

The 89-year-old Buffett, popularly known as ‘Oracle of Omaha' is followed by investors across the globe including India. A complete selloff could also turn investors back in India slightly cautious about the airline sector, suggest experts.

Companies would avoid official travel and would rather prefer conducting meetings over video conference. People, at large, will also avoid leisure travel (to the extent possible) at least for the next 6 to 12 months, suggest experts.

“I, therefore, agree with the views of ‘Oracle of Omaha' that the airlines industry might not be a very lucrative sector in the short term. In India as well, the airline sector's recovery will depend on a stimulus from the government as the margins in the sector are paper-thin,” Gaurav Garg, Head of Research, CapitalVia Global Research Limited-Investment Advisor told Moneycontrol.

“Warren Buffet has previously said that during the times when dark clouds fill the economic skies and rain gold, one should come out with buckets and not tablespoons, I would suggest to continue following the same in these times too,” he said.

Two of the listed companies have also taken a beating – InterGlobe Aviation has plunged a little over 25 percent so far in 2020 while SpiceJet is down by a little over 60 percent in the same period.

As airlines and airports prepare to resume operations, once the lockdown is lifted and the government gives the green signal – experts feel that it would not be the same. There is a likelihood of prices moving higher, and demand for travel is expected to remain low amid COVID-19 fears.

Given that the majority of the airlines companies are burdened with considerable debt in the balance sheet coupled with higher fixed cost in form of rental and other operating costs, the current pandemic is expected to pose further challenges for the aviation companies for an extended period, suggest experts.

Experts advise investors to bring down their exposure to the airline. If they are long term investor then they could hold the stock, they say.

“The travel restrictions across the world have put many related industries into a severe economic crisis which also includes the airlines business that has remained shut in India since late March. And the decision to divest the entire stake in US airlines stock by legendary investors (Warren Buffett) will certainly have a negative feedback loop for the aviation industry as a whole,” Dinesh Rohira is a Founder & CEO of 5nance.com told Moneycontrol.

“With the mounting challenges ahead with subdued demand, short term investors should ideally exit or reduce to extreme levels from airline stocks to be invested in defensive play,” he said.

Rohira further added that nevertheless, the lower commodity price coupled with the re-opening of the economy should help revive the businesses in the next 1-2 years from now, and therefore, investors with longer duration can still allocate capital to relatively quality stocks.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/warren-buffett-offloads-us-airline-stocks-time-to-sell-indigo-spicejet-5218821.html
"May 04, 2020 10:19 AM IST",-2,Nishant Kumar,Tech Mahindra shares plunge 8% after Q4 numbers; top brokerages remain mixed,"MacquarieAs per CNBC TV-18, Macquarie has an 'outperform' call on Tech Mahindra but cut the target price to Rs 738 from Rs 839.
CLSACLSA has maintained 'outperform' call on Tech Mahindra but cut the target price to Rs 635 from Rs 920, reported CNBC-TV18.
We cut revenue estimates by 16-17 percent and margin by 200-250 bps for FY21-22,"" said CLSA.
Kotak Institutional EquitiesKotak has a 'buy' call on Tech Mahindra but cut the target price to Rs 360 from Rs 680.
Tech Mahindra has been slower in enabling work-from-home (WFH) access in comparison to its peers, indicating supply issues may not completely ease out in the near-term.","Brokerages have a mixed view on the stock. While some maintained their positive stance on the stock, some cut the target prices and some analysts downgraded the stock to sell.","Shares of Tech Mahindra plunged nearly 8 percent in early trade on BSE on May 4, reacting to the company's March quarter numbers released on the previous trading session on April 30.

Tech Mahindra March quarter results were below analyst estimates, and the pain seen in the March quarter is likely to extend in Q1FY21, suggest experts. The IT company on April 30 posted a 29 percent year-on-year fall in profit at Rs 803.9 crore for the quarter ended March 2020.

Brokerages have a mixed view on the stock. While some maintained their positive stance on the stock, some cut the target prices and some analysts downgraded the stock to sell.

Morgan Stanley

CNBC-TV18 reported Morgan Stanley has maintained an 'overweight' call on the stock with a target price at Rs 680 and said that Q4 performance was weaker than expected as COVID-19 impaired growth and margin.

Morgan Stanley is of the view that the company has an opportunity to gain market share in BPS.

""Margin improvement plan could get pushed out by a year. We cut EPS estimates by 11 percent for FY21 and 3 percent for FY22,"" said Morgan Stanley.

It highlighted that the valuation of the stock is cheap against other large-cap peers.

Macquarie

As per CNBC TV-18, Macquarie has an 'outperform' call on Tech Mahindra but cut the target price to Rs 738 from Rs 839.

""Higher exposure to BPS business will put pressure on growth in near-term,"" said Macquarie, adding that the delay in deal ramp-ups due to COVID-19 induced uncertainty will weigh on growth.

CLSA

CLSA has maintained 'outperform' call on Tech Mahindra but cut the target price to Rs 635 from Rs 920, reported CNBC-TV18.

""We see headwinds from slowed discretionary spending in the enterprise segment. Margin will be under pressure in FY21 on lower volumes and pricing discounts. We cut revenue estimates by 16-17 percent and margin by 200-250 bps for FY21-22,"" said CLSA.

CLSA added that continued strong deal win momentum provides hope of a recovery in the second half of the year.

Jefferies

Jefferies has a buy call on the stock. It raised the target price to Rs 615 from Rs 590.

As per CNBC-TV18, Jefferies underscored that the disappointing Q4 as communications business was surprisingly weak and the performance of the company was disappointed on both revenue growth & EBIT margin.

Jefferies finds a total contract value of $505 million a silver lining.

""Revenue decline led by communications though some of this is likely transitory. 5-G spend ramp-up and demand-side pressures will be key going forward,"" said Jefferies.

Kotak Institutional Equities

Kotak has a 'buy' call on Tech Mahindra but cut the target price to Rs 360 from Rs 680. The brokerage expects Tech Mahindra's EBIT margin to decline to 10.2 percent in FY21.

Kotak said it saw growth normalisation in FY22 after a poor FY21. It has trimmed FY21-22 EPS estimates by 10-22 percent on Q4 disappointment.

Investec

Investec has a buy call on the stock with a target price at Rs 630.

""Q1FY21 is likely to be another quarter of meaningful revenue declines. We cut our FY21 and FY22 EPS estimates by 4.3 percent and 0 percent, respectively,"" said the brokerage.

Investec said its estimates factor in revenue drops over Q1 and Q2 and weak margin in the first half of the year and added that the revenue and margin performance in Q1 will be key to stock performance.

Motilal Oswal

Motilal Oswal downgraded the stock to Neutral with a target price of Rs 590.

Sharp revenue decline and EBIT margin contraction were disappointing given the COVID-19 impact on March were only limited to just two to four weeks across the core geographies.

This indicates what lies ahead in subsequent quarters when the full impact of the COVID-19 crisis is likely to kick in. Tech Mahindra has been slower in enabling work-from-home (WFH) access in comparison to its peers, indicating supply issues may not completely ease out in the near-term.

Motilal Oswal downgraded its EPS estimates over FY21–22E by 22–25 percent in light of the disappointing results and downbeat commentary.

Edelweiss Securities

Edelweiss Securities maintained its buy rating on Tech Mahindra post-March quarter results but slashed its 12-month target price to Rs 640 from Rs 796 earlier.

“We believe the current quarter pain is likely to extend in Q1FY21 as well and is in line with our trimming of estimates (on 9th April 2020) for the company and the sector. In view of the current uncertainty and lower growth, we trim our multiple to 14.5x (16.0x earlier), in line with a cut in our sector multiples,” said the note.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/tech-mahindra-shares-plunge-8-after-q4-numbers-top-brokerages-remain-mixed-5217551.html
"May 04, 2020 08:20 AM IST",-2,,Tech Mahindra – Wait for the storm to pass,"We would recommend adding Tech Mahindra for the long-term but only in the event of deeper cuts in the market.
@moneycontrolcom Madhuchanda Dey",We would recommend adding Tech Mahindra for the long-term but only in the event of deeper cuts in the market.,"We would recommend adding Tech Mahindra for the long-term but only in the event of deeper cuts in the market.

@moneycontrolcom Madhuchanda Dey",https://www.moneycontrol.com/news/business/moneycontrol-research/tech-mahindra-wait-for-the-storm-to-pass-5217131.html
"May 04, 2020 11:48 AM IST",-2,Nishant Kumar,HUL shares decline 5%; top global brokerages keep positive view on the stock,"Credit Suisse (CS)As per CNBC-TV18, CS has an 'outperform' call on HUL with a target price of Rs 2,400.
It raised the target price to Rs 2,650 from Rs 2,350 but cited that the uncertainty on demand will persist.
JPMorganJPMorgan has maintained a 'hold' call on HUL but trimmed the target price to Rs 2,397 from Rs 2,516, reported CNBC-TV18.
We are positive on the company's portfolio and execution capabilities and await a better entry point with valuations at 48 times FY22E earnings and lower earnings visibility,"" said JPMorgan.
JefferiesAs per CNBC-TV18, Jefferies has a buy call on HUL but cut the target price to Rs 2,525 from Rs 2,750.","Most brokerage firms forecast fell in earnings as well as volume disruptions but they maintained a 'buy' rating on the stock. After a 14 percent rally, most experts feel that valuations still remain high but it is a good 'buy on dips' stock in the long-term.","Hindustan Unilever Limited (HUL) has committed Rs 100 crore to help in the fight against coronavirus. HUL will also donate 2 crores pieces of Lifebuoy soaps. HUL will provide free supplies of sanitation and hygiene products such as hand sanitizers, bar soaps and floor cleaners. HUL will donate Rs 10 crore to upgrade the health care facilities in testing centres and hospitals.(Image: Moneycontrol)

Shares of Hindustan Unilever (HUL) declined over 5 percent in morning trade on BSE on May 4, reacting to the company's March quarter scorecard.

The company on April 30 reported a profit of Rs 1,519 crore in the fourth quarter, registering a 1.2 percent decline YoY due to the lockdown in the second half of March.

Most brokerage firms forecast fell in earnings as well as volume disruptions but they maintained a 'buy' rating on the stock. After a 14 percent rally, most experts feel that valuations still remain high but it is a good 'buy on dips' stock in the long-term.

Credit Suisse (CS)

As per CNBC-TV18, CS has an 'outperform' call on HUL with a target price of Rs 2,400.

CS finds Q4 decline not relevant as it was driven by the last 10 days' performance. CS cut HUL's earnings marginally by 2-3 percent.

""Lower ad spends, cost savings and input cost tailwinds will offset lower revenue growth. Earnings growth will also be aided by GSK merger impact,"" CS said.

CS highlighted that large-scale downtrading will be the key risk to watch out for.

HSBC

HSBC has a buy rating on HUL. It raised the target price to Rs 2,650 from Rs 2,350 but cited that the uncertainty on demand will persist.

""This one-off quarter doesn't reduce the company's structural appeal,"" CNBC-TV18 reported HSBC saying so.

The company will spring back to growth as soon as the situation normalises, HSBC said.

HSBC is of the view that FY21 will still likely be a resilient year. Optically expensive valuation builds in reasonable long-term expectations, HSBC said.

Macquarie

As per CNBC-TV18, Macquarie has an outperform call on HUL with a target price at Rs 2,500.

It said adjusted Q4 profit was 10 percent below its estimates due to lower sales. Macquarie said the company is its top pick and a marquee recommended stock.

JPMorgan

JPMorgan has maintained a 'hold' call on HUL but trimmed the target price to Rs 2,397 from Rs 2,516, reported CNBC-TV18.

""Below-estimate Q4 results reflected on-ground reality for the FMCG industry during COVID. Pressures will continue into Q1 on likely change in consumer buying patterns,"" said JPMorgan.

JP Morgan has cut its estimates by 4 percent and 3 percent for FY21 and FY22, respectively.

""We build in weaker near and medium-term recovery. We are positive on the company's portfolio and execution capabilities and await a better entry point with valuations at 48 times FY22E earnings and lower earnings visibility,"" said JPMorgan.

Jefferies

As per CNBC-TV18, Jefferies has a buy call on HUL but cut the target price to Rs 2,525 from Rs 2,750.

Jefferies highlighted that the management commentary was cautious, but it refrained from providing demand outlook.

The global brokerage firm has cut FY21-22 EPS estimates by 3-5 percent to factor in lower revenue and said it did not see risk to margin and the company is better placed than peers.

Jefferies said near-term pressure in share price will be an opportunity to buy the stock.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hul-shares-decline-5-top-global-brokerages-keep-positive-view-on-the-stock-5217891.html
"May 04, 2020 07:33 AM IST",1,Nishant Kumar,"Hot Stocks | Here's why ONGC, Bharti Airtel are a buy for short term","In fact, in the recent meltdown, the stock prices plunged to the year 2004 lows.
Importantly, the recent rally in the stock prices is backed by considerably higher volumes.
So, we recommend going long on a decline towards Rs 75 for a positional target of Rs 92 in the comingdays.
In addition, prices have now closed above the higher end of Bollinger Band which indicates strong momentum upmove after the recent consolidation.
Looking at all the above evidence, we sense a strong upside in the counter.","March was one of the worst months for our market, but fortunately, this was followed by a stupendous April during which, we managed to recoup 50 percent of the damage done in March.","Sameet Chavan

During the last week of March, our market somehow managed to stabilise and then saw some decent recovery thereafter.

Until April 28, Nifty had been struggling to surpass 9,400 mark, but due to strong buying momentum in the last couple of sessions, Nifty finally broke out and went on to close convincingly above 9,800-mark.

March was one of the worst months for our market, but fortunately, this was followed by a stupendous April during which, we managed to recoup 50 percent of the damage done in March.

It was a broad-based rally and some of the laggards like financials and auto contributed heavily, which provided credence to the move.

Looking at the overall setup, Nifty is very much poised for an extended move towards 10,200-10,400, which would be seen as a strong hurdle for the market.

Traders should start lighting up positions in this zone and then wait for further signals.

There is an important development happening on the global front over the last couple of days, which cannot be overlooked.

US President Donald Trump has threatened China to impose new tariffs which could lead to the resumption of a trade war. Market participants across the globe look intimidated, resulting in a sharp decline across the globe.

SGX Nifty, too, reacted negatively to this development and is showing a massive cut. On May 4, we need to see how our market reacts to it and if they open in line with SGX Nifty, 9,300 and 9,100 would be seen as

crucial supports.

If the market fails to hold that level, it will apply brakes on the recent optimism and in this case, we will have to revisit our view.

However, if our market doesn't react to the tune of SGX Nifty and shows some buying interest at lower levels, the above-mentioned bull case scenario remains valid.

So, all eyes would be on global development which would dictate the immediate path of action for our market.

Here are two stock recommendations for the next 3-4 weeks:

ONGC | Buy | LTP: Rs 79.75 | Target price: Rs 92 | Stop loss: Rs 68 | Upside: 15%

This one of the ‘Maharatna' companies of India has been underperforming for several years now. In fact, in the recent meltdown, the stock prices plunged to the year 2004 lows.

Fortunately, after marking a low around Rs 46, we witnessed a decent recovery in this stock and in the process, it has managed to confirm a breakout from the ‘Symmetrical Triangle' pattern.

Importantly, the recent rally in the stock prices is backed by considerably higher volumes.

So, we recommend going long on a decline towards Rs 75 for a positional target of Rs 92 in the coming

days.

Bharti Airtel | Buy | LTP: Rs 514.55 | Target price: Rs 560 | Stop loss: Rs 491 | Upside: 9%

This stock has been consolidating above the 50 and 89-EMA for the last few sessions and has now broken above this consolidation on the upside, confirming a continuation pattern known as ‘Pennant'.

The said breakout is supported by a good increase in volume. In addition, prices have now closed above the higher end of Bollinger Band which indicates strong momentum upmove after the recent consolidation.

In addition, the momentum oscillator RSI is pointing northward after the recent dip, supporting the buy call.

Looking at all the above evidence, we sense a strong upside in the counter.

(The author is Chief Technical & Derivatives Analyst at Angel Broking)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/hot-stocks-heres-why-ongc-bharti-airtel-are-a-buy-for-short-term-5215051.html
"May 04, 2020 10:45 AM IST",-2,Kshitij Anand,Sell in May and go Away? 10-year data suggests otherwise,"It is an investment strategy in which investors sell stock in May and re-enter markets in early November.
Nifty50 closed in the green in 6 out of the last 10 years, data from AceEquity showed.
Investors' wealth rose by nearly Rs 16 lakh crore in April.
FIIs were net sellers of equities worth nearly Rs 21,000 crore in May 2013, followed by Rs 16,000 crore outflows in May 2014, and nearly Rs 10,000 crore selloff recorded in May 2019.
They poured in more than Rs 13,000 crore in May 2018, followed by over Rs 9,000 crore buying in May 2017, and over Rs 7,000 crore in May 2016.","Data from the last 10 years suggest that bulls got an upper hand seven times in the month of April. Nifty50 closed in the green in 6 out of the last 10 years, data from AceEquity showed.","After rallying over 14 percent in April, all eyes are on the month of May which is often linked with the age-old Wall Street saying ‘Sell in May and Go away'.

It is an investment strategy in which investors sell stock in May and re-enter markets in early November. It's based on the belief that the market produces lower returns from May to October.

In terms of benchmark returns, bulls have managed to push the index in the green almost 60 percent of the time in May in the last 10 years, while there has been some selling from foreign investors as they remain net sellers 50 percent of the times in the same period.

Nifty50 closed in the green in 6 out of the last 10 years, data from AceEquity showed.

The Nifty50 jumped nearly 8 percent in May 2014, followed by a 4 percent rally in May 2016 and a 3.4 percent gain in May 2017 — three of the biggest gains in May in the last 10 years.

On the other hand, Nifty fell four times in May in the last 10 years — in 2012 (over 6 percent), 2010 (3.6 percent), 2011 (3.2 percent), and 2018 (0.03 percent).

Most experts feel that the age-old saying might just come true for D-Street in 2020 because the 30 percent rally from the March lows was more of a relief rally, and investors will be better off booking profits at higher levels.

“At the current level, we have a cautious view in the market, unless the global health environment improves with a better treatment & vaccination in the future. We term this as a bear rally, the sustainability of which is difficult in the short-term given rising cascading economy effect,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol

“We are advising traders to capitalise on this rally and book gains in the near-term. Long-term investors can accumulate in the dip,” he said.

Investors' wealth rose by nearly Rs 16 lakh crore in April. The average market capitalisation of the BSE-listed companies grew from Rs 113.48 lakh crore from March 31 to Rs 129.41 lakh crore recorded on April 30.

D-Street seems to be taking comfort in the fact that the United States Food and Drug Administration (USFDA) has granted emergency use authorisation (EUA) for the investigational antiviral remdesivir to treat COVID-19 patients.

Apart from the use of new drugs, investors are also pinning hopes on second stimulus package from the government to cushion the economic impact of COVID-19 on India.

But, a possible Trade War between the US and China could derail the market recovery. The US President Donald Trump said his administration was crafting retaliatory measures against China as punishment for the coronavirus outbreak, once again sparking tariff fears that rattled markets through much of the last two years, said a Reuters report.

“Domestic markets have been mirroring the directions from the US markets. Positives start, as the Indian market is taking cues from the international markets, driven by the success of the Gilead drug and expectations of stimulus and partial opening up of the economy in green,” Pankaj Bobade, Head- Fundamental Research, Axis Securities Limited told Moneycontrol.

“It is too early to talk about the market movements for the month of May. The political activities on the international platforms are heating up, which are likely to have an impact on international market movements,” he said.

FII Activity:

Foreign institutional investors (FIIs) pulled out more than Rs 65,000 crore from the cash segment of the Indian equity markets in March, as per provisional data, and little over Rs 5,000 crore in April.

If we look at the historical data, they have net sellers about 50 percent of the time in the last 10 years in May. FIIs were net sellers of equities worth nearly Rs 21,000 crore in May 2013, followed by Rs 16,000 crore outflows in May 2014, and nearly Rs 10,000 crore selloff recorded in May 2019.

On the other hand, mutual funds were mostly net buyers in the last ten years in the month of May. They poured in more than Rs 13,000 crore in May 2018, followed by over Rs 9,000 crore buying in May 2017, and over Rs 7,000 crore in May 2016.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/sell-in-may-and-go-away-10-year-data-suggests-otherwise-5215371.html
"May 04, 2020 01:23 PM IST",2,Nishant Kumar,Rakesh Jhunjhunwala increases stake in Rallis India in Q4FY20,"Ace investor Rakesh Jhunjhunwala added 2.75 lakh shares in agrochemicals firm Rallis India during the March quarter of FY20.
His stake in Rallis India rose from 9.79 percent in the December quarter to 9.93 percent in the March quarter.
""Agro related industry is looking attractive during the current scenario and Rallis India is the best pick from this sector.
Shares of Rallis traded 2.62 percent up at Rs 219.30 on BSE around 13:10 hours IST.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.","Data available with BSE shows that Jhunjhunwala held as much as 1,93,05,820 shares in Rallis at the end of March 2020 against 1,90,30,820 shares held at the end of December 2019.","Ace investor Rakesh Jhunjhunwala added 2.75 lakh shares in agrochemicals firm Rallis India during the March quarter of FY20.

His stake in Rallis India rose from 9.79 percent in the December quarter to 9.93 percent in the March quarter.

Data available with BSE shows that Jhunjhunwala held as much as 1,93,05,820 shares in Rallis at the end of March 2020 against 1,90,30,820 shares held at the end of December 2019.

During the March quarter, the stock climbed 4 percent on BSE against an almost 29 percent fall in the benchmark Sensex.

Market experts and analysts are hoping that agro sector stocks may do well in the near term as this is one of the very few sectors that have little impact of COVID-19.

""Agro related industry is looking attractive during the current scenario and Rallis India is the best pick from this sector. We are recommending a buy in a staggered manner for medium to long term,"" Sumit Bilgaiyan, Founder of Equity99 said in an interview to Moneycontrol.

Rallis is known for its deep understanding of Indian agriculture, sustained contact with farmers, quality agrochemicals, branding & marketing expertise along with its strong product portfolio.

Rallis is also known for its manufacturing capabilities and ability to develop new processes and formulations, hence it is considered as a preferred partner for contract manufacturing by leading global corporations.

Shares of Rallis traded 2.62 percent up at Rs 219.30 on BSE around 13:10 hours IST.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/rakesh-jhunjhunwala-increases-stake-in-rallis-india-in-q4fy20-5218641.html
"May 04, 2020 11:38 AM IST",-2,Sandip Das,"D-Street Buzz: Auto stocks tumble after April sales crash; Tata Motors, Maruti top losers","Among the sectors, the auto index was down over 6 percent as auto makers declared a dismal set of April sales numbers.
The top losers included Tata Motors which was one of the top index losers.
The company had zero sales in the domestic market in April 2020, MSI said in a statement.
S&P BSE Auto shed over 6 percent with the top losers being Motherson Sumi, Tata Motors, Apollo Tyres, Maruti Suzuki and Hero MotoCorp.
Share price of Eicher Motors shed over 4 percent after the company's total sales went down 98 percent at 85 units against 3,961 units (YoY).",The auto index was down over 6 percent as auto makers declared a dismal set of April sales numbers.,"The Indian stock market tumbled on May 4 after the government extended the lockdown for another two weeks in an attempt the arrest the spread of coronavirus.

Sensex is down 1,618.22 points or 4.8 percent at 32099.40, and the Nifty fell 464.60 points or 4.71 percent at 9395.30.

Among the sectors, the auto index was down over 6 percent as auto makers declared a dismal set of April sales numbers.

The top losers included Tata Motors which was one of the top index losers. It was down 10 percent and was one of the most active stocks in terms of value on NSE with 5,80,15,737 quantities traded at 11:30 hours.This was followed by Bharat Forge and Motherson Sumi Systems which tanked over 10 percent.

Share price of Maruti Suzuki was down over 7 percent after the company did not sell a single unit in the domestic market last month due to coronavirus-led nationwide lockdown. The company had zero sales in the domestic market in April 2020, MSI said in a statement. The company, however, exported 632 units from Mundra port following resumption of port operations.

S&P BSE Auto shed over 6 percent with the top losers being Motherson Sumi, Tata Motors, Apollo Tyres, Maruti Suzuki and Hero MotoCorp.

Share price of Eicher Motors shed over 4 percent after the company's total sales went down 98 percent at 85 units against 3,961 units (YoY).

Mahindra & Mahindra shares was also down 4 percent intraday on May 4 after the company sold zero units in the domestic market in April due to coronavirus-led nationwide lockdown. It, however, dispatched 733 vehicles to overseas markets during the last month.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Hero MotoCorp in a filing to the exchanges said that the company will commence operations in graded manner at Gurugram, Dharuhera and Haridwar plants, along with Global Parts Centre in Rajasthan. Shares of the company was trading lower by over 7 percent.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-auto-stocks-tumble-after-april-sales-crash-tata-motors-maruti-top-losers-5218001.html
"May 03, 2020 10:13 AM IST",1,Kshitij Anand,"Any correction near 9,400 level would be a good entry point: Vikas Jain","We remain positive on markets and any correction near to 9,400 levels would be a good entry point as the resistances will act as support from the current levels, Vikas Jain, Senior Research Analyst at Reliance Securities, said in an interview with Moneycontrol's Kshitij Anand.
Among stocks, there was positive news flow from the quarterly results like IndusInd Bank, Ambuja Cement and Hexaware Technologies and expectations of strong results from Reliance Industries helped the overall market momentum.
We remain positive on markets and any correction near to 9,400 levels would be a good entry point as the resistances will act as support from current levels.
It could be a good entry point for the stock to accumulate on declines.
We expect a positive opening on May 4 (Monday), but the upside could be capped as multiple resistances are placed in the range of 1,550-1,600 levels near to its previous tops.","The later part of the results season is always very weak, which could also pull the markets lower in the second half of May, Vikas Jain, Senior Research Analyst at Reliance Securities, told Moneycontrol.","We remain positive on markets and any correction near to 9,400 levels would be a good entry point as the resistances will act as support from the current levels, Vikas Jain, Senior Research Analyst at Reliance Securities, said in an interview with Moneycontrol's Kshitij Anand.

Here are the edited excerpts of the interview:

Q. A strong day to end the week! While the Sensex is back above 33,000, the Nifty50 reclaimed 9,800. What is fuelling the market rally on D-Street?

A. The Nifty50 closed 7.7 percent higher for the week post the breakout above 9,500 levels and positive momentum from the global markets led to a sharp up move.

Among stocks, there was positive news flow from the quarterly results like IndusInd Bank, Ambuja Cement and Hexaware Technologies and expectations of strong results from Reliance Industries helped the overall market momentum.

The monthly expiry and crossover of key resistance levels resulted in short covering in the index options due to which the markets ended at the highest point in the expiry month.

Q. As we close the month of April on a positive note after a massacre in March, how is May likely to pan out for investors. There is a very popular Wall Street adage ‘Sell in May and Go Away'? Do you think we could hold onto gains if not why?

A. The Nifty50 closed 14.1 percent higher for the April expiry to post one of the best months of gains in the last decade with strong positive momentum across sectors and stocks.

The Nifty50 has rallied by about 31 percent from its swing low of 7,511 recorded in March. The pullback started since the countrywide lockdown came into effect and got stronger with global markets pullback.

The adage ‘Sell in May and Go Away' did not hold true in recent years as we have ended positively in May month for the last five years.

We believe there could be some more positive momentum till 10,400 levels and then correction could set in as the 200-week average and 38.2 percent pullback from its 52-week lows are placed in the range of 10,350-10,400 levels.

The later part of the results season is always very weak which could also pull the markets lower in the second half of May.

Q. What is your call on banking and auto stocks which have run up quite sharply in the week gone by?

A. The Nifty Bank was being a laggard in the current up move but private banks gained traction post the results of HDFC Bank and gained further traction as other private banks announced their full-year results.

PSU banking has remained flat trading near to its all-time lows and we could expect a strong up move in May as the monthly candle ends in a Doji pattern and the set up on daily and weekly charts looks positive.

Auto sector has moved up 33 percent from its 52-week low. We expect some weakness as individual stocks are being in the overbought zone on the daily charts and on the higher side the 200-Day average is placed at 7,200 levels which will act as a strong resistance. The risk-reward is not favourable from current levels.

Q. What are the important factors which investors could track in the coming week and in the month of May which could dictate the trend for markets?

A. In the coming week, D-Street's reaction from Nifty50 companies like HUL, Reliance Industries and Tech Mahindra would be the key to watch and how the global markets pan out.

We remain positive on markets and any correction near to 9,400 levels would be a good entry point as the resistances will act as support from current levels.

The Q4FY20 results season would move into the third week and selectively, the lockdown will also open in non-containment zones of various states which will be important to watch for the manufacturing and industrial activities to resume.

Q. What is your view on Tech Mahindra and HUL which came out with results on April 30? What should investors do — buy, sell or hold?

A. HUL has already witnessed a sharp correction in the past two weeks and the results were largely in-line with expectations as it has gained market share in the overall business and low volume growth is mainly due to low stocking.

Tech Mahindra posted a weak set of numbers. We expect a weak opening for the stock but one should buy on dips near its support at lower levels in the range of 490-500 levels. It could be a good entry point for the stock to accumulate on declines.

Q. What are your view on RIL results and the rights issue, and what should investors do? Do you see a positive/negative reaction on May 4 (Monday)?

A. The results are in-line except for the exceptional loss which dragged the overall profits. But consumer business and Jio subsidiary reported stronger growth for the quarter.

Reliance Industries' rights issue of Rs 53,125 crore is priced at Rs 1,257, the ratio of 1:15 held by shareholders, which will enable shareholders to increase the holdings at a lower price compared to the closing of Rs 1,467 per share.

We expect a positive opening on May 4 (Monday), but the upside could be capped as multiple resistances are placed in the range of 1,550-1,600 levels near to its previous tops.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust, which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/any-correction-near-9400-level-would-be-a-good-entry-point-vikas-jain-5214671.html
"May 03, 2020 01:12 PM IST",-1,Sunil Matkar,"RIL may see profit-booking on Monday due to global jitters, but analysts remain optimist on long-term growth","Reliance Industries (RIL) met street estimates in its January-March quarter results fueled by stellar growth in Jio, retail and digital businesses.
O2C may get Rs 3.5 lakh crore of valuations then the stock could cross magical Rs 10 lakh crore market cap again,"" he added.
He too was disappointed with the rights issue pricing but said that the fall in topline, EBITDA and EBIT of Reliance Retail given the lockdown was not disappointing.
The proposed rights issue would be the first by RIL in three decades.
""The rights issue is a step towards the company's target of becoming a zero-net debt company by end of current fiscal.","Vikas Jain of Reliance Securities said the rights issue would enable shareholders to increase the holdings at a lower price compared to Thursday's closing of Rs 1,467 per share.","Reliance Industries (RIL) met street estimates in its January-March quarter results fueled by stellar growth in Jio, retail and digital businesses. However, an exceptional loss of Rs 4,267 crore due to the fall in oil prices and demand destruction following the coronavirus outbreak capped profits.

Analysts are of the opinion that the stock may witness profit booking on Monday primarily due to a steep fall in equity markets as trade tensions between the US and China resurfaced.

SGX Nifty on Friday was down nearly 500 points whereas benchmark indices rallied nearly 8 percent last week.

Another reason for profit-taking could be the sharp rally seen in Reliance share price recently. The stock shot up 67.5 percent since March 23 to Rs 1,467.05 on April 30 amid growth in the telecom business and Jio-Facebook deal.

""Reliance has rallied more than 60 percent, it could see some sell-off in a couple of weeks due to weak global cues, but that will be a buy or there will be a good time to buy at Rs 1,257, the rights issue price,"" Prakash Diwan of Altamount Capital Management told CNBC-TV18.

Prashanth Tapse, AVP Research at Mehta Equities also feels technically RIL may see an attempt of profit booking at the current levels as it has seen a rally from Rs 875.65 (March 23) and Thursday's close Rs 1,467.05 (April 30).

But experts maintained a positive stance on the stock given the expected growth in the new-age business of Jio and Retail which are yet to be factored in.

They see tremendous growth in RIL after Q4 FY20 and Q1 FY21, once the lockdown induced pain is soothed.

According to them, there are multiple moats for the company such as the expected growth in consumer businesses, ongoing due diligence with Saudi Aramco, expected hiving off oil-to-chemical (O2C) business, another Facebook-like deal in Jio Platforms. They also expect RIL to become net debt-free ahead of schedule which could drive market capitalisation of the business back above Rs 10 lakh crore soon.

""We still have Saudi Aramco deal on track, so it is a very different premium attached to optionality on the stock. Though there was a disappointment on the pricing of the rights issue, the stock will definitely come back as the new-age businesses will start getting pencilled in,"" Prakash Diwan said.

""Reliance is not extremely expensive even at Rs 1,400 plus level given the kind of projections of the new-age business of Jio and Retail. O2C may get Rs 3.5 lakh crore of valuations then the stock could cross magical Rs 10 lakh crore market cap again,"" he added.

SP Tulsian of sptulsian.com also said, ""I don't think Q4 numbers or EPS estimates for FY21 are relevant at this point of time. Saudi Aramco due diligence is on track which gives certainty that deal is going to happen.""

""The company will be moving before NCLT for hiving off O2C business and its commitment to raising Rs 1 lakh crore by Q1 FY21. Hence, if we add cash flow of Rs 40,000-50,000 crore for FY21, the company will be able to achieve the target of making it debt-free on a net of cash basis, because the net debt as of March 31 FY20 is Rs 1.61 lakh crore,"" he added.

He too was disappointed with the rights issue pricing but said that the fall in topline, EBITDA and EBIT of Reliance Retail given the lockdown was not disappointing.

The company reported gross refining margin at $8.9 a barrel, which was much ahead of street estimates of $7.2-8.0 a barrel. GRM in Q3 FY20 was at $9.2 a barrel.

Reliance Jio reported a healthy 72.7 percent sequential (177 percent YoY) increase in profit at Rs 2,331 crore with 387.5 million subscribers as of March 2020 against 370 million in the previous quarter, while average revenue per user increased to Rs 130.60 from Rs 128 crore QoQ.

""GRM at $8.9 a barrel is out of the box and far better than expectations. Jio ARPU is a tad lower as we were expecting at Rs 135, but incrementally they also added subscribers, tweak in data pack which will have a strong impact on current quarter's earnings (Q1FY21),"" Prakash Diwan said.

The company announced India's biggest rights issue of Rs 53,125 crore, in the ratio of 1 equity share for every 15 equity shares held by shareholders, at a price of Rs 1,257 per share against Thursday's closing of Rs 1,467.05 per share. The proposed rights issue would be the first by RIL in three decades.

""The rights issue is a step towards the company's target of becoming a zero-net debt company by end of current fiscal. Promoters are expected to fully subscribe to the rights issues which will instil confidence in investors mind about promoters commitment to the business in addition to improving the balance sheet strength. We believe investors should take this positively,"" Ashish Chaturmohta, Head of Technical and Derivatives, Sanctum Wealth Management told Moneycontrol.

Vikas Jain, Senior Research Analyst at Reliance Securities said the rights issue would enable shareholders to increase the holdings at a lower price compared to Thursday's closing of Rs 1,467 per share.

Reliance Industries is expected to complete the capital raising programme totalling over Rs 1.04 lakh crore by Q1FY21, which includes the investment by Facebook in Jio Platforms, the upcoming rights issue and the previous investment by British Petroleum in FY20.

In addition to the Facebook investment, ""RIL has received strong interest from other strategic and financial investors and is in good shape to announce a similar-sized investment in the coming months,"" said the company.

With strong visibility to these equity infusions, RIL is set to achieve net-zero debt status ahead of its own aggressive timeline.

Mukesh Ambani in his AGM speech in August last year said, ""We have a very clear roadmap to becoming a zero net debt company within the next 18 months that is by March 31, 2021.""

While maintaining a buy call with a target at Rs 1,601, Prabhudas Lilladher said it tweaked estimates for FY21/22 as it believes RIL is well placed to capitalize on growth opportunities in the digital and retail space.

""Fundraising plans of Rs 1 lakh crore will help RIL to tide over the tough post-COVID-19 pandemic situation, especially in the hydrocarbons business,"" the brokerage added.

Motilal Oswal also maintained buy call on the stock and said, ""RIL's Q4 FY20 consolidated and standalone EBITDA was in line with our estimates.""

The brokerage valued the stock at Rs 1,618 per share (from earlier Rs 1,589), based on SOTP with equity values of Rs 358 per share for the core business, Rs 500 (earlier Rs 450) for Retail and Rs 760 (earlier Rs 750) for Jio.

""We value the core segment of Refining and Petrochem at 6.0x FY22E EV/EBITDA, factoring in the enhanced delayed coker capacity, the widening of crude blend window for maximizing distillate yields prior to the IMO and the revival in Petchem margins for the company under its flexible feedstock utilization,"" the brokerage said.

Disclaimer: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

'Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.'",https://www.moneycontrol.com/news/business/markets/ril-may-see-profit-booking-on-monday-due-to-global-jitters-but-analysts-remain-optimist-on-long-term-growth-5215631.html
"May 04, 2020 08:24 AM IST",-2,Kshitij Anand,Time to turn slightly cautions after April rally; deploy ‘Bear Put Spread' on Nifty,"Bank Nifty outperformed last week and so did many short-heavy sectors.
First, the rollovers and Bank Nifty were above three-month average while the OI data for Nifty indicates more pressure by unwinding participants leading to 17 percent drop in OI expiry over expiry (EoE), Bank Nifty did see augmentation in this expiry as well.
This could be seen in the 21 percent rise in OI for Bank Nifty EoE.
Bank Nifty looks to have rolled forward the additions through the April expiry.
Looking at the daily OI activity, Bank Nifty has added the majority of shorts, indicating the persistence of pessimism getting rolled forward.","'Bear Put spread' is a moderately bearish strategy built by buying a Put close to the current market price of the underlying and selling the same expiry Put, but of a strike lower than the Put bought.","Shubham Agarwal

The Nifty50 witnessed an extraordinary move on the expiry, which saw the index rallying by over 3 percent on April 30. Bank Nifty outperformed last week and so did many short-heavy sectors.

Last week's contribution of nearly 10 percent is almost equivalent to the expiry gain for the index. The Nifty, on the other hand, had a better run in this expiry adding gains of close to 14 percent from an expiry-to-expiry basis.

However, Open Interest (OI) tells a different story. First, the rollovers and Bank Nifty were above three-month average while the OI data for Nifty indicates more pressure by unwinding participants leading to 17 percent drop in OI expiry over expiry (EoE), Bank Nifty did see augmentation in this expiry as well.

This could be seen in the 21 percent rise in OI for Bank Nifty EoE. The Nifty's unwinding can be attributed to a logical development of short-covering this expiry as the short hedges unwind in a rising market.

Bank Nifty looks to have rolled forward the additions through the April expiry. Looking at the daily OI activity, Bank Nifty has added the majority of shorts, indicating the persistence of pessimism getting rolled forward.

On an aggregate basis to OI has augmented for overall futures participation in excess of 12 percent which is a reasonable increment.

This, along with the fact that 94 out of 143 participating stocks carried forward longs into May expiry is an indication of a slight bit of overconfidence considering the current state of global uncertainty prevailing especially around the novel coronavirus pandemic. Sentimentally, the key indicators are to a certain extent into their recent extremes.

On an aggregate basis to OI has augmented for overall futures participation in excess of 12 percent which is a reasonable increment. Carry forward of longs into May expiry is an indication of a slight bit of overconfidence considering the current state of global uncertainty prevailing especially around the pandemic.

Sentimentally, the key indicators are to a certain extent, into their recent extremes as India VIX has more than halved this expiry.

While some reduction can be attributed to the reduction of the shock impact due to passage of time, yet, considering the mean-reverting nature of such variables like India VIX, it makes sense to pay attention to the sharp move pushing the index into the relative extreme.

Looking at option composition too, we are getting a similar vibe as the OIPCR for the Nifty has ended the week at 1.89. The contribution of last day rise could be one of the factors but the ratio is at its year high.

In a situation when we are completely immobile physically, this kind of optimism is alarming.

Anomaly in Index and Stock futures OI action along with overshooting Optimism indicated by sentiments, prices as well as heavy participation calls for caution; hence, a short hedge via weekly Bear Put Spread is advised.

Bear Put spread is a moderately bearish strategy. The strategy is built by buying a Put close to the current market price of the underlying and selling the same expiry Put but of a strike lower than the Put bought.

The sold Put strike would be limit the profit but fund the put buying. Profits are limited to the difference between strikes minus the net premium paid.

Strategy details

Considering the indications from global exchanges with deep cut expectations for Nifty in the opening on May 4, referencing any trade based on April 30's close would not be prudent. Hence, instead of strategy details, strategy guidelines are mentioned.

As soon as opening volatility settles in 5-10 minutes of opening, one may choose a Strike closer to the current market price to BUY and at least 200-300 points lower strike to SELL.

This quick guide to the strategy would help in getting the details of pay-off ready before execution.

(The author is CEO & Head of Research at Quantsapp Private Limited.)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/time-to-turn-slightly-cautions-after-april-rally-deploy-bear-put-spread-on-nifty-5214921.html
"May 02, 2020 01:12 PM IST",2,Kshitij Anand,"Auto index up 30% from lows in a month; Buy on Maruti, Escorts & Minda: Vinod Nair","Optimism has also developed that the economy will open in a phase-wise manner, given the reduction in the rate of virus spread.
We term this as a bear rally, the sustainability of which is difficult in the short-term given rising cascading economy effect.
A) Banking stocks are under the assistance of supportive measures by RBI & the government to support the economy.
The highest concern is on SME, MSME, and continuity of business in the near to medium-term.
In the auto sector, the stocks that have lower debt and a rich balance-sheet are expected to outperform in the auto segment, post-COVID-19.",The auto index has given a return of 30 percent in the last 1 month from its low due to the expectation that the government's stimulus package on the economy will benefit the industry & sales will improve in Q2.,"A) Push in global liquidity, the expectation of a bonanza stimulus in India, developments on the treatment, and supportive chart parameters are the main reasons for the momentum while economic fundamentals continue to be dim.

Optimism has also developed that the economy will open in a phase-wise manner, given the reduction in the rate of virus spread.

A) At the current level, we have a cautious view on the market, unless the global health environment improves with better treatment and vaccination in the future.

We term this as a bear rally, the sustainability of which is difficult in the short-term given rising cascading economy effect.

We are advising traders to capitalise on this rally and book gains in the near-term. Long-term investors can accumulate on dips.

A) Banking stocks are under the assistance of supportive measures by RBI & the government to support the economy. The highest concern is on SME, MSME, and continuity of business in the near to medium-term.

Even though a good amount of weak credit growth and higher provisions during Q1 and Q2 is factored in price, we remain cautious due to asset quality concern & downgrade in outlook.

Having said that private banks' premium valuations have beaten down, presenting an opportunity for long-term investors. Banks having exposure in the retail segment with a good branch presence, better loan mix, and comfortable balance sheets like HDFC Bank, ICICI Bank, and SBI will stand out.

In the auto sector, the stocks that have lower debt and a rich balance-sheet are expected to outperform in the auto segment, post-COVID-19.

The auto index has given a return of 30 percent in the last 1 month from its low due to the expectation that the government's stimulus package on the economy will benefit the industry & sales will improve in Q2.

However, improvement in demand and change in consumer spending might have a longer impact on the sector. Currently, the index is trading at 18x on a 1-year fwd basis which is 13 percent premium to its five-year historical average at 16x.

We have a cautious view in the short-term with a selective Buy rating on Maruti Suzuki, Escorts, and Minda Industries Ltd.

A) A large portion of Indian company results is likely to be released in the month of May with a negative bias. Possibility of opening the economy, the size & effectiveness of the fiscal stimulus to be announced will define the trend of the domestic market in the near-term.

While globally, the grim economic data, news regarding treatment, and vaccination are the watchlist.

A) Tech Mahindra posted weak results as profit fell by 29 percent on a YoY basis to Rs 803 cr. The EBIT margin is a big miss and came at 10 percent.

Telecom is a very important business mix for the company which has a positive outlook due to higher consumer spending in telecom & data.

We believe that the entire IT space will go through transformation post-COVID pandemic and with respect to Tech Mahindra, as most companies have delayed their 5G CAPEX that could impact the telecom revenue for the stock. We are downgrading forecast and outlook on the stock.

COVID-19 has impacted HUL in terms of demand and supply but comparing to other stocks and sectors the outlook has not deteriorated much.

On the demand side, already subdued rural demand could further impact by lower-income with the weaker sale of crops amid labor and supply chain issues.

But, monsoon will play a vital role in demand. As the economy improves, we expect V-shape recovery and have a HOLD rating.

The company plants are running at 70-75 percent of the capacity and is expected to be among the best performing stock in the near to medium term given the cautious trend of the market.

A) The medium to long term outlook of RIL has significantly improved on account of its plan to consolidate its key assets which will create value to shareholders through strategic development, equity infusion, and deleveraging of balance sheet.

The proposed right issue (Rs 53,000 crore) is a step in that direction. The total amount of proceeds is likely to be about Rs 1,04,000 crore (Rights, Facebook & BP), excluding transactions with Aramco & Financial investor.

Going ahead, there will be challenges in cyclical business that would be offset by digital & retail business. However, in the near term, weak oil prices are likely to impact its cash cow (refining and petro-chemicals business), dilution in equity, high leverage, and uncertainty in business post-COVID, which will impact the performance of the stock in the near to medium-term.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/auto-index-up-30-from-lows-in-a-month-buy-on-maruti-escorts-minda-vinod-nair-5214151.html
"May 02, 2020 02:23 PM IST",2,Sunil Matkar,Story in a chart: Inverse Head and Shoulders pattern in Petronet LNG suggests buying opportunity,"In technical analysis, an Inverse Head and Shoulders pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal.
In the standard Inverse Head and Shoulders pattern, we connect the high after the left shoulder with the high created after the head.
Petronet LNG is trading in an upmove while forming Inverse Head & Shoulders pattern and this pattern has been completed on a close above Rs 228 mark.
Inverse Head & Shoulders pattern and buy signal on Petronet LNGBuy Signal1.
A decisive close above neckline (Rs 228) of Inverse Head & Shoulders pattern will give a pattern breakout.2.",We recommend buying Petronet LNG above Rs 228 levels with a stop loss of Rs 203 for higher targets of Rs 275.,"Shabbir Kayyumi

Why to Buy Petronet LNG?

In technical analysis, an Inverse Head and Shoulders pattern describes a specific chart formation that projects a bearish-to-bullish trend reversal.

An Inverse Head and Shoulders reversal pattern forms after a downtrend, and its completion marks a trend reversal to uptrend. In the standard Inverse Head and Shoulders pattern, we connect the high after the left shoulder with the high created after the head.

A trendline is drawn by connecting these highest points of the two peaks, which is called 'Neckline'. This trendline is the most important component of Inverse H&S pattern.

Petronet LNG is trading in an upmove while forming Inverse Head & Shoulders pattern and this pattern has been completed on a close above Rs 228 mark. This stock is trading near strong resistance line standing around Rs 228 levels which is tested multiple times earlier & it also suggests a strong bullish bias to continue further after a breakout.

Recent formation of Inverse Head & Shoulders classical pattern has given a breakout by trading only above Rs 228 mark, suggests buying in the stock for higher targets of Rs 275. Volume will also add further insight while trading these patterns. Decent volume participation while giving breakout will also give support to Inverse H&S pattern.

Figure.1. Inverse Head & Shoulders pattern and buy signal on Petronet LNG

Buy Signal

1. A decisive close above neckline (Rs 228) of Inverse Head & Shoulders pattern will give a pattern breakout.2. Prices are already trading above short-term moving average 20 DMA which will define bullish short-term trend.3. Mid-term moving average 50 day moving average defines mid-term trend is very well augur with bulls as prices are sustained and trading above it.

4. Decent volume participation while pattern breakout will also give additional confirmation.

Profit Booking

Target as per Inverse Head & Shoulders pattern is calculated by adding height of head (H) to neckline which comes to Rs 275, however one can book profits near previous swing high which is around Rs 270 levels.

Stop Loss

Entire bullish view negates on breaching of right shoulder on closing basis and one should exit from long position. In case of Petronet, it is placed around Rs 203 levels.

Conclusion

We recommend buying Petronet LNG above Rs 228 levels with a stop loss of Rs 203 for higher targets of Rs 275 as indicated in above chart.

The author is Head - Technical Research, Narnolia Financial Advisors.

Disclosure: Narnolia Financial Advisors/Analyst (s) does/do not have any holding in the stocks discussed but these stocks may have been recommended to clients in the past. Clients of Narnolia Financial Advisors Ltd. may be holding aforesaid stocks. The stocks recommended are based on our analysis which is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/story-in-a-chart-inverse-head-and-shoulders-pattern-in-petronet-lng-suggests-buying-opportunity-5214581.html
"May 04, 2020 03:10 PM IST",2,Sandip Das,"Bharti Airtel share price jumps 3% after 4G deal with Nokia, volumes surge 77%","The stock was trading close to its all-time high of Rs 569 per share and was quoting at Rs 531.00, up Rs 16.65, or 3.24 percent at 14:40 hours.
“The Company already has a long term strategic partnership with Nokia since a decade for enhancement of the network capacity of its networks, amongst others.
As a part of its ongoing business requirements, the Company has renewed and enhanced its on-going relationship with Nokia to boost its network capacity and customer experience,” Bharti Airtel said in exchange filing.
According to Moneycontrol SWOT Analysis powered by Trendlyne Bharti Airtel has shown strong momentum with price above short, medium and long term moving averages.
Sameet Chavan of Angel Broking recommends buying Bharti Airtel with target price at Rs 560, an upside of 9 percent.","The scrip was one of the most active stocks on NSE in terms of value with 3,09,38,299 shares being traded.","Telecom major Bharti Airtel share prices jumped over 4 percent intraday on May 4 after Finnish telecom gear maker Nokia had announced signing a deal worth Rs 7,500 crore with the telecom service provider to enhance the mobile operator's network capacity in nine circles across the country.

The stock was trading close to its all-time high of Rs 569 per share and was quoting at Rs 531.00, up Rs 16.65, or 3.24 percent at 14:40 hours. It witnessed spurt in volume by more than 2.00 times and was trading with volumes of 891,425 shares, compared to its five day average of 501,323 shares, an increase of 77.81 percent.

“The Company already has a long term strategic partnership with Nokia since a decade for enhancement of the network capacity of its networks, amongst others. As a part of its ongoing business requirements, the Company has renewed and enhanced its on-going relationship with Nokia to boost its network capacity and customer experience,” Bharti Airtel said in exchange filing.

The scrip was one of the most active stocks on NSE in terms of value with 3,09,38,299 shares being traded.

According to Moneycontrol SWOT Analysis powered by Trendlyne Bharti Airtel has shown strong momentum with price above short, medium and long term moving averages.

The company has zero promoter pledge, and the book value is also improving for the last 2 years.

In terms of technical rating on Moneycontrol, it is very bullish.

Sameet Chavan of Angel Broking recommends buying Bharti Airtel with target price at Rs 560, an upside of 9 percent. He is of the view that the stock has been consolidating above the 50 and 89-EMA for the last few sessions and has now broken above this consolidation on the upside, confirming a continuation pattern known as ‘Pennant'. The momentum oscillator RSI is pointing northward after the recent dip, supporting the buy call.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/bharti-airtel-share-price-jumps-3-after-4g-deal-with-nokia-volumes-surge-77-5219251.html
"May 04, 2020 11:50 AM IST",-2,Kshitij Anand,HUL to underperform in short term given expensive valuations: Ashish Chaturmohta,"edited excerpts:Q) What is fuelling market rally on D-Street?
It needs to be seen that the market can sustain at current levels and some profit booking may be expected.
A) The HUL result was disappointing with a volume de-growth of 7 percent, the number not seen even during the demonetisation period.
In the short run, the stock is expected to underperform given the expensive valuations and poor quarterly performance.
However, in the medium term, HUL should farewell as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions.","In the medium term, HUL should farewell as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions.","HUL is expected to underperform given the expensive valuations and poor quarterly performance, but, in the medium term, HUL could do well as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions, Ashish Chaturmohta, Head of Technical and Derivatives, Sanctum Wealth Management., said in an interview with Moneycontrol's Kshitij Anand.

edited excerpts:

Q) What is fuelling market rally on D-Street?

A) As the coronavirus brought the global economy to a standstill, the market world over witnessed a rout. In April, bounce back was seen after a vertical fall.

Initially, it was led by defensive sectors like FMCG and Pharma. Recently, it was fueled by Auto and Commodity relief rally along with Banks and IT sector.

A) The Nifty50 has now retraced 50 percent of the whole decline, so the index is approaching a resistance zone in terms of retracement levels.

It needs to be seen that the market can sustain at current levels and some profit booking may be expected.

A) Though banking stocks have rallied recently, they are not out of the woods yet and are still within a range of 6 weeks. So, banks need to show follow-through action from here on for a fresh rally to emerge.

The auto sector was in pain long before the pandemic hit and was one the weakest sector. So, for now, it seems like a relief rally coming off a low base.

A) Relaxation in lockdown, economic policy measures, and how the activity at the ground is picking level is likely to dictate the market direction, going forward.

Results season has already started and it would provide a peek on how earnings will be impacted in next quarter.

A) The HUL result was disappointing with a volume de-growth of 7 percent, the number not seen even during the demonetisation period. Personal care and ice cream segments witnessed a soft demand leading to the weak performance of the company.

In the short run, the stock is expected to underperform given the expensive valuations and poor quarterly performance. However, in the medium term, HUL should farewell as it will be a key beneficiary of the rural demand recovery and one of the least impacted companies from COVID-19 led disruptions.

Tech Mahindra too disappointed the street with a 29 percent fall in earnings. COVID-19 led disruptions are bringing extraordinary changes in the business models of the IT industry. Hence, it will be important to see who all are able to adapt to the rapid changes.

While the stock has corrected by about 35 percent over the last two months, it not expected to rally in the near term in absence of any strong trigger.

A) RIL reported a resilient performance in all the segments even in this challenging quarter. The company also announced a rights issue of Rs 53,125 crore. This is a step towards the company's target of becoming a zero-net debt company by end of current fiscal.

Promoters are expected to fully subscribe to the rights issues which will instil confidence in investors' minds about promoters' commitment to the business in addition to improving the balance sheet strength. We believe investors should take this positively.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/markets/hul-to-underperform-in-short-term-given-expensive-valuations-ashish-chaturmohta-5214991.html
"May 04, 2020 11:46 AM IST",-2,Adit Minocha,Investor wealth plummets Rs 5.15 lakh crore in early trade as equities tank,"Investors witnessed a wealth erosion of Rs 5.15 lakh crore in BSE-listed companies in morning trade on Monday tracking a heavy selloff in the market, with benchmark Sensex plunging over 1,700 points.
The BSE barometer tanked 1,752.55 points to a low of 31,965.07 in the early trading session.
Led by the weak trend in the equity market, the market capitalisation of BSE-listed companies fell by Rs 5,15,308.99 crore to Rs 1,24,26,311.83 crore.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyDuring the last week that was holiday-shortened, the BSE barometer rallied 2,390.40 points or 7.63 per cent.","Investors witnessed a wealth erosion of Rs 5.15 lakh crore in BSE-listed companies in morning trade on Monday tracking a heavy selloff in the market, with benchmark Sensex plunging over 1,700 points.","Investors witnessed a wealth erosion of Rs 5.15 lakh crore in BSE-listed companies in morning trade on Monday tracking a heavy selloff in the market, with benchmark Sensex plunging over 1,700 points.

The BSE barometer tanked 1,752.55 points to a low of 31,965.07 in the early trading session.

Led by the weak trend in the equity market, the market capitalisation of BSE-listed companies fell by Rs 5,15,308.99 crore to Rs 1,24,26,311.83 crore.

ICICI Bank was the top laggard in the Sensex pack, tumbling nearly 9 per cent, followed by IndusInd Bank, Bajaj Finance, Tata Steel and HDFC.

Sun Pharma was the sole gainer in the BSE index.

The selloff in other Asian equities also played major lower in dragging sentiments lower.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

During the last week that was holiday-shortened, the BSE barometer rallied 2,390.40 points or 7.63 per cent.",https://www.moneycontrol.com/news/business/investor-wealth-plummets-rs-5-15-lakh-crore-in-early-trade-as-equities-tank-5218281.html
"April 30, 2020 11:07 AM IST",2,,Momentum plays: These 5 stocks could give 15-20% returns in 3 months,"Post the breakout price, it has retraced back to neckline level and formed a bullish pole and pennant continuation pattern on the daily chart.
The stock recently touched an all-time high of 18,500 on high volumes indicating buying participation in the stock.
After forming a bullish pole and pennant continuation pattern on the daily chart and now seeing a breakout.
The relative strength index has given a positive crossover with its average on the daily chart.
The relative strength index has given a negative crossover with its average on the daily chart.","Bearish Wedge pattern would be negated once the Nifty50 starts to trade above 9,600 levels on a sustainable basis. In that case, the Nifty can rally towards 9830 and 9970 levels on the upside.","Ashish Chaturmohta

The Nifty opened in the positive and then trended higher steadily throughout the day. But, profit-booking towards the closing trade saw the index settle closing off its highs on Wednesday.

The Nifty50 ended at 9,553. The broader market indices BSE Midcap and Smallcap underperformed the benchmark indices with a gain of 1 percent and 1.04 percent respectively for the day.

Though the Nifty50 has cleared the resistance of 9,400 levels, it continues to be in Bearish Rising Wedge pattern on the daily chart.

It (the pattern) would be negated once the Nifty50 starts to trade above 9,600 levels on a sustainable basis. In that case, the Nifty can rally towards 9830 and 9970 levels on the upside.

On the downside, if the Nifty50 breaks below 9300 levels, then it can see a deeper decline, as it would also confirm the breakdown of the ‘Wedge Pattern'. Thus, it can see a decline towards 9,100 and then towards 8,800 levels.

In Nifty May monthly expiry options, the maximum open interest for Put is seen at strike price 9,000 while Call maximum open interest is seen at 9500 and 10,000.

Since it is early it is early in the next series and open interest data is spread out to suggest any range. India VIX has seen major correction since March high of 86.6 to the current level of 34 which has been supporting the market in the up move.

Here is a list of top 5 stocks ideas which could give 15-20% return in the next 1-3 months:

Bharti Airtel Ltd: Buy| LTP: Rs 496| Stop loss: Rs 470| Target: Rs 600| Upside 20%

The stock has seen a major multi-year consolidation between 540 and 220 odd levels on the monthly chart. The last up move from the bottom end of the range has been on high volumes indicating accumulation at lower levels in the stock.

The recent correction from all-time of 569 has taken support at the 200-Days moving average around 400 odd levels. Also, in the process, the stock has retraced 61.8% Fibonacci retracement of the major rise from 254 to 569 levels.

On the short-term, the stock has formed a double bottom formation between 400 and 490 odd levels on the daily chart. Post the breakout price, it has retraced back to neckline level and formed a bullish pole and pennant continuation pattern on the daily chart.

Thus, the stock can be bought at current levels and on dips towards 485 with a stop loss below 470, and a target of 600 levels.

Abbott India Ltd: Buy| LTP: Rs 17,984| Stop Loss: Rs 17,100| Target: Rs 20,700| Upside 15%

The stock is in a long-term uptrend forming a higher top and a higher bottom formation on the daily as well as on the weekly chart.

In the month of March, the stock witnessed a correction and then immediately bounced back after taking support around the 100-Day moving average.

The stock recently touched an all-time high of 18,500 on high volumes indicating buying participation in the stock.

After forming a bullish pole and pennant continuation pattern on the daily chart and now seeing a breakout. Thus, indicating resumption of the uptrend.

The relative strength index has given a positive crossover with its average on the daily chart. Thus, the stock can be bought at current levels and on dips towards 17750 with a stop loss below 17100, and a target of 20700 levels.

Bajaj Finserv Ltd: Buy| LTP: Rs 4,997| Stop Loss: Rs 4750| Target: Rs 5,750| Upside 15%

The stock has seen a sharp correction from the all-time high of 9950 in January this year and then touched a low of 4160 in late March. Since then, the stock has been trading at lower levels and retesting the low holding above the low.

For the last five weeks, the stock has been trading in a range of 5100 and 4300 odd levels. Volumes during this period have been high indicating buying participation in the stock at lower levels.

Stochastic has moved above the oversold levels on the weekly chart indicating the stock is likely to see bounce-back rally after consolidation. Thus, the stock can be bought at current levels and on dips towards 4925 with a stop loss below 4750, for a target of 5750 levels.

Tata Consumer Products Ltd: Buy| LTP: Rs 354| Stop Loss: Rs 335 | Target: Rs 410| Upside 15%

The stock has touched an all-time high of 408 in early February this year and then hit a low of 214 in late March. Here, the stock took support at its 200-Week Moving Average which has acted as support on the previous major decline as well.

The recent fall in the stock has been on below-average volumes compared to high volumes on the up move – which indicates a corrective decline in the stock.

Now, the bounce-back has crossed key Fibonacci retracement of 61.8% of the fall 408 to 214. The relative strength index has given positive crossover with its average on the weekly chart.

Thus, the stock can be bought at current levels and on dips towards 349, with a stop loss below 335, and a target of 410 levels.

NTPC: Sell| LTP: Rs 90| Stop Loss: Rs 95| Target: Rs 75| Downside 16%

The stock is in a downtrend forming a lower top and lower bottom on the daily as well as on the weekly chart. The stock broke the key support level of 90 and then hit a low of 73.

Subsequent bounce back to 100 levels is facing resistance. Volumes on the decline were high indicating selling pressure while the recent rally from the lows was on low volumes.

The relative strength index has given a negative crossover with its average on the daily chart. Thus, the stock can be sold at current levels and on the rise towards 92, with a stop loss above 95, and a target of 75 levels.

(The author is Head of Technical and Derivatives, Sanctum Wealth Management)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/momentum-plays-these-5-stocks-could-give-15-20-returns-in-3-months-5205661.html
"April 30, 2020 10:04 AM IST",1,Sandip Das,Motherson Sumi shares jump 9% after Morgan Stanley maintains overweight call,"Share price of Motherson Sumi Systems jumped 9 percent in the morning trade on April 30 after global research firm Morgan Stanley maintained its overweight call on the stock with a target at Rs 103 per share.
It expects a sharp earnings recovery in FY22 as volumes normalise, according to a report by CNBC-TV18.
The company in a filing to the exchanges informed that more than half of its production facilities around the world have resumed operations.
Download a copy: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.
Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",The company in a filing to the exchanges informed that more than half of its production facilities around the world have resumed operations.,"Share price of Motherson Sumi Systems jumped 9 percent in the morning trade on April 30 after global research firm Morgan Stanley maintained its overweight call on the stock with a target at Rs 103 per share.

It expects a sharp earnings recovery in FY22 as volumes normalise, according to a report by CNBC-TV18.

The stock price has surged over 46 percent in the last one month and was quoting at Rs 88.85, up Rs 7.45, or 9.15 percent at 09:30 hours.

The company in a filing to the exchanges informed that more than half of its production facilities around the world have resumed operations. The leading auto component manufacturer assured that its workers are taking all necessary precautions.

The company in a statement on Wednesday said that more than 80 of its 152 manufacturing plants across the world have now operational. ""While 30 per cent of them are now running at more than 80 per cent capacities, rest of them are now running at up to 50 per cent capacities and slowly and steadily gearing up,"" Motherson Sumi said.

The board of auto components major has given in-principle approval to raise Rs 1,000 crore to enhance liquidity during uncertain times of coronavirus pandemic, according to a company statement.

Motherson Sumi Chairman Vivek Chaand said, ""Our team has done a phenomenal job in almost doubling MSSL's turnover over the last five years to USD 9.6 billion on an unaudited basis.”

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​",https://www.moneycontrol.com/news/business/stocks/motherson-sumi-shares-jump-9-after-morgan-stanley-maintains-overweight-call-5205981.html
"April 30, 2020 05:03 PM IST",1,Kshitij Anand,The Market Podcast | Pankaj Pandey lists out 10 companies with balance sheet strength to ride COVID-19 crisis,"There is strong uncertainty on how the future will pan out, but one thing is certain that companies with strong balance sheet strength should be able to ride out comfortably from the COVID-19 related story, Pankaj Pandey, Head of Research at ICICIdirect said in a ‘Market Podcast' with Moneycontrol.
If one looks at the brighter side of the situation, when it (COVID-19 lockdown) ends, will bring strong “pent up demand” across various sectors/business.
Hence, there are several dislocated opportunities across the “pent up demand” theme.
He lists out a few companies that will be direct beneficiaries of the above theme.
More importantly, companies have a track record of creating shareholder wealth across business cycles.",Tune in to The Market Podcast with Kshitij Anand to find out what transpired in the markets this week.,"There is strong uncertainty on how the future will pan out, but one thing is certain that companies with strong balance sheet strength should be able to ride out comfortably from the COVID-19 related story, Pankaj Pandey, Head of Research at ICICIdirect said in a ‘Market Podcast' with Moneycontrol.

If one looks at the brighter side of the situation, when it (COVID-19 lockdown) ends, will bring strong “pent up demand” across various sectors/business. Hence, there are several dislocated opportunities across the “pent up demand” theme.

He lists out a few companies that will be direct beneficiaries of the above theme. The universe of stocks that we would like to bet have the following in common –

a) Strong brands and products with an established distribution network coupled with reasonable pricing power

b) Credible management and clean governance record, who have seen such turbulence in the past and have come out stronger from such a crisis

c) From a financial perspective, these companies have solid balance sheets coupled with the ability to generate strong cash flows and comfortable leverage profiles.

More importantly, companies have a track record of creating shareholder wealth across business cycles.",https://www.moneycontrol.com/news/podcast/the-market-podcast-pankaj-pandey-lists-out-10-companies-with-balance-sheet-strength-to-ride-covid-19-crisis-5202201.html
"April 30, 2020 12:39 PM IST",1,Sunil Matkar,Glenmark Pharma share price up 9% on nod to trials for possible COVID-19 drug,"Glenmark Pharma share price gained 9 percent intraday on April 30 after the company received approval from the Indian health regulator to conduct clinical trials for Favipiravir antiviral tablets for COVID-19.
Glenmark is the first pharmaceutical company in India to be given approval by the regulator to start the trial on COVID-19 patients in the country.
The company had received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir antiviral tablets on COVID-19 patients, Glenmark said in BSE filing.
Download a copy""After having successfully developed the API and the formulations through its in-house R&D team, Glenmark is all geared to immediately begin clinical trials on Favipiravir on COVID-19 patients in India.
The clinical trial will let us know the efficacy of this molecule on COVID-19 patients,"" said Sushrut Kulkarni, Executive Vice President – Global R&D.","Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections, the company has said.","Glenmark Pharma share price gained 9 percent intraday on April 30 after the company received approval from the Indian health regulator to conduct clinical trials for Favipiravir antiviral tablets for COVID-19.

The stock, which has rallied 70 percent during the month, was trading at Rs 342.55, up Rs 12.85, or 3.90 percent, on the BSE at 1201 hours.

Glenmark is the first pharmaceutical company in India to be given approval by the regulator to start the trial on COVID-19 patients in the country.

The company had received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir antiviral tablets on COVID-19 patients, Glenmark said in BSE filing.

The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation.

Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections, the Mumbai-based company said.

Having internally developed the API and the formulations for the product, Glenmark filed the product for clinical trials with the DCGI and got the go-ahead for conducting the trial on mild to moderate patients, it said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

""After having successfully developed the API and the formulations through its in-house R&D team, Glenmark is all geared to immediately begin clinical trials on Favipiravir on COVID-19 patients in India. The clinical trial will let us know the efficacy of this molecule on COVID-19 patients,"" said Sushrut Kulkarni, Executive Vice President – Global R&D.",https://www.moneycontrol.com/news/business/markets/glenmark-pharma-share-price-up-9-on-nod-to-trials-for-possible-covid-19-drug-5206711.html
"April 30, 2020 10:01 AM IST",1,,RIL share price rises 2% ahead of March quarter earnings,"Reliance Industries (RIL) share price rose 2 percent in early trade ahead of its March quarter earnings.
The company's January-March quarter earnings are expected to get strong support from Jio business, though refining business could see some decline due to fall in oil prices and nationwide lockdown, according to brokerages.
Brokerages feel the consolidated profit and revenue may see marginal decline sequentially due to some weakness in the refining business, but margin may get support from petrochemicals and telecom segments.
Also Read - RIL to report Q4 earnings today: Jio business expected to support numbersGross refining margin for the quarter is likely to be around $8.0 a barrel against $9.2 a barrel in December quarter 2019.
At 09:33 hrs Reliance Industries was quoting at Rs 1,445.95, up Rs 19.75, or 1.38 percent on the BSE.",Gross refining margin for the quarter is likely to be around $8.0 a barrel against $9.2 a barrel in December quarter 2019.,"Reliance Industries (RIL) share price rose 2 percent in early trade ahead of its March quarter earnings.

The company's January-March quarter earnings are expected to get strong support from Jio business, though refining business could see some decline due to fall in oil prices and nationwide lockdown, according to brokerages.

Brokerages feel the consolidated profit and revenue may see marginal decline sequentially due to some weakness in the refining business, but margin may get support from petrochemicals and telecom segments.

Also Read - RIL to report Q4 earnings today: Jio business expected to support numbers

Gross refining margin for the quarter is likely to be around $8.0 a barrel against $9.2 a barrel in December quarter 2019.

At 09:33 hrs Reliance Industries was quoting at Rs 1,445.95, up Rs 19.75, or 1.38 percent on the BSE.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Reliance Industries Ltd, which owns Jio, is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.",https://www.moneycontrol.com/news/business/stocks/ril-share-price-rises-2-ahead-of-march-quarter-earnings-5206121.html
"April 30, 2020 09:57 AM IST",-1,Rakesh Patil,Hexaware Technologies share price falls 3% post result; Morgan Stanley raises target,"Hexaware Technologies share price fell 3 percent in early trade on April 30 after the company announced its March quarter earnings.
The company has reported a 4.7 percent sequential increase in consolidated profit at Rs 174.96 crore in the first quarter of CY20, driven by forex gains.
The company's profit in the previous quarter stood at Rs 167.8 crore.
Forex gains for the quarter were at Rs 43.41 crore against Rs 0.38 crore in the December quarter.
Also Read - Hexaware Q1 sequential profit up 4.3%, suspends FY20 guidanceMorgan Stanley has maintained equal-weight rating on the stock and raised the target to Rs 275 from Rs 250 per share.",Motilal Oswal has downgraded EPS estimates over FY21–22E by 13–15%. The stock is currently trading at 15x Mar'21 E EPS.,"Hexaware Technologies share price fell 3 percent in early trade on April 30 after the company announced its March quarter earnings.

The company has reported a 4.7 percent sequential increase in consolidated profit at Rs 174.96 crore in the first quarter of CY20, driven by forex gains.

The company's profit in the previous quarter stood at Rs 167.8 crore. Forex gains for the quarter were at Rs 43.41 crore against Rs 0.38 crore in the December quarter.

The company follows the calendar year (January-December) as its financial year.

Revenue from operations grew by 0.8 percent quarter-on-quarter to Rs 1,541.75 crore, but dollar revenue declined 1.7 percent to $210.6 million and revenue degrowth in constant currency was at 1.1 percent QoQ.

Also Read - Hexaware Q1 sequential profit up 4.3%, suspends FY20 guidance

Morgan Stanley has maintained equal-weight rating on the stock and raised the target to Rs 275 from Rs 250 per share.

The company sees an opportunity to gain a market share. The margin weakness could continue in the near term, said Morgan Stanley.

We see limited catalysts in the near term and trim CY20 EPS estimate 4.8%, but largely maintain C21/C22 EPS estimate, it added.

Morgan Stanley expects longer-term revenue growth better than some of the peers.

Motilal Oswal has downgraded EPS estimates over FY21–22E by 13–15%. The stock is currently trading at 15x Mar'21 E EPS.

It has maintained a neutral rating with a target of Rs 306. The target price is based on 13x Mar'22E EPS.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Relatively weaker commentary (v/s that of peers) and the possibility of a further downside in certain key accounts may keep multiples under check. Additionally, a heavier balance sheet and the overhang around an impending stake sale by Barings should further weigh on multiples, it added.",https://www.moneycontrol.com/news/business/stocks/hexaware-technologies-share-price-falls-3-post-result-morgan-stanley-raises-target-5205751.html
"May 01, 2020 08:59 AM IST",2,Kshitij Anand,Consumer discretionary & pharma to lead the next bull run; 20 stocks in Morgan Stanley focus list,"Sectors such as consumer discretionary, healthcare, and energy may lead the next big bull market replacing financial and consumer staples that have lead the charge in the past, Morgan Stanley said in a strategy note.
“In our view, financials and consumer staples, which led the previous bull market, may give way to consumer discretionary and healthcare,” the note said.
Meanwhile, the re-rating of consumer staples has taken the sector's metrics to well over 2-SD above their 20-year average.
“But, if history is a guide, the leadership of the next bull market could shift to consumer discretionary and healthcare.
It also fits the description of being unloved, under-owned, and undervalued,” said the note.","Morgan Stanley removed Godrej Consumer, HDFC, and MCX from their focus list, and added Sun Pharma, Apollo Hospitals, and Lupin to the list.","Sectors such as consumer discretionary, healthcare, and energy may lead the next big bull market replacing financial and consumer staples that have lead the charge in the past, Morgan Stanley said in a strategy note.

“In our view, financials and consumer staples, which led the previous bull market, may give way to consumer discretionary and healthcare,” the note said.

For the past seven years, financials have been investors' favorite sector, representing almost 30 percent of the Nifty market cap at the peak. Meanwhile, the re-rating of consumer staples has taken the sector's metrics to well over 2-SD above their 20-year average.

“But, if history is a guide, the leadership of the next bull market could shift to consumer discretionary and healthcare. These sectors are unloved, under-owned, and undervalued based on the metrics we have used,” highlighted the note.

The rational which the global investment bank gave behind the analysis is that both sectors are underweighted in institutional portfolios, have lost share in the Nifty's market cap, are reporting profitability well below history, and are trading below historical average relative to valuations.

Fundamentally, the outlook for both shall improve in the coming months. “The third sector that deserves mention is energy. It also fits the description of being unloved, under-owned, and undervalued,” said the note.",https://www.moneycontrol.com/news/business/technicals/consumer-discretionary-20-stocks-in-morgan-stanley-focus-list-5208841.html
"May 02, 2020 11:13 AM IST",2,Kshitij Anand,Two stocks doubled while 19 rose over 50% in BSE500 in April lockdown mania,"Sensex and Nifty50 rallied more than 14 percent each in April during the lockdown boosting both the indices above their crucial resistance levels.
The S&P BSE Smallcap index was up 15.54 percent while the S&P BSE Midcap index gained 13.66 percent during the same period.
Riding the momentum, two stocks in BSE500 index more than doubled in April - Jain Irrigation Systems, and Reliance Infrastructure.
And, as many as 19 stocks rose more than 50 percent in the same period.
This is the highest series to series gain since May 2009.",Investors' wealth rose by nearly Rs 16 lakh cr in a month. The average market capitalisation of the BSE-listed companies grew from Rs 113.48 lakh cr as on March 31 to Rs 129.41 lakh cr recorded on April 30.,"What a month! Sensex and Nifty50 rallied more than 14 percent each in April during the lockdown boosting both the indices above their crucial resistance levels. The S&P BSE Sensex reclaimed 33,000 while the Nifty50 is back above 9,800.

The broader markets performed largely in line with benchmark indices. The S&P BSE Smallcap index was up 15.54 percent while the S&P BSE Midcap index gained 13.66 percent during the same period.

Riding the momentum, two stocks in BSE500 index more than doubled in April - Jain Irrigation Systems, and Reliance Infrastructure.

And, as many as 19 stocks rose more than 50 percent in the same period. These include Aurobindo Pharma, Ashoka Buildcon, Laurus Labs, CESC, Reliance Power, Reliance Capital.

Investors' wealth rose by nearly Rs 16 lakh cr in a month. The average market capitalisation of the BSE-listed companies grew from Rs 113.48 lakh cr as on March 31 to Rs 129.41 lakh cr recorded on April 30.

Selling by foreign institutional investors also slowed in April which supported the sentiment. FIIs were net sellers for a little over Rs 5000 cr in the cash segment of Indian equity markets compared to over Rs 65000 cr selloff in March.

More than 50 percent of the BSE500 stocks outperformed the S&P BSE Sensex in April, and as many as 37 stocks hit their fresh 52-week high in the same period that includes names like Asian Paints, HUL, AU Small Finance Bank, Dabur India, Sun Pharma, Alembic Pharma, and Laurus Labs, etc. among others.

Although new cases spiked from 146 as on March 31 to 1823 as on April 30, according to India COVID-19 tracker, but D-Street took comfort from the various stimulus packages announced by central bankers across the globe including India, say experts.

“Indian markets cheered on hopes of another possible fiscal stimulus from the Indian government. Emerging markets like Thailand, Malaysia, and developed markets like the US have supplemented their economies with stimulus packages in the range of 10-15 percent of their GDP which has triggered markets and brought about the strong retracement from the lows,” Umesh Mehta, Head of Research, Samco Securities told Moneycontrol.

“Hence, the current market rally in India is nothing more than a globally orchestrated rally. Going head markets would largely take cues from any updates on the lifting of the extended lockdown, quantum and coverage of the possible stimulus package from our government as well as domestic mutual fund's behavior,” he said.

Technical View:

The Nifty50 broke the four series losing streak as it gained 14 percent in the April series. This is the highest series to series gain since May 2009.

The Nifty50 continued to form higher highs – higher lows for the fourth consecutive week and formed a bullish candle on both weekly and monthly scale.

“Now, the 50% retracement level of the entire fall from 12430 to 7511 levels, which is placed at 9970, would be immediate hurdle for the Nifty and a sustainable move above the same may pull the index towards 10200 - 10300 levels,” Chandan Taparia, Derivative & Technical Analyst, Motilal Oswal Financial Services Ltd told Moneycontrol.

“On the flipside, downside support is shifting higher to 9700 and then 9400 levels. Traders are advised to trade with positive bias till the time Nifty holds above 9700 zone,” he said.

Since it is the beginning of the May monthly series, open interest (OI) activity is scattered at various strikes. The maximum Call OI is placed at 9500, and then towards 10,000 strikes while maximum Put OI is placed at 9,000, and then towards 8,500 strikes.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/two-stocks-doubled-while-19-rose-over-50-in-bse500-in-april-lockdown-mania-5212441.html
"May 02, 2020 08:10 AM IST",1,Kshitij Anand,Investors' can hold HUL post March quarter results; sell Tech Mahindra: Umesh Mehta,"A) Indian markets cheered on hopes of another possible fiscal stimulus from the Indian government.
A) Quarterly earnings of HDFC Bank, Axis Bank, and IndusInd Bank were not as bad as the Street expected.
Tech Mahindra disappointed investors with its quarterly numbers wherein profits fell around 30 percent and revenue declined 1.70 percent.
The pandemic and consequent lockdown in India and across the globe has disrupted the IT industry which will impact Tech M's revenue too.
It would be advisable to SELL Tech Mahindra as there are other large players which would provide better-investing opportunities going forward.","HUL's quarterly show missed Street estimates on an overall front and the underlying volumes contracted by 7 percent as demand fell due to the COVID-19 lockdown, the highest decline since demonetization quarter.","HUL's resilient business model, low debt and healthy balance sheet would help steer the company through these tough times, investors are advised to hold this stock from a long-term perspective, Umesh Mehta, Head of Research, Samco Securities, said in an interview with Moneycontrol's Kshitij Anand.

edited excerpts:

Q) A strong day to end the week! The Sensex is back above 33,000 while Nifty50 reclaimed 9,800. What is fuelling market rally on D-Street?

A) Indian markets cheered on hopes of another possible fiscal stimulus from the Indian government. Emerging markets like Thailand, Malaysia, and developed markets like the US have supplemented their economies with stimulus packages in the range of 10-15 percent of their GDP which has triggered markets and brought about the strong retracement from the lows. Hence, the current market rally in India is nothing more than a globally orchestrated rally.

Q) As we close the month of April on a positive note after a massacre in March – how is May likely to pan out for investors. There is a very popular Wall Street adage ‘Sell in May and Go Away'? Do you think we could hold onto gains if not why?

A) Given that Indian markets' sentiment is largely driven by sentiments in the global markets, especially the US market, the month of May could be possibly driven by sentiments in the global economy.

One cannot ignore the fact that Indian market participants are dearly waiting for a big fiscal stimulus package 2.0 and given the limitations government have with its finances, not much is expected which can keep prices under pressure.

To add to it, once the lockdown ends, bourses might factor in the ground reality which isn't rosy.

A) Quarterly earnings of HDFC Bank, Axis Bank, and IndusInd Bank were not as bad as the Street expected. And therefore, the rally which was witnessed in financials was an event-driven relief rally.

In addition to this, the management of Axis Bank stated that only 10-12 percent of the bank's borrowers by number have opted for a moratorium and HDFC Bank too provided similar numbers; however, they are hopeful that if lockdown gets lifted quickly the ground level situation may start to normalise.

Moving on to the auto stocks, even before this lockdown, the auto industry was going through its worst phase, but nonetheless, it is expected that an adequate government stimulus might address this sector's difficulty.

Given the oversold levels with the slightest news of production approval at some factories, investors jumped right in to accumulate stocks at reasonable valuations.

A) Going head, the markets would largely take cues from any updates on the lifting of the extended lockdown, quantum and coverage of the possible stimulus package from our government as well as domestic mutual fund's behaviour from the reported inflows and outflows for the month of April.

A) HUL's quarterly show missed Street estimates on an overall front and the underlying volumes contracted by 7 percent as demand fell due to the COVID-19 lockdown, the highest decline since demonetisation quarter.

The profit declined 1.20 percent on a YoY basis to Rs 1,519 crore for the quarter ended March whereas revenue fell 9.4 percent to Rs 9,011 crore largely due to the disruption in supply in March.

However, HUL's resilient business model, low debt and healthy balance sheet would help steer the company through these tough times, investors are advised to hold this stock from a long-term perspective.

Tech Mahindra disappointed investors with its quarterly numbers wherein profits fell around 30 percent and revenue declined 1.70 percent. During the year, the company's margins narrowed 450 basis points to 7.70 percent.

The pandemic and consequent lockdown in India and across the globe has disrupted the IT industry which will impact Tech M's revenue too. It would be advisable to SELL Tech Mahindra as there are other large players which would provide better-investing opportunities going forward.

A) Since Reliance Industries is a conglomerate, certain business segments have performed and surpassed expectations while some have disappointed. Excellent performance by Reliance Jio with ARPU coming in at Rs 130.6 has further offset the poor performance of Petrochemicals and Retail.

But, on a whole, the result was largely in line with the market's views. However, the rights issue ratio of 1:15 at a price of Rs, 1257 per share is slightly overpriced which might cause a challenge to attract retail investors, and hence there can be a slight dip in its stock on Monday.

Investors holding it for a long term horizon of 3-5 years can remain invested as the efforts to reduce debt, digital growth, deal with Facebook, etc. are all positives for the company.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/investors-can-hold-hul-post-march-quarter-results-sell-tech-mahindra-umesh-mehta-5211151.html
"May 01, 2020 01:06 PM IST",2,Sunil Matkar,'SBI Card among 3 companies that can re-capture lost ground',"Also, we believe SBI Cards and Payment Services is another company to look into.
Thus, it is quite clear that a good recovery for the credit card industry is expected.
Already, SBI Card has narrowed the borrowing limit.
Therefore, altogether the risk of NPA for the credit card industry seems better than others.
Thus, SBI Card being the sole listed player in terms of the credit card industry with extensive credit card portfolio would regain strength.","Given the uncertainties surrounding COVID-19, change in consumer behavior is much likely & thus the value for insuring oneself would be acknowledged as a pure risk cover rather than just an investment product.","Manali Bhatia

The current situation demands of investment opportunities in various stocks or sectors that one can look into. Valuations for most companies have dropped to nearly 50 percent making them lucrative.

Clearly, it's the right time for investment opportunities. But, in which stocks and sectors, is the question.

The global markets are settling now as the number of cases abroad is saturating. In India too, expected easing of restrictions in tranches is may fuel market further. A stimulus package has already been announced and another one is likely soon. Thus, at this time it is prudent to invest in a well-diversified portfolio consisting of strong fundamentals, healthy ratios and one which has the potential to re-energise post lockdown.

Given the uncertainties surrounding COVID-19, change in consumer behavior is much likely & thus the value for insuring oneself would be acknowledged as a pure risk cover rather than just an investment product. As a result, this would lead to higher demand for high margin protection products in the future. Thus, investment in such companies would give healthy returns once the market gets back on track.

ICICI Prudential Life is a leader in private sector life insurance companies in India with an AUM (assets under management) of Rs 1.71 lakh crore and in-force sum assured of approximately Rs 13.60 lakh crore. Its strong brand, robust distribution network, sustainable business model, and high persistency ratio adds competitive strength to its business model. In the next 3-4 years, the VNB (value of new business) is expected to double.

Similarly, Nippon Life Asset Management, being the sole promoter of Nippon India (75 percent holding) & given its credibility worldwide, shall remain stable. No doubt, the pandemic is likely to create a deep impact on profitability and earnings. But, we believe Nippon can shape up again in the next 3-6 months. It's true that whole Mutual fund industry cannot collapse, though revenue streams and cash flows may get minimal to some extent. Therefore, the near term outlook seems challenging but, we believe the industry will reclaim its lost ground with meaningful pick up in asset growth over the long term. In fact, growing consumer traction towards investment in financial assets, limited players, low penetration, huge market potential, high return ratios and zero debt, could lead the stock to higher levels but all this will happen in long term.

Also, we believe SBI Cards and Payment Services is another company to look into. It has the highest credit rating with AAA/stable rating (as per ICRA & Crisil). FIIs had increased stake from 3.53 percent (at the time of listing) to 4.03 percent (at the end of March), and DIIs to 3.04 percent from 1.6 percent. It is making up plans for special focus on online spends post lockdown. Generally, credit cardholders belong to educated, high rated and corporate clients having the capability to repay dues on time (especially for short term).

Thereby, a credit card holder would repay dues on priority rather than taking moratorium announced by RBI as one has to pay a huge interest of around 40-45 percent annually or 3-3.5 percent monthly. Instead, would prefer moratorium on term loans by banks or other financial institutions where the interest of 9-10 percent is being charged annually. Thus, it is quite clear that a good recovery for the credit card industry is expected.

Already, SBI Card has narrowed the borrowing limit. Therefore, altogether the risk of NPA for the credit card industry seems better than others. Though, the credit card industry is looking weak in the near term due to cautious discretionary spends, in the longer-term, as the businesses resume operations, we believe this industry will pick up pace.

Thus, SBI Card being the sole listed player in terms of the credit card industry with extensive credit card portfolio would regain strength.

(The author is Senior Research Analyst at Rudra Shares & Stock Brokers.)

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/sbi-cards-among-3-companies-that-can-re-capture-lost-ground-5210741.html
"April 30, 2020 06:56 PM IST",2,Kshitij Anand,"RIL to raise Rs 53,000 crore via 1:15 rights issue at Rs 1,257 a share","Reliance Industries (RIL) has announced fundraising of Rs 53,125 crore by way of a 1:15 rights issue, the company said in a statement on the BSE announcing its quarterly and annual results.
One share will be offered for every 15 shares held at Rs 1,257, a 14 percent discount to the closing price for April 30.
The board of directors kept the issue price at Rs 1,257 per equity share which is 14.31 percent discount to Thursday's closing price of Rs 1,467 on the BSE.
Rights Entitlement Ratio: 1 equity share for every 15 equity shares held by eligible shareholders as on the record date.
On April 22, Reliance Industries, Jio Platforms, and Facebook Inc signed binding agreements for an investment of Rs 43,574 crore by Facebook into Jio Platforms.","The board of directors kept the issue price at Rs 1,257 per equity share which is 14.31 percent discount to Thursday's closing price of Rs 1,467 on the BSE.","Reliance Industries (RIL) has announced fundraising of Rs 53,125 crore by way of a 1:15 rights issue, the company said in a statement on the BSE announcing its quarterly and annual results.

One share will be offered for every 15 shares held at Rs 1,257, a 14 percent discount to the closing price for April 30.

The board of directors kept the issue price at Rs 1,257 per equity share which is 14.31 percent discount to Thursday's closing price of Rs 1,467 on the BSE.

Rights Entitlement Ratio: 1 equity share for every 15 equity shares held by eligible shareholders as on the record date.

The stock closed nearly 3 percent higher at Rs 1,467 on the BSE.

""We are fully committed on our investment plans in our consumer businesses and new initiatives. We are at the doorsteps of a huge opportunity and our rights issue and all other equity transactions will strengthen Reliance and position us to create substantial value for all our stakeholders,"" Mukesh D. Ambani, Chairman and Managing Director, Reliance Industries Limited said in the release.

On April 22, Reliance Industries, Jio Platforms, and Facebook Inc signed binding agreements for an investment of Rs 43,574 crore by Facebook into Jio Platforms.

Also Read: RIL Q4: Exceptional loss drags profit to Rs 6,348 crore

Reliance Industries, the country's largest listed company by market capitalisation on April 30 reported a consolidated profit of Rs 6,348 crore during January-March quarter 2020, registering a decline of 45.5 percent QoQ and 38.7 percent YoY.

Note: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/ril-aims-to-raise-rs-53000-cr-via-115-rights-issue-price-set-at-14-discount-5208331.html
"April 30, 2020 11:46 AM IST",2,Sandip Das,"D-Street Buzz: Nifty Auto spikes 5% led by Tata Motors; Bharat Forge, Motherson Sumi up 11-12%","Sensex jumped 978.91 points or 2.99 percent at 33699.07, and the Nifty spiked 279.70 points or 2.93 percent at 9833.05.
The auto index is the outperforming sector, up over 5 percent as auto companies have started resuming partial manufacturing activities after over a month of lockdown.
Share price of Bharat Forge gained 12 percent while Hero MotoCorp, Ashok Leyland and Mahindra & Mahindra are the other gainers.
It was trading with volumes of 49,258 shares, compared to its five day average of 42,994 shares, an increase of 14.57 percent.
Brokerage firm Geojit Financial Services has a buy on Maruti Suzuki with target at Rs 6,100 while Kotak Securities has a buy on Mahindra & Mahindra with target at Rs 625 per share.","Nifty Auto jumped over 5 percent led by Tata Motors, Bharat Forge, Motherson Sumi Systems and Ashok Leyland.","The Indian stock market jumped 3% to a near seven-week high as global sentiment improved on promising early results from a COVID-19 treatment trial.

Sensex jumped 978.91 points or 2.99 percent at 33699.07, and the Nifty spiked 279.70 points or 2.93 percent at 9833.05.

The auto index is the outperforming sector, up over 5 percent as auto companies have started resuming partial manufacturing activities after over a month of lockdown.

Among the gainers, Tata Motors shares surged over 13 percent and has touched upper circuit of Rs 85.95 per share at 11:15 hours with around 6,84,48,108 shares changing hands. The stock price gained over 29 percent in the last 1 month and was trading with volumes of 2,912,598 shares, compared to its five day average of 2,390,654 shares, an increase of 21.83 percent.

The other gainers included Motherson Sumi Systems which jumped 10 percent after global research firm Morgan Stanley maintained its overweight call on the stock with target at Rs 103 per share. It expects a sharp earnings recovery in FY22 as volumes normalise, according to a report by CNBC-TV18. The stock touched upper circuit of Rs 89.50 per share and was trading with volumes of 1,528,296 shares, compared to its five day average of 1,262,703 shares, an increase of 21.03 percent.

Share price of Bharat Forge gained 12 percent while Hero MotoCorp, Ashok Leyland and Mahindra & Mahindra are the other gainers. Bajaj Auto was up over 3 percent. The company's Managing Director Rajiv Bajaj, on April 29 said the company will resume operations at plants only when dealerships open up, adding that he expects the two-wheeler manufacturer to operate at about 50 percent capacity next month.

Share price of Maruti Suzuki was up over 4 percent with the stock gaining over 22 percent in the last 1 month. It was trading with volumes of 49,258 shares, compared to its five day average of 42,994 shares, an increase of 14.57 percent.

Brokerage firm Geojit Financial Services has a buy on Maruti Suzuki with target at Rs 6,100 while Kotak Securities has a buy on Mahindra & Mahindra with target at Rs 625 per share.

Among the auto names, the stocks which hit upper circuit included Mahindra CIE Automotive, Amforge Industries, Varroc Engineering, Tirupati Tyres, JMT Auto, Sintercom India and Metalyst Forgings.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/stocks/d-street-buzz-nifty-auto-spikes-5-led-by-tata-motors-bharat-forge-motherson-sumi-up-11-12-5206531.html
"April 30, 2020 11:15 AM IST",1,Kshitij Anand,Promoters raise stake in over 60 companies in past 2 years; worth a look?,"Insider buying/selling by promoters/ promoter groups is on many occasions a lead indicator guiding investor decision making.
These include Bajaj Auto, GMR Infra, IDFC First Bank, JSW Steel, Sun Pharma, Tata Steel, Tata Power, and Tata Chemicals.
However, the circumstances in which the stake was increased or decreased should be analyzed before making an investment decision, suggest experts.
Not all companies in which promoters raised stake are strong fresh buys, suggest experts.
“There is no golden rule that investors need to reduce their holding as soon as the promoters cut stake.",Theory suggests that an increase in promoter holding is usually considered as a positive sign while a decrease is usually considered negative.,"Making a buy or sell decision is the most crucial task in building your portfolio. One of the ways in which investors can make a buy or a sell decision is by analyzing what the promoter of the company is doing. Insider buying/selling by promoters/ promoter groups is on many occasions a lead indicator guiding investor decision making. Close LKP Securities has compiled Insider Data for the past 28 months beginning January 2018 so as to present few interesting insights in which there are 23 companies in which promoters have reduced stake, and there are over 60 companies in which promoters have raised stake in the same period. related news India in a Bear Market! We continue to focus on LQV companies for investments: Unmesh Kulkarni

'US-China trade war noise likely to be high given US elections this year'

Investors lose Rs 36 lakh crore since Jan; experts say allocate 35-60% portfolio to equities There are as many as 66 companies in which promoters have raised stake since 2018. These include Bajaj Auto, GMR Infra, IDFC First Bank, JSW Steel, Sun Pharma, Tata Steel, Tata Power, and Tata Chemicals. An increase or decrease in promoter holding brings stocks under investors' radar. Theory suggests that an increase in promoter holding is usually considered as a positive sign while a decrease is usually considered negative. However, the circumstances in which the stake was increased or decreased should be analyzed before making an investment decision, suggest experts. “When promoters raise stakes in companies like Tata Power at such low levels it provides confidence to investors who are rattled with the steep fall witnessed in the stock price of Tata Power,” S Ranganathan, Head of Research at LKP Securities told Moneycontrol. “Similarly, when SME companies like Sripipes witness promoter buying it tends to boost the confidence of investors. The buying seen in large groups like the Bajaj Group is also a pointer towards the confidence displayed by promoters in such times,” he said. Ranganathan further added that other factors that an Investor should keep in mind while pressing the ‘buy' button after looking at promoter buying include capital allocation policies in the business which many times do not capture in return ratios.

Not all companies in which promoters raised stake are strong fresh buys, suggest experts. If you already hold them in their portfolio then you could hold on to them. The promoters increasing stake in their respective companies is an encouraging sign for the investor as it showcases confidence from the promoter in its business. But, it should not be the only criteria, and investors should use other parameters such as valuations and industry-specific factors before pressing the buy button. “Considering the current volatile scenario, we would recommend investors to gradually accumulate some of the prominent names like Bajaj Auto, HCL Tech, Asian Paints, Berger Paints, Dabur India, Tata Chemical, and Tata Steel,” Ajit Mishra, VP Research, Religare Broking Ltd told Moneycontrol. “Even though some of these companies are cyclical, we believe that with their strong fundamental track record, strong parentage, these companies would be able to wither the storm,” he said. Promoters reducing stake: There are as many as 23 companies excluding PSUs in which promoters have reduced stake since 2018 that include names like ZEE Entertainment, Wipro, M&M, Lux Industries, Emami, Axis Bank, and Bajaj Consumer Care etc. among others.

The promoter offloading its stake from his company is certainly not a good sign. However, there are various other reasons why promoters could have reduced the stake, and investors should not base their decision based on just one parameter. “There is no golden rule that investors need to reduce their holding as soon as the promoters cut stake. Since it could be due to regulatory requirements, deleverage, to bring in new investors, to raise capital, etc. which may be positive for the stocks,” Vinod Nair, Head of Research at Geojit Financial Services told Moneycontrol. “So better look for reasons like pledging, funding issue of promoters or group and weak outlook which is very negative for the stock,” he said. Mishra of Religare Broking highlighted three scenarios under which promoters could raise the stake. In the first category, there are companies where promoter holding is greater than 75 percent thus they need to abide by the rules of bringing it to 75 percent levels and there is nothing to worry about. “However, in the second category, the promoter is selling a stake in companies such as Emami, Jyothy labs, Zee Entertainment, Lux Industries, Liberty shoes as there are facing high debt issues and the promoters have pledged their shares,” said Mishra. “And, lastly, there could be a case wherein the promoters are consistently reducing their stake. Investors should maintain extra caution with their existing investment in the companies which fall under category 2 and 3 and should try and reduce their investment as they tend to underperform the markets in the long run and also witness extreme volatility,” he explained.

Note: The tables are for reference only and not buy or sell ideas

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/promoters-raise-stake-in-over-60-companies-in-past-2-years-worth-a-look-5201281.html
"May 01, 2020 12:01 PM IST",1,Nishant Kumar,Brokerages recommend these 12 stocks in time of uncertainty; do you own any?,"With no relief in sight, investors must look for stocks that have the potential to endure the pain.
From a long-term perspective, brokerages suggest these 12 stocks that can give you healthy returns.
Maruti Suzuki | Buy | LTP: Rs 5,055 | Target price: Rs 7,400 | Upside: 46%Maruti is one of the best stocks in the domestic passenger vehicle segment.
Alkem Laboratories | Buy | LTP: Rs 2,661.95 | Target price: Rs 3,300 | Upside: 24%As much as 67 percent of revenue comes from domestic generic and API business.
Dr. Reddy's Laboratories | Buy | LTP: Rs 3,882 | Target price: 4,382 | Upside: 13%Apart from a strong product profile, the company benefits from a diverse geographic presence.",Experts point out that the COVID-19 pandemic came in stages across the world and its fading away also will happen in phases over the next few quarters.,"As the coronavirus pandemic continues to inflict pain on the market and the economy, there is much uncertainty as to when COVID-19 will come under control.

At this juncture, it seems that the pain will linger and there are tougher days ahead for the businesses and the economy.

Experts point out that the COVID-19 pandemic came in stages across the world and its fading away also will happen in phases over the next few quarters.

With no relief in sight, investors must look for stocks that have the potential to endure the pain.

""Investors should look for quality with reasonable growth in businesses. Lower debt and higher cash generation companies will be better placed,"" said Vikas Jain, Senior Research Analyst at Reliance Securities.

From a long-term perspective, brokerages suggest these 12 stocks that can give you healthy returns. Take a look:

Analyst: Vikas Jain, Senior Research Analyst at Reliance Securities

Bharti Airtel | Buy | LTP: Rs 493 | Target price: 700 | Upside: 42%

The company is a beneficiary of being an emerging duopoly with large subscriber base and regular price hikes, higher data consumption with respect to work from home (WFH), digital payments and OTT

platforms.

Lesser capex requirements in the near future is also a key positive for the stock.

""It has scaled an all-time high breaking its 10-year range with strong volumes and recent correction provides a good opportunity for the target of Rs 700 levels over the next 2 years,"" said the analyst.

HDFC Bank | Buy | LTP: Rs 970.05 | Target price: 1,200 | Upside: 24%

One of the best stocks to own in the financial sector - HDFC Bank - is well-positioned to deliver strong business momentum with advances growth of 20 percent, consistent margin of 4 percent and impeccable asset quality to aid return ratios.

""Unlocking of its subsidiaries listing will also add value, going forward. The stock trades at 2.4 times FY21E adjusted book value, recent correction in price is providing comfort as trades at 30 percent discount to its

10-year average,"" said the analyst.

HDFC | Buy | LTP: Rs 1,827.95 | Target price: 2,200 | Upside: 20%

The growth prospectus for HDFC remains strong on the back of strong parentage, large balance sheet to raise and deploy money regularly and increased housing demand.

""Increasing credit by the banks subsidiary provides an opportunity for further penetration of client base and stable margins to deliver consistent growth in earnings and valuations,"" said the analyst.

The stock has strong support near to 1,400 levels near to its 34-month averages.

Maruti Suzuki | Buy | LTP: Rs 5,055 | Target price: Rs 7,400 | Upside: 46%

Maruti is one of the best stocks in the domestic passenger vehicle segment.

Strong parentage and recent Toyota tie-up should help Maruti surpass near-term challenges and emerge stronger.

""Debt-free balance sheet with a shorter working capital cycle, higher ROE, and 50 percent market share for the last decade are the key positives to own the stock for long term after a 50 percent correction from its all-time high,"" said the analyst.

Tech Mahindra | Buy | LTP: Rs 531.50 | Target price: Rs 650 | Upside: 22%

The global impact of COVID-19 is likely to result in a material deterioration of the demand environment for IT companies but the analyst believes it is a good opportunity to add as once the pandemic fades a lot of new deals and orders may flow from across the world.

Operating margins are likely to benefit from rupee depreciation, lower fixed costs as IT companies are gearing to WFH over the next years which will improve margins.

The stock is one of the laggards in the current bounce but the analyst expects it to outperform from the current levels and said it remains one of the top picks in the IT sector.

Analyst: Jyoti Roy, DVP Equity Strategist, Angel Broking

Hindustan Unilever | Buy | LTP: Rs 2,234 | Target price: Rs 3,080 | Upside: 38%

The analyst expects Hindustan Unilever to report a healthy bottom-line CAGR of about 12 percent over FY2019-22E due to healthy volume growth on the back of a strong brand and wide distribution network.

Bata India | Buy | LTP: Rs 1,335 | Target price: Rs 1,561 | Upside: 17%

The analyst expects Bata India to report net revenue CAGR of about 11 percent to nearly Rs 3,974 crore over FY2019-22E mainly due to increasing brand consciousness among Indian consumers, new product launches, a higher number of store additions in tier II/ III cities and focus on high growth women's segment.

Further, on the bottom-line front, the analyst expects CAGR of nearly 20 percent to Rs 562 crore over the same period on the back of margin improvement due to increasing premium product sales.

Larsen & Toubro Infotech | Buy | LTP: Rs 1,460 | Target price: Rs 1,803 | Upside: 23%

The company has a very strong exposure to the BFSI and manufacturing verticals which accounts for nearly 45 percent and 17.5 percent of the company's revenues and are amongst the least impacted vertical due to

the shutdown on account of COVID-19.

The company doesn't have a very large exposure to service-oriented verticals like travel and tourism which are amongst the worst impacted due to the COVID–19 outbreak.

""We expect the company to outperformance the sector. Rupee depreciation to help the company's topline and bottom-line positively. After the recent correction the stock is available at reasonable valuations,"" said the analyst.

Alkem Laboratories | Buy | LTP: Rs 2,661.95 | Target price: Rs 3,300 | Upside: 24%

As much as 67 percent of revenue comes from domestic generic and API business.

""Anti-infectives and Cronic businesses continue to provide revenue growth for Alkem. It is expected to outperform the Indian pharmaceutical market (IPM) by 1.5 times growth rate for the next two years. We expect Alkem to grow its top line by 13-15 percent in the upcoming years,"" said the analyst.

Brokerage: Anand Rathi Shares & Stock Brokers

Divi's Laboratories | Buy | LTP: Rs 2,369.75 | Target price: Rs 2,510 | Upside: 6%

Divi's Laboratories has negligible borrowings and aims to maintain a similar level of debt in the next 3-5 years.

In terms of growth, the company has outpaced the industry growth over the years and has registered a CAGR of 14 percent over the past five years in a market scenario which is not very favourable for the sector. In addition to growth, the company has maintained healthy margins of nearly 40 percent.

""Considering the company's impressive performance over the years and the government's focus on Indian API manufacturers which are likely to be a big positive for the company in the near term, we believe that the company is well-positioned to take advantage of this opportunity,"" said the brokerage.

Dr. Reddy's Laboratories | Buy | LTP: Rs 3,882 | Target price: 4,382 | Upside: 13%

Apart from a strong product profile, the company benefits from a diverse geographic presence.

Further, in line with its strategy to boost India business, recently, the company inked deal with Wockhardt to acquire select divisions of its branded generics business in India and a few other international

territories of Nepal, Sri Lanka, Bhutan and Maldives for Rs 1,850 crore.

The deal comprises a business portfolio of 62 brands in multiple therapies and is expected to close by Q1FY21.

""The company should continue to witnesses strong growth in India, emerging markets, Europe and PSAI business driven by volume growth, new launches and improving realizations,"" said the brokerage.

ICICI Bank | Buy | LTP: Rs 367.65 | Target price: Rs 617 | Upside: 68%

With improving asset quality and better growth trends, the brokerage believes ICICI Bank is favourably positioned to deliver superior profitability and return ratios.

""We have factored in the latest information into our model and revised our estimates. We continue to remain positive on the company over medium to longer-term perspective,"" said the brokerage.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/brokerages-recommend-these-12-stocks-in-time-of-uncertainty-do-you-own-any-5203781.html
"April 30, 2020 10:34 AM IST",1,Sandip Das,Morepen Labs share price jumps 5% after UK standards body certifies company's Himachal unit,"Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating.
The share price of Morepen Laboratories jumped 5 percent in morning trade on April 30 after the company received certification from BSI (British Standards Institution, UK) for its medical devices manufacturing facility at Baddi (Himachal Pradesh).
Morepen Laboratories has received the prestigious ISO-13485 certification from BSI (British Standards Institution, UK) for its state-of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh).
Experts rigorously audited the manufacturing facility and management systems, and the company was awarded the certification based on the comprehensive audit procedures undertaken by the notified body, it added.
Download a copyEarlier this month, the company received the license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller, (HP) for its Baddi plant in Himachal Pradesh.","The stock surged over 100 percent in the last 1 month. There were pending buy orders of 299 shares, with no sellers available.","Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?

The share price of Morepen Laboratories jumped 5 percent in morning trade on April 30 after the company received certification from BSI (British Standards Institution, UK) for its medical devices manufacturing facility at Baddi (Himachal Pradesh).

The stock has almost doubled over the last month and was quoting at Rs 18.65, up Rs 0.88, or 4.95 percent at 09:45 hours. There were pending buy orders of 299 shares, with no sellers.

Morepen Laboratories has received the prestigious ISO-13485 certification from BSI (British Standards Institution, UK) for its state-of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh). The certification has been awarded for the manufacturing, distribution and aftersales service of all point-of-care diagnostic medical devices and their accessories manufactured at the company's facility in Baddi, the company said in a filing to the exchanges.

Experts rigorously audited the manufacturing facility and management systems, and the company was awarded the certification based on the comprehensive audit procedures undertaken by the notified body, it added.

""This ISO-13485 certification opens new vistas for Morepen to export its diagnostic devices to various countries across the globe and also to seek CE (Conformité Européene) Certification for the European Union. Having complied with all the important technical and regulatory guidelines for the Quality Management Systems as per ISO-13485, the company is confident of securing CE certification for its products as a next step,"" said Sushil Suri, Chairman and Managing Director, Morepen Laboratories.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Earlier this month, the company received the license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller, (HP) for its Baddi plant in Himachal Pradesh.",https://www.moneycontrol.com/news/business/stocks/morepen-labs-share-price-jumps-5-after-uk-standards-body-certifies-companys-himachal-unit-5206161.html
"April 30, 2020 02:37 PM IST",2,Sunil Matkar,"Brokerages initiate buy on 11 stocks after COVID-led fall, expect 10-49% upside","The majority of experts started advising clients to accumulate quality stocks in a gradual manner with a long term view, while as the valuations suppressed, brokerages also initiated coverage on some good stocks with potential double-digit returns.
Here are 11 stocks where brokerages initiated coverage with a buy call and see 10-49 percent upside:Sumitomo Chemical: Buy | Target: Rs 280 | Return: 19.5 percent""We expect the animal nutrition business along with CRAMS opportunity to change the business mix in the medium to long term.
Minda Industries: Buy | Target: Rs 300 | Return: 12.9 percent""MIL is uniquely positioned in the domestic auto ancillary space as a provider of a wide variety of product solutions straddling established and growing opportunities.
UPL: Buy | Target: Rs 500 | Return: 38.7 percentEmkay Global initiated coverage on UPL with a buy rating and a target price of Rs 500 with overweight stance in sector EAP.
Dr Lal PathLabs: Buy | Target: Rs 1,762 | Return: 10 percent""Dr Lal PathLabs' (DLPL) Revenue grew at a 16.2 percent CAGR (FY15-19), helped by strategic business model and wide network.",Majority of experts started advising clients to accumulate quality stocks in a gradual manner with a long term view,"The market, after seeing the March nightmare (down 23 percent) due to COVID-19 crisis, managed to recover a bit in April following up move in global peers, and stimulus measures taken by central banks to support economies.

In April so far, indices have gained 9 percent each, and if we include gains of last week of March, then the recovery is at 25 percent since the lockdown.

The rally is on the hopes of another round of stimulus package from the government, sharp fall in oil prices, and partial opening up of the economy in developed nations.

The upside is capped though as the number of cases of COVID-19 is still on the rise globally and domestically, experts feel.

""Given the sharp correction of over 30 percent in the last 2 months, markets have more than discounted the March quarter results. The focus on the market is now on recovery of the economy from a virtually zero base of April 2020 as lockdown opens in the next few weeks,"" Sailesh Raj Bhan, Deputy CIO – Equity Investments, Nippon India Mutual Fund told Moneycontrol.

""As normalcy returns close to festival season, the economic activity can see significant come back in H2 of FY21. With interest rates, oil prices, inflation remaining muted and likelihood of a good monsoon, FY22 can be a materially positive year, possibly matching or exceeding FY20 and well ahead of FY21,"" he said.

The majority of experts started advising clients to accumulate quality stocks in a gradual manner with a long term view, while as the valuations suppressed, brokerages also initiated coverage on some good stocks with potential double-digit returns.

Here are 11 stocks where brokerages initiated coverage with a buy call and see 10-49 percent upside:

Sumitomo Chemical: Buy | Target: Rs 280 | Return: 19.5 percent

""We expect the animal nutrition business along with CRAMS opportunity to change the business mix in the medium to long term. In turn, this could translate into an improvement in the operational performance. Further, ECC's expertise in active manufacturing should benefit SCI given the latter largely depends on imports of key molecules. Thus, a reduction in import and likely improvement in captive consumption should aid gross margins and thereby OPM. Given that no major capex is lined up in the coming future, the company should generate decent FCF in the years to come,"" said ICICI Direct which initiated coverage on the stock with a buy rating and arrived at a target price of Rs 280.

Berger Paints: Buy | Target: Rs 595 | Return: 12.3 percent

""Berger Paints is likely to report revenue, earnings CAGR of 11%, 32%, respectively, in FY19-22E supported by elevated margins (backed by benign raw material prices) and lower corporate tax. Further, with the dominance of limited players and intact long term growth drivers, the premium valuation of the company is justified due to its robust fundamentals (strong distribution, debt free status and consistent positive CFO),"" said ICICI Direct which initiated coverage on the stock with a buy rating and a target price of Rs 595.

Minda Industries: Buy | Target: Rs 300 | Return: 12.9 percent

""MIL is uniquely positioned in the domestic auto ancillary space as a provider of a wide variety of product solutions straddling established and growing opportunities. The company is also one of the few credible players in the high growth potential segments of airbags and alloy wheels. MIL possesses a steady state organic business riding on value migration i.e. higher kit value. We like MIL courtesy its progressive product profile, healthy capital efficiency and consistent positive CFO generation,"" said ICICI Direct which initiated coverage on MIL with a buy rating, valuing the stock at Rs 300.

Cera Sanitaryware: Buy | Target: Rs 3,073 | Return: 39.5 percent

""Cera Sanitaryware (CRS) is expected to increase its revenue/PAT at 7 percent CAGR, over FY18-22 amid series of challenges including GST, demonetisation, overall lull in the economy and the current COVID-19 crisis. In the same period, EBIT margin is likely to improve to around 15 percent from 13.9 percent and return on capital employed (ROCE) is expected at around 19 percent. Like combating the difficult phase of GST and demonetisation, we expect CRS to overcome even the current challenging situation post COVID-19. As the company continues to outsource manufacturing, its capex requirement remains limited,"" said Centrum Broking which initiated coverage on the stock with a buy rating and target price of Rs 3,073.

Kajaria Ceramics: Buy | Target: Rs 508 | Return: 49.3 percent

""Kajaria Ceramics' (KJC) prudent capital allocation, strong focus on balance sheet strengthening and sharp eye on EBITDA margins will assist in maintaining its leadership position and gear up for strong leaps as business cycle reverses. With healthy return ratios and margins, KJC will be the best bet in the industry. We value KJC at an average of 15-year long business cycle and past five years (to capture the recent earnings trend),"" said Centrum Broking which initiated coverage on the stock with a buy rating and arrived at target price of Rs 508.

Adani Ports: Buy | Target: Rs 390 | Return: 42.8 percent

""Adani Ports and Special Economic Zone (APSEZ) is rapidly consolidating its position with targeted investments and acquisitions aimed at expanding its hinterland coverage. APSEZ's front ended investments and strong partnerships have led to rapid cargo scale up with around 60 percent of the cargo being sticky,"" said Centrum Broking which initiated coverage on APSEZ with buy and a price target of Rs 390.

""While we expect 3.7 percent decline in cargo growth in FY21 for existing assets, we see APSEZ being well placed to capitalise on a likely growth recovery in FY22. Core EBITDA CAGR of 15.8 percent over FY20-22 and robust operating cash flows support capex and acquisition plans. While Net Debt/EBITDA should expand to 3.9x in FY21 due to KPCL acquisition, we expect it to revert to 3.1x by FY22,"" it added.

Gujarat Pipavav Port: Buy | Target: Rs 72 | Return: 31.4 percent

""Gujarat Pipavav Port's (GPPL) container cargo growth has trailed industry due to loss of services caused by consolidation in the shipping industry. Realisations and margins meanwhile have sustained outside of impact of an adverse cargo mix. While we expect 8 percent decline in container cargo volumes in FY21 (13 percent growth in FY22 on a low base), cash flows should remain strong led by absence of debt or significant capex commitments,"" said Centrum Broking which initiated coverage with buy rating and DCF based price target of Rs 72 per share.

""The stock factors a prolonged growth slump with reverse DCF implying 0 percent CAGR in container cargo till September 2028 (end of the concession period – assuming no extension). GPPL's strong credentials and historic dividend yield of 6.4 percent protects downside,"" it added.

UPL: Buy | Target: Rs 500 | Return: 38.7 percent

Emkay Global initiated coverage on UPL with a buy rating and a target price of Rs 500 with overweight stance in sector EAP. ""Market share gains, merger synergies and deleveraging should drive re-rating.""

""UPL has been gaining market share over the last five years despite flat industry growth, driven by new products and geographic launches. With the acquisition of Arysta, UPL has been able to fill portfolio gaps in major geographies and is poised to gain market share,"" the brokerage said.

""EBITDA margins started to improve from Q3FY20 (466bps YoY) as merger synergies kicked in. With better margins, reduction in working capital days, UPL's net debt/EBITDA should improve to 2.2x in FY22E from 3.5x in FY20,"" it added.

Dr Lal PathLabs: Buy | Target: Rs 1,762 | Return: 10 percent

""Dr Lal PathLabs' (DLPL) Revenue grew at a 16.2 percent CAGR (FY15-19), helped by strategic business model and wide network. Factoring in coronavirus impact for Q4FY20 and early FY21, we estimate revenue to grow at a 14.0 percent CAGR FY20-22E. EBITDA margin remained in the range of 24-26 percent over FY15-19. Given the fixed costs of 48-50 percent, we expect EBITDA margin to remain under pressure for FY21E (24.5 percent) and expand in FY22E (25.8 percent),"" said Geojit Securities which initiated the coverage with a buy rating on the stock and a target price of Rs 1,762.

Company has solid balance sheet, with no debt and cash & cash equivalent of Rs 775 crore as on December 2019, it added.

Cochin Shipyard: Buy | Target: Rs 356 | Return: 45.3 percent

""Due to its expertise in shipbuilding & ship repairing and strong, long lasting relations with its key clients, Cochin Shipyard (CSL) is benefitted to provide important warship products in the coming years. The order book size of these projects is at a healthy Rs 15,300 crore to be delivered over the next 2-3 years. This visibility is enough long term and will lead to a good growth in revenues and profitability. Considering its strong order book with IAC and ASWC projects at the helm in the shipbuilding business, expectations of more order wins through RFP bidding, we expect a significant escalation of topline, margins and bottomline from FY21 over an elongated period of 2-3 years,"" said LKP Securities which initiated the coverage with a buy rating and a target of Rs 356.

On profitability front too, the brokerage expects solid movement driven by higher contribution from competitively bid projects, positive operating leverage, zero LD provisions, higher contribution from the ship repairing projects & capacity expansion, superior efficiency ratios and balance sheet strength.

It anticipates stable return ratios with maintenance of healthy dividend payouts and yield.

L&T Technology Services: Buy | Target: Rs 1,432 | Return: 24.1 percent

""L&T Technology Services (LTTS) is supported by a proficient management team and promoters, wherein LTTS enjoys a strong execution track record and its positioning in key markets which are poised to grow fast which will significantly ramp up the company's operating profitability and hence we believe that LTTS is well positioned for long term sustainable growth. Furthermore, Company will invest in competency building and broadening LTTS presence within each of segments which will make the LTTS more attractive,"" said Arihant Capital Markets which initiated coverage on LTTS with a buy rating and arrived at a target price of Rs 1,432.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",https://www.moneycontrol.com/news/business/markets/brokerages-initiate-buy-on-11-stocks-after-covid-led-fall-expect-10-49-upside-5199921.html
"April 30, 2020 01:44 PM IST",1,Sandip Das,Just Dial share price jumps 7% after Board approves share buyback,"Just Dial share price jumped over 7 percent intraday on April 30 after the board approved a proposal for buyback of up to 31,42,857 equity shares.
The Board of Directors, at a meeting on April 30, approved buyback of up to 31,42,857 equity shares (representing 4.84 percent of the total paid-up equity share capital) at a maximum price of Rs 700 per equity share payable in cash, for an aggregate maximum amount of up to Rs 220,00,00,000 excluding transaction costs, the company told the exchanges.
The stock, which has jumped over 48 percent in the last one month, was quoting at Rs 417, up Rs 27.20, or 6.98 percent at 1328 hours.
Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.
Download a copyJust Dial provides local search-related services to users in India through multiple platforms.","The Board of Directors of the company approved the proposal for buyback of up to 31,42,857 equity shares.","Just Dial share price jumped over 7 percent intraday on April 30 after the board approved a proposal for buyback of up to 31,42,857 equity shares.

The Board of Directors, at a meeting on April 30, approved buyback of up to 31,42,857 equity shares (representing 4.84 percent of the total paid-up equity share capital) at a maximum price of Rs 700 per equity share payable in cash, for an aggregate maximum amount of up to Rs 220,00,00,000 excluding transaction costs, the company told the exchanges.

The stock, which has jumped over 48 percent in the last one month, was quoting at Rs 417, up Rs 27.20, or 6.98 percent at 1328 hours.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

Just Dial provides local search-related services to users in India through multiple platforms.",https://www.moneycontrol.com/news/business/stocks/just-dial-share-price-jumps-7-after-board-approves-share-buyback-5207151.html
"April 30, 2020 07:25 PM IST",2,,Investor wealth jumps Rs 7.68 lakh crore in four days of market rally,"Investors' wealth jumped Rs 7.68 lakh crore in four days of market rally, with the Sensex ralling 997 points on Thursday.
Rising for the fourth straight session, the 30-share BSE Sensex settled 997.46 points, or 3.05 percent, higher at 33,717.62.
During the holiday-shortened week, the Sensex rallied 2,390.40 points or 7.63 percent.
Led by the improved sentiment, the market capitalisation of the BSE-listed companies gained Rs 7,68,168.35 crore to Rs 1,29,41,620.82 crore in four trading days.
In the broader market, the BSE Midcap and Smallcap indices rose up to 1.46 percent.","During the holiday-shortened week, the Sensex rallied 2,390.40 points or 7.63 percent.","Investors' wealth jumped Rs 7.68 lakh crore in four days of market rally, with the Sensex ralling 997 points on Thursday. Rising for the fourth straight session, the 30-share BSE Sensex settled 997.46 points, or 3.05 percent, higher at 33,717.62.

During the holiday-shortened week, the Sensex rallied 2,390.40 points or 7.63 percent.

Led by the improved sentiment, the market capitalisation of the BSE-listed companies gained Rs 7,68,168.35 crore to Rs 1,29,41,620.82 crore in four trading days.

""Markets this week rallied from the lows seen in March 2020. After almost a month of lockdown the world over, early signs of easing of the same along with some signs of the flattening of the COVID-19 curve spurred hope of economic activity resuming albeit at a slow pace. Some promise of a possible cure with positive preliminary results of a few drugs also added to hope and optimism,"" Shibani Sircar Kurian, executive vice-president, fund manager and head (equity research) of Kotak Mahindra Asset Management Company, said.

ONGC was the top gainer in the Sensex pack, rallying 13.40 percent, followed by HCL Tech, Hero MotoCorp, TCS, Maruti and Infosys.

In the broader market, the BSE Midcap and Smallcap indices rose up to 1.46 percent.

BSE metal index zoomed 8.27 percent, followed by auto, IT, teck and oil and gas.

""The Indian markets had a strong run on the last trading day of the week, buoyed by encouraging drug trials result in the US to treat COVID-19,"" Religare Broking Ltd Vice-President (Research) Ajit Mishra said.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

On the BSE, 1,342 companies advanced and 1,093 declined, while 171 remained unchanged.",https://www.moneycontrol.com/news/india/investor-wealth-jumps-rs-7-68-lakh-crore-in-four-days-of-market-rally-5209111.html
"April 30, 2020 10:34 AM IST",2,Kshitij Anand,Sensex reclaims Mount 33K: 4 factors that fuelled the rally,"Sectorally, the action was seen in metals, IT, auto, banks, capital goods, and consumer durable stocks.
Nifty Bank rose more than 2 percent supported by gains in Bandhan Bank, Federal Bank, RBL Bank, ICICI Bank, and Axis Bank, etc.
We have collated a list of four factors which could be fuelling rally on D-Street:Strong Global Cues:Yes, Indian markets woke up to some strong gains seen on Wall Street, and a steady trend was seen in other Asian markets which could certainly have a rub-off effect on Indian markets as well.
Japan's Nikkei, returning from a holiday on Wednesday, jumped 2 percent to a seven-week high as well.
The U.S. economy suffered its sharpest decline in 11 years, with the first-quarter GDP contracting at a 4.8 percent quarterly annualized rate.","Sectorally, the action was seen in metals, IT, auto, banks, capital goods, and consumer durable stocks.","Indian market rallied for the fourth consecutive day in a row on April 30 as bulls pushed the S&P BSE Sensex above 33k, while Nifty50 also reclaimed 9,800 levels tracking positive global cues as well as stimulus hopes back home.

Sectorally, the action was seen in metals, IT, auto, banks, capital goods, and consumer durable stocks.

Nifty Bank rose more than 2 percent supported by gains in Bandhan Bank, Federal Bank, RBL Bank, ICICI Bank, and Axis Bank, etc. among others.

We have collated a list of four factors which could be fuelling rally on D-Street:

Strong Global Cues:

Yes, Indian markets woke up to some strong gains seen on Wall Street, and a steady trend was seen in other Asian markets which could certainly have a rub-off effect on Indian markets as well.

Asian stocks rose to a fresh seven-week high. Japan's Nikkei, returning from a holiday on Wednesday, jumped 2 percent to a seven-week high as well.

Australia's ASX 200 rose 2.3 percent. The Shanghai Composite rose 1 percent. Markets in Hong Kong and South Korea were closed for public holidays, said a Reuters report.

Gilead's Remdesivir trial data lift sentiment:

US drug major Gilead Sciences on April 29 announced encouraging preliminary clinical trial data of its experimental antiviral drug Remdesivir that's been considered as a potential medication against novel coronavirus, or COVID-19, pandemic.

The study showed that 64.5 percent of the patients who received the shorter five days of treatment have recovered, compared with 53.8 percent of the group who were treated for 10 days.

The Remdesivir study is closely watched by medical experts and governments across the world as the pandemic had claimed the lives of around 2.2 lakh people. As of now, there are no approved medicines for COVID-19.

Also read - Coronavirus | Why Gilead's Remdesivir trial data is significant in fight against COVID-19

US Fed leaves rates near zero:

The U.S. Federal Reserve left interest rates near zero and gave no indication of lifting them any time soon. The US Fed chair Powell warns worst is ahead, vows continued support.

The U.S. economy suffered its sharpest decline in 11 years, with the first-quarter GDP contracting at a 4.8 percent quarterly annualized rate.

The U.S. Treasury Secretary Steven Mnuchin said on Wednesday he is ready to invest more capital in new or expanded Federal Reserve coronavirus rescue lending programs but is not considering more aid to struggling airlines at the moment, said a Reuters report.

Mnuchin told reporters during a video news briefing that he was deliberately holding in reserve some $259 billion from the $2.2 trillion coronavirus rescue legislation passed in late March, it said.

Continuity of business activity:

The Ministry of Home Affairs (MHA) said the government will be issuing new guidelines to fight the novel coronavirus pandemic and that the same will come into effect from May 4, a day after the second phase of national lockdown ends.

""Details regarding this shall be communicated in the days to come,"" MHA said. This could possibly mean that the government is looking at easing some of the restrictions.

Moneycontrol Ready Reckoner Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others. Download a copy

(With inputs from Reuters)",https://www.moneycontrol.com/news/business/markets/sensex-reclaims-mount-33k-4-factors-which-could-be-fuelling-the-rally-5206241.html